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Abstract 
 
The research presented herein describes synthetic applications of an allylic 
azide rearrangement, mainly focusing on its combination with the intramolecular 
Schmidt reaction to afford vinyl-substituted bicyclic lactams.  
Undesired stereochemistry was obtained in the initial synthetic route to an 
advanced intermediate of natural product pinnaic acid, in which a home-made 
electrochemistry apparatus was involved in the key step to modify the tricyclic lactam. 
The combination of allylic azide rearrangement and intramolecular Schmidt reaction 
afforded the target with desired stereochemistry, and the synthesis of the 
cyclobutanone was achieved by an asymmetric [2+2] cycloaddition.  
Prior to its combination with the intramolecular Schmidt reaction, the 
rearrangement of allylic azides was studied from different perspectives such as 
substrate, time, temperature, and Lewis acid. Next, the combined reaction was studied 
with the cyclohexanone-based allylic azide, whose stereochemical outcomes were 
rationalized by the conformational analysis and computational calculations. Different 
substituents on the cyclic ketone ring system were found to have different impacts on 
the diastereoselectivity. During this process, a chloro-Prins reaction was found as the 
major side-reaction, and carbocation-mediated allylic azide rearrangement was 
confirmed. Dihedral angle was utilized to explain why and in which cases the six-
membered intermediate proceeds through chair or boat conformation for fused 
bicyclic system. This reaction was also utilized to produce twisted amides via cation-
π interaction, along with the use of other by-products from different Lewis acids. The 
 iv 
utilization of this methodology to finish the total synthesis of alkaloid 205B is 
underway.  
Initial studies of the combination of allylic azide rearrangement and alkyne-
azide cycloaddition were conducted. Also the reorganization of allylic azides was 
utilized to generate 2-azadiene species, which may undergo Diels-Alder reactions or 
electrocyclizations.  
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CHAPTER 1 
 
STUDIES TOWARDS THE SYNTHESIS OF PINNAIC ACID 
 
1.1 Introduction 
1.1.1 Pinnaic acid and related natural products 
Pinnaic acid,1 which represents a novel class of marine alkaloids characterized by a 
highly functionalized azaspiro[4,5]decane ring system, was isolated from the Okinawan 
bivalve Pinna muricata in 1996 by Uemura and co-workers. Its C17 stereochemistry was 
later determined through Danishefsky’s total synthesis.2,3 However, its absolute configuration 
has not yet been confirmed due to the limited amount of naturally occurring sample. There 
are several related natural products with the same 6-aza-spiro[4,5]decane skeleton, such as 
tauropinnaic acid,1 halichlorine,4 and pinnarine5 (Figure 1), which were isolated by the same 
group. Tauropinnaic acid was obtained together with pinnaic acid from the same plant.  
Halichlorine and pinnarine were isolated from the black marine sponge Halichondria okadai 
Kadota, in 1996 and 2011, respectively. The structure of pinnarine was further confirmed by 
its synthesis from pinnaic acid (Scheme 1).5 Thus, pinnarine and pinnaic acid have the same 
absolute configuration by the comparison of CD spectra of synthetic and natural products.  
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Figure 1. Pinnaic acid and related natural products.  
 
Scheme 1. Conversion of (-)-pinnaic acid to pinnarine. 
 
1.1.2 Biological activities 
Pinnaic acid and tauropinnaic acid are specific inhibitors of a cytosolic 85 KDa 
phospholipase (cPLA2) with an in vitro IC50 of 0.2 mM and 0.09 mM, respectively.
1 The 
cPLA2 enzyme specifically recognizes the sn-2 acyl bond of phospholipids and hydrolyzes it 
releasing arachidonic acid, which can be further modified by cyclooxygenases into 
inflammatory mediators such as prostaglandins and leukotrienes.  
 3 
Initially, halichlorine was reported to inhibit the induction of vascular cell-adhesive 
molecule-1 (VCAM-1) with an IC50 7 ug/mL.
4 More recently, halichlorine was found to 
inhibit lipopolysaccharide (LPS)-induced transcription factor nuclear factor-kB (NF-kB) and 
thus reduce the expression of VCAM-1 and monocyte adhesion to endothelial cells.6 It also 
inhibits L-type Ca2+ channels in vascular smooth muscle cells to reduce vascular 
contractions.7 Based on those discoveries, halichlorine could be applied to treat 
atherosclerosis and hypertension. No biological activity has been reported for pinnarine. 
 
1.1.3 Total syntheses 
Apart from these interesting biological activities, pinnaic acid’s total synthesis is 
even more impressive for the synthetic chemistry community. To date there have been five 
reported total syntheses of pinnaic acid. They were reported by Danishefsky in 2001,2,3 
Arimoto in 2003 and 2007,8,9 Heathcock in 2004,10 and Zhao in 2007.11,12 A review of this 
field appeared in 2005.13  
Danishefsky and co-workers started from (R)-(-)-phenylglycinol and methyl 2-(2-
oxocyclopentyl)acetate (1-1) to construct tricyclic ring (1-2) with high diastereoselectivity, 
followed by methylation and allylation to afford aza-tertiary compound 1-4 (Scheme 2). After 
the aza-1,6 addition precursor 1-5 was obtained by the hydroboration and cross-coupling, 
aldehyde 1-6 afforded enone 1-7 via a Horner-Wadsworth-Emmons reaction (HWE reaction). 
The selective reduction of ketone 1-7 gave (14S,17R) and (14S,17S) diastereomers of pinnaic 
acid. The (14R,17R) and (14R,17S) diastereomers were obtained through the same strategy, 
starting from compound 1-9. By a combination of total synthesis and chemical degradation of 
synthetic samples, pinnaic acid was assigned as the (14S,17R) diastereomer. The total 
synthesis of pinnaic acid was achieved in 19 linear steps from ketone 1-1. 
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Scheme 2. Danishefsky and coworkers’ synthetic route to pinnaic acid diastereomers.  
In 2003, Arimato and co-workers used a Curtius rearrangement to set the aza-tertiary 
center in cyclopentane 1-14 (Scheme 3). The following ozonolysis and Horner-Wadsworth-
Emmons reaction (HWE) gave the enone 1-15, which was followed by the hydrogenation-
cyclization to give spiro compound 1-16. The second HWE reaction helped set up the 
 5 
unsaturated ester sidechain of 1-17. The total synthesis of pinnaic acid was accomplished 
following Danishefsky’s strategy, in 19 linear steps from 1-12.  
 
Scheme 3. Arimoto and coworkers’ synthetic route to pinnaic acid.  
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Scheme 4. Heathcock and coworkers’ synthetic route to pinnaic acid.  
After Danishefsky and Arimoto’s total syntheses, Heathcock used a different strategy 
to accomplish the total synthesis of pinnaic acid, tauropinnaic acid, and halichlorine, from the 
common late-stage intermediate 1-27 (Scheme 4). Aza-tertiary compound 1-23 was obtained 
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from 1-pyrrolidinyl-cyclopentene (1-19) using similar methodology as Danishefsky reported. 
The subsequent cross-metathesis and reductive amination then provided azaspiro[4,5]decane 
1-24, and β-lactam 1-25 was obtained by subsequent hydrolysis. The next HWE and 
asymmetric reduction afforded the bottom diol sidechain of 1-26. The newly formed aldehyde 
1-27 served as the key intermediate to all three natural products. The HWE reaction of 1-27 
finished the end-game of pinnaic acid in 17 linear steps. Three forms of pinnaic acid, 
zwitterion 1-28, conjugate base 1-29, and its conjugate acid (not shown) were also studied. 
By comparing their spectral data, the originally isolated pinnaic acid was then most likely 
considered as the zwitterion, carboxylate, or a mixture of these two forms.  
 
Scheme 5. Arimoto and coworkers’ 2nd synthetic route to pinnaic acid.  
In 2007, Arimoto reported their 2nd-generation total synthesis of pinnaic acid 
(Scheme 5). This time, they used a Beckmann rearrangement to set the aza-substituted 
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tertiary center of bicyclic lactam 1-32. Bicyclic compound 1-35 was obtained, following their 
1st generation strategy. Two consecutive cross-metathesis reactions finished installing the top 
ester and bottom diol sidechains, respectively. In this way, the total synthesis of pinnaic acid 
was finished in 25 linear steps from (R)-(+)-pulegone.  
 
Scheme 6. Zhao and coworkers’ synthetic route to pinnaic acid.  
In the same year, Zhao used a retro-Nef reaction to convert ketone 1-41 to nitro 
group 1-42, and the following alkylation finished the setup of the aza-substituted tertiary 
carbon (Scheme 6). Azaspiro[4,5]decane 1-45 was obtained from the reductive amination of 
1-44. Two separate HWE reactions then gave pinnaic acid in a total of 26 linear steps.  
 
1.1.4 Synthetic routes towards azaspiro[4,5]decane core structure 
Besides its total synthesis, pinnaic acid’s architectural core structure, 6-
azaspiro[4,5]decane, has attracted additional attention from organic chemists. This probably 
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resulted from the existence of three common ways to end the total synthesis of pinnaic acid, 
either through HWE reaction, cross-metathesis, or a mixture of both. There are two important 
considerations for the synthesis of this core structure: (1) the introduction of the aza-tertiary 
center and (2) spiro[4,5] ring closure. In the reported total syntheses, the ring-closure is either 
through reductive amination or aza-michael addition. However, methods for the introduction 
of the aza-tertiary carbon center varied considerably, such as allylation of an in-situ generated 
acyliminium ion, Curtius rearrangement, Beckmann rearrangement, or α-alkylation of nitro 
group. Obviously, there are many other methods to construct the azaspiro[4,5]decane system, 
some of which are discussed below.  
In 2003, Takasu and co-workers reported a cascade radical reaction involving radical 
translocation and cyclization reaction to achieve the construction of the azaspirobicyclic 
framework (Scheme 7).14 An aryl radical, generated from bromide 1-48, cleaves an inactive 
C-H bond by [1,5] radical translocation to form α-aminyl radical, which is able to react 
successively with an intramolecular double bond to form the decane system 1-49. 
Eschenmoser coupling reaction was utilized to afford the vinylogous amide 1-50. 
Hydrogenation and lactamization afforded tricyclic lactam 1-52.   
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Scheme 7. Takasu and coworkers’ synthetic route of core structure.  
 
Scheme 8. Kibayashi and coworkers’ synthetic route to the core structure.  
The acylnitroso compound was generated from the oxidation of hydroxamic acid 1-
55, and the following intramolecular ene reaction proceeded to yield the spirolactam 1-56 
(Scheme 8).15,16 Subsequent manipulations gave tricyclic lactam 1-58.   
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Scheme 9. Feldman and coworkers’ synthetic route to the core structure.  
Alkynyliodonium salt chemistry was exploited to construct tricyclic lactam 1-66 by 
Feldman and co-workers in 2004 (Scheme 9).17 Prepared from stannane 1-61 using Stang’s 
reagent, alkynyliodionium salt 1-62 formed alkylidene-carbene intermediate 1-63, which can 
insert to the neighboring C-H bond with strict retention of configuration to form bicyclic 
lactam 1-64. Two chemically identical C-Sn bonds were distinguished by magnesium 
bromide, due to the proximity of the enone portion to the quaternary propyl stannane 
appendage, to form tricyclic lactam 1-65. The following transformations afforded key core 
structure 1-66.  
The same core structure was prepared later by Padwa and co-workers in 2010, using 
a well-established tandem conjugate addition/dipolar cycloaddition protocol developed in his 
group (Scheme 10).18 The conjugate addition of oxime 1-68 to 2,3-bisphenylsulfonyl-1,3-
butadiene 1-67 formed a transient nitrone intermediate, which underwent a dipolar 
cycloaddition to form bicyclic isoxazolidines 1-69 and 1-70. Raney Ni reduction of the N-O 
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bond, subsequent desulfonylation, and cyclization furnished tricyclic lactam 1-71. Lactam 1-
66 was obtained by further transformations. 
 
Scheme 10. Padwa and coworkers’ synthetic route to the core structure.  
 
Scheme 11. Clive and coworkers’ synthetic route to the core structure.  
Clive and co-workers used chiral base auxiliary assisted desymmetrization, which 
proved problematic upon scaling up, to give piperidine 1-74 (Scheme 11).19,20 The next 
transformations gave lactam 1-79, which was cyclized to afford lactam 1-80. Aldehyde 1-81 
was obtained after several steps. 
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The same core structure was obtained recently by Stockman and co-workers (Scheme 
12).21 The key step was an intramolecular ene/1,3 dipolar cycloaddition protocol to give the 
tricyclic ring of 1-84. The subsequent reduction, oxidation, HWE reaction, and cyclization 
provided tricyclic lactam 1-81.  
 
Scheme 12. Stockman and coworkers’ synthetic route to the core structure.  
 
1.2 Evolution of our designs 
Research in the Aubé laboratories has long focused on the synthesis of nitrogen-
containing natural products using the intramolecular Schmidt reaction. The intramolecular 
Schmidt reaction has demonstrated its particular utility in the total synthesis of complex 
natural products, such as stenine,22 lepadiformines,23 and alkaloid 223A.24 As an alkaloid with 
a unique skeleton, pinnaic acid attracted our attention and we envisioned an efficient way to 
construct this core structure using an intramolecular Schmidt reaction. As described in the 
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introduction, the endgame strategies used by previous workers toward pinnaic acid are similar. 
Thus, we only focused on the synthesis of its core structure.  
All the known tricyclic lactams used to synthesize pinnaic acid are listed in Figure 2. 
Most of them were prepared through multiple steps and only rarely in an enantiopure form. 
They can be classified in two categories: [5,6,6] and [5,5,6] tricyclic lactams, each having 
different side-chain appendages. For [5,5,6] tricyclic lactams, the methylated lactam could be 
easily obtained by LDA-mediated methylation with high diastereoselectivity as reported.16 
Our goal was to develop an enantioselective synthetic route to one of the core structures listed 
in Figure 2.  
 
Figure 2. Known tricyclic lactam towards pinnaic acid.  
Initially, we focused on the synthesis of [5,6,6] tricyclic lactam 1-93, the precursor of 
known lactam 1-81 (Scheme 13). Koga’s elegant method would be used in the most 
important and challenging step, a conjugate addition of vinyl Grignard to the chiral imine 
derived from aldehyde 1-87.25 Trapping the enolate with alkyl halide could afford tertiary 
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aldehyde 1-88. Unsaturated ketone 1-91 should be obtained by vinylation and subsequent 
ring-closing cross-metathesis. Conjugate addition by methyl cuprate could help set up exo-
methyl group and the next intramolecular Schmidt should give the key lactam 1-93.  
 
Scheme 13. Initial design.  
When we tried to prepare aldehyde 1-87 from compound 1-94 in the above design, 
we envisioned that an asymmetric Nazarov reaction followed by reductive alkylation could 
be used to get Schmidt precursor 1-92 (Scheme 14). When attempting to realize this strategy, 
there were some issues of this synthetic route: (1) compound 1-95 is volatile and formed in 
low yield and (2) Nazarov cyclization had the same problems. At the same time, we realized 
that we could utilize a [2+2] cycloaddition/Schmidt strategy, and thus we stopped our 
pursuits of this route in Scheme 14.  
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Scheme 14. Initial synthetic route.  
The [2+2] cycloaddition/Schmidt strategy was based on [5,5,6] tricyclic lactam 1-66 
(Figure 3). Fortunately, a wonderful electrochemistry apparatus was developed by Dr. Kevin 
Frankowski around that time after his study with Prof. Kevin Moeller’s group at Washington 
University in Saint Louis. This method could functionalize the potential Schmidt product 1-
99 to form an iminium ion 1-98, followed by the allylation and methylation to afford known 
core structure 1-66 (Figure 3). The Schmidt precursor 1-100 is easily prepared from known 
cyclobutanone 1-101, which can be prepared through two methods: ketene and 
keteneiminium-mediated [2+2] cycloadditions. Ghosez and co-workers previously developed 
chiral amide-assisted [2+2] cycloaddition to afford enantiopure cyclobutanones.26 We 
envisioned that the enantiopure form of 1-101 could be prepared through this methodology.  
 
Figure 3. Electrochemistry-mediated retrosynthetic analysis. 
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In the above design, the allyl group and methyl group would be introduced at a late 
stage. In our ideal design, the side chain could be introduced in the early stage via an allylic 
azide rearrangement/Schmidt cascade reaction. We also considered the possibility of the 
introduction of the methyl group in the early stage.  
Alternatively, known tricyclic lactam 1-103 could be synthesized from 1-104 by 
hydroboration/oxidation (Figure 4). In this approach, one of four interconverting allylic azide 
isomers could proceed to the intramolecular Schmidt reaction to generate lactam 1-104. The 
allylic azide rearrangement is facile at room temperature and its major isomer is azide 1-106, 
which can be prepared by the azide displacement of bromide 1-107.  
 
Figure 4. Allylic azide rearrangement/Schmidt mediated retrosynthetic analysis. 
The next problem was to find an efficient way to prepare this bromide. The ideal 
would be to prepare methylated cyclobutanone derivative 1-107 (R=Me) (Figure 5). A 
common method to prepare such allylic bromides is through radical-mediated allylic 
bromination using NBS. There are two types of substrates suitable for this radical reaction. 
One is the internal olefin 1-108 (or 1-109), and the other terminal olefin 1-111. 
Cyclobutanone 1-108 might be prepared from C2-symmetric amide 1-113 by chiral amide-
assisted asymmetric [2+2] cycloaddition via a keteniminium ion intermediate although no 
related compounds were reported. Even though the methyl group on the olefin affects this 
cycloaddition, methylated and non-methylated olefins can be present in one molecule (such 
as 1-114) and compete to produce either cyclobutanone 1-109 or 1-110. This also helps us to 
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more fully understand the [2+2] cycloaddition. The known compound 1-111 is prepared by a 
competitive [2+2] cycloaddition via a ketene intermediate preferentially reacting with the 
closer olefin.27 We also tried to get its enantiopure form through the chiral amide-assisted 
asymmetric [2+2] cycloaddition from 1-115.  
Another method to prepare allylic bromide 1-107 (R=H) is cross metathesis of 1-112 
with allylbromide. Cyclobutanone 1-112 is also known, but its asymmetric synthesis had not 
been reported. We also envisioned preparing its enantiopure form from C2-symmetric amide 
1-116. 
 
Figure 5. Possible methods for the preparation of allylic azide.  
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1.3 [2+2] cycloaddition 
1.3.1 Mechanistic discussions 
The [2+2] cycloaddition, which involves two olefins to form cyclobutane derivatives, 
is one of the most powerful pericyclic reactions. Based on the frontier molecule orbital (FMO) 
theory, the HOMO of one ethylene and the LUMO of another cannot approach each other in 
the same face (suprafacial-suprafacial interaction) due to the unmatched phasing, and thus no 
constructive interaction can occur (Figure 6a). But, if the interaction mode of one ethylene is 
changed from suprafacial to antarafacial, this cycloaddition is thermally allowed, and 
designated as [π2s + π2a] (Figure 6b). However, this construction is difficult to achieve in 
practice due to the existing steric interaction between the substituents of one alkene and the 
molecular plane of another.  
 
Figure 6. [2+2] cycloaddition. (a) Face-to-face interaction. (b) Crossed approach.  
Although this kind of hindrance is much less for cumulene systems in comparison to 
those of normal alkenes, not all of them can easily undergo [2+2] cycloaddition at or below 
room temperature. There are three well-known types of cumulene systems: allenes, ketenes, 
and keteniminium ions. Although there are many reported [2+2] cycloaddition reactions of 
allenes to afford cyclobutane and cyclobutene derivatives under thermal conditions (over 
200 °C), most are considered to involve diradical intermediates in a stepwise mechanism 
instead of a concerted process, as have been thoroughly reviewed.28  
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In contrast, ketenes and their nitrogen analogs, keteniminium ions, have been much 
more common substrates for [2+2] cycloadditions since the beginning of the last century. 
There are some controversies over the detailed mechanism of the [2+2] cycloaddition 
between ketenes and alkenes although it is generally considered a concerted process.29 
Initially, this reaction was described as a [π2s + π2a] cycloaddition by Woodward and 
Hoffmann, suprafacial on the alkene and antarafacial on the ketene because of steric 
hindrance (Figure 8A). However, it is insufficient to consider the molecular orbitals of ketene 
as merely two orthogonal π systems.30 Bottoni and co-workers used MCSCF studies to 
calculate the π orbitals of ketene and its relevance to alkenes, and found that there is some 
mixing of orbitals with C-H bonds and the lone pairs of oxygen (Figure 7).31 They also 
compared three different interactions between ketenes and alkenes: supra-antara, parallel, and 
perpendicular approaches. Their results supported this idea that the ethylene attacks the 
middle carbon of ketene from a plane parallel to the ketene plane. A similar result was found 
by Houk and Wang in the same year through ab initio molecular orbital calculations. They 
indicated electrophilic interaction of the central carbon of ketene using in-plane πC=O* orbital 
with πC=C orbital of the olefin in an asynchronous process, and the next cycloaddition 
resulting from the perpendicular addition of C-C HOMO orbital of ketene to alkenes (Figure 
8B).32 This process is designated as [π2s + (π2s + π2s)] cycloaddition.
33  
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Figure 7. π orbitals of ketene and ethylene.  
 
Figure 8. [2+2] cycloaddition between ketene and alkene. (a) Woodward and Hoffmann’s 
approach. (b) Houk and Wang’s approach. 
In contrast to many computational studies of [2+2] cycloaddition between ketene and 
alkene, only two articles reported on [2+2] cycloadditions between keteniminium ions and 
alkene until now. Importantly, their results are similar to those reported for ketenes. In 1999, 
Ghosez, Houk and coworkers used a silyl group as the stereodirecting group to achieve high 
diastereoselectivity in the [2+2] cycloaddition (Scheme 15).34 Through ab initio and density 
functional theory methods, they found the electrophilic in-plane attack of the middle carbon 
of keteniminium ion to the alkene to form two possible bridged enamine cations, one of 
which is stabilized by silicon, whereas the other is not. Steric hindrance could also be another 
reason for high diastereoselectivity, with the big silyl group capable of blocking the 
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electrophilic attack of the keteniminium ion to form the minor isomer. Similar results were 
obtained by Fang and coworkers.35  
 
Scheme 15. Silicon-involved intramolecular [2+2] cycloaddition of keteniminium ion. 
 
1.3.2 [2+2] cycloaddition reaction 
In this section, only intramolecular [2+2] cycloadditions related to this project are 
discussed.  
Intramolecular [2+2] cycloaddition reactions of ketene with alkene are similar to 
intermolecular [2+2] cycloaddition, in which the addition of alkene to ketene has two 
pathways: fused and crossed pathways to form compounds 1-127 and 1-128, respectively 
(Figure 9). This regioselectivity is determined by the electronic pattern of alkenes. If the 
internal carbon of the alkene is more substituted, i.e. making the terminal carbon of alkene 
more nucleophilic, the [n,2,0] bicyclic cyclobutanones 1-127 are produced via the fused 
pathway. Otherwise, when the terminal carbon of alkene is more substituted, i.e., making the 
internal carbon of alkene more nucleophilic, the [n,1,1] bicyclic cyclobutanones 1-128 are 
obtained via a crossed pathway.  
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Figure 9. Different pathways for intramolecular [2+2] cycloadditions.  
Keteniminium ions are isoelectronic to ketenes, but they lack one free electron pair as 
on the oxygen, which makes ketenes have the 1,2-dipolar character, although both have the 
vinyl cation character (Figure 10). Thus, this kind of difference imparts many advantages to 
keteniminium ions over ketenes in the [2+2] cycloaddition, such as a lesser tendency to 
undergo dimerization or polymerization reactions, ready availability, and being easy to 
handle. The conditions associated with this cycloaddition reactions are mild and reactions 
often occur in the excellent yields. The chemistry of keteniminium ions was reviewed in late 
1980s36 and last year.37  
 
Figure 10. Electronic comparison of ketenes and keteniminium ions.  
In 1995, Dowd and coworkers reported the synthesis of compound 1-101 and its free 
radical ring expansion (Scheme 16).38 First, chloride 1-129 was prepared using a one-pot 
dialkylation of the dianion of acetic acid. Following that, [2+2] cycloadditions were carried 
out via both ketene and keteniminiun ion intermediates. The better yield was obtained from 
the keteniminium salt. 
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Scheme 16. Synthetic routes of compound 1-101.  
The preparation of compound 1-112 was reported by Snider and coworkers (Scheme 
17).39 Importantly, only fused product 1-112 was obtained without any observation of crossed 
product 1-133. Furthermore, the substrate 1-132 possessed σ-symmetry, simplifying this [2+2] 
cycloaddition.  
 
Scheme 17. Preparation of compound 1-118. 
In 2005, Belanger and coworkers reported a competitive [2+2] cycloaddition 
(Scheme 18).27 They first investigated the competition between different tethered lengths. 
The formation of five-membered ring product 1-111 was much faster than the formation of 
six-membered ring product 1-134, which was not observed in the reaction. In order to further 
understand the electronic impact of alkene on the [2+2] cycloaddition without the 
interference from steric hindrance, ketene was generated in situ from acid 1-135 and then 
reacted with two competitive styrenes with different substituents on the para position. The 
observed ratio of 1-136 and 1-137 indicated that the electron-rich alkene was favorable for 
the [2+2] cycloaddition. Its Hammett constant ρ was calculated to -1.39, which indicates a 
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modest charge development at the transition state. More important is that only crossed cyclo-
adduct is obtained without any fused adduct.  
 
Scheme 18. Competitive [2+2] cycloadditions. 
The thermal retro-ene/[2+2] cycloaddition reaction of ene-ynol ethers was reported 
by Minehan and coworkers (Scheme 19).40 tert-Butyl alkynyl ethers 1-138 are known for 
their retro-ene reaction with the release of isobutylene gas at low temperature to result in the 
formation of ketene, which could react intramolecularly with alkene to form cyclobutanones 
1-139.  
 
Scheme 19. The thermal retro-ene/[2+2] cycloaddition reaction of ene-ynol ether.  
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Recently, Tu and coworkers reported the crossed [2+2] cycloaddition of a ketenimine 
generated in situ from triazole under mild conditions (Scheme 20).41 1,6-Enynes 1-140 first 
reacted with tosyl azide via a copper-catalyzed Huisgen cycloaddition to form triazoles, 
which was followed by the release of N2 gas to afford the ketenimine intermediate. Due to the 
electronic partner of phenol-substituted alkene, crossed [2+2] cycloaddition afforded 
compound 1-141 after the hydrolysis.  
 
Scheme 20. The crossed [2+2] cycloaddition of a ketenimine generated in situ from trizole. 
Similar work was reported by Hsung and coworkers (Scheme 21).
42
 N-Allyl 
ynamides is known to be transformed to ketenimines under the Pd catalysis. The following 
crossed [2+2] cycloadditions furnished compound 1-143.  
 
Scheme 21. The crossed [2+2] cycloadditions of ketenimines generated in situ from N-allyl 
ynamides.  
The keteniminium ion-involved [2+2] cycloaddition was first reported by Leon 
Ghosez in 1972.43,44 An advantage of keteniminium [2+2] cycloaddition over that of ketene is 
that enantioselective [2+2] cycloaddition could be achieved under the assistance of chiral 
 27 
amines. The first asymmetric version was reported in 1982, although only a modest 
enantiomeric excess (ee) was obtained (Scheme 22).45 Its full discussion and mechanistic 
investigation have been reported.46 The best result was obtained when using trans-2,5-
dimethylpyrrolidine as the chiral auxiliary. They also proposed a molecular model to 
rationalize the enantioselectivity obtained (Figure 11). As described in the section 1.3.1, 
alkene added in-plane to the middle carbon of the keteniminium salt. The top face was 
blocked because of the bulky tosyl amine group. There are four possible orientations of 
alkene, 1, 2, 3, and 4, when attacking from bottom of the keteniminium salt. Orientations 3 
and 4 are not favored due to the pseudo-axial proton in the chiral pyrrolidine ring. Orientation 
2 is unfavorable, which would result from the steric hindrance between cyclopentane and 
tosyl amine group in the same face of cyclobutanone. High enantioselectivity was obtained 
through orientation 1, and the pyrrolidine ring rotation and cyclobutane ring closure finished 
the synthesis of cyclobutane iminium ion. The subsequent hydrolysis afforded the 
enantiopure cyclobutanones. 
 
Scheme 22. The first enantioselelctive [2+2] cycloaddition.  
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Figure 11. Stereochemistry of keteniminium-involved [2+2] cycloaddition. 
The first intramolecular keteniminium ion-involved asymmetric [2+2] cycloaddition 
was reported in 1990.47 Since then, this asymmetric version has been utilized to synthesize 
the advanced intermediate of prostaglandins (Scheme 23).48,26  
 
Scheme 23. Key step for the synthesis of an advanced intermediate of prostanglandin. 
 
1.3.3 Results and discussions 
The preparation of [2+2] cycloaddition starting materials. Although our eventual 
goal was to achieve an asymmetric [2+2] cycloaddition, we first tested the strategy using the 
racemic [2+2] adduct. Based on that work, we should be able to transfer the established 
conditions to the asymmetric cycloaddition. As described before, the racemic [2+2] product 
could be obtained through either a ketene or keteniminium ion (Figure 12). Ketene is usually 
generated from acyl chloride under basic conditions and high temperature, and the following 
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cyclization directly affords cyclobutanone. Alternatively, the amide can form a keteniminium 
ion under strong dehydration conditions such as triflic anhydride, and the following 
cycloaddition affords [2+2] iminium ion, which is followed by hydrolysis to give 
cyclobutanone. There are two more steps to get cyclobutanones through the keteniminium ion, 
amide formation and hydrolysis of keteniminium ion. Despite that, this method offers the 
significant advantage that enantiopure cyclobutanone could be obtained from this if the 
pyrrolidine portion is replaced by a chiral auxiliary, such as trans-2,5-dimethylpyrrolidine 
(2R,5R or 2S,5S). Therefore, we opted to explore both methods to synthesize the racemic 
cyclobutanones. While the ketene synthetic route gives the cyclobutanone quickly, the 
keteniminium ion synthetic route establishes the methods possible to the asymmetric [2+2] 
cycloaddition. 
 
Figure 12. General scheme of [2+2] cycloaddition. 
Dowd and co-workers reported the one-pot dialkylation of the dianion of acetic acid 
using 3.2 eq LDA to prepare compound 1-151 (X = OH) (Scheme 24).38 Unfortunately, this 
direct route was unsuccessful in our hands. We also tried to use tert-butyl acetate and amide 
1-155 as substrates; however, they were still not successful. 
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Scheme 24. Unsuccessful attempts of one-pot dialkylation.  
Thus we turned our attention to the preparation of the [2+2] starting materials 
through mono-alkylation. Commercially available hept-6-enoic acid 1-152 was transformed 
to acid 1-129, 1-153, and 1-132 respectively in modest yields using LDA as base and 1,3-
dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU) as the additive (Scheme 25).  
 
Scheme 25. Synthesis of [2+2] cycloaddition starting materials (acids).  
The corresponding amides were also prepared by the simple alkylation of amide 1-
154 with the corresponding halide partners (Scheme 26). Amide 1-159 was the over-alkylated 
product of amide 1-155 with (E)-6-iodo-2-hexene, obtained in 31% yield. 
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Scheme 26. Synthesis of [2+2] cycloaddition starting materials (amide). 
[2+2] cycloaddition reaction. Based on our retro-analysis in Figure 5, we first 
focused on the preparation of cyclobutanone 1-108 from amide 1-159 under keteniminium 
ion-mediated [2+2] cycloaddition conditions (Scheme 27). However, we did not get our 
desired product. Instead, compound 1-160 was obtained in 38% yield. We speculated that 
methyl substituted alkene is favored for crossed [2+2] cycloaddition. As known, 1H and 13C 
chemical shifts in the NMR spectroscopy can indicate the electron density of atoms. For 
amide 1-159, both H1 and H2 have the same chemical shift, and the 
13C chemical shift of C2 is 
131.1, whereas C1 is 125.0 (Figure 13). While this is consistent with the view that carbon C1 
is slightly more nucleophilic than C2, the electronic contribution was insufficient to overcome 
the steric hindrance of the [2+2] cycloaddition leading to bridged product.  
There are two possible pathways in the [2+2] cycloaddition, which lead to 1-160 and 
1-108, respectively. Both pathways use the π electrons of the alkene as the nucleophile. But, 
the actual bond formation occurs on the different carbons of alkene. Because both carbons of 
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alkene have similar nucleophilic ability, steric hindrance plays more importance in this 
reaction. In intermediate C, the bond was formed between the terminal carbon of alkene and 
middle carbon of keteniminium ion, so the methyl group is close to the pseudo-axial 
hydrogen of the horizontal pyrrolidine, causing the steric hindrance. When the pyrrolidine 
orientation was rotated to the perpendicular plane, even more steric hindrance resulted 
between the methyl group and two hydrogens of the pyrrolidine in transition state D. 
However, when the bond was formed between the internal carbon of alkene and middle 
keteniminium ion, the methyl group is far from the two hydrogens of pyrrolidine ring. This is 
the reason why cyclobutanone 1-160 is the sole product.  
 
Scheme 27. Crossed [2+2] cycloaddition of methyl-substituted amide 1-159.  
 
Figure 13. 
1H and 13C chemical shifts of amide 1-159.  
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When we treated amide 1-156 with [2+2] cycloaddition conditions, cyclobutanone 1-
109 and 1-162 were obtained in 35% yield with 2:1 ratio. We did not observe any production 
of 1-110. It meant that there is only minor energy difference between pathways leading to 
methyl-substituted olefin and non-methylated olefin. As discussed in Figure 13, reaction 
occurs on carbon C4 due to steric hindrance although there is not too much difference 
between the nucleophilicity of C3 and C4 (Figure 14). Carbon C1 is more nucleophilic than C2 
from both points. Although NMR is not a good predicator of this reaction, the product ratio 
indicates that the difference is pretty small. Furthermore, both compounds are inseparable.  
 
Scheme 28. [2+2] cycloaddition of amide 1-156. 
 
Figure 14. 1H and 13C chemical shifts of amide 1-156. 
Building on the lessons learned from our first two attempts, we turned our attention 
to prepare non-methylated cyclobutanone precursors. Amide 1-157 was treated under the 
[2+2] cycloaddition conditions, a mixture of [2+2] cycloadducts were obtained, along with 
the double-bond migrated amide 1-156. Specifically, we identified cyclobutanones 1-111 and 
1-109 in the reaction mixture. The reaction conditions provided several opportunites for 
double bond migration: 1) at starting material stage; 2) at keteniminium ion stage, 3) at 
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iminium ion stage. We have not established at which stage the migration of double bond 
occurs. 
 
Scheme 29. [2+2] cycloaddition of amide 1-157. 
Cyclobutanone 1-101 was also prepared by keteniminium ion-mediated [2+2] 
cycloaddition from 1-131 in 39% yield as a mixture with 1-163 with 15:1 ratio (Scheme 30). 
Both compounds are inseparable.  
 
Scheme 30. [2+2] cycloaddition of amide 1-131. 
In comparison, ketene-mediated [2+2] cycloadditions were also tested to get the same 
compounds, with better results (Scheme 31). As reported,27 the cycloaddition of 1-153 did not 
produce any of 1-134.  
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Scheme 31. Ketene-mediated [2+2] cycloadditions. 
Spectral difference of crossed and fused [2+2] cycloadducts. Both ketene and 
keteniminium ion mediated [2+2] cycloadditions produced fused and crossed [2+2] 
cycloadducts. From spectral data, we can clearly differentiate them (Figure 15). Although 
both compounds have one carbonyl carbon, one quaternary carbon, and one tertiary carbon, 
the proton connecting to the tertiary carbon is also at the α–position of carbonyl group for 
cyclobutanone 1-163. Its 1H and 13C chemical shifts are markedly different from those of 
fused cyclobutanone 1-101.  
 
Figure 15. Spectral data of fused and crossed [2+2] adducts.  
 36 
Preparation of chiral amide. As our research progressed, we also needed to access 
enantiopure cyclobutanone 1-108. Based on the reported intramolecular asymmetric [2+2] 
cycloaddition,26 the desired chiral auxiliary is (2R,5R)-(−)-trans-2,5-dimethylpyrrolidine. 
Because it is pretty expensive ($190/50 mg, Aldrich), we first tried to optimize the reaction 
conditions using its enantiomer, (2S,5S)-(+)-trans-2,5-dimethylpyrrolidine (N-Boc, $188/500 
mg, Aldrich).  
First, acid 1-132 was converted to acyl chloride using oxalyl chloride under the 
catalysis of DMF and condensed with (2S,5S)-(+)-trans-2,5-dimethylpyrrolidine to afford 
amide 1-165 using aqueous NaOH as the base (Scheme 32). The corresponding 1-166 was 
also prepared by this method. In some reactions, dimethyl amide 1-167 was obtained as a 
byproduct. This likely resulted from the decomposition of Vilsmeier reagent generated from 
DMF and oxalyl chloride to eject dimethyl amine. Amide 1-168 is also observed as a 
byproduct when the reaction was quenched with saturated aqueous ammonium chloride.  
 
Scheme 32. Synthesis of chiral amides. 
During the course of reaction optimization, we were surprised to find that amide 1-
169 was obtained as the major product when triethylamine was used as the base (Scheme 33).  
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Scheme 33. Preparation of chiral amide using triethylamine as base.  
When we tried to rationalize this result, a retro-ene reaction is a good explanation 
although there is another possibility (A) there (Figure 16). Ketene, generated from acyl active 
anhydride under basic conditions, would react with triethylamine to form a zwitterion. One 
possibility is that the nucleophile in the reaction might attack the α carbon in the amine to 
form the product (pathway A). Under the assistance of the enolate intermediate, a retro-ene 
reaction may proceed to form the amide product, along with the release of ethylene as a 
byproduct (pathway B). Another possibility is that ene reaction occurred in an intermolecular 
way without the support from an enolate intermediate (pathway C).  
 
Figure 16. Retro-ene reaction. 
In order to differentiate them, DIEA was used as the base in the reaction (Scheme 34) 
since the nucleophilicity of DIEA is much weaker due to the steric hindrance of the bulky 
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isopropyl group. The formation of diisopropyl amide 1-170 would indicate that the ene 
reaction pathway is the likely explanation.  
 
Scheme 34. Diisopropylamide formation.  
Asymmetric [2+2] cycloaddition. With chiral amide in hand, this material was 
subjected to the [2+2] cycloaddition conditions26 to afford a mixture of iminium ions 1-171 
and 1-172 (Scheme 35). Fortunately, we found that these products are stable to silica gel 
column isolation, and we are able to confirm the relative stereochemistry of 1-171 by NOE 
experiments (Figure 17). Hydrolysis attempts in neutral water, which usually worked for 
hydrolysis of pyrrolidine substrate, did not work for this chiral bulky iminium substrate. 
Successful hydrolysis was obtained under basic conditions to afford cyclobutanones (S)-1-
112 and (S)-1-133 with 96% ee and 80% ee, respectively, which is determined by GC. Both 
steps can be done in a one-pot sequence, analogous to racemic substrates.  
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Scheme 35. Synthesis of enantiopure cyclobutanone. 
 
Figure 17. NOE correlations for iminium ion 1-171. 
The same result was obtained when (2R,5R)-(−)-trans-2,5-dimethylpyrrolidine was 
used as the chiral auxiliary (Scheme 36). GC chromatograms of cyclobutanones 1-112, (R)-1-
112 and (R)-1-133 were shown in Figure 18, Figure 19, and Figure 20.  
 
Scheme 36. Synthesis of cyclobutanone (R)-1-112.  
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Figure 18. GC chromatogram of 1-112.  
 
Figure 19. GC chromatogram of (R)-1-112.  
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Figure 20. GC chromatogram of (R)-1-133.  
Asymmetric [2+2] cycloaddition model. The C2-symmetry of the keteniminium ion 
allows a thorough discussion of the stereochemical outcomes using only one side chain 
(Figure 21). Theoretically, there are eight attack directions of olefin to keteniminium ion. The 
side chain under consideration approaches from the top of keteniminium/pyrrolidine plane, 
and therefore the olefin in the side chain cannot reach the keteniminium ion from the bottom 
of keteniminium/pyrrolidine plane because there are only three carbons between olefin and 
the end carbon of keteniminium ion. So attack directions d, e, and f are impossible for this 
scenario. There are two bulky methyl groups on the two sides of keteniminium ion in the 
keteniminium/pyrrolidine plane, and these can block the olefin’s attack to the keteniminium 
from perpendicular to the perspective of the keteniminium/pyrrolidine plane. Moreover, these 
kinds of attacks (c and g) are not favorable based on the computational results. Direction h’s 
attack is also blocked by the up methyl group. The favored attack directions should lie in the 
direction a or b, or between a and b.  
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Figure 21. Attack directions of olefin to keteniminium ion. 
Besides the attack directions of olefin, the olefin orientation also affects the 
stereochemical outcome of this reaction (Figure 22). There are two orientations of olefin: A 
and B. One’s sidechain is outward (A), and the other’s inward (B). Each one has two 
interaction models depending on which carbon of double bond contributes more to this 
interaction. The nucleophilic internal carbon of intermediate A attacks the middle carbon of 
keteniminium ion to form intermediate C. Although it is the π electrons of the double bond 
which act as the nucelophile during the attack, the bond formed between keteniminium 
middle carbon and internal olefin carbon is actually short in order to generate crossed [2+2] 
product. Along with that, a primary unstable carbocation is also formed. The following 
rotation of pyrrolidine ring provides a chance of electron flow from lone pairs of nitrogen to 
enamine bond, and finally they go to the primary carbocation carbon to form bridged bicycle 
adduct K. The pathway A-D-H-L is similar except the short bond forms between terminal 
olefin and middle keteniminium carbon, and the carbocation is a more stable secondary one. 
This pathway would afford the fused cyclobutane derivative L. There is one more argument 
that a relatively strained cyclohexene is formed in the pathway A-C-G-K instead of a 
relatively loose cycloheptene for pathway A-D-H-L, which would rationalize why the fused 
[2+2] cycloadduct is the major one. The pathways B-E-I-M and B-F-J-N afford the 
corresponding enantiomers by the same logic as above.  
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Figure 22. Fused and crossed asymmetric [2+2] cycloaddition pathways.  
In order to clarify the relative energy diagram, different views for each intermediate 
are shown in Figure 23. The bonded carbon of alkene in each intermediate is always closer to 
the middle carbon of keteniminium ion while the un-bonded carbon of alkene is much closer 
to the terminal carbon of keteniminium ion. As discussed above, the ring strain and 
carbocation stability make D more stable than C. The attack direction of the double bond 
makes the conformation of intermediates E and F more strained, clearly indicated by their 
side views. This explained the origin of high enantioselectivity. From top view of F, the 
existence of up methyl group (at pseudo equatorial position) affords a primary carbocation 
closer to terminal carbon of keteniminium ion, and facilitates the second bond-formation. A 
similar situation is seen for intermediate D. The pseudo axial hydrogen atom does not have 
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much impact on the conformations of these intermediates because its small size does not 
allow steric interaction with the double bond or even its attached hydrogens. Compared to the 
energy difference between C and D, the difference between E and F is much less. In other 
words, the energy difference of D and E, which leads to the generation of (R)-1-112 and (S)-
1-112, is higher than that of C and F, leading to the formation of (R)-1-133 and (S)-1-133. 
This is the reason why the enantiomeric excess of crossed product is less than fused [2+2] 
product.  
 
Figure 23. Different views of intermediates in the asymmetric [2+2] cycloaddition. 
Absolute configuration determination. Although comparison to known examples 
allowed us to deduce the absolute configuration of our products, we still desired to further 
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confirm our assignment. The most straightforward way to determine absolute configuration is 
through heavy-atom assisted crystallography, if possible. We first reduced the ketone to 
alcohol (10:1 ratio), then condensed with 4-bromobenzoyl chloride to form ester 1-175. 
However, recrystallization attempts did not give crystalline material, but rather a fine powder. 
Similar crystallinity issues arose using Mosher’s esters 1-177 and 1-178. An alternate 
approach to determine its absolute configuration would be measuring the chemical shift 
difference between 1-177 and 1-178; however, these esters were inseparable. Due to the 
existing difficulty, we tried to determine it later by the modification of tricyclic lactam 
scaffold.  
 46 
 
Scheme 37. Studies toward absolute configuration determination. 
 
1.4 Electrochemistry-mediated synthesis towards pinnaic acid 
1.4.1 Introduction  
In recent years, there has been a considerable increase in the use of electrochemical 
reactions in organic synthesis although it is far from a routine technique. A tutorial review49 
and several comprehensive reviews50,51,52,53,54 have summarized recent advances in this field.  
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A powerful tool in organic chemistry, electrochemistry can selectively introduce and 
remove electrons from organic molecules under mild conditions to generate a wide variety of 
reactive intermediates (radical-ions) on any scale. Many of these transformations are unique 
to electrochemistry. However, the requirement of specialized equipment puts off many 
synthetic chemists. 
There are two types of organic electrochemical reactions, oxidations and reductions 
(Figure 24). Oxidations take place at the anode, and one/two electrons are removed from 
electroactive species to generate highly reactive intermediate radical-cations, commonly 
referred to as anodic oxidation. Likewise, one or two electrons are added to electroactive 
species at the cathode to produce highly reactive intermediate radical-anion, named as 
cathodic reduction. A variety of cyclization reactions can ensue from the initial radical-ion 
species, named as anodic cyclization and cathodic cyclization.  
 
Figure 24. Schematic of an electrochemical setup. 
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Apparatus. Electrochemical setups usually contain an electroactive species, solvent, 
electrolyte, at least two electrodes (anode and cathode, or reference electrode), and/or various 
additives. In Table 1, there are commonly used components for each category. The choice of 
solvents is fairly broad, and electrolytes are typically salts that dissociate into ions and make 
the solution conductive. Electrodes have to be stable to the reactions conditions, and allow for 
the transfer of electrons in solution. The electrode’s physical form can provide a way to 
moderate the current density on the surface area of electrode to accomplish the current-
density-sensitive reactions. In order to achieve the best result of any chemical reactions, the 
choice of aforementioned components often need to be optimized.  
Table 1. Common components in the organic electrochemistry.  
Solvent 
Methanol, THF, acetic acid, dichloromethane, acetonitrile, 
nitromethane, water. 
Electrolyte 
Lithium perchlorate (LiClO4), tetrabutylammonium tetrafluroborate 
(Bu4NBF4), tetraethylammonium tosylate (Et4NOTs), 
tetrabutylammonium acetate (Bu4NOAc), any other 
tetralkylammonium salt (R4N
+). 
Anode material 
C (graphite), Pt, Au, Pt-Ti, TiO2-Ti, RuO2-Ti, PbO2-Pb, RVC 
(reticulated vitreous carbon). 
Cathode material C (graphite), almost any metal. 
Electrode’s form Rod, plate, wire, net gauze, sponge (RVC). 
 
Besides the above parameters, an electron source must be used to apply a potential, 
usually achieved by a potentiostat. It can also be used to control the current during the 
constant current experiments.  
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There are two types of electrochemistry experiments: constant current and controlled 
potential. In a constant current experiment that the flow of the current through the cell is held 
at a constant value by the potentiostat, the potential at the electrode surface begins to rise due 
to the resistance of electrolyte. And it will continue to rise until the oxidation potential of 
electroactive species is reached. Once reached, it will keep unchanged for the time period that 
all the material at this oxidation potential is consumed. After that, the potential will continue 
to climb until the oxidation potential of a second electroactive species or the solvent is 
reached. A disadvantage of this experiment is over-oxidation when the substrate has more 
than one electroactive functional group.  
Selective oxidation can be achieved in controlled potential experiments by keeping 
the potential at a set value. As the electroactive species is consumed, the resistance increases 
and then the current decreases, and hence it takes longer to oxidize or reduce the starting 
material. The disadvantage is that it may be difficult to drive a controlled potential 
experiment to completion. 
There are two basic choices for the construction of electrochemical reactors: an 
undivided cell or a divided cell. In the undivided cell set-up, both reduction and oxidation are 
allowed to happen within the same compartment, which could be a beaker, vial, or round-
bottom flask. More attention needs to be given to the chemistry occurring at the auxiliary 
electrode because the substrate there is exposed to all species present in the reaction, such as 
starting material, newly-formed product, and electrolyte. Byproducts generated there might 
affect the starting materials or products. Typically, undivided cells are commonly used for 
constant current experiments because of their ease of construction.  
The divided cell is an alternative solution for this cross-interference but more 
complex. It uses a small, porous frit to physically separate the anodic and cathodic 
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compartments, which only allows for the transfer of electrons. It can be employed in either 
constant current or controlled potential experiments.  
Anodic oxidation. Anodic oxidation takes one/two electrons away from a neutral 
substrate to generate a reactive radical cation intermediate that can undergo either direct 
manipulations or cascade reactions. This offers synthetic chemists a unique opportunity to 
construct new bonds while the functionality is either increased or preserved in order to further 
manipulate the generated product.  
Two common applications of this chemistry are amidic oxidation and olefin coupling. 
Amidic oxidation is the oxidative generation of N-acyliminium ions from amides and 
carbamates (Figure 25). One of the lone pair of electrons in the nitrogen atom of amide is 
removed to produce nitrogen radical cation. The hydrogen in the neighboring carbon of 
nitrogen atom is removed as a proton while one additional electron is also lost to generate an 
N-acyliminium ion, which is followed by the nucleophilic attack to produce the product.  
 
Figure 25. The mechanism of amidic oxidation.  
Intramolecular anodic olefin coupling reactions take one electron away from an 
electron-rich alkene (Figure 26). The generated radical cation may be trapped with an 
intramolecular nucleophile to form a new C-C bond along with the proton loss from the 
nucleophile. The newly-formed radical usually reacts with protic solvent to form the product. 
These reactions reverse the polarity of the electron rich alkene to be oxidized, and transform 
it into an electrophile. Overall, the oxidation of a substrate having two nucleophiles leads to a 
coupling of the two nucleophiles. Such transformations open up the possibility of developing 
new methods for the construction of ring systems. 
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Figure 26. The mechanism of olefin coupling. 
There are some questions as to why the generated radical cation from electron-rich 
alkene does not react with protic solvent to form new products (Figure 26). Intramolecular 
reaction is one of the arguments. But there are some specific explanations from an 
electrochemistry standpoint. It is generally accepted that the oxidation/reduction of the 
electroactive species takes place on the electrode surface in the compact layer (a few Å away 
from electrode). Far from the anode, the potential drops exponentially through the bulk 
solution, where the potential is not high enough to oxidize the electroactive species. For 
olefin coupling, the cyclization with inactive nucleophile is kinetically faster than the 
diffusion through bulk solution. This is the reason that highly reactive radical-cations and 
radical-anions can be generated in the presence of nucleophilic and protic solvents. 
Amidic oxidation and olefin coupling reactions have been utilized in the syntheses of 
complex molecules. There is a wonderful demonstration of intramolecular anodic olefin 
coupling reaction’s application in the total synthesis of natural product ent-guanacastepene E 
(Scheme 38).55,56 Trauner and coworkers successfully achieved the construction of 
guanacastepne polycyclic skeleton using furan as the electron-rich alkene and TBS enol ether 
as the nucleophile to construct 1-182 in this olefin-coupling reaction.   
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Scheme 38. Application of olefin coupling in the total synthesis of guanacastepene E. 
Cathodic reduction. In comparison to the popularity of anodic oxidation, cathodic 
reduction is less used in organic reactions. But it has its own unique characteristics. As 
opposite to anodic oxidation, cathodic reduction adds one/two electrons to electroactive 
species (Figure 27). So it can reverse the polarity of its substrate, such as a carbonyl group, 
electron-deficient alkene, and the β carbon of α, β-unsaturated carbonyl compound, and then 
make the reactive carbon become nucleophilic instead of its electrophilic character.57  
 
Figure 27. A cyclization involving cathodic reduction. 
One demonstration is the formal synthesis of the natural product quadrone (Scheme 
39).58 Cathodic reduction was utilized in the key step to build the bicyclic ring 1-184 by Little 
and coworkers.  
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Scheme 39. Application of cathodic reduction in the formal synthesis of quadrone. 
In conclusion, electrochemistry is a the powerful tool in organic chemistry and it is 
beginning to gain more popularity due to its unique characteristics. Its prominent character is 
to trigger umpolung reactivity for multiple functional groups.  
 
1.4.2 Electrochemistry apparatus  
Specialized equipment, especially the potentiostat, can be viewed as an obstacle by 
synthetic chemists to utilize electrochemical methodology as a traditional technique. Moeller 
and coworkers successively found that 6-volt lantern batteries could be used to get 
electrochemical results similar to those using commercial equipment.59 Recently, Boydston 
and coworkers demonstrated the organocatalyzed anodic oxidation of aldehydes to esters 
powered by D-cell batteries.60  
In order to expand the utility of the intramolecular Schmidt reaction in organic 
synthesis, we were interested in developing a method to modify such Schmidt products 
(Figure 28). There are also a number of potential applications toward to the total syntheses of 
natural products, such as tuberostemonine.  
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Figure 28. Diversification of a representative Schmidt product. 
Dr. Kevin Frankowski of our lab conceived of the use of a discarded recharging 
adapter of electronic devices, such as mobile phones, as a suitable voltage power source for 
electrochemical reactions. He successfully obtained positive results for amidic oxidation to 
generate the acyliminium ion precursors (Figure 29).61  
 
Figure 29. Home-made electrochemistry apparatus. 
The adapter Kevin used is 6V/300mA, and the adapter I used is 5.0V/0.7A. Each 
afforded good results. The current shown on the device’s label is the maximum current, but 
the voltage is the actual potential applied to our reaction.  
 
1.4.3 Results and discussion  
Intramolecular Schmidt reaction. After the azide displacement, the intramolecular 
Schmidt reaction proceeded smoothly in high yield (Scheme 40).  
Graphite Anode 
 
Graphite Cathode 
Recharging Adapter 
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Scheme 40. Intramolecular Schmidt reaction.  
We imagined that the bond between carbonyl group and cyclopentane is a bit weak 
due to the ring strain of cyclobutanone. In principle, nitrene could be formed under thermal 
conditions and the following insertion can give Schmidt product 1-99 (Scheme 41). However, 
attempted reactions under several conditions such as refluxing in chlorobenzene or the 
addition of catalytic amount of AIBN, known to facilitate the generation of nitrene, did not 
lead to 1-99.  
 
Scheme 41. Nitrene-mediated Schmidt reaction. 
We also wanted to combine [2+2] cycloaddition with intramolecular reaction 
(Scheme 42). However, no good results were obtained. It is possible that the nitrogen in the 
azide group is a better nucleophile than the amide towards triflic anhydride, which may 
interfere with the [2+2] step.  
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Scheme 42. Proposed combination of [2+2] cycloaddition and Schmidt reaction.  
Electrochemsitry. The home-made electrochemistry apparatus was used to develop 
a general method to prepare complex acyliminium ion precursors. We first used amide 1-155 
as the model system to optimize the conditions (Scheme 43). The acyliminium ion precursor 
1-186 can be obtained in 55% yield. When the same condition was applied for tricyclic 
lactam 1-99, compound 1-187 was obtained in 36% yield, along with other impurities of the 
general form 1-188 after silica gel column purification. When crude product 1-187 was used 
directly for the next allylation, compound 1-189 was obtained in 56% yield. However, the 
stereochemistry of the product was not suitable for advancement to pinnaic acid.   
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Scheme 43. Electrochemistry-mediated synthesis. 
Acyliminium ion, generated from 1-187 under the Lewis acid conditions, has two 
conformations, each of which has two reactive pathways (Figure 30). One is through a chair-
like transition state and the other a twist-boat like transition state. For conformation A, the 
allyl nucleophile attacks the acyliminium ion from top face to form chair-like TS, and leads 
to compound 1-189. If the attack is from the bottom face, a twist-boat like transition state 
reacts to form 1-97. For conformation B, a chair-like TS gives 1-97 and the twisted boat 1-
189. Because transition state energy is much higher for twist-boat than chair, the formation of 
major products should be from chair-like transition state. Then the distribution of products 
really depends on which conformation is more stable. For conformation A, the joint bond 
between cyclopentane and pyrrolidin-2-one ring lies on the pseudo-equatorial position. 
However, it is on the pseudo-axial position for conformation B. As shown in Figure 30, it is 
on the same plane for all the bonds connecting acyliminium ion. If the joint bond is at the 
pseudo-axial position, this makes the pyrrolidin-2-one ring very strained (dihedral angle is 
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pretty large). So the conformation B is less likely formed during the formation of 
acyliminium ion. Therefore, compound 1-189 is a major product.  
 
Figure 30. Mechanism for the allylation of N-acyliminium ion. 
Due to the undesired stereochemistry based on our rationale, we imagined that the 
right stereochemistry could be obtained by the hydride attack of allylic acyliminium ion 
(Figure 31). The methoxy group of 1-187 was transferred to an electron-withdrawing group. 
This group must have the ability to make the α-H acidic, which could be deprotonated and 
alkylated with allyl bromide. This group also must be able to be released to form allyl 
acyliminium ion, which could be attacked by hydride from the top face to our desired product 
1-97.  
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Figure 31. Strategy to modify the undesired stereochemistry of 1-187.  
The phenylsulfonyl group is initially used as the functional group to modify the 
undesired stereochemistry. However, we did not obtain the product in good yield when we 
tried to prepare it (Scheme 44). Maybe compound 1-190 is unstable during the silica gel 
column purification, and eliminated to 1-191.   
 
Scheme 44. Sulfonyl synthetic route.  
After the determination of its relative stereochemistry, we found that the α hydrogen 
(as shown) is always at the pseudo-equatorial position and its 1H chemical shift is a little 
higher than its β partner (Figure 32). This is due to the downfield H atom being placed in the 
deshielding area of the lactam carbonyl group.  
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Figure 32. Spectral data of tricyclic lactams. 
 
1.5 Allylic azide rearrangement/Schmidt-mediated synthesis towards pinnaic acid 
The combination of allylic azide rearrangement and intramolecular Schmidt reaction 
was initially considered as a solution to the pinnaic acid problem. However, we did not use 
this substrate for our initial studies of this sequence because this system belongs to the 
relatively unfavored 4-C tethered Schmidt reaction (azide is 4 carbons away from α-position 
of ketone). Chapter 2 details our initial studies of this combined reaction, which are not 
discussed in the pinnaic acid context below.  
Preparation of allylic azides. Allylic azides could be prepared by azide 
displacement of the corresponding allylic bromides (Scheme 45). Allylic bromides were 
prepared by allylic bromination using NBS or cross-metathesis with allyl bromide. First, we 
used allylic bromination of cyclobutanone 1-111 to prepare bromide 1-192, along with some 
di-brominated compound 1-192a. After recognizing that cyclobutanone 1-111 could not be 
prepared in an enantiopure form, we investigated a route to bromide 1-192 via cross-
metathesis, which gave product in a high E/Z ratio.   
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Scheme 45. Preparation of allylic bromide. 
A mixture of isomeric allylic azides 1-193 was successfully obtained through azide 
displacement in 88% yield with 65:9:13:13 ratio from 1H NMR in acetone (Scheme 46). 
Allylic azide rearrangement is facile at room temperature.  
 
Scheme 46. Preparation of allylic azides. 
Allylic azide rearrangement/intramolecular Schmidt reaction condition 
screening. First, we screened a variety of conditions to effect this transformation. We found 
1.5 equiv TiCl4 in refluxing dichloroethane to be the best condition, affording a 10:1 dr of 
products in 68% yield (Table 2). Although there are other minor products (<3%), the major 
products are our desired products 1-194 and 1-195.  
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Table 2. Allylic azide rearrangement/intramolecular Schmidt reaction condition screening. 
 
 
Conditions 
Yield 
(1-194+1-196) 
Ratio 
(1-194:1-196) 
Note 
1 3 eq TiCl4, DCM, rt 35% 5 : 2 
 
2 3 eq TiCl4, toluene, 80 °C 35% 5:1 
 
3 3 eq BF3·OEt2, DCM, -78 °C 
  
decomposed 
4 TFA, 0 °C 
  
decomposed 
5 3 eq SnCl4, DCM, reflux 
  
decomposed 
6 1.5 eq TiCl4, DCM, reflux 48% 4:1 
 
7 1.5 eq TiCl4, CHCl3, reflux 54% 10:1 
 
8 1.5 eq TiCl4, DCE, reflux 68% 10:1 
 
9 1.5 eq TiCl4, CCl4, reflux 24% 8:1 
 
10 1.5 eq TiCl4, toluene, reflux 41% 20:1 
 
 
After that, we attempted to rationalize our results. Based on the mechanism (Figure 
33), there are two possible ring systems: normal amide and twisted amide, which result from 
the bond migration a or b respectively. Usually the formation of twisted amide needs specific 
conformation and higher energy. In this case, it should be tough to obtain the twisted amide. 
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There are also two possible nucleophilic attack pathways of azide to the carbonyl group of 
cyclobutanone: syn and anti. The azepane ring is flexible so that both pathways should be 
possible. We crudely calculated the possible intermediates, whose conformations as we 
thought could have minimum energies, using Chem-3D program through the minimized 
energy of MM2 calculations. The results showed that anti-attack needs ~3-5 kcal/mol higher 
than the corresponding syn-attack. As known in organic chemistry, the most stable 
conformation of cycloheptane ring is not the chair conformation because there are some 
eclipsing hydrogens. Actually for our case, the chair conformation is the most stable 
conformation for our case because of the fused cyclobutane ring, whose two C-C bonds are at 
the eclipsing position (Table 3). The calculated results indicated that conformation B is more 
stable than conformation A, which leads to lactam 1-194 as the major product. As shown in 
Figure 34, the interaction of endo-CH2 in the cyclobutane ring with pseudo-axial hydrogen of 
azepane ring for conformation A is large, in comparison to the interaction of pseudo-axial 
CH2 in the cyclopentane ring with pseudo-axial hydrogen of azepane ring for conformation B.  
We also calculated the energies of two products using the same program (Table 3). 
We found that lactam 1-194 is not more stable than 1-195 although its vinyl group is at 
pseudo-equatorial position. Maybe there is some A1,3 strains between the carbonyl group and 
vinyl group in the molecular conformation of 1-194 (Figure 34). Although the vinyl group of 
1-195 is at the pseudo-axial position, the computational results indicated that 1-195 is more 
stable.   
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Figure 33. Mechanism of Schmidt reaction in the synthesis of pinnaic acid. 
 
Table 3. Calculated results of intermediates in the Schmidt reaction. 
Intermediate 
 
   
Chem-3D 
model 
    
Cal. energy 
(kcal/mol) 
54.3 51.1 22.4 21.5 
 
 
Figure 34. Steric interaction of intermediates and products.  
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Studies of minor lactams. We also identified some minor products produced during 
the combined allylic azide rearrangement/Schmidt reaction. Our initial hypothesis was that 
the twisted amide was produced in this reaction (see chapter 2). After examining the detailed 
spectra, we speculated that maybe there is one carbon missed in the cross-metathesis. 
Ruthenium-H catalyst is known for this olefin isomerization.62 Grubbs catalysts are also 
known to convert an O- or N-allyl substrate to an O- or N-propenyl product.63 It was reported 
that the isomerized substrate for all-carbon substrate is the minor product during the cross-
metathesis using Grubbs catalysts.62 This would explain how we could get a mixture of one-
carbon less Schmidt product through the whole process shown in Scheme 47.  
 
Scheme 47. Grubbs catalyst mediated isomerization. 
We next tried to synthesize those Schmidt products directly to further confirm this 
speculation (Scheme 48). Starting from cyclobutanone 1-112, we tested the allylic oxidation 
conditions to get allylic alcohol 1-201; however, the yield was low. Then we turned to allylic 
bromination to get allylic bromide 1-197; the product was obtained in 61% yield. The 
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following azide displacement afforded a mixture of interconverted allylic azides in 42% yield. 
The combined allylic azide rearrangement and intramolecular Schmidt reaction was 
accomplished using TiCl4 in refluxing dichloromethane. However, this reaction is much more 
complex than the homologous reaction. We suspected that the reaction mixture contained 
twisted amides and halo-Prins side products (the latter will be discussed thoroughly in 
Chapter 2). Fortunately, compounds 1-199 and 1-200 were isolated and confirmed to be the 
minor products during the preparation of lactam 1-194, as expected.  
 
Scheme 48. Preparation of lactams 1-199 and 1-200.  
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To complete the formal synthesis, the final step was achieved using a 
hydroboration/oxidation reaction in 83% yield (Scheme 49). Thus, we have achieved a formal 
synthesis of natural product pinnaic acid. We also compared our spectral data with the values 
reported by Kibayaqi (Table 4 and Table 5).15  
 
Scheme 49. End-game reaction. 
 
Table 4. Comparison table of 1H NMR characterization data. 
Found Reference15 
3.72-3.79 (m, 2H) 3.65-3.75 (m, 2H) 
3.29-3.34 (m, 1H) 3.24-3.30 (br m, 1H) 
3.00 (br s, 1H) 3.13 (br s, 1H) 
2.84-2.93 (m, 1H) 2.79-2.88 (m, 1H) 
2.65 (dd, J = 18.0 Hz, 10.4 Hz, 1H) 2.60 (dd, J = 18.0 Hz, 10.3 Hz, 1H) 
2.07-2.17 (m, 2H) 2.02-2.11 (m, 2H) 
1.79-2.00 (m, 4H) 1.74-1.94 (m, 4H) 
1.69-1.77 (m, 1H) 1.63-1.72 (m, 1H) 
1.57-1.67 (m, 5H) 1.56-1.64 (m, 5H) 
1.35-1.57 (m, 3H) 1.38-1.57 (m, 2H) 
 1.30-1.39 (m, 1H) 
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Table 5. Comparison table of 13C NMR characterization data. 
Found Reference15 ∆ value 
174.28 (C) 174.13 0.15 
74.09 (C) 73.99 0.10 
60.97 (CH2) 60.76 0.21 
53.74 (CH) 53.56 0.18 
42.04 (CH) 41.99 0.05 
38.48 (CH2) 38.40 0.08 
36.49 (CH2) 36.46 0.03 
35.45 (CH2) 35.37 0.08 
34.92 (CH2) 34.90 0.02 
33.65 (CH2) 33.62 0.03 
32.15 (CH2) 32.04 0.11 
25.21 (CH2) 25.16 0.05 
22.50 (CH2) 22.49 0.01 
 
We also imagined that alcohol 1-58 could be made through the combination of aza-
Michael addition and intramolecular Schmidt reaction (Scheme 50). The α,β-unsaturated 
aldehyde was prepared by cross-metathesis in 37% yield. We tried several conditions to 
combine the aza-Michael addition and intramolecular Schmidt reactions, however, without 
success. 
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Scheme 50. The combination of aza-Michael addition and Schmidt reactions.  
Determination of absolute configuration. Since we were not able to establish the 
absolute configuration at the cyclobutanone stage, we attempted derivatization of the 
penultimate compound. We still relied on heavy-atom assisted crystallography technique to 
determine the absolute configuration through esterification with 4-bromobenzoyl chloride 
(Scheme 51). Unfortunately, ester 1-207 was not crystalline, and better results may have been 
found using carbamates or nitrobenzoyl analogue.  
 
Scheme 51. Esterification of alcohol 1-58.  
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1.6 Conclusion  
We carried out the studies toward the synthesis of advanced intermediates of the 
natural product pinnaic acid. In one approach, an electrochemistry mediated manipulation of 
an intramolecular Schmidt product was utilized to synthesize the advanced intermediate, 
tricyclic lactam 1-97 (Scheme 52). A ketene-mediated [2+2] cycloaddition was used to get 
intramolecular Schmidt starting material, which afforded un-modified tricyclic lactam. 
Utilizing anodic oxidation, this lactam was modified to give an acyliminium ion, which was 
attacked by nucleophiles to give allylated tricyclic lactam 1-189. Unfortunately, product with 
the undesired stereochemistry was obtained. From another perspective, this sequence is 
complementary to the discovery in the combination of allylic azide rearrangement and 
intramolecular Schmidt reaction, and both methods can afford epimeric tricyclic lactams.  
 
Scheme 52. Electrochemistry-mediated synthesis towards pinnaic acid.  
The synthesis of an advanced intermediate of pinnaic acid was ultimately achieved 
by the combination of allylic azide rearrangement and intramolecular Schmidt reaction 
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(Scheme 53). An enantioselective [2+2] cycloaddition was accomplished under the assistance 
of chiral amine to afford product of 96% ee in 61% yield. The following cross-metathesis and 
azide displacement afforded a mixture of interconverting allylic azides, whose rearrangement 
is facile at room temperature. The combination of allylic azide rearrangement and 
intramolecular Schmidt reaction was accomplished to give tricyclic lactam 1-194 with 10:1 dr 
in 68% yield following a screening of reaction conditions. The formal synthesis was finished 
by the hydroboration and oxidation sequence to give the reported advanced intermediate.  
 
Scheme 53. Asymmetric [2+2] cycloaddition involved synthesis of advanced intermediate.  
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1.7 Experimental data  
 
(E)-6-Iodo-2-hexene. Following the reported procedure,64 to a solution of (E)-4-
hexen-1-ol (1.0 g, 10 mmol) and Et3N (1.6 g, 15 mmol) in CH2Cl2 (30 mL) at 0 °C under Ar 
atmosphere was added dropwise methane sulfonylchloride (1.26 g, 11.0 mmol). The solution 
was stirred overnight. The resulting solution was diluted with CH2Cl2 (30 mL), washed 
successively with HCl (0.5 M, 35 mL), saturated aqueous NaHCO3 (75 mL), and H2O (2 × 75 
mL), dried (Na2SO4), filtered, and concentrated in vacuo to give the crude mesylate as an oil 
(2.4 g). The mesylate was added to a solution of NaI (4.25 g, 25.0 mmol) in acetone (30 mL) 
and heated to reflux overnight. After cooling to room temperature, the reaction mixture was 
diluted with hexane (50 mL), washed with brine, dried (Na2SO4), filtered, and concentrated in 
vacuo to give pure (E)-6-iodo-2-hexene (1.71 g, 82%) as a colorless oil. The spectral data 
matched with reported data.64  
 
6-Iodo-1-hexene. According to the procedure described for (E)-6-iodo-2-hexene, 5-
hexen-1-ol (12.5 g, 125 mmol) afforded 6-iodo-1-hexene (28.0 g, 107%) as a colorless oil. 
The spectral data matched with reported data.65  
 
5-Iodo-1-pentene. Following the reported procedure,66 to a solution of 5-bromo-1-
pentene (11.6 g, 77.9 mmol) in dry acetone (200 mL) was added sodium iodide (23.2 g, 156 
mmol). The reaction mixture was stirred and heated at reflux for 3.5 h. The reaction mixture 
was cooled to room temperature; pentane and water were added. The phases were separated, 
and the organic phase was extracted with pentane. The combined organic phases were 
washed with brine and dried over anhydrous sodium sulfate. After filtration and removal of 
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solvent at reduced pressure, 5-iodo-1-pentene was obtained (14.0 g, 92%) as a colorless oil, 
which was used in the next synthetic step without further purification. The spectral data 
matched with reported data.66  
 
2-(4-Chlorobutyl)hept-6-enoic acid (1-129).
38 According to the procedure described 
for 2-(pent-4-en-1-yl)oct-7-enoic acid (1-153), hept-6-enoic acid (1-152) (1.02 g, 8.00 mmol) 
and 1-bromo-4-chlorobutane (1.65 g, 9.60 mmol) afforded after chromatography acid 1-129 
(1.20 g, 69%) as a colorless oil. Acid 1-129: Rf = 0.35 (20% EtOAc/hexanes); IR (neat) 3071, 
2942, 1702, 1286 cm-1; HRMS (ESI) m/z calculated for C22H37Cl2O4 (2M-H)
+ 435.2069, 
found: 435.2035; 1H NMR (400 MHz, CDCl3) δ 1.42-1.55 (m, 6H), 1.63-1.73 (m, 2H), 1.76-
1.83 (m, 2H), 2.08 (q, J = 7.2 Hz, 2H), 2.35-2.42 (m, 1H), 3.54 (t, J = 6.8 Hz, 2H), 4.96-5.05 
(m, 2H), 5.75-5.82 (m, 1H), 11.07 (br, 1H); 13C NMR (100 MHz, CDCl3) δ 24.7 (CH2), 26.5 
(CH2), 31.3 (CH2), 32.5 (CH2), 32.4 (CH2), 33.5 (CH2), 44.7 (CH2), 45.3 (CH), 114.8 (CH2), 
138.3 (CH), 182.8 (C).  
 
2-(Pent-4-en-1-yl)oct-7-enoic acid (1-153). Following the reported procedure,27 n-
BuLi (2.3M in hexane, 8.0 mL, 18.4 mmol) was slowly added to a solution of 
diisopropylamine (1.92 g, 19.0 mmol) in THF (20 mL) at 0 °C under N2 atmosphere. After 1 
h at 0 °C, a precooled solution of hept-6-enoic acid (0.836 g, 6.53 mmol) and DMPU (2.0 g, 
16 mmol) in THF (10 mL) was slowly added. After 1.5 h at room temperature, 6-iodo-1-
hexene (1.98 g, 9.40 mmol) was slowly added. The resulting mixture was warmed slowly to 
room temperature and stirring overnight. Saturated ammonium chloride was used to quench 
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the reaction. After separation, the aqueous layer was washed with ethyl ether three times. The 
combined organic layers were washed with brine, dried over anhydrous sodium sulfate, and 
concentrated. The residue was chromatographed (5-50% EtOAc/hexanes) to yield acid 1-153 
(1.12 g, 68%) as a colorless oil. Acid 1-153: Rf = 0.20 (100% EtOAc/hexanes); IR (neat) 
2932, 1705 cm-1; HRMS (ESI) m/z calculated for C13H21O2 (M-H)
- 209.1542, found: 
209.1597; 1H NMR (400 MHz, CDCl3) δ 1.41-1.58 (m, 8H), 1.63-1.70 (m, 2H), 2.03-2.09 (m, 
4H), 2.35-2.41 (m, 1H), 4.95-5.06 (m, 4H), 5.77-5.85 (m, 2H), 11.15 (br, 1H); 13C NMR (100 
MHz, CDCl3) δ 26.6 (CH2), 26.8 (CH2), 28.8 (CH2), 31.5 (CH2), 31.9 (CH2), 33.5 (CH2), 33.6 
(CH2), 45.4 (CH), 114.4 (CH2), 114.7 (CH2), 138.4 (CH), 138.7 (CH), 182.9 (C).  
 
2-(Pent-4-en-1-yl)hept-6-enoic acid (1-132).
39 According to the procedure described 
for 2-(pent-4-en-1-yl)oct-7-enoic acid (1-153), hept-6-enoic acid (1-152) (1.90 g, 14.8 mmol) 
and 5-iodo-1-pentene (2.94 g, 15.0 mmol) afforded after chromatography acid 1-132 (1.66 g, 
57%) as a colorless oil. Acid 1-132: Rf = 0.35 (20% EtOAc/hexanes); IR (neat) 2940, 1705, 
911 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.47-1.58 (m, 6H), 1.64-1.74 (m, 2H), 2.08 (q, J = 
6.8 Hz, 4H), 2.35-2.43 (m, 1H), 4.96-5.06 (m, 4H), 5.76-5.86 (m, 2H), 11.52 (br, 1H); 13C 
NMR (100 MHz, CDCl3) δ 26.6 (CH2), 31.5 (CH2), 33.6 (CH2), 45.3 (CH), 114.8 (CH2), 
138.4 (CH), 182.7 (C). 
 
1-(Pyrrolidin-1-yl)ethanone (1-155). To a suspension of pyrrolidine (7.1 g, 10 
mmol) in a mixed solvent of dichloromethane (50 mL) and aqueous NaOH (1 M, 30 mL) at 
0 °C under N2 atmosphere was added dropwise a solution of acetyl chloride (12 g, 15 mmol) 
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in dichloromethane (15 mL). The resulting mixture was stirred for 3 h. After separation, the 
aqueous layer was extracted with dichloromethane twice. The combined organic layers were 
washed with brine, dried over anhydrous sodium sulfate. The concentration afforded pure 
amide 1-155 (7.4 g, 65%) as a colorless oil. The spectral data matched with reported data.67  
 
1-(Pyrrolidin-1-yl)hept-6-en-1-one (1-154).  
Method I: To a solution of hept-6-enoic acid (1-152) (0.85 g, 6.6 mmol) in 
dichloromethane (100 mL) at 0 °C under N2 atmosphere was added one drop of DMF, 
followed by the dropwise addition of oxalyl chloride (1.3 mL, 20 mmol). The resulting 
mixture was stirred at 0 °C for 0.5 h and at room temperature for 2 h. The solvent was 
removed in rotovap. The residue was dissolved in dichloromethane (100 mL), followed by 
the slow addition of pyrrolidine (1.42 g, 20.0 mmol). The resulting mixture was stirred 
overnight, and then washed successively with 1 M HCl, 1 M NaOH, and brine, dried over 
anhydrous sodium sulfate. Concentration afforded amide 1-154 (1.25 g, 100%) as a colorless 
oil.  
Method II: To a solution of 1-(pyrrolidin-1-yl)ethanone (1-155) (3.4 g, 30 mmol) in 
THF (80 mL) at -78 °C under N2 atmosphere was added freshly prepared LDA (1 M, 36 mL, 
36 mmol). After 0.5 h at -78 °C, 5-bromo-1-pentene (5.4 g, 36 mmol) was slowly added. The 
resulting mixture was slowly warmed to room temperature in 2 h. Saturated ammonium 
chloride was used to quench the reaction. After separation, the aqueous layer was washed 
with ethyl acetate three times. The combined organic layers were washed with brine, dried 
over anhydrous sodium sulfate, and concentrated. The residue was chromatographed (5-50% 
EtOAc/hexanes) to yield amide 1-154 (4.3 g, 79%) as a colorless oil and 2-(pent-4-en-1-yl)-
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1-(pyrrolidin-1-yl)hept-6-en-1-one (0.7 g, 9%) as a colorless oil. Amide 1-154: Rf = 0.25 (50% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 1.41-1.49 (m, 2H), 1.63-1.72 (m, 2H), 1.81-
1.89 (m, 2H), 1.92-1.99 (m, 2H), 2.05-2.12 (m, 2H), 2.27 (t, J = 7.2 Hz, 2H), 3.41 (t, J = 6.8 
Hz, 2H), 3.46 (t, J = 6.9 Hz, 2H), 4.94 (ddt, J = 10.2, 2.1, 1.2 Hz, 1H), 5.01 (dq, J = 17.1, 1.7 
Hz, 1H), 5.81 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 24.4, 24.4, 
26.1, 28.8, 33.6, 34.6, 45.6, 46.60, 114.5, 138.7, 171.6.  
 
2-(Pent-4-en-1-yl)-1-(pyrrolidin-1-yl)hept-6-en-1-one. Rf = 0.35 (50% 
EtOAc/hexanes); IR (neat) 2929, 1640, 1444 cm-1; HRMS (ESI) m/z calculated for C16H28NO 
(M+H)+ 250.2171, found: 250.2181; 1H NMR (400 MHz, CDCl3) δ 1.30-1.50 (m, 6H), 1.63-
1.72 (m, 2H), 1.81-1.90 (m, 2H), 1.95 (q, J = 6.4 Hz, 2H), 2.00-2.08 (m, 4H), 2.48 (tt, J = 9.1, 
4.9 Hz, 1H), 3.49 (q, J = 7.1 Hz, 4H), 4.95 (ddd, J = 10.2, 2.0, 1.0 Hz, 1H), 5.00 (dq, J = 17.1, 
1.6 Hz, 1H), 5.79 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 24.4, 26.2, 
27.0, 32.5, 34.0, 43.8, 45.6, 46.7, 114.5, 138.7, 174.7. 
 
2-(4-Chlorobutyl)-1-(pyrrolidin-1-yl)hept-6-en-1-one (1-131).
38 To a solution of 
amide 1-154 (625 mg, 3.50 mmol) in THF (30 mL) at -78 °C under N2 atmosphere was added 
freshly prepared LDA (1.0 M, 4.9 mL, 4.9 mmol). After 2 h at -78 °C, 1-bromo-4-
chlorobutane (720 mg, 4.20 mmol) was slowly added. The resulting mixture was slowly 
warmed to room temperature and stirring overnight. Saturated ammonium chloride was used 
to quench the reaction. After separation, the aqueous layer was washed with ethyl acetate 
three times. The combined organic layers were washed with brine, dried over anhydrous 
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sodium sulfate, and concentrated. The residue was chromatographed (5-50% EtOAc/hexanes) 
to yield amide 1-131 (670 mg, 83%) as a colorless oil. Amide 1-131: Rf = 0.65 (100% 
EtOAc/hexanes); IR (neat) 2936, 1638, 1432 cm-1; HRMS (ESI) m/z calculated for 
C15H27ClNO (M+H)
+ 272.1781, found: 272.1779; 1H NMR (400 MHz, CDCl3) δ 1.31-1.50 
(m, 6H), 1.62-1.73 (m, 2H), 1.74-1.82 (m, 2H), 1.85-1.91 (m, 2H), 1.93-1.99 (m, 2H), 2.00-
2.09 (m, 2H), 2.49 (tt, J = 9.4, 4.7 Hz, 1H), 3.46-3.59 (m, 6H), 4.92-4.97 (m, 1H), 5.00 (dq, J 
= 17.2, 1.6 Hz, 1H), 5.79 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
24.4, 25.0, 26.2, 26.9, 32.1, 32.5, 32.8, 33.9, 43.8, 45.0, 45.6, 46.7, 114.6, 138.6, 174.4. 
 
(E)-2-(Pent-4-en-1-yl)-1-(pyrrolidin-1-yl)oct-6-en-1-one (1-156). According to the 
procedure described for amide 1-131, amide 1-154 (363 mg, 2.00 mmol) and (E)-6-Iodo-2-
hexene (465 g, 2.20 mmol) afforded after chromatography amide 1-156 (475 mg, 85%) as a 
colorless oil. Amide 1-156: Rf = 0.55 (50% EtOAc/hexanes); HRMS (ESI) m/z calculated for 
C17H30NO (M+H)
+ 264.2327, found: 264.2320; 1H NMR (400 MHz, CDCl3) δ 1.24-1.49 (m, 
6H), 1.58-1.72 (m, 5H), 1.80-1.91 (m, 2H), 1.91-2.00 (m, 4H), 2.00-2.09 (m, 2H), 2.46 (tt, J 
= 9.0, 5.0 Hz, 1H), 3.49 (dt, J = 8.6, 6.9 Hz, 4H), 4.94 (ddt, J = 10.2, 2.1, 1.1 Hz, 1H), 5.00 
(dq, J = 17.1, 1.6 Hz, 1H), 5.37-5.44 (m, 2H), 5.79 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 17.9, 24.4, 26.2, 27.0, 27.7, 32.5, 32.6, 32.8, 34.0, 43.8, 45.56, 
46.7, 114.5, 125.0, 131.1, 138.7, 174.7.  
 
2-(Pent-4-en-1-yl)-1-(pyrrolidin-1-yl)oct-7-en-1-one (1-157). According to the 
procedure described for amide 1-131, amide 1-154 (625 mg, 3.50 mmol) and 6-iodo-1-hexene 
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(700 mg, 4.20 mmol) afforded after chromatography amide 1-157 (470 mg, 52%) as a 
colorless oil. Amide 1-157: Rf = 0.35 (50% EtOAc/hexanes); IR (neat) 2928, 1639, 1437 cm
-1; 
HRMS (ESI) m/z calculated for C17H30NO (M+H)
+ 264.2327, found: 264.2320; 1H NMR 
(400 MHz, CDCl3) δ 1.21-1.49 (m, 8H), 1.60-1.71 (m, 2H), 1.80-1.90 (m, 2H), 1.91-1.99 (m, 
2H), 2.00-2.08 (m, 4H), 2.41-2.50 (m, 1H), 3.48 (q, J = 7.0 Hz, 4H), 4.91-4.95 (m, 2H), 4.95-
5.02 (m, 2H), 5.73-5.84 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 24.4, 26.2, 27.0, 27.2, 29.1, 
32.5, 32.8, 33.7, 34.0, 43.9, 45.6, 46.7, 114.3, 114.5, 138.9, 138.9, 174.8. 
 
(E)-1-(Pyrrolidin-1-yl)oct-6-en-1-one (1-158). According to the procedure 
described for amide 1-131, amide 1-155 (625 mg, 3.50 mmol) and (E)-6-iodo-2-hexene (3.15 
g, 15.0 mmol) afforded after chromatography amide 1-158 (680 mg, 35%) and amide 1-159 
(870 mg, 31%) as a colorless oil. Amide 1-158: Rf = 0.25 (50% EtOAc/hexanes); HRMS (ESI) 
m/z calculated for C12H22NO (M+H)
+ 196.1701, found: 196.1682; 1H NMR (400 MHz, 
CDCl3) δ 1.35-1.45 (m, 2H), 1.59-1.70 (m, 5H), 1.86 (q, J = 6.6 Hz, 2H), 1.96 (q, J = 6.6 Hz, 
2H), 2.22-2.29 (m, 2H), 3.41 (t, J = 6.8 Hz, 2H), 3.47 (t, J = 6.8 Hz, 2H), 5.40-5.44 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 17.9, 24.4, 24.5, 26.1, 29.4, 32.4, 34.7, 45.6, 46.6, 125.0, 
131.1, 171.8. 
 
(E)-2-((E)-Hex-4-en-1-yl)-1-(pyrrolidin-1-yl)oct-6-en-1-one (1-159). Amide 1-159: 
Rf = 0.50 (50% EtOAc/hexanes); HRMS (ESI) m/z calculated for C18H32NO (M+H)
+ 
278.2484, found: 278.2441; 1H NMR (400 MHz, CDCl3) δ 1.25-1.36 (m, 4H), 1.37-1.47 (m, 
2H), 1.57-1.69 (m, 8H), 1.81-1.90 (m, 2H), 1.90-2.01 (m, 6H), 2.45 (tt, J = 8.9, 5.0 Hz, 1H), 
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3.45-3.51 (m, 4H), 5.38-5.43 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 17.9, 24.4, 26.2, 27.7, 
32.6, 32.8, 43.8, 45.6, 46.7, 125.0, 131.1, 174.8.  
 
(E)-2-(4-Chlorobutyl)-1-(pyrrolidin-1-yl)oct-6-en-1-one. According to the 
procedure described for amide 1-131, amide 1-156 (391 mg, 2.00 mmol) and 4-bromo-1-
chlorobutane (380 mg, 2.2 mmol) afforded after chromatography the title amide (335 mg, 82% 
brsm) and amide 1-156 (113 mg) as a colorless oil. The title amide: Rf = 0.60 (100% 
EtOAc/hexanes); HRMS (ESI) m/z calculated for C16H29ClNO (M+H)
+ 286.1938, found: 
286.1921; 1H NMR (400 MHz, CDCl3) δ 1.23-1.35 (m, 2H), 1.36-1.49 (m, 4H), 1.56-1.71 (m, 
5H), 1.72-1.82 (m, 2H), 1.82-1.92 (m, 2H), 1.92-2.01 (m, 4H), 2.47 (tt, J = 9.1, 4.9 Hz, 1H), 
3.45-3.58 (m, 6H), 5.34-5.46 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 17.9, 24.4, 25.0, 26.2, 
27.6, 32.1, 32.6, 32.8, 43.8, 45.0, 45.6, 46.7, 125.1, 131.0, 174.5. 
 
(1S*, 5R*, 7R*)-1-((E)-Hex-4-en-1-yl)-7-methylbicyclo[3.1.1]heptan-6-one (1-
160). To a solution of amide 1-159 (726 mg, 2.60 mmol) and 2,6-di-tert-butyl-4-methyl 
pyridine (1.23 g, 6.02 mmol) in anhydrous 1,2-dichloroethane (20 mL) under N2 atmosphere 
at reflux was added dropwise a solution of triflic anhydride (1.47 g, 5.20 mmol) in anhydrous 
1,2-dichloroethane (10 mL) over a period of 16 h using syringe pump. After the addition, the 
resulting mixture was allowed to reflux for additional 30 h. The reaction was cooled to room 
temperature and the solvent was removed under reduced pressure. Carbon tetrachloride (25 
mL) and water (25 mL) were added and the mixture was heated to reflux for 6 h. The 
resulting mixture was cooled to room temperature and two phases separated. The organic 
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phase was dried over anhydrous sodium sulfate. The concentrated residue was purified by 
chromatography (1-5% EtOAc/hexanes) to afford cyclobutanone 1-160 (210 mg, 39%) as a 
colorless oil. Cyclobutanone 1-160: Rf = 0.25 (5% EtOAc/hexanes); 
1H NMR (400 MHz, 
CDCl3) δ 1.00 (d, J = 6.8 Hz, 3H), 1.18-1.30 (m, 1H), 1.38-1.48 (m, 3H), 1.56-1.64 (m, 1H), 
1.63-1.67 (m, 3H), 1.74-1.84 (m, 1H), 1.92-2.00 (m, 3H), 2.07 (ddd, J = 12.9, 7.7, 3.6 Hz, 
1H), 2.22-2.33 (m, 3H), 2.60 (t, J = 3.2 Hz, 1H), 5.37-5.46 (m, 2H); 13C NMR (101 MHz, 
CDCl3) δ 14.6, 17.9, 18.9, 23.6, 28.0, 33.1, 33.3, 35.8, 38.6, 62.1, 67.5, 125.2, 131.0, 215.4.  
 
(1R*, 5S*)-5-((E)-Hex-4-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-109) and (1S*, 5R*, 
7R*)-1-(pent-4-enyl)-7-methylbicyclo[3.1.1]heptan-6-one (1-162). To a solution of amide 
1-156 (432 mg, 1.65 mmol) and collidine (242 mg, 2.00 mmol) in anhydrous 1,2-
dichloroethane (17 mL) under N2 atmosphere at reflux was added dropwise a solution of 
triflic anhydride (508 mg, 1.80 mmol) in anhydrous 1,2-dichloroethane (5 mL) over a period 
of 2 h using a syringe pump. After addition, the resulting mixture was allowed to reflux for 
additional 24 h. The reaction was cooled to room temperature and the solvent was removed 
under reduced pressure. Carbon tetrachloride (20 mL) and water (20 mL) were added and the 
mixture was heated to reflux for 7 h. The resulting mixture was cooled to room temperature, 
aqueous HCl (1 M, 2 mL, 2 mmol) was added and two phases were separated. The organic 
phase was dried over anhydrous sodium sulfate. The concentrated residue was purified by 
chromatography (1-5% EtOAc/hexanes) to afford a mixture of cyclobutanone 1-109 and 1-
162 (2:1 ratio, 131 mg, 41%, 62% brsm) as a colorless oil and amide 1-156 (142 mg). 
Cyclobutanone 1-109 (diagnostic peaks only): Rf = 0.45 (5% EtOAc/hexanes); 
1H NMR (400 
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MHz, CDCl3) δ  1.63-1.68 (m, 3H), 2.44 (dd, J = 18.4, 4.5 Hz, 1H), 2.58-2.62 (m, 1H), 3.12 
(dd, J = 18.4, 9.5 Hz, 1H), 5.35-5.46 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 62.1, 67.4, 
125.2, 130.9. Cyclobutanone 1-162 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 
1.00 (d, J = 6.8 Hz, 3H), 2.55-2.59 (m, 1H), 4.97 (ddt, J = 10.2, 2.2, 1.2 Hz, 2H), 5.02 (dq, J 
= 17.1, 1.6 Hz, 1H), 5.81 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
114.7, 138.5.  
 
(1R*, 5R*)-5-(Hex-5-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-111). To a solution of 
2-(pent-4-en-1-yl)oct-7-enoic acid (1-153) (0.95 g, 4.5 mmol) and one drop of DMF (2 drops) 
in benzene (15 mL) at 0 °C under N2 atmosphere was dropwise added oxalyl chloride (2.30 
mL, 26.5 mmol). After 0.5 h at room temperature, the reaction mixture was heated to reflux 
for 1.5 h. After the raction was cooled to room temperature, the solvent and excess oxalyl 
chloride was removed under reduced pressure. Toluene (10 mL) was added and removed 
again. This procedure was repeated twice. To a refluxing solution of triethylamine (4.5 mL, 
32 mmol) in toluene (50 mL) under N2 atmosphere was added dropwise a solution of the 
above residue in toluene (10 mL) using a syringe pump over 2 h. After the addition, the 
reaction mixture was allowed to reflux for another 24 h. After the reaction mixture was 
cooled to room temperature, water was added. After separation, diethyl ether was used to 
extract the product. The combined organic layers were washed with brine, dried over 
anhydrous sodium sulfate, and concentrated. The concentrated residue was purified by 
chromatography (0.5-5% EtOAc/hexanes) to afford cyclobutanone 1-111 (720 mg, 83%) as a 
colorless oil. Cyclobutanone 1-111: Rf = 0.30 (10% EtOAc/hexanes); IR (neat) 2932, 1772, 
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1069 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.25-1.48 (m, 5H), 1.54-1.73 (m, 4H), 1.79-1.83 (m, 
2H), 1.98-2.09 (m, 3H), 2.45 (dd, J = 4.4 Hz, 18.4 Hz, 1H), 2.55-2.59 (m, 1H), 3.12 (dd, J = 
9.6 Hz, 18.4 Hz, 1H), 4.94-5.03 (m, 2H), 5.75-5.82 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 
25.0 (CH2), 25.1 (CH2), 29.4 (CH2), 32.7 (CH2), 32.9 (CH2), 33.6 (CH2), 33.9 (CH), 35.4 
(CH2), 49.3 (CH2), 75.9 (C), 114.4 (CH2), 138.8 (CH), 218.3 (C).  
 
(1R*, 5S*)-5-(4-Chlorobutyl)bicyclo[3.2.0]heptan-6-one (1-101) and (1R*, 5R*)-
1-(4-chlorobutyl)bicyclo[3.1.1]heptan-6-one (1-163).  
Method I: To a solution of 2-(4-chlorobutyl)hept-6-enoic acid (1-131) (1.20 g, 5.50 
mmol) and one drop of DMF (2 drops) in benzene (15 mL) at 0 °C under N2 atmosphere was 
dropwise added oxalyl chloride (2.40 mL, 27.5 mmol). After 0.5 h at room temperature, the 
reaction mixture was heated to reflux for 1.5 h. After the reaction was cooled to room 
temperature, the solvent and excess oxalyl chloride was removed under reduced pressure. 
Toluene (10 mL) was added and removed again. This procedure was repeated twice. To a 
refluxing solution of triethylamine (4.63 mL, 33 mmol) in toluene (50 mL) under N2 
atmosphere was added dropwise a solution of the above residue in toluene (15 mL) using 
syringe pump in 3 h. After the addition, the reaction mixture was allowed to reflux for 
another 24 h. After the reaction mixture was cooled to room temperature, water was added. 
After separation, diethyl ether was used to extract the product. The combined organic layers 
were washed with brine, died over anhydrous sodium sulfate, and concentrated. The 
concentrated residue was purified by chromatography (0.5-5% EtOAc/hexanes) to afford 
fused cyclobutanone 1-101 (850 mg, 83%) as a colorless oil and a mixture of fused and 
crossed byclobutanone 1-101 and 1-163 (7:1 ratio, 30 mg, 3%) as a colorless oil.  
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Method II: To a solution of 2-(4-chlorobutyl)-1-(pyrrolidin-1-yl)hept-6-en-1-one 1-
131 (865 mg, 3.17 mmol) and 2,6-di-tert-butyl-4-methyl pyridine (1.95 g, 9.50 mmol) in 
anhydrous dichloromethane (50 mL) under N2 atmosphere at reflux was added dropwise a 
solution of triflic anhydride (2.23 g, 7.90 mmol) in anhydrous dichloromethane (11 mL) over 
a period of 10 h using syringe pump. After the addition, the resulting mixture was allowed to 
reflux for additional 24 h. The reaction was cooled to room temperature and the solvent was 
removed under reduced pressure. Carbon tetrachloride (25 mL) and water (25 mL) were 
added and the mixture was heated to reflux for 10 h. The resulting mixture was cooled to 
room temperature and two phases got separated. The organic phase was dried over anhydrous 
sodium sulfate. The concentrated residue was purified by chromatography (1-5% 
EtOAc/hexanes) to afford a mixture of fused and crossed cyclobutanone 1-101 and 1-163 
(15:1 ratio, 150 mg, 39%, 70% brsm) and amide 1-131 (380 mg). Cyclobutanone 1-101: Rf = 
0.30 (20% EtOAc/hexanes); IR (neat) 2945, 1771, 1449 cm-1; HRMS (ESI) m/z calculated for 
C11H18ClO (M+H)
+ 201.1046, found: 201.1029; 1H NMR (400 MHz, CDCl3) δ 1.32-1.41 (m, 
2H), 1.54-1.66 (m, 4H), 1.73-1.83 (m, 6H), 1.97 (dd, J = 6.4 Hz, 12.8 Hz, 1H), 2.41 (dd, J = 
4.4 Hz, 18.4 Hz, 1H), 2.53-2.57 (m, 1H), 3.09 (dd, J = 9.6 Hz, 18.4 Hz, 1H), 3.49 (t, J = 6.8 
Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 23.0 (CH2), 24.9 (CH2), 32.3 (CH2), 32.6 (CH2), 
32.92 (CH2), 34.0 (CH), 35.3 (CH2), 44.7 (CH2), 49.2 (CH2), 75.6 (C), 217.7 (C). Ketone 1-
163 (diagnostic peaks only): Rf = 0.27 (20% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 
2.18-2.23 (m, 2H), 2.95-2.98 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 18.1 (CH2), 21.8 (CH2), 
28.9 (CH2), 31.7 (CH2), 32.90 (CH2), 33.03 (CH2), 38.8 (CH2), 44.8 (CH2), 54.9 (CH), 65.9 
(C), 214.0 (C). The following data were used to assign cyclobutanone 1-101 and 1-163.  
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(1R*,5R*)-5-(Pent-4-enyl)bicyclo[3.2.0]heptan-6-one (1-112) and (1S*,5R*)-5-
(pent-4-enyl)bicyclo[3.1.1]heptan-6-one (1-133). According to the procedure described for 
(1R*, 5S*)-5-(4-chlorobutyl)bicyclo[3.2.0]heptan-6-one 1-101, 2-(pent-4-en-1-yl)hept-6-
enoic acid (1-132) (600 mg, 3.00 mmol) afforded after chromatography a mixture of fused 
and crossed byclobutanone 1-112 and 1-133 (25:1 ratio, 400 mg, 75%) as a colorless oil. 
Ketone 1-112: Rf = 0.35 (5% EtOAc/hexanes); chiral GC (column: Astec ChiralDEX
TM B-
DM; 45-190 °C at 3 °C /min) (±)-1-112:  tR = 31.38 min and 32.03 min; 
1H NMR (400 MHz, 
acetone) δ 1.34-1.42 (m, 2H), 1.52-1.71 (m, 4H), 1.79-1.82 (m, 3H), 1.98-2.07 (m, 3H), 2.43 
(dd, J = 4.4 Hz, 17.2 Hz, 1H), 2.55-2.58 (m, 1H), 3.11 (dd, J = 8.4 Hz, 14.4 Hz, 1H), 4.95-
503 (m, 2H), 5.73-5.82 (m, 1H); 13C NMR (100 MHz, acetone) δ 24.9 (CH2), 25.0 (CH2), 
32.6 (CH2), 32.7 (CH2), 34.0 (CH2), 34.1 (CH2), 35.3 (CH2), 75.2 (C), 114.7 (CH2), 138.4 
(CH), 218.2 (C). Ketone 1-133: Rf = 0.60 (10% EtOAc/hexanes); chiral GC (column: Astec 
ChiralDEXTM B-DM;  45-190 °C at 3 °C/min) (±)-1-133: tR = 33.34 min and 33.62 min; IR 
(neat) 2931, 1771, 1117 cm-1; HRMS (ESI) m/z calculated for (C12H18O+H)
+ 179.1436, found: 
179.1443; 1H NMR (400 MHz, CDCl3) δ 1.36-1.47 (m, 3H), 1.48-1.58 (m, 1H), 1.62-1.69 (m, 
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2H), 1.77-1.87 (m, 2H), 2.00-2.09 (m, 3H), 2.21-2.28 (m, 3H), 2.98-3.03 (m, 1H), 4.95-5.05 
(m, 2H), 5.75-5.86 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 18.1 (CH2), 23.8 (CH2), 28.9 
(CH2), 32.0 (CH2), 33.1 (CH2), 34.2 (CH2), 38.9 (CH2), 54.9 (CH), 66.2 (C), 114.7 (CH2), 
138.6 (CH), 214.6 (C). The following data were used to assign ketone 1-133.  
 
 
 
1-((2S,5S)-2,5-Dimethylpyrrolidin-1-yl)-2-(pent-4-enyl)hept-6-en-1-one (1-165). 
A solution of (S,S)-N-Boc-2,5-dimethylpyrrolidine (200 mg, 1.00 mmol) in hydrochloric 
diethyl ether (2.0 M, 10 mL, 20 mmol) was stirred overnight. According to the procedure 
described for chiral amide (R, R)- 1-166, 2-(pent-4-en-1-yl)hept-6-enoic acid (1-132) (200 mg, 
1.00 mmol) afforded after chromatography chiral amide 1-165 (160 mg, 75%) as a colorless 
oil. Amide 1-165: [α]
546
25
 -15.2 (c 3.0, dichloromethane). The spectral data matched with the 
data of 1-166.  
 
1-((2R,5R)-2,5-Dimethylpyrrolidin-1-yl)-2-(pent-4-enyl)hept-6-en-1-one (1-166). 
To a stirred solution of 2-(pent-4-enyl)hept-6-enoic acid (1-132) (108 mg, 0.550 mmol) and 
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one drop of DMF in dichloromethane (5 mL) at 0 °C was slowly added oxalyl chloride (0.47 
mL, 5.5 mmol). The resulting reaction mixture was allowed to warm to room temperature and 
was stirred for 5 h. The solvent was removed under reduced pressure. To a stirred solution of 
(2R,5R)-2,5-dimethylpyrrolidine (50 mg, 0.50 mmol) and 2.5 M aqueous NaOH (2 mL, 5 
mmol) in dichloromethane (6 mL) at 0 °C was slowly added a solution of the above residue 
in dichloromethane (5 mL). The resulting reaction mixture was allowed naturally to warm to 
room temperature and was stirred overnight. Saturated aqueous NH4Cl was used to quench 
the reaction. The aqueous layer was extracted three times with dichloromethane, washed with 
brine, dried over Na2SO4, filtered, and concentrated. The resulting residue was purified by 
silica gel chromatography (4-7% EtOAC/hexanes) to afford amide 1-166 (105 mg, 77%) as a 
colorless oil and amide 1-167 (25 mg, 20%) as a colorless oil. Amide 1-166: [α]
546
25
 +17.0 (c 
3.5, dichloromethane); Rf = 0.35 (20% EtOAc/hexanes); IR (neat) 2967, 2930, 1635, 1418 
cm
-1
; HRMS (ESI) m/z calculated for (C18H31NO+H)
+
 278.2484, found: 278.2484; 
1
H NMR 
(400 MHz, CDCl3) δ 1.15 (d, J = 3.2 Hz, 3H), 1.16 (d, J = 3.2 Hz, 3H), 1.36-1.43 (m, 5H), 
1.45-1.54 (m, 3H), 1.57-1.62 (m, 1H), 1.65-1.70 (m, 1H), 2.01-2.23 (m, 6H), 2.39-2.45 (m, 
1H), 4.03 (quintet, J = 6.4 Hz, 1H), 4.24 (quintet, J = 6.4 Hz, 1H), 4.91-5.00 (m, 4H), 5.72-
5.84 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 18.9 (CH3), 22.5 (CH3), 26.4 (CH2), 27.2 (CH2), 
29.0 (CH2), 30.9 (CH2), 31.9 (CH2), 33.3 (CH2), 33.9 (CH2), 34.1 (CH2), 43.4 (CH), 53.0 
(CH), 53.2 (CH), 114.4 (CH2), 114.5 (CH2), 138.6 (CH), 138.7 (CH), 174.6 (C). 
 
N,N-Dimethyl-2-(pent-4-en-1-yl)hept-6-enamide (1-167). Amide 1-167: Rf = 0.25 
(20% EtOAc/hexanes); IR (neat) 2928, 1639, 1398 cm-1; HRMS (ESI) m/z calculated for 
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C14H26NO (M+H)
+ 224.2014, found: 224.2043; 1H NMR (400 MHz, CDCl3) δ 1.30-1.50 (m, 
6H), 1.63-1.71 (m, 2H), 2.01-2.08 (m, 4H), 2.64-2.71 (m, 1H), 2.99 (s, 3H), 3.07 (s, 3H), 
4.93-5.02 (m, 4H), 5.74-5.84 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 26.9 (CH2), 32.5 (CH2), 
33.9 (CH2), 35.7 (CH or CH3), 37.4 (CH or CH3), 41.0 (CH or CH3), 114.6 (CH2), 138.6 (CH), 
176.2 (C).  
 
2-(Pent-4-en-1-yl)hept-6-enamide (1-168). According to the procedure described 
for chiral amide 1-166, amide 1-168 was obtained as a side product when the reaction was 
quenched with saturated ammonium chloride. Amide 1-168: a colorless oil, Rf = 0.30 (100% 
EtOAc/hexanes); IR (neat) 3374, 2932, 1642, 1460 cm-1; HRMS (ESI) m/z calculated for 
C12H22NO (M+H)
+ 196.1701, found: 196.1714; 1H NMR (400 MHz, CDCl3) δ 1.38-1.50 (m, 
6H), 1.58-1.68 (m, 2H), 2.04-2.10 (m, 4H), 2.10-2.15 (m, 1H), 4.95-5.04 (m, 4H), 5.48 (br, 
1H), 5.76 (br, 1H), 5.74-5.84 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 26.8 (CH2), 32.4 (CH2), 
33.7 (CH2), 47.0 (CH), 114.7 (CH2), 138.4 (CH), 178.4 (C). 
 
N,N-Diethyl-2-(pent-4-en-1-yl)hept-6-enamide (1-169). To a suspension of 2-
(pent-4-en-1-yl)oct-7-enoic acid (50 mg, 0.25 mmol), HOBt (42 mg, 0.30 mmol), DMAP (6 
mg, 0.05 mmol), triethylamine (101 mg, 1.00 mmol), and (2R,5R)-2,5-dimethylpyrrolidine 
(10 mg, 0.10 mmol) in DMF (3 mL) was added EDCI (60 mg, 0.30 mmol). The resulting 
mixture was stirred at room temperature overnight. Ethyl acetate and water was added to 
quench the reaction. After the separation, the aqueous layer was washed with ethyl acetate 
three times. The combined organic layers were washed with brine and dried over anhydrous 
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sodium sulfate. The concentrated residue was purified by chromatography (5-20% 
EtOAc/hexanes) to afford amide 1-169 (28 mg, 44%) as a colorless oil. Amide 1-169: Rf = 
0.20 (20% EtOAc/hexanes); IR (neat) 2931, 1640, 1462 cm-1; HRMS (ESI) m/z calculated for 
C16H30NO (M+H)
+ 252.2327, found: 252.2281; 1H NMR (400 MHz, CDCl3) δ 1.13 (t, J = 7.2 
Hz, 3H), 1.85 (t, J = 7.2 Hz, 3H), 1.32-1.49 (m, 6H), 1.61-1.70 (m, 2H), 2.02-2.08 (m, 4H), 
2.51-2.58 (m, 1H), 3.33-3.43 (m, 4H), 4.93-5.03 (m, 4H), 5.75-5.85 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 13.1 (CH3), 15.0 (CH3), 27.0 (CH2), 32.7 (CH2), 34.0 (CH2), 40.4 (CH2), 41.1 
(CH), 41.8 (CH2), 114.5 (CH2), 138.7 (CH), 175.2 (C).  
 
N,N-Diisopropylhept-6-enamide (1-170). To a solution of hept-6-enoic acid (1-152) 
(57 mg, 0.20 mmol) and catalytic amount of DMF (1 drops) in dichloromethane (3 mL) at 
0 °C under N2 atmosphere was dropwise added oxalyl chloride (0.1 mL, 1 mmol). After 0.5 h 
at room temperature, the solvent and excess oxalyl chloride was removed under reduced 
pressure. Dichlromethane (10 mL) was added and removed again. The above residue was 
dissolved in dichloromethane (5 mL) under N2 atmosphere and cooled to 0 °C. 
Diisopropylethylamine (128 mg, 1.00 mmol) and (2R,5R)-2,5-dimethylpyrrolidine (10 mg, 
0.10 mmol) was added slowly. The reaction mixture was stirred overnight. Water was used to 
quench the reaction. After separation, dichloromethane was used to extract the product. The 
combined organic layers were washed with brine, died over anhydrous sodium sulfate, and 
concentrated. The concentrated residue was purified by chromatography (5-20% 
EtOAc/hexanes) to afford amide 1-170 (62 mg, 66%) as a colorless oil. Amide 1-170: Rf = 
0.25 (20% EtOAc/hexanes); IR (neat) 2966, 1645, 1441 cm-1; HRMS (ESI) m/z calculated for 
C13H25NONa (M+Na)
+ 234.1834, found: 234.1834; 1H NMR (400 MHz, CDCl3) δ 1.19 (d, J 
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= 6.4 Hz, 3H), 1.37 (d, J = 6.4 Hz, 3H), 1.37-1.47 (m, 2H), 1.59-1.67 (m, 2H), 2.05-2.11 (m, 
2H), 2.25-2.29 (m, 2H), 3.47 (br, 1H), 3.92-3.99 (m, 1H), 4.92-5.03 (m, 1H), 5.75-5.85 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 20.7 (CH3), 21.0 (CH3), 24.9 (CH2), 28.7 (CH2), 33.6 
(CH2), 35.2 (CH2), 45.5 (CH), 48.2 (CH), 114.4 (CH2), 138.7 (CH), 171.8 (C).  
 
(1S,5S)-5-(Pent-4-enyl)bicyclo[3.2.0]heptan-6-one ((S)-1-112) and (1R,5S)-5-
(pent-4-enyl) bicyclo[3.1.1]heptan-6-one ((S)-1-133). According to the procedure described 
for (R)-1-112, amide 1-166 afforded after chromatography (S)-1-112 (61%). Iminium ion (S)-
1-171 and (S)-1-172: [α]
546
25
 +79.0 (c 1.2, dichloromethane); Ketone (S)-1-112: [α]
546
25
 +73.0 
(c 0.12, dichloromethane).  
 
(1R,5R)-5-(Pent-4-enyl)bicyclo[3.2.0]heptan-6-one ((R)-1-112) and (1S,5R)-5-
(pent-4-enyl) bicyclo[3.1.1]heptan-6-one ((R)-1-133). One-pot procedure: To a refluxing 
solution of amide 1-166 (87 mg, 0.31 mmol) and 2,6-di-tert-butyl-4-methylpyridine (81 mg, 
0.39 mmol) in 1,2-dichloroethane (5 mL) was added a solution of triflic anhydride (97 mg, 
0.35 mmol) in 1,2-dichloroethane (2 mL) over 12 h using a syringe pump. The solution was 
allowed to reflux for another 5 h, after which the reaction was cooled to room temperature 
and concentrated. To the residue in a mixed solvent of acetone (4 mL) and water (4 mL) was 
added potassium carbonate (217 mg, 1.57 mmol). The resulting mixture was heated to reflux 
for 3 h. After the reaction was cooled to room temperature, 1 M HCl was used to adjust the 
pH to 2-3. The aqueous layer was extracted three times with diethyl ether, washed with brine, 
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dried over anhydrous sodium sulfate, filtered, and concentrated. The resulting residue was 
purified by silica gel chromatography (0.1% EtOAC/hexanes) to afford ketone (R)-1-112 (34 
mg, 61%) as a colorless oil and ketone (R)-1-133 (5 mg, 9%) as a colorless oil. Ketone (R)-1-
112: [α]
546
25
 -100.0 (c 1.35, dichloromethane); tR = 32.03 min (chiral GC column: Astec 
ChiralDEXTM B-DM; 45-190 °C at 3 °C/min); Rf = 0.65 (10% EtOAc/hexanes); spectral data 
matched with reported data.S13 Ketone (R)-1-133: tR = 33.62 (chiral GC column: Astec 
ChiralDEXTM B-DM; 45-190 °C at 3 °C/min).  
Two-pot procedure:  To a refluxing solution of amide 1-166 (43 mg, 0.155 mmol) 
and 2,6-di-tert-butyl-4-methylpyridine (40 mg, 0.194 mmol) in 1,2-dichloroethane (5 mL) 
was added a solution of triflic anhydride (48 mg, 0.17 mmol) in  1,2-dichloroethane (2 mL) 
over 12 h using syringe pump. The solution was allowed to reflux for another 5 h, after which 
the reaction was cooled down to room temperature and concentrated. The resulting residue 
was purified by silica gel chromatography (0.5%-4% MeOH/DCM) to afford a mixture of 
iminium ion (R)-1-171 and (R)-1-172 as a colorless oil (55 mg, 87%, 7:1 ratio). Iminium ion 
(R)-1-171 and (R)-1-172: [α]
546
25
 -115.0 (c 1.05, DCM); HRMS (ESI) m/z calculated for (M-
OTf)+  (C18H30N+) 260.2378, found: 260.2351. IR (neat): 2941, 1684, 1263, 1152, 1030 cm-
1. Iminium ion (R)-1-171: 1H NMR (400 MHz, CDCl3) δ 1.39 (d, J = 6.8 Hz, 3H), 1.49 (d, J = 
6.8 Hz, 3H), 1.38-1.52 (m, 2H), 1.58-1.68 (m, 1H), 1.69-1.75 (m, 1H), 1.76-1.85 (m, 4H), 
1.92 (dd, J = 6.4 Hz, 12.8 Hz, 1H), 1.98-2.04 (m, 1H), 2.06-2.18 (m, 3H), 2.40 (septet, J = 
6.8 Hz, 1H), 2.61 (septet, J = 6.8 Hz, 1H), 2.74 (dd, J = 4.0 Hz, 20.4 Hz, 1H), 2.90 (quintet, J 
= 4.8 Hz, 1H), 3.91 (dd, J = 6.0 Hz, 20.4 Hz, 1H), 4.50 (quintet, J = 6.8 Hz, 1H), 4.84 
(quintet, J = 6.8 Hz, 1H), 4.98-5.06 (m, 2H), 5.72-5.83 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 18.9 (CH3), 21.8 (CH3), 23.8 (CH2), 25.3 (CH2), 29.3 (CH2), 30.6 (CH2), 31.9 (CH2), 33.3 
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(CH2), 33.6 (CH2), 34.7 (CH2), 36.7 (CH), 38.2 (CH2), 62.3 (CH), 62.8 (CH), 66.6 (C), 115.7 
(CH2), 120.9 (q, J = 317 Hz, CF3), 137.5 (CH), 200.3 (C); 
19 F NMR (376.5 MHz, CDCl3) δ -
78.24. Iminium ion (R)-1-172 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.41 (d, 
J = 6.8 Hz, 3H), 1.51 (d, J = 6.8 Hz, 3H), 3.68 (t, J = 6.8 Hz, 1H), 4.58 (quintet, J = 6.8 Hz, 
1H), 4.92 (quintet, J = 6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 19.1 (CH2), 20.9 (CH2), 
22.4 (CH2), 23.3 (CH2), 29.6 (CH2), 33.5 (CH2), 33.7 (CH2), 35.1 (CH2), 36.8 (CH2), 39.8 
(CH2), 48.1 (CH2), 60.9 (CH2), 62.3 (CH2), 63.6 (CH2), 115.5 (CH2), 137.6 (CH), 199.0 (C). 
The following data and NOE correlations were used to assign Iminium ion (R)-1-171 and (S)-
1-171.  
 
 
 
To a mixture of iminium ions (R)-1-171 and (R)-1-172 (55 mg, 0.135 mmol) in a 
mixed solvent of acetone (3 mL) and water (3 mL) was added potassium carbonate (93 mg, 
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0.68 mmol). The resulting mixture was heated to reflux for 3 h.  After the reaction was cooled 
down to room temperature, 1 M HCl was used to adjust to pH = 2~3.  Diethyl ether was used 
to extract the product.  The aqueous layer was extracted three times with diethyl ether, 
washed with brine, dried over Na2SO4, filtered and concentrated. The resulting residue was 
purified by silica gel chromatography (0.1% EtOAC/hexanes) to afford ketone (R)-1-112 (17 
mg, 71%) as a colorless oil and ketone (R)-1-133 (2.5 mg, 10%) as a colorless oil. 
Recovery of (2R,5R)-2,5-dimethylpyrrolidine A stirred aqueous solution (~10 mL) 
from the above procedure, which contains (2R,5R)-2,5-dimethylpyrrolidine (~ 0.97 mmol), 
was adjusted to pH ~ 13-14 using 2.5 M aqueous NaOH, followed by the addition of DCM 
(10 mL). The resulting mixture was cooled to 0 °C and a solution of 2-(pent-4-enyl)hept-6-
enoyl chloride (1.1 mmol) in DCM (5 mL) was added slowly. The resulting reaction mixture 
was allowed naturally to rise to room temperature and was stirred overnight. Saturated 
aqueous NH4Cl was used to quench the reaction.  The aqueous layer was extracted 3× with 
DCM, washed with brine, dried over Na2SO4, filtered, and concentrated.  The resulting 
residue was purified by silica gel chromatography (4%-7% EtOAC/hexanes) to afford 1-166 
(176 mg, 65%, recovery rate: 85%) as a colorless oil. 
 
(1R*,5R*,6S*)-5-(Pent-4-en-1-yl)bicyclo[3.2.0]heptan-6-ol (1-173) and 
(1R*,5R*,6R*)-5-(pent-4-en-1-yl)bicyclo[3.2.0]heptan-6-ol (1-174). To a solution of 
cyclobutanone 1-112 (166 mg, 0.930 mmol) in methanol (12 mL) at 0 °C under N2 
atmosphere was added slowly sodium borohydride (106 mg, 2.80 mmol). After the reaction 
mixture was stirred for 3 h, aqueous ammonium chloride was used to quench the reaction. 
Methanol was removed under reduced pressure. Diethyl ether and water were added and after 
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the separation, the aqueous layer was washed with diethyl ether three times. The combined 
organic layers were washed with brine and dried over sodium sulfate. The concentration 
afforded a mixture of alcohols 1-173 and 1-174 (10:1 ratio, 150 mg, 90%) as a colorless oil, 
which was used directly in the next step. Alcohols 1-173 and 1-174 (10:1 ratio): IR (neat) 
3336, 2930, 1074 cm-1; Alcohol 1-173: 1H NMR (400 MHz, acetone) δ 1.13 (td, J = 11.6, 7.4 
Hz, 1H), 1.21-1.36 (m, 2H), 1.37-1.47 (m, 3H), 1.48-1.58 (m, 2H), 1.70-1.80 (m, 1H), 1.88-
1.99 (m, 2H), 2.00-2.13 (m, 3H), 2.36 (dt, J = 12.6, 8.8 Hz, 1H), 3.75 (d, J = 5.4 Hz, 1H), 
3.95 (dt, J = 8.8, 6.1 Hz, 1H), 4.88-4.96 (m, 1H), 4.96-5.06 (m, 1H), 5.82 (ddt, J = 17.0, 10.2, 
6.7 Hz, 1H); 13C NMR (100 MHz, acetone) δ 24.2 (CH2), 26.0 (CH2), 30.0 (CH2), 32.2 (CH2), 
32.5 (CH2), 34.3 (CH2), 37.5 (CH), 40.0 (CH2), 55.4 (C), 69.6 (CH), 113.8 (CH2), 139.0 (CH). 
Alcohol 1-174 (diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.85-3.92 (m, 1H); 
13C NMR (100 MHz, acetone) δ 24.4 (CH2), 25.5 (CH2), 31.9 (CH2), 32.2 (CH2), 33.8 (CH2), 
34.7 (CH2), 36.3 (CH2), 37.3 (CH), 54.5 (C), 71.2 (CH), 113.6 (CH2), 139.2 (CH). The 
following data and NOE correlations were used to assign alcohol 1-173.  
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(1S,5S,6R)-5-(Pent-4-en-1-yl)bicyclo[3.2.0]heptan-6-yl 4-bromobenzoate (1-175) 
and (1S,5S,6S)-5-(pent-4-en-1-yl)bicyclo[3.2.0]heptan-6-yl 4-bromobenzoate (1-176). 
According to the procedure for the preparation of alcohols 1-173 and 1-174, (S)-1-112 (28 
mg, 0.16 mmol) afforded a mixture of alcohols, which was used directly in the next step 
without further purification. According to the procedure described for lactam 1-207, the 
above residue and 4-bromobenzoyl chloride (110 mg, 0.500 mmol) afforded after 
chromatography (0.1% EtOAc/hexanes) a mixture of ester 1-175 and 1-176 (47 mg, 82%) as 
a powder. Ester 1-175 and 1-176 (10:1 ratio): [α]
546
25
 -18.7 (c 2.45, dichloromethane); Rf = 
0.85 (10% EtOAc/hexanes); IR (neat) 2933, 1717 cm-1; Ester 1-175: 1H NMR (400 MHz, 
CDCl3) δ 1.25-1.49 (m, 4H), 1.51-1.72 (m, 4H), 1.83-1.92 (m, 1H), 1.94-2.03 (m, 2H), 2.07 
(q, J = 7.1 Hz, 2H), 2.19 (q, J = 6.4 Hz, 1H), 2.63 (dt, J = 13.5, 8.9 Hz, 1H), 4.93-5.08 (m, 
3H), 5.82 (ddt, J = 16.9, 10.1, 6.7 Hz, 1H), 7.60 (d, J = 8.6 Hz, 2H), 7.91 (d, J = 8.7 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 24.3 (CH2), 26.1 (CH2), 30.1 (CH2), 31.7 (CH2), 32.9 (CH2), 
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34.3 (CH2), 38.2 (CH), 38.8 (CH2), 54.8 (C), 73.1 (CH), 114.5 (CH2), 127.9 (C), 129.5 (C), 
131.0 (CH), 131.7 (CH), 138.9 (CH), 165.1 (C). Ester 1-176 (diagnostic peaks only): 13C 
NMR (100 MHz, CDCl3) δ 24.5 (CH2), 25.9 (CH2), 31.3 (CH2), 32.0 (CH2), 32.2 (CH2), 34.6 
(CH2), 36.2 (CH2), 38.0 (CH), 52.3 (C), 74.8 (CH), 114.5 (CH2), 131.1 (CH), 131.1 (CH), 
131.7 (CH), 138.9 (CH). 
 
(S)-(1R,5R,6S)-5-(Pent-4-en-1-yl)bicyclo[3.2.0]heptan-6-yl 3,3,3-trifluoro-2-
methoxy-2-phenylpropanoate (1-177) and (S)-(1S,5S,6R)-5-(pent-4-en-1-yl)bicyclo[3.2.0] 
heptan-6-yl 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (1-178). To a suspension of 
Mosher’s acid (117 mg, 0.500 mmmol) and two drops of DMF in hexane (10 mL) at room 
temperature under N2 atmosphere was added slowly oxalyl chloride (0.43 mL, 5 mmol). After 
the resulting mixture was stirred for 2 h, the solid residue was filtrated and the filtrate 
concentrated. To the resulting residue and DMAP (122 mg, 1.00 mmol) was added a solution 
of alcohol 1-173 and 1-174 (10:1 ratio, 40 mg, 0.22 mmol) in dichloromethane (3 mL) at 
room temperature. After stirred overnight, the resulting mixture was concentrated. The 
concentrated residue was purified by chromatography (0.25% EtOAc/hexanes) to afford a 
mixture of esters 1-177 and 1-178 (1:1 ratio, 84 mg, 96%) as a powder. Esters 1-177 and 1-
178 (1:1 ratio): Rf = 0.45 (5% EtOAc/hexanes); IR (neat) 2948, 1747, 1169 cm
-1; HRMS (ESI) 
m/z calculated for C44H54F6O6Na (2M+Na)
+ 815.3722, found: 815.3718; 1H NMR (400 MHz, 
acetone) δ 1.15-1.34 (m, 3H), 1.34-1.64 (m, 11H), 1.64-1.88 (m, 7H), 1.96 (ddd, J = 13.4, 5.5, 
4.0 Hz, 1H), 2.01-2.12 (m, 4H), 2.17 (q, J = 6.5 Hz, 2H), 2.62 (dtd, J = 13.4, 8.8, 2.5 Hz, 2H), 
3.57 (q, J = 1.0 Hz, 3H), 3.58 (q, J = 1.0 Hz, 3H), 4.91-5.15 (m, 6H), 5.80-5.88 (m, 2H), 
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7.46-7.53 (m, 6H), 7.53-7.60 (m, 4H); 13C NMR (100 MHz, acetone) δ 24.0 (CH2), 24.2 
(CH2), 25.4 (CH2), 25.5 (CH2), 29.6 (CH2), 29.8 (CH2), 31.3 (CH2), 31.5 (CH2), 32.3 (CH2), 
33.97 (CH2), 34.00 (CH2), 38.3 (CH), 38.5 (CH), 38.8 (CH2), 38.9 (CH2), 54.3 (CH), 54.84 
(C), 54.87 (C), 54.89 (C), 54.90 (C), 54.92 (C), 74.2 (CH), 74.5 (CH), 113.97 (CH2), 114.01 
(CH2), 123.61 (q, J = 286 Hz, C), 123.64 (q, J = 286 Hz, C), 127.29 (CH), 127.31 (CH), 
127.37 (CH), 127.38 (CH), 128.37 (CH), 128.39 (CH), 129.62 (CH), 129.64 (CH), 132.4 (C), 
132.5 (C), 138.7 (CH), 165.2 (C), 165.2 (C). 
 
(1R*, 5S*)-5-(4-Azidobutyl)bicyclo[3.2.0]heptan-6-one (1-100) and (1R*, 5R*)-1-
(4-azidobutyl)bicyclo[3.1.1]heptan-6-one. The suspension of a mixture of fused and crossed 
cyclobutanone 1-101 and 1-163 (~20:1 ratio, 243 mg, 1.20 mmol) and sodium azide (390 mg, 
6.00 mmol)  in DMF (3 mL) under N2 atmosphere was heated to 80 °C for 4 h. After the 
reaction mixture was cooled to room temperature, diethyl ether and water were added. After 
the separation, the aqueous layer was extracted with diethyl ether three times. The combined 
layers were washed with water, brine, and dried over anhydrous sodium sulfate. The 
concentrated residue was directly used in the next step without further purification. Azide 1-
100: 1H NMR (400 MHz, CDCl3) δ 1.29-1.46 (m, 3H), 1.50-1.70 (m, 5H), 1.75-1.89 (m, 3H), 
2.03 (dd, J = 12.7, 6.2 Hz, 1H), 2.46 (dd, J = 18.5, 4.6 Hz, 1H), 2.54-2.61 (m, 1H), 3.13 (dd, 
J = 18.4, 9.5 Hz, 1H), 3.29 (t, J = 6.7 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 22.9, 25.0, 
29.3, 32.68, 32.70, 34.0, 35.3, 49.3, 51.2, 75.6, 217.8. Crossed azide (diagnostic peaks only): 
1H NMR (400 MHz, CDCl3) δ 2.19-2.28 (m, 3H), 2.98-3.04 (m, 1H); 
13C NMR (100 MHz, 
CDCl3) δ 18.1, 21.7, 28.9, 32.0, 33.1, 38.9, 51.3, 55.0, 65.9, 214.2.  
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Octahydrocyclopenta[i]indolizin-6(7H)-one (1-99). To a solution of the above 
residue in dichloromethane (10 mL) at 0 °C under N2 atmosphere was added slowly titanium 
tetrachloride (1 M in DCM, 3.6 mL, 3.6 mmol). After the reaction mixture stirred overnight, 
saturated aqueous sodium bicarbonate was used to quench the reaction. After the separation, 
the aqueous layer was extracted with DCM three times. The combined organic layers were 
washed with brine and dried over anhydrous sodium sulfate. The concentrated residue was 
purified by chromatography (50-200% EtOAc/hexanes) to afford lactam 1-99 (200 mg, 93% ) 
as a colorless oil. Lactam 1-99: Rf = 0.35 (100% EtOAc/hexanes); IR (neat) 2936, 1682, 1417 
cm-1; HRMS (ESI) m/z calculated for C11H18NO (M+H)
+ 180.1388, found: 180.1391; 1H 
NMR  (400 MHz, CDCl3) δ 1.20-1.60 (m, 9H), 1.64-1.68 (m, 1H), 1.72-1.84 (m, 2H), 1.94-
2.00 (m, 1H), 2.11-2.18 (m, 1H), 2.52-2.60 (m, 2H), 3.97 (dd, J = 2.8 Hz, 13.2 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 21.7 (CH2), 24.5 (CH2), 25.0 (CH2), 33.9 (CH2), 34.9 (CH2), 37.5 
(CH2), 37.8 (CH2), 37.8 (CH2), 41.8 (CH), 71.3 (C), 172.3 (C).  
 
2-(4-Azidobutyl)-1-(pyrrolidin-1-yl)hept-6-en-1-one (1-185). A suspension of 
chloride 1-131 (733 mg, 2.68 mmol) and sodium azide (873 mg, 13.4 mmol) in DMF (10 mL) 
was heated to 80 °C for 2 h. Diethyl ether and water were added to quench the reaction. After 
separation, the aqueous layer was extracted with diethyl ether three times. The combined 
organic layers were washed with brine, and dried over anhydrous sodium sulfate. The 
concentration afforded azide 1-185 (811 mg, 104%) as a colorless oil, which was used 
directly in the next step. Azide 1-185: IR (neat) 2935, 2095, 1638, 1433 cm
-1
; HRMS (ESI) 
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m/z calculated for C30H53N6O2 (2M-N2+H)
+ 529.4230, found: 529.4257; 1H NMR (400 MHz, 
CDCl3) δ 1.27-1.48 (m, 6H), 1.53-1.60 (m, 2H), 1.61-1.72 (m, 2H), 1.82-1.87 (m, 2H), 1.92-
1.97 (m, 2H), 1.99-2.06 (m, 2H), 2.46 (tt, J = 9.1, 5.0 Hz, 1H), 3.17-3.31 (m, 2H), 3.47 (q, J = 
7.1 Hz, 4H), 4.90-4.95 (m, 1H), 4.98 (dq, J = 17.2, 1.6 Hz, 1H), 5.77 (ddt, J = 16.9, 10.2, 6.7 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 24.4, 24.9, 26.2, 26.9, 29.1, 32.4, 32.5, 33.9, 43.8, 
45.6, 46.7, 51.3, 114.6, 138.6, 174.4.  
 
(4R*,7aR*,10aS*)-4-Methoxyoctahydrocyclopenta[i]indolizin-6(7H)-one (1-187). 
To a three-necked round-bottom flask equipped with graphite anode, graphite cathode, and 
stirring bar, was added under N2 atmosphere a solution of octahydrocyclopenta[i]indolizin-
6(7H)-one (1-99) and tetraethylammonium tosylate (603 mg, 2.00 mmol) in anhydrous 
methanol (20 mL). Our home-made apparatus was used to charge the potential. The resulting 
reaction mixture was stirred for 48 h. The solvent was removed under reduced pressure. 
Diethyl ether was added to the residue and some white solid formed. After the filtration, the 
filtrate was concentrated to afford lactam 1-187, which was used in the next step without 
further purification. Pure sample was obtained after column chromatography. Lactam 1-187: 
a colorless oil, Rf = 0.55 (EtOAc); IR (neat) 2939, 1689, 1398 cm
-1; HRMS (ESI) m/z 
calculated for C12H19NO2Na (M+Na)
+ 232.1313, found: 232.1290; 1H NMR (400 MHz, 
CDCl3) δ 1.42-1.75 (m, 8H), 1.81-1.93 (m, 3H), 2.11-2.26 (m, 3H), 2.69 (dd, J = 2.8 Hz, 8.6 
Hz, 1H), 3.26 (s, 3H), 5.25 (d, J = 4.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 17.1 (CH2), 
25.1 (CH2), 30.1 (CH2), 33.7 (CH2), 37.8 (CH2), 38.0 (CH2), 38.1 (CH2), 42.4 (CH), 55.2 
(CH3), 70.8 (C), 79.7 (CH), 175.2 (C).  
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(4S*,7aR*,10aS*)-4-Allyloctahydrocyclopenta[i]indolizin-6(7H)-one (1-189). To 
a solution of the above residue and allyl trimethylsilane (103 mg, 0.900 mmol) in anhydrous 
dichloromethane (10 mL) at 0 °C under N2 atmosphere was added dropwise titanium 
tetrachloride (1 M in DCM, 0.3 mL, 0.3 mmol). The resulting reaction mixture was stirring 
overnight at room temperature. Saturated aqueous sodium bicarbonate was used to quench the 
reaction. After separation, the aqueous layer was extracted with DCM three times. The 
combined organic layers were washed with brine and dried over anhydrous sodium sulfate. 
The concentrated residue was purified by chromatography (20-200% EtOAc/hexanes) to 
afford lactam 1-189 (13 mg, 56%) as a colorless oil and eliminated lactam 1-191 (5 mg, 27%) 
as a colorless oil. (No eliminated product was observed when the reaction was carried out at -
78 °C). Lactam 1-189: Rf = 0.35 (100% EtOAc/hexanes); IR (neat) 2936, 1678, 1404 cm
-1; 
HRMS (ESI) m/z calculated for C14H22NO (M+H)
+ 220.1701, found: 220.1694; 1H NMR 
(400 MHz, CDCl3) δ 1.32-1.42 (m, 2H), 1.44-1.69 (m, 3H), 1.69-1.85 (m, 6H), 1.92-2.02 (m, 
1H), 2.11-2.18 (m, 1H), 2.18-2.25 (m, 1H), 2.28-2.47 (m, 2H), 2.61-2.70 (m, 1H), 4.41 (q, J 
= 7.4 Hz, 1H), 5.04-5.06 (m, 1H), 5.06-5.12 (m, 1H), 5.80 (ddt, J = 17.1, 10.3, 6.8 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ 17.3 (CH2), 25.6 (CH2), 27.2 (CH2), 33.4 (CH2), 37.3 (CH2), 
37.9 (CH2), 38.0 (CH2), 38.3 (CH2), 43.5 (CH), 47.9 (CH), 70.6 (C), 117.0 (CH2), 135.9 (CH), 
173.5 (C). 
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(4S,7aR,10aS)-4-Allyl-7,7-dimethyloctahydrocyclopenta[i]indolizin-6(7H)-one. 
To a solution of lactam 1-189 (16 mg, 0.073 mmol) in anhydrous THF (5 mL) at -78 °C 
under N2 atmosphere was added dropwise freshly-prepared LDA (1 M in THF, 0.22 mL, 0.22 
mmol). After the resulting mixture was stirred for 0.5 h at -78 °C, methyl iodide (142 mg, 1 
mmol) was added dropwise. The resulting mixture was allowed to warm to room temperature 
and stirred overnight. Saturated ammonium chloride was added to quench the reaction. After 
the separation, the aqueous layer was extracted with ethyl acetate three times and the 
combined organic layers were washed with brine and dried over anhydrous sodium sulfate. 
The concentrated residue was purified by chromatography (2-20% EtOAc/hexanes) to afford 
the title lactam (7 mg, 39%) as a colorless oil. Lactam: Rf = 0.25 (20% EtOAc/hexanes); IR 
(neat) 2932, 1677 cm-1; HRMS (ESI) m/z calculated for C16H26NO (M+H)
+ 248.2014, found: 
248.1988; 1H NMR (400 MHz, CDCl3) δ 1.10 (s, 3H), 1.21 (s, 3H), 1.32-1.41 (m, 1H), 1.46-
1.85 (m, 10H), 1.87-1.93 (m, 1H), 1.93-2.00 (m, 1H), 2.28-2.46 (m, 2H), 4.40 (q, J = 7.1 Hz, 
1H), 5.01-5.11 (m, 2H), 5.79 (ddt, J = 17.0, 10.2, 6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
17.6, 22.1, 25.9, 27.0, 27.4, 30.0, 37.3, 38.4, 38.4, 42.0, 47.9, 55.9, 67.9, 116.8, 136.0, 178.9. 
 
(4R*,7aR*,10aS*)-4-(Phenylsulfonyl)octahydrocyclopenta[i]indolizin-6(7H)-one 
(1-190). According to the procedure described for the preparation of lactam 1-187, lactam 1-
99 (179 mg, 1.00 mmol) afforded after chromatography lactam 1-187 (76 mg, 36%) and 1-
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188 (106 mg). To a white suspension of 1-188 (100 mg), benzenesulfinic acid sodium salt 
(246 mg, 1.5 mmol), and magnesium sulfate (180 mg, 1.50 mmol) in dichloromethane (5 mL) 
at room temperature under N2 atmosphere was added slowly TFA (171 mg, 1.50 mmol). The 
reaction mixture was stirred overnight. Water was added to quench the reaction, and the 
aqueous layer was washed with dichloromethane three times. The combined organic layers 
were washed with brine, dried over anhydrous sodium sulfate. The concentrated residue was 
purified by chromatography (2-20% EtOAc/hexanes) to afford lactam 1-190 (45 mg, 30%) as 
a colorless oil and lactam 1-191 (17 mg, 20%) as a colorless oil. Lactam 1-190: Rf = 0.35 
(100% EtOAc/hexanes); IR (neat) 2945, 1664, 1145 cm-1; HRMS (ESI) m/z calculated for 
C17H21NO3SNa (M+Na)
+ 342.1140, found: 342.1133; 1H NMR (400 MHz, CDCl3) δ 1.40-
1.52 (m, 2H), 1.65-1.82 (m, 5H), 1.85-1.93 (m, 2H), 2.07 (dd, J = 6.4 Hz, 18.0 Hz, 1H), 2.23-
2.37 (m, 2H), 2.42-2.62 (m, 3H), 5.42 (d, J = 7.6 Hz, 1H), 7.28-7.59 (m, 2H), 7.64-7.68 (m, 
1H), 7.97-7.99 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 17.8 (CH2), 22.5 (CH2), 24.9 (CH2), 
33.0 (CH2), 37.2 (CH2), 37.5 (CH2), 37.6 (CH2), 43.7 (CH), 68.8 (CH), 70.7 (C), 129.0 (CH), 
129.1 (CH), 133.9 (CH), 137.9 (C), 175.1 (C). 
 
(7aR*,10aS*)-1,2,7a,8,9,10-hexahydrocyclopenta[i]indolizin-6(7H)-one (1-191). 
Lactam 1-191: Rf = 0.45 (100% EtOAc/hexanes); IR (neat) 2951, 1745, 1694 cm
-1; HRMS 
(ESI) m/z calculated for C11H16NO (M+H)
+ 178.1232, found: 178.1222; 1H NMR (400 MHz, 
CDCl3) δ 1.35-1.43 (m, 1H), 1.64-1.86 (m, 7H), 2.16-2.24 (m, 3H), 2.41-2.47 (m, 1H), 2.73 
(dd, J = 10.8 Hz, 18.0 Hz, 1H), 5.14-5.17 (m, 1H), 6.76 (dt, J = 2.0 Hz, 6.0 Hz, 1H); 13C 
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NMR (100 MHz, CDCl3) δ 21.0 (CH2), 23.8 (CH2), 32.8 (CH2), 33.3 (CH2), 37.1 (CH2), 37.9 
(CH2), 41.7 (CH), 69.9 (C), 110.1 (CH), 121.4 (CH), 171.7 (C). 
 
(1R,5S)-5-(6-Bromohex-4-enyl)bicyclo[3.2.0]heptan-6-one (1-192).  
Method I: To a stirred solution of Hoveyda-Grubbs 2nd generation catalyst (32 mg, 
0.050 mmol, 5 mol%) in dichloromethane (2 mL) under N2 atmosphere at room temperature 
was slowly added a solution of ketone (R)-1-112 (154 mg, 0.860 mmol) and allyl bromide 
(0.25 mL, 3.0 mmol) in dichloromethane (2 mL). The reaction mixture was stirred overnight, 
then concentrated and the residue was purified by silica gel chromatography (0.05%-0.5% 
EtOAC/hexanes) to afford bromide (R)-1-192 as an oil (173 mg, 74% (or 82% brsm), E/Z 8:1) 
and ketone (R)-1-112 (15 mg). Bromide (R)-1-192: [α]
546
25
 -68.0 (c 4.7, dichloromethane); Rf 
= 0.55 (10% EtOAc/hexanes); IR (neat) 2938, 1766, 1205 cm-1. E isomer: 1H NMR (400 
MHz, CDCl3) δ 1.34-1.44 (m, 2H), 1.53-1.71 (m, 4H), 1.78-1.85 (m, 3H), 1.98-2.09 (m, 3H), 
2.45 (dd, J = 4.4 Hz, 18.4 Hz, 1H), 2.55-2.59 (m, 1H), 3.11 (dd, J = 9.6 Hz, 18.4 Hz, 1H), 
3.95 (d, J = 6.4 Hz, 2H), 5.67-5.75 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 24.9 (CH2), 25.0 
(CH2), 32.4 (CH2), 32.68 (CH2), 32.77 (CH2), 33.4 (CH2), 34.0 (CH), 35.4 (CH2), 49.3 (CH2), 
75.7 (C), 126.8 (CH), 135.8 (CH), 217.96 (C). Z isomer (diagnostic peaks only): 1H NMR 
(400 MHz, CDCl3) δ 4.01 (d, J = 8.4 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 25.2 (CH2), 
27.17 (CH2), 27.26 (CH2), 32.8 (CH2), 75.6 (C), 125.7 (CH), 135.2 (CH), 217.89 (C).  
Method II: To a solution of cyclobutanone 1-111 (500 mg, 2,60 mmol) and NBS 
(510 mg, 2.86 mmol) in chlorobenzene (26 mL) at refluxing temperature under N2 
atmosphere was added catalytic amount of BPO. The heating was continued for 7 h. After the 
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resulting mixture was cooled to room temperature, the solvent was removed under reduced 
temperature. The concentrated residue was purified by chromatography (1.5% 
EtOAc/hexanes) to afford bromide 1-192 (320 mg, 45%, 66% brsm E/Z 10:1), dibromide 1-
192a (76 mg, 8%, 12% brsm) and cyclobutanone 1-111 (154 mg).   
 
(1R*,5S*)-5-(3,6-Dibromohex-4-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-192a). Rf = 
0.50 (10% EtOAc/hexanes); IR (neat) 2947, 1768, 1204 cm-1; 1H NMR (400 MHz, CDCl3) δ 
1.33-1.43 (m, 1H), 1.63-1.74 (m, 2H), 1.74-1.94 (m, 5H), 2.00-2.12 (m, 2H), 2.47 (dd, J = 
18.5, 4.6 Hz, 1H), 2.51-2.61 (m, 1H), 3.15 (ddd, J = 18.5, 9.4, 4.2 Hz, 1H), 3.94 (d, J = 5.7 
Hz, 2H), 4.46 (dd, J = 8.5, 5.4 Hz, 1H), 5.86-5.92 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
24.96, 25.00, 30.98, 30.99, 31.2, 31.4, 32.60, 32.63, 34.2, 34.5, 34.69, 34.79, 35.1, 35.4, 49.1, 
49.3, 53.2, 53.4, 74.7, 74.8, 128.30, 128.37, 135.43, 135.48, 216.94, 216.96. 
 
(1R,5S,E)-5-(6-Azidohex-4-enyl)bicyclo[3.2.0]heptan-6-one (1-193a), (1R,5S,Z)-5-
(6-azidohex-4-enyl)bicyclo[3.2.0]heptan-6-one (1-193b), (1R,5S)-5-( (R)-4-azidohex-5-
enyl)bicyclo [3.2.0]heptan-6-one (1-193c), and (1R,5S)-5-((S)-4-azidohex-5-
enyl)bicyclo[3.2.0]heptan-6-one (1-193d). A suspension of (1R,5S)-5-(6-bromohex-4-
enyl)bicyclo[3.2.0]heptan-6-one ((R)-1-192) (145 mg, 0.540 mmol) and sodium azide (210 
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mg, 3.20 mmol) in DMF (3 mL) at room temperature was allowed to stir overnight. Diethyl 
ether and water were added and the aqueous layer was washed with diethyl ether three times. 
The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, 
and concentrated. The resulting residue was purified by silica gel chromatography (0.2%-1% 
EtOAC/hexanes) to afford a mixture of azides 1-193a, 1-193b, 1-193c, and 1-193d as a 
colorless oil (110 mg, 88%, 65:9:13:13 ratio from 1H NMR in acetone; 68:6:13:13 from 1H 
NMR in CDCl3). Azides 1-193a, 1-193b, 1-193c, and 1-193d: [α]
546
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 -78.8 (c 4.4, 
dichloromethane); Rf = 0.40 (10% EtOAc/hexanes); IR (neat) 2942, 2098, 1771, 1247 cm
-1; 
HRMS (ESI) m/z calculated for (C26H38N4O2+H)
+ 439.3073 (corresponding to (2M-N2+H)
+),  
found: 439.3075. Azide 1-193a: 1H NMR (400 MHz, acetone) δ 1.36-1.44 (m, 2H), 1.53-1.71 
(m, 5H), 1.78-1.85 (m, 3H), 1.88-1.96 (m, 1H), 2.08-2.18 (m, 1H), 2.43 (dd, J = 4.4 Hz, 18.4 
Hz, 1H), 2.54-2.64 (m, 1H), 3.13 (dd, J = 9.6 Hz, 18.4 Hz, 1H), 3.77 (d, J = 6.4 Hz, 2H), 
5.55-5.63 (m, 1H), 5.79-5.86 (m, 1H); 
13
C NMR (100 MHz, CDCl3) δ 24.98 (CH2), 25.03 
(CH2), 32.55 (CH2), 32.58 (CH2), 32.68 (CH2), 34.1 (CH), 35.3 (CH2), 49.3 (CH2), 52.8 
(CH2), 75.7 (C), 123.4 (CH), 136.3 (CH), 217.8 (C). Azide 1-193b (diagnostic peaks only): 
1H NMR (400 MHz, acetone) δ 3.90 (d, J = 7.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
122.52, 136.14. Azides 1-193c and 1-193d (diagnostic peaks only): 1H NMR (400 MHz, 
acetone) δ 4.00 (q, J = 6.8 Hz, 1H), 5.27-5.36 (m, 2H), 5.79-5.86 (m, 1H). Azides 1-193b, 1-
193c and 1-193d (diagnostic peaks only): 13C NMR (100 MHz, CDCl3) δ 64.81 (CH), 64.84 
(CH2), 118.2 (CH2), 135.6 (CH). 
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(4R,7aR,10aS)-4-Vinyl-octahydrocyclopenta[i]indolizin-6(7H)-one (1-194) and 
(4S,7aR, 10aS)-4-vinyl-octahydrocyclopenta[i]indolizin-6(7H)-one (1-195). To a refluxing 
solution of azides 1-193a, 1-193b, 1-193c, and 1-193d (110 mg, 0.470 mmol) in anhydrous 
1,2-dichloroethane (24 mL) under N2 atmosphere was added titanium tetrachloride (0.71 mL, 
1 M in dichloromethane, 0.71 mmol). After being allowed to reflux for 15 h, saturated 
aqueous ammonium chloride was added to the cooled reaction mixture, which was allowed to 
stir overnight. The aqueous layer was washed twice with dichloromethane. The aqueous layer 
was neutralized by saturated aqueous sodium bicarbonate and extracted twice with 
dichloromethane. The combined organic layers were washed with saturated aqueous sodium 
bicarbonate, brine, and were dried over anhydrous sodium sulfate. The concentrated residue 
was purified by silica gel chromatography (10% EtOAc/hexanes) to afford 1-194 as a 
colorless oil (60 mg, 62%) and 1-195 as a colorless oil (6 mg, 6%). Lactam 1-194: [α]
546
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+21.6 (c 2.0, dichloromethane); Rf = 0.50 (100% EtOAc/hexanes, twice); IR (neat) 2937, 
1683, 1401 cm-1; HRMS (ESI) m/z calculated for (C13H19NO+H)
+ 206.1545, found: 206.1522; 
1H NMR (400 MHz, CDCl3) δ 1.42-1.55 (m, 3H), 1.58-1.77 (m, 6H), 1.78-1.85 (m, 1H), 
1.85-1.95 (m, 2H), 2.08 (ddd, J = 1.2 Hz, 4.0 Hz, 17.6 Hz, 1H), 2.15-2.23 (m, 1H), 2.64 (dd, 
J = 10.4 Hz, 17.6 Hz, 1H), 3.66 (t, J = 8.8 Hz, 1H), 5.06-5.13 (m, 2H), 6.58-6.67 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 21.9 (CH2), 24.9 (CH2), 32.3 (CH2), 33.6 (CH2), 35.3 (CH2), 36.9 
(CH2), 38.2 (CH2), 42.3 (CH), 58.2 (CH), 72.7 (C), 113.1 (CH2), 138.3 (CH), 173.1 (C). 
Lactam 1-195: Rf = 0.55 (100% EtOAc/hexanes, twice); IR (neat) 2937, 1698, 1388 cm
-1; 
HRMS (ESI) m/z calculated for (C13H19NO+H)
+ 206.1545, found: 206.1515; 1H NMR (400 
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MHz, CDCl3) δ 1.19-1.27 (m, 1H), 1.36-1.47 (m, 4H), 1.58-1.75 (m, 6H), 1.84-1.87 (m, 2H), 
2.05-2.09 (m, 1H), 2.45 (t, J = 5.2 Hz, 1H), 3.67-3.72 (m, 1H), 5.05-5.12 (m, 2H), 6.25-6.33 
(m, 1H); 13C NMR (100 MHz, CDCl3) δ 18.85 (CH2), 18.89 (CH2), 26.2 (CH2), 28.9 (CH2), 
33.3 (CH2), 35.2 (CH2), 41.5 (CH), 44.7 (CH2), 54.9 (CH), 60.7 (C), 112.0 (CH2), 140.3 (CH), 
177.8 (C). The following data were used to assign lactams 1-194 and 1-195.  
 
 
 
 
(1R*,5S*)-5-((S*)-3-Hydroxypent-4-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-201) 
and (1R*,5S*)-5-((R*)-3-hydroxypent-4-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-201). To a 
suspension of SeO2 (22 mg, 0.20 mmol) and salicylic acid (28 mg, 0.20 mmol) in 
dichloromethane (2 mL) at 0 °C under N2 atmosphere was added slowly TBHP (5 M in 
hexane, 0.15 mL, 0.75 mmol). After the reaction mixture was stirred for 20 min, a solution of 
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cyclobutanone 1-112 (178 mg, 1.00 mmol) in dichloromethane (2 mL) was added. The 
resulting mixture was stirred overnight, and 10% aqueous KOH solution and diethyl ether 
were added. After the separation, the aqueous layer was washed with diethyl ether three times. 
The combined organic layers were washed with brine and dried over sodium sulfate. The 
concentrated residue was purified by chromatography (0.5-10% EtOAc/hexanes) to afford a 
mixture of cyclobutanone 1-201 (2:1 ratio (arbitrarily assigned), 15 mg, 8%) as a colorless oil 
and lactone 1-202 (32 mg, 16%) as a colorless oil. Ketone 1-201 (2:1 ratio): Rf = 0.30 (20% 
EtOAc/hexanes); IR (neat) 3420, 2939, 1764, 1065 cm-1; HRMS (ESI) m/z calculated for 
C24H36O4Na (2M+Na)
+ 411.2511, found: 411.2515. Major isomer: 1H NMR (400 MHz, 
CDCl3) δ 1.40 (dt, J = 6.4 Hz, 9.6 Hz, 1H), 1.51-1.58 (m, 1H), 1.63-1.75 (m, 4H), 1.75-1.90 
(m, 3H), 2.02-2.09 (m, 1H), 2.46 (dd, J = 4.6 Hz, 18.4 Hz, 1H), 2.53-2.63 (m, 1H), 3.13 (dd, 
J = 9.6 Hz, 18.4 Hz, 1H), 4.06-4.16 (m, 1H), 5.11-5.26 (m, 2H), 5.82-5.91 (m, 1H); 13C NMR 
(100 MHz, CDCl3) δ 24.98 (CH2), 28.8 (CH2), 32.7 (CH2), 32.9 (CH2), 34.1 (CH), 35.4 (CH2), 
49.2 (CH2), 73.2 (CH), 75.4 (C), 115.0 (CH2), 140.8 (CH), 218.0 (C). Minor isomer 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.14 (dd, J = 9.6 Hz, 18.4 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ 25.01 (CH2), 28.7 (CH2), 32.8 (CH2), 34.2 (CH), 35.1 (CH2), 
49.1 (CH2), 73.1 (CH), 75.3 (C), 140.78 (CH), 217.9 (C). 
 
(3aR*,6aR*)-6a-(Pent-4-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one (1-202). 
Lactone 1-202: Rf = 0.40 (20% EtOAc/hexanes); IR (neat) 2942, 1763, 1189 cm
-1; HRMS 
(ESI) m/z calculated for C24H36O4Na (2M+Na)
+ 411.2511, found: 411.2512; 1H NMR (400 
MHz, CDCl3) δ 1.48-1.60 (m, 4H), 1.61-1.78 (m, 4H), 1.87-1.93 (m, 1H), 2.06-2.11 (m, 3H), 
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2.30 (dd, J = 2.6 Hz, 18.4 Hz, 1H), 2.50-2.58 (m, 1H), 2.87 (dd, J = 10.4 Hz, 18.4 Hz, 1H), 
4.97-5.05 (m, 2H), 5.76-5.85 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 23.5 (CH2), 24.0 (CH2), 
33.8 (CH2), 34.4 (CH2), 37.0 (CH2), 38.1 (CH2), 38.8 (CH2), 42.2 (CH), 98.0 (C), 115.1 (CH2), 
138.1 (CH), 177.4 (C).  
 
(1R*,5S*)-5-(5-Bromopent-3-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-197). To a 
suspension of cyclobutanone 1-112 (520 mg, 2.92 mmol) and NBS (623 mg, 3.50 mmol) in 
carbon tetrachloride (30 mL) at refluxing temperature under N2 temperature was added 
catalytic amount of BPO. The heating was continued for 2 h. After the resulting mixture was 
cooled to room temperature, the solvent was removed under reduced temperature. The 
concentrated residue was purified by chromatography (0.5% EtOAc/hexanes) to afford 
bromide 1-197 (460 mg, 61%, E/Z: 6:1) as a colorless oil. Bromide 1-197 (6:1 ratio): Rf = 
0.30 (10% EtOAc/hexanes); IR (neat) 2946, 1765, 1204 cm-1; HRMS (ESI) m/z calculated for 
C24H33BrO2Na (2M-HBr+Na)
+ 455.1562, found: 455.1557. Bromide E-isomer: 1H NMR (400 
MHz, CDCl3) δ 1.38 (td, J = 12.6, 6.3 Hz, 1H), 1.65-1.75 (m, 3H), 1.76-1.89 (m, 3H), 2.02 
(dd, J = 12.8, 6.3 Hz, 1H), 2.05-2.13 (m, 1H), 2.20-2.29 (m, 1H), 2.42-2.50 (m, 1H), 2.54-
2.63 (m, 1H), 3.13 (dd, J = 18.5, 9.5 Hz, 1H), 3.94 (d, J = 6.6 Hz, 1H), 5.65-5.81 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 24.9 (CH2), 28.4 (CH2), 32.2 (CH2), 32.7 (CH2), 33.3 (CH2), 34.1 
(CH), 35.4 (CH2), 49.3 (CH2), 75.3 (C), 126.6 (CH), 135.7 (CH), 217.4 (C). Bromide Z-
isomer (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.99 (d, J = 8.3 Hz, 2H); 
13C 
NMR (100 MHz, CDCl3) δ 23.4 (CH2), 27.0 (CH2), 125.7 (CH), 135.0 (CH). 
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(1R*,5S*)-5-((E)-5-Azidopent-3-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-198a), 
(1R*,5S*)-5-((Z)-5-azidopent-3-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-198b), (1R*,5S*)-5-
((S*)-3-azidopent-4-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-198c), and (1R*,5S*)-5-((R*)-3-
azidopent-4-en-1-yl)bicyclo[3.2.0]heptan-6-one (1-198d). According to the procedure 
described for azides 1-193a, 1-193b, 1-193c, and 1-193d, bromide 1-197 (480 mg, 0.187 
mmol) afforded by silica gel chromatography (0.2%-1% EtOAC/hexanes) a mixture of azides 
1-198a, 1-198b, 1-198c, and 1-198d as a colorless oil (173 mg, 42%, 63:7:15:15 ratio from 
1H NMR in acetone; 65:7:14:14 from 1H NMR in CDCl3). Azides 1-198a, 1-198b, 1-198c, 
and 1-198d: Rf = 0.50 (10% EtOAc/hexanes); IR (neat) 2947, 2093, 1766 cm
-1; HRMS (ESI) 
m/z calculated for C12H17N3ONa (M+Na)
+ 242.1269, found: 242.1252. Azide 1-198a: 1H 
NMR (400 MHz, acetone) δ 1.44 (td, J = 12.6, 6.2 Hz, 1H), 1.63-1.76 (m, 3H), 1.80-1.87 (m, 
3H), 1.94 (dd, J = 12.6, 6.5 Hz, 1H), 2.04-2.15 (m, 1H), 2.23-2.32 (m, 1H), 2.44 (dd, J = 18.3, 
4.5 Hz, 1H), 2.56-2.67 (m, 1H), 3.16 (dd, J = 18.3, 9.6 Hz, 1H), 3.77 (d, J = 6.5 Hz, 2H), 5.61 
(dtt, J = 14.8, 6.6, 1.4 Hz, 1H), 5.76-5.89 (m, 1H); 13C NMR (100 MHz, acetone) δ 24.7 
(CH2), 28.3 (CH2), 32.3 (CH2), 32.5 (CH2), 33.9 (CH), 34.9 (CH2), 48.9 (CH2), 52.3 (CH2), 
75.3 (C), 123.4 (CH), 136.1 (CH), 215.3 (C). Azide 1-198b (diagnostic peaks only): 1H NMR 
(400 MHz, acetone) δ 3.91 (d, J = 7.3 Hz, 2H); 13C NMR (100 MHz, acetone) δ 122.5 (CH), 
135.4 (CH). Azides 1-198c and 1-198d (diagnostic peaks only): 1H NMR (400 MHz, acetone) 
δ 3.95-4.01 (m, 1H), 5.28-5.37 (m, 2H), 5.76-5.89 (m, 1H); 13C NMR (100 MHz, acetone) δ 
65.0 (CH), 117.7 (CH2), 117.8 (CH2), 135.89 (CH), 135.93 (CH), 215.1 (C).  
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(3S*,6aR*,9aS*)-3-Vinylhexahydro-1H-cyclopenta[g]pyrrolizin-5(6H)-one (1-
199) and (3R*,6aR*,9aS*)-3-Vinylhexahydro-1H-cyclopenta[g]pyrrolizin-5(6H)-one (1-
200). According to the procedure described for lactam 1-194, azides 1-198a, 1-198b, 1-198c, 
and 1-198d (58 mg, 0.26 mmol) afforded after chromatography a mixture of twisted lactam 
1-201 (one isomer) and azide 1-202 (5:3 ratio, 3 mg), and a mixture of lactams 1-199, 1-200 
and azide 1-202 (2.1:1:1 ratio, 13 mg). (Their stereochemistry is not defined) Lactam 1-199 
(or 1-200, major isomer): Rf = 0.35 (100% EtOAc/hexanes); IR (neat) 2950, 1686, 1386 cm
-1; 
HRMS (ESI) m/z calculated for C12H18NO (M+H)
+ 192.1388, found: 192.1393; 1H NMR 
(500 MHz, CDCl3) δ 1.37-1.45 (m, 1H), 1.48-1.52 (m, 1H), 1.59-1.66 (m, 2H), 1.68-1.75 (m, 
3H), 1.78-1.88 (m, 2H), 2.29 (ddd, J = 17.6, 7.3, 1.3 Hz, 1H), 2.32-2.39 (m, 1H), 2.43-2.49 
(m, 1H), 2.74 (dd, J = 17.6, 10.6 Hz, 1H), 3.99 (t, J = 8.7 Hz, 1H), 5.08-5.11 (m, 1H), 5.16 
(dt, J = 17.1, 1.0 Hz, 1H), 5.89 (ddd, J = 17.1, 10.2, 8.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
δ 24.6 (CH2), 32.8 (CH2), 35.3 (CH2), 35.7 (CH2), 39.0 (CH2), 41.4 (CH), 43.3 (CH2), 56.8 
(CH), 80.2 (C), 115.5 (CH), 137.3 (CH2), 172.9 (C). Lactam 1-200 (or 1-199, minor isomer) 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 2.07-2.13 (m, 1H), 2.70-2.73 (m, 1H), 
4.17 (t, J = 7.7 Hz, 1H), 5.88 (ddd, J = 17.2, 10.3, 7.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
δ 20.1 (CH2), 24.9 (CH2), 31.9 (CH2), 34.6 (CH2), 46.0 (CH2), 48.5 (CH), 54.5 (CH), 70.2 (C), 
115.3 (CH2), 136.9 (CH), 173.5 (C) [or 173.8 (C)]. The following data were used to assign 
lactam 1-200 (or 1-199).  
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(5aS*,8aS*)-3-Vinyloctahydro-2,5a-methanocyclopenta[c]azepin-9-one (1-201). 
Lactam 1-201: Rf = 0.55 (10% EtOAc/hexanes, twice); IR (neat) 2953, 1690 cm
-1; HRMS 
(ESI) m/z calculated for C12H17NONa (M+Na)
+ 214.1208, found: 214.1208; 1H NMR (500 
MHz, CDCl3) δ 1.30-1.37 (m, 1H), 1.47-1.51 (m, 1H), 1.56-1.64 (m, 2H), 1.65-1.72 (m, 1H), 
1.72-1.85 (m, 4H), 2.29-2.37 (m, 2H), 2.43-2.49 (m, 1H), 2.70 (dd, J = 17.6, 10.6 Hz, 1H), 
4.28 (q, J = 7.8 Hz, 1H), 4.99 (dt, J = 10.3, 1.5 Hz, 1H), 5.15 (dt, J = 17.0, 1.5 Hz, 1H), 5.78 
(ddd, J = 17.0, 10.3, 5.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 24.7 (CH2), 33.4 (CH2), 
34.0 (CH2), 37.6 (CH2), 39.0 (CH2), 41.0 (CH), 41.7 (CH2), 56.8 (CH), 79.2 (CH), 113.9 
(CH2), 139.0 (CH), 177.4 (C). The following data were used to assign lactam 1-201.  
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(3aR*,4aR*,5R*,8aS*)-5-(Azidomethyl)-6-chlorodecahydrocyclopenta-[1,4] 
cyclobuta-[1,2]benzen-4a-ol (1-202). Azide 1-202 (diagnostic peaks only): 1H NMR (400 
MHz, CDCl3) δ 3.68 (s, 1H), 3.70-3.74 (m, 1H), 4.23-4.27 (m, 1H); 
13C NMR (100 MHz, 
CDCl3) δ 63.3 (CH2), 69.3 (CH2), 70.6 (CH2). 
 
(4R,7aR,10aS)-4-(2-Hydroxyethyl)-octahydrocyclopenta[i]indolizin-6(7H)-one 
(1-58). To an oven-dried flask at 0 °C under nitrogen atmosphere was added BH3·THF 
complex (1 M in THF, 1.25 mL, 1.25 mmol), followed by the addition of 2-methyl-2-butene 
(2 M in THF, 1.25 mL, 2.50 mmol). After stirring at 0 °C for 2 h, the above solution was 
added to lactam 1-194 (40 mg, 0.20 mmol) in THF (2 mL) at 0 °C. The resulting reaction 
mixture was allowed to rise to room temperature and stir overnight. The resulting mixture 
was cooled to 0 °C, followed by the addition of 3 M aqueous NaOH (2.1 mL) and H2O2 (30% 
w/w in H2O, 1 mL). The resulting reaction mixture was allowed to rise to room temperature 
over 2 h. Ethyl acetate was used to extract the product. The aqueous layer was extracted three 
times with ethyl acetate and the combined organic layers were washed with brine, dried over 
anhydrous sodium sulfate, filtered, and concentrated. The resulting residue was purified by 
silica gel chromatography (0.8%-2% MeOH/dichloromethane) to afford lactam 1-58 (35 mg, 
83%) as an oil. [α]
546
25
 -22.6 (c 0.9, dichloromethane). Rf = 0.35 (5% MeOH/DCM); spectral 
data matched with reported data.15 
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(E)-6-((1S,5R)-7-oxobicyclo[3.2.0]heptan-1-yl)hex-2-enal (1-203). To a solution of 
cyclobutanone 1-112 (534 mg, 3.00 mmol) and acrolein (90% purity, 1.0 mL, 15 mmol) in 
dichloromethane (8 mL) under N2 atmosphere at room temperature was slowly added Grubbs 
2nd generation catalyst (305 mg, 0.030 mmol, 10 mol%). The reaction mixture was heated to 
reflux for 38 h. After the resulting mixture was cooled to room temperature, the solvent was 
removed under reduced pressure, and the residue was purified by silica gel chromatography 
(3%-15% EtOAC/hexanes) to afford compound 1-203 as an oil (230 mg, 37% (or 85% brsm)) 
and ketone 1-112 (300 mg). Ketone 1-203: Rf = 0.25 (20% EtOAc/hexanes); IR (neat) 2945, 
1768, 1697 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.36 (td, J = 12.6, 6.4 Hz, 1H), 1.45-1.53 (m, 
1H), 1.59-1.72 (m, 4H), 1.77-1.87 (m, 3H), 2.02 (dd, J = 12.9, 6.1 Hz, 1H), 2.30-2.38 (m, 2H), 
2.45 (dd, J = 18.5, 4.6 Hz, 1H), 2.55 (dt, J = 10.0, 5.1 Hz, 1H), 3.11 (dd, J = 18.5, 9.4 Hz, 
1H), 6.10 (ddt, J = 15.6, 7.9, 1.3 Hz, 1H), 6.81 (dt, J = 15.6, 6.8 Hz, 1H), 9.49 (d, J = 7.9 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ 24.0 (CH2), 24.9 (CH2), 32.6 (CH2), 32.8 (CH2), 33.0 
(CH2), 34.2 (CH), 35.3 (CH2), 49.2 (CH2), 75.5 (C), 133.3 (CH), 157.8 (CH), 193.9 (CH), 
217.4 (C). 
 
2-((4R*, 7aR*, 10aS*)-6-Oxodecahydrocyclopenta[i]indolizin-4-yl)ethyl 4-
bromobenzoate (1-207). To a solution of 4-bromobenzoyl chloride (17 mg, 0.075 mmol) in 
anhydrous dichloromethane (2 mL) at room temperature under N2 atmosphere was added 
DMAP (12 mg, 0.10 mmol). After the resulting mixture was stirred for 15 min, a solution of 
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alcohol 1-58 (10 mg, 0.050 mmol) in dichloromethane (1 mL) was slowly added. The 
resulting mixture was stirred overnight. Dichloromethane and saturated sodium bicarbonate 
were added to quench the reaction. After separation, the aqueous layer was extracted twice 
with dichloromethane. The combined organic layers were washed with saturated aqueous 
sodium bicarbonate, brine, and were dried over anhydrous sodium sulfate. The concentrated 
residue was purified by silica gel chromatography (10%-30% EtOAc/hexanes) to afford ester 
1-207 (7 mg, 38%) as a white powder. Lactam 1-207: [α]
546
25
 -64.0 (c 0.35, dichloromethane); 
Rf = 0.50 (100% EtOAc/hexanes); IR (neat) 2932, 1719, 1679, 1271 cm
-1; HRMS (ESI) m/z 
calculated for C20H25BrNO3 (M+H)
+ 406.1018, found: 406.1021; 1H NMR (400 MHz, CDCl3) 
δ 1.37-1.43 (m, 1H), 1.46-1.73 (m, 8H), 1.77-1.88 (m, 2H), 1.92-2.01 (m, 1H), 2.01-2.12 (m, 
2H), 2.12-2.20 (m, 1H), 2.64 (dd, J = 17.6, 9.7 Hz, 1H), 3.19 (ddd, J = 14.0, 10.0, 5.0 Hz, 
1H), 3.24-3.33 (m, 1H), 4.43-4.54 (m, 2H), 7.60 (d, J = 8.7 Hz, 2H), 7.91 (d, J = 8.6 Hz, 2H); 
13
C NMR (100 MHz, CDCl3) δ 23.0 (CH2), 25.3 (CH2), 31.4 (CH2), 31.8 (CH2), 33.8 (CH2), 
35.1 (CH2), 36.5 (CH2), 38.2 (CH2), 42.0 (CH), 52.9 (CH), 63.9 (CH2), 73.7 (C), 127.9 (C), 
129.4 (C), 131.1 (CH), 131.7 (CH), 165.8 (C), 174.0 (C). 
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CHAPTER 2 
 
COMBINED ALLYLIC AZIDE REARRANGEMENT AND 
INTRAMOLECULAR SCHMIDT REACTION 
 
2.1 Introduction 
Intramolecular Schmidt reaction. The intramolecular Schmidt reaction of alkyl 
azides and ketones was discovered in 1991 as a method to prepare polycyclic lactams (Figure 
35).68,69 This reaction has been applied by our group and other groups to the total syntheses of 
natural products such as stenine,22 aspidospermidine,70 alkaloids 223A24 and 251F.71 The 
diversification of these polycyclic lactams such as stenine can also help to find some hit or 
lead compounds with interesting biological activities.  
 
Figure 35. Intramolecular Schmidt reaction.  
The detailed mechanism of intramolecular Schmidt reaction is listed in Figure 36. 
There are four possible pathways, three of which lead to normal fused bicyclic lactam 2-3 and 
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one of which produces twisted amide 2-12. For equatorial side chain conformer 2-4, azide 
can attack the ketone from both faces. Recently, Tantillo and coworkers reported a 
computational analysis of the intramolecular Schmidt reaction.72 The azidohydrin 
intermediate is ~9–10 kcal/mol lower than the protonated starting material. The transition 
state from azidohydrin to lactam is 5–7 kcal/mol higher than the protonated ketones. The 
lactam 2-3 is ~70–80 kcal/mol lower than azidohydrin intermediates.  
 
Figure 36. Plausible mechanism of intramolecular Schmidt reaction. 
If α-substituent of the ketone can stabilize the diazonium ion via cation-n or cation-π 
interaction, twisted amide 2-12 could become the major product.73,74 Such lactams have 
unique properties, as briefly reviewed below.   
Twisted amides. The amide is one of the basic functional groups in organic 
chemistry, and has arisen many fundamental interests in structural organic chemistry and 
biological chemistry. The traditional amide bond is generally planar, resulting from 
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conjugation of the nitrogen lone pair with the π orbital of carbonyl group (Figure 37). This 
delocalization leads to a weakened double bond and a strengthened C–N bond with partial 
double bond characters, which are reflected in low reactivities, protonation at oxygen atom 
instead of nitrogen atom, and tolerance to hydrolysis.75 The rotation of C–N bond is also 
hindered and its E/Z isomerization energy is relatively high, about 20 kcal/mol. Twisting of 
this C–N bond restricts the delocalization of carbonyl with nitrogen, and thus leads to a new 
breed of amides, refered to twisted amides.75,76 Winkler-Dunitz parameters, used to describe 
how twisted the amide is, are calculated as designated in Figure 37.77  
 
Figure 37. Comparison of normal and twisted amides.  
Twisted amide can be obtained by embedding an amide bond into a bicyclic or 
tricyclic ring system, which can force the amide bond have no choice but to exist in a highly 
destabilized manner. Some well-known twisted amides are shown in Figure 38.78-83 Kirby’s 
amide is known as “most twisted amide”.78  
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Figure 38. The most well-known twisted amides. 
Twisted amide has a different physical and spectral profile from traditional amide 
(Table 6). Twist angle ranges from 0o to 90o, and the N-C(O) bond is longer than a traditional 
amide and shorter than an amine. However, there is no big difference for the bond length of 
carbonyl group. The stretching frequency and carbon NMR chemical shift of carbonyl group 
range from those of traditional amide to those of ketone. Their ionization potentials are also 
different.   
Table 6. Physical and spectral parameters of amides.  
Substrate τ/o χN/
o χC/
o 
N-C(O) 
/Ǻ 
C=O 
/Ǻ 
υC=O 
/cm-1 
13C(C=O) 
/ppm 
ethylamine - - - 1.47 - - - 
acetamide - - - 1.38 1.22 1681 178 
acetone - - - - 1.213 1749 207 
1-methylpiperidin-2-one 2.5 0.0 0.0 1.325 1.233 1653 165 
Kirby (2-13) 90.5 60.0 0.0 1.475 1.196 1732 200 
Aubé (2-16) 51.5 36.1 12.8 1.387 1.218 1697 188 
Aubé (2-17) 43.2 33.8 16.3 1.363 1.234 1685 185 
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This twist of amide bond is coupled with formal rehybridization of nitrogen to sp3, 
which gives this nitrogen a pyramidal configuration. In comparison with traditional amides, 
the nitrogen of twisted amide is more basic. Its carbonyl group also has some ketone 
character. 
The most common comparison between twisted amides and traditional amides is 
hydrolysis of the amide bond.84 The half-life for hydrolysis of Kirby’s and Stoltz’s twisted 
amides is less than 10 minutes, while it is around 500 years for traditional amides.  
These novel reactivities of twisted amides have been explored to allow them to take 
part in reactions that are not possible with traditional amides, such as ketal formation,80 facile 
reduction,85 oxidative cleavage,83 epoxidation,86 Wittig reaction,80 hydrogenation,83 
ammonium salt formation,87 and nucleophilic addition (Figure 39).85  
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Figure 39. The novel reactivities of twisted amide. 
Allylic azide rearrangement. The rearrangement of allylic azides has been known 
since 1960, when it was first reported by Winstein and coworkers.88 They found that crotyl 
azide rearranges reversibly to give α-methylallyl azide and γ,γ-dimethylallyl azide give α,α-
dimethylallyl azide. They demonstrated that the methyl substitution only increases the rate of 
equilibration by about 3 times, and this rate is only increased by 10 times even if the solvent 
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is changed from pentane to 70% aqueous acetone. It is also interesting to know that allylic 
azide is not solvolyzed, even in 70% aqueous acetone. They also observed a ∆S value around 
-10 eu for isomerization of α,α-dimethylallyl azides in different solvent systems. Winstein 
and coworkers also indicated the small change of polar character and small solvent effect in 
the azide isomerization, indicating the covalent bonding in the transition state.  
VanderWerf and Heasley from the University of Kansas reported the rearrangement 
of allylic diazides, and found that electron-withdrawing group destabilizes this transition state 
and then the rate of rearrangement is also decreased.89 The transition state was described by 
them, best as a nearly planar, six-membered ring.  
Fokin, Sharpless, and coworkers reported the Huisgen [3+2] cycloaddition and 
epoxidation reactions of isomeric allylic azides (Scheme 54).90 Reactivities of different types 
of allylic azides were compared to find that tertiary azides were more reactive than those of 
primary and secondary azides. However, there was no big difference in the reaction rate 
between primary and secondary azides for both reactions. They also found that H-bonding 
could have an important effect on these allylic azide systems.  
 
Scheme 54. Huisgen [3+2] cycloaddition and epoxdiation of allylic azides.  
Carell and coworkers reported an unusual discovery about the preparation of allylic 
azide from allylic alcohol via SN2 and syn-SN2′ pathways (Scheme 55).
91 The 1,3-transposed 
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product of 2-39 is also its enantiomer, and thus this makes the determination of its 
isomerization rate easier. They used optical rotation to track its isomerization rate at different 
temperatures, and observed that allylic azide rearrangement is almost inhibited at 0 °C.   
 
Scheme 55. Preparation of allylic azide through SN2 and syn-SN2′ pathways.  
Spino and coworkers found that p-menthane-3-carboxaldehyde is a useful chiral 
auxiliary in organic synthesis, especially for the total synthesis of alkaloids.92 Allylic alcohol 
2-42 was prepared with very high selectivity employing trimethyl aluminum as the catalyst, 
and the following anti-SN2′ Mitsunobu reaction also provided allylic azide 2-43 with very 
high diastereoselectivity.93,94 This allylic azide has been used in the total syntheses of 
alkaloids such as coniine,94 lentiginosin,94 pumiliotoxin,94 aspidofractinine,95 euphococcintine, 
and adaline.96  
 
Figure 40. Spino’s allylic azide and its application in the synthesis.  
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Recently, Craig and coworkers reported the combination of allylic azide 
rearrangement and different types of Claisen rearrangements (Scheme 56).97 The 
equilibrating process of isomeric allylic azides was terminated by the subsequent Claisen 
rearrangement, in which only two isomers of allylic azides can proceed. In the Johnson-
Claisen reaction, they proposed that only E-isomer 2-47 of allylic azides was existed in the 
equilibrium, and was the only isomer that contributed to the Claisen reaction. The 
conformation of E-isomer forces the R2 group of transition states 2-48 and 2-49 to the 
pseudo-axial position. The different orientation of azide stereochemistry, in combination with 
axial R2 group, can differentiate both transitions state. Actually, they did not get good 
selectivity for this combination (Table 7). A slightly better selectivity was obtained for the 
combination of allylic azide rearrangement with Ireland-Claisen reaction.   
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Scheme 56. Combination of allylic azide rearrangement and Claisen reaction. 
 
Table 7. Johnson and Ireland-Claisen reactions.  
entry R1 R2 
syn:anti  
(Johnson-Claisen) 
syn:anti 
 (Ireland-Claisen) 
a n-C5H11 H 50:50 84:16 
b n-C5H11 Me 59:41 68:32 
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c Me Me 60:40 91:9 
d c-Hex Me 63:37 82:18 
e Ph H - 75:25 
f 2-Pyridyl Me - - 
g Me Ph 50:50 73:27 
 
The allylic azide rearrangement allows for the existence of Z-isomer 2-58 of isomeric 
allylic azides, if only in small amount. If the temperature increases, the proportion of 2-58 
also increases. Despite this, Craig and coworkers did not take the Z-isomer into consideration 
(Figure 41), nor did they run temperature-variable NMR experiments to make sure that there 
is no Z-isomer involved in the diethoxyethene stage at high temperature. The Z-isomer 
transition state should be much stable than those having E isomers because its R2 appendage 
of the former lies at the pseudo-equatorial position of transition state. This can explain why 
Ireland-Claisen got higher selectivity than Johnson-Claisen rearrangement because both 
equatorial groups of Ireland-Claisen magnify the difference of azide stereochemistry.  
 
Figure 41. Intermediates in the Johnson and Ireland-Claisen reactions.  
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2.2 Combined allylic azide rearrangement and intramolecular Schmidt reaction  
In our planning for the synthesis of pinnaic acid’s advanced intermediate, we 
imagined whether allylic azide rearrangement and Schmidt reaction could be combined. The 
initial studies in the pinnaic acid project verified the feasibility of this combination reaction. 
Because that substrate belongs to four-carbon tethered Schmidt reaction, three-carbon 
tethered version, the more common one of Schmidt reaction, was investigated here (Scheme 
57).  
 
Scheme 57. Combination of allylic azide rearrangement and intramolecular Schmidt reaction.  
Based on the Curtin-Hammett principle and early transition state theory (Figure 42), 
we hypothesized that: 1) four isomers of allylic azides would equilibrate faster than the 
Schmidt reaction would occur; 2) the azide of E-isomer of allylic azides can not reach the 
carbonyl to form productive azidohydrin intermediate; 3) for Z-isomer of allylic azides, the 
formation of an 8-membered azidohydrin ring, resulted from the attack of azide to carbonyl 
group, is relatively slow, in comparison with the formation of 6-membered ring from two 
internal isomers; 4) formation of lactams would be kinetically controlled via the preferential 
formation of intermediates I and II (both arising from equatorial attack of azide onto ketone); 
and 5) the stereochemical outcome of the reaction would roughly reflect the relative stability 
of I and II, favoring compound 2-66a by a ratio that would roughly reflect the A value of a 
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vinyl group (1.49 or 1.68 kcal/mol), or ≥93:7 dr. So a highly diastereoselective ratio would be 
expected.  
 
Figure 42. Mechanism of combination of allylic azide rearrangement and intramolecular 
reaction. 
 
2.3 Allylic azide preparation 
Allylic azides are usually prepared from the azide displacement of its corresponding 
bromide, which can be obtained from two methods: direct allylic bromination or cross-
metathesis (Figure 43). Initially, NBS-mediated allylic bromination was used under the 
radical initiator benzoyl peroxide to get bromide 2-68, and some dibromo products were 
found as sideproducts. Better result was obtained by the cross-metathesis using HG-2 as the 
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catalyst between olefin and allyl bromide. Later, it was found that cross-metathesis and azide 
displacement can be combined in a one-pot reaction.  
 
Figure 43. Preparation of allylic azides.  
Most olefins were prepared by the alkylation of hydrazone and its subsequent 
hydrolysis (Figure 44). The hydrazone was quickly accessed by the condensation between 
ketone and dimethyl hydrazine.   
 
Figure 44. Preparation of olefins.  
Some olefins were prepared by the direct alkylation of ketones or Hosomi-Sakurai 
reaction (Figure 45), and the stereochemistry of one ketone was confirmed by X-ray 
crystallography (Figure 46).   
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Figure 45. Preparation of olefins using alkylations and conjugate additions.  
   
Figure 46. ORTEP representation of (2S*,4R*)-2-(but-3-enyl)-4-tert-butyl-2-(4-methoxy-
phenyl)cyclohexanone.  
The 3,3-dimethyl cyclohexanone substrate was difficult to prepare. After several 
failed attempts, it was finally prepared from Hagemann’s ester 2-79 (Scheme 58). The first 
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alkylation occurred at 2 position and the subsequent decarboxylation and conjugate reduction 
afforded the desired ketone 2-82.  
 
Scheme 58. Preparation of 3,3-dimethyl-containing substrate.  
The 1,3-cyclohexandione substrate was prepared from known aldehyde 2-83 
(Scheme 59). Due to stronger electrophilicity of aldehyde than ketone, the attack of vinyl 
Grignard reagent occurred selectively at the carbonyl group of aldehyde. The following 
Mitsunobu reaction afforded the desired allylic azides 2-85.  
 
Scheme 59. Preparation of 1,3-diketone substrate. 
Phenyl substituted allylic azides 2-91 only have two isomers due to the strongly 
conjugated styrene system (Scheme 60). 2-(But-3-en-1-yl)cyclohexanone was protected as 
ketal form 2-87, followed by oxidation and vinyl attack to afford allylic alcohol 2-89. Azide 
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displacement and deprotection provided a mixture of allylic azides 2-91a and 2-91b in a 1:1 
ratio, whose stereochemistry was arbitrarily assigned. Before the azide displacement, the 
deprotection gave a separable mixture of three compounds 2-92, 2-93 and 2-94. Two of them 
can be utilized to afford a mixture of allylic azides 2-91 with 2:1 and 1:2 ratios, respectively.  
 
Scheme 60. Preparation of phenyl-substituted allylic azides.  
 
2.4 Allylic azide rearrangement 
Introduction. Regarding the transition state of allylic azide rearrangement, Winstein 
and coworkers stated “the azide isomerization is an instructive example in the whole 
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spectrum of merging ion pair and non-ionic cyclic rearrangement mechanisms of allylic 
rearrangement.”88 VanderWerf and coworkers described this transition state as “a nearly 
planar, six-membered ring”.89 After that, based on our knowledge, there has been no more 
discussion until now, except some computational calculations.  
In 2004, Saripinar and coworkers reported the rearrangement of cyclic allylic diazide 
and used PM3 calculation to rationalize why cis-1,4-diazidocyclohex-2-ene and cis-1,4-
diazidocyclohept-2-ene can, cis-1,4-diazidocyclopent-2-ene and cis-1,4-diazidocyclooct-2-
ene cannot, rearrange to their corresponding isomers.98 Through the PM3 calculation, they 
compared several different transition states and found that the energy barrier for an allylic 
azide is lowest on a six-membered ring. It is only 39.5 kcal/mol for cyclohexene, 46.1 for 
cycloheptene, 50.2 for cyclopentene, 52.9 for cyclooctene. This explains why cyclopentene 
and cyclooctene cannot undergo allylic azide rearrangement.  
In 2010, Jabbari used CBS-QB3 and density functional studies to explore the [3,3]-
sigmatropic rearrangement of allylic azides and found that this reaction is a concerted process 
that proceeds via a half-chair transition state.99 The activation barrier for the simplified allylic 
azide rearrangement is 20-22 kcal/mol.   
Allylic azide rearrangement. As discussed above, allylic azide rearrangement is 
facile at room temperature due to its low energy barriers. Allylic azides are usually composed 
of three isomers: trans, cis, and internal isomers (Figure 47). There is a considerable 
resemblance between allylic azide rearrangement and ynamide aza-claisen rearrangement. It 
is highly possible that allylic azide rearrangement undergoes through a six-membered ring 
with half chair conformation, as computational calculations predicted. In order to interpret 
this transition state as clear as possible, chair conformation 2-106, instead of half-chair 
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conformation 2-105, is used to resemble the transition state of allylic azide rearrangement in 
this context.   
 
Figure 47. Allylic azide rearrangement and its mechanism.  
Herein, the easily understandable chair-conformation is still used to clarify the 
stereochemistry issue due to its same results as half-chair conformation although chair-
conformation is not preferred in the actual allylic rearrangement. If one of the appendages in 
the isomeric allylic azides has one or two chiral centers, there are two diastereo-differentiated 
internal isomers 2-107c and 2-107d (Figure 48). The change between trans 2-107a and cis 2-
107b must go through internal isomers 2-107c and 2-107d via transition states 2-108 and 2-
109, or 2-110 and 2-111. Usually, the trans 2-107a is most stable due to less steric hindrance 
while the cis isomer 2-107b is least stable due to A1,3 strain. Its reaction coordinate is also 
shown in Figure 48, in which cis 2-107b has the highest energy. In some cases, cis isomer 2-
107b is more stable than internal isomers 2-107c and 2-107d if the carbon of the alkyl chain 
next to the allylic azide is quaternary, which is to be discussed later. The steric crowding 
pushes the azide away from that, thus favoring the stable existence of cis isomer 2-107b.  
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Figure 48. Schematic presentation of allylic azide rearrangement with chiral substituents.  
Figure 49 shows the allylic azide rearrangement with two appendages along two 
sides of the allylic azide. Based on the sigmatropic rearrangement, isomer 2-112a can be 
converted to 2-112b but not to 2-113 with the inverted stereochemistry. This will help us 
understand why carbocation is involved in this allylic azide rearrangement, which is to be 
explained later in this chapter. 
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Figure 49. Schematic presentation of allylic azide rearrangement with two substituents.  
 
Spectral data for ratio determination. All the interconvertible isomers of allylic 
azides are discernible in the proton (1H) or carbon (13C) NMR spectra using either CDCl3 or 
acetone as the solvent (Figure 50). Ha1 always shows up as a doublet splitting in the 
1H NMR 
spectrum. In 1H NMR of the CDCl3 solution, Hb1 and Hc1 usually overlap; however, they are 
easily recognized in the acetone solution due to doublet splitting for Hb1, whose coupling 
constant is slightly smaller (~6.8 Hz) than Ha1’s (~7.2 Hz), and quartet splitting for Hc1. In all 
the 1H NMR spectra, Ha3, Hb3 and Hc2 are mixed together, as Ha2 and Hb2 are; but Hc3 are 
easily identified due to its chemical shift and coupling pattern. So, the rough ratio can be 
obtained by combining the recognition of Ha1, Hb1 and Hc1 in the acetone solution. The ratio 
of a:b:c is equal to ½ integration of Ha1 : ½ integration of Hb1 : integration of Hc1. In CDCl3 
solution, it should be ½ integration of Ha1 : ½ [integration of (Hb1 + Hc1) – ½ integration of 
Hc3]: ½ integration of Hc3 due to the overlapping of Hb1 and Hc1. Both methods give the 
similar results. In addition, two internal isomers should be considered in the case of chiral 
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substituents in the molecule. Then the equation should be modified correpondingly to get the 
ratio of four isomers.  
For all the carbon NMR spectra, the combination of 13C and DEPT was utilized to 
easily recognize carbons Cc3 and Cc2 due to their tertiary carbon nature and chemical shift. 
The comparison between 1H NMR and 13C NMR can help identify the remaining carbons; in 
some cases, the integration of 13C peaks is necessary. The rough ratio can be obtained from 
recognition of Ca1, Cb1 and Cc1, or from the integration of carbonyl groups. In most cases, 
1H 
NMR can not identify the difference between two internal isomers; but the integration of two 
Cc2 carbons can tell their differences, although they are same in most cases. Due to a big 
error margin in the integration of 13C peaks, this method is only recommended as a last resort.  
 
Figure 50. Proton and carbon numbering of allylic azides. 
The 1H NMR spectrum of 2-146 is shown in Figure 51. The ratio of four isomers 
(a:b:c:d) is 1.0 : 0.1 [ ½ * (0.50 + 0.08 – ½ * 0.77) ] : 0.19 (¼ * 0.77) : 0.19, which is 
converted to 65:7:14:14 in 100% percentage in CDCl3, but it is 63:7:15:15 in acetone solution. 
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Figure 51. 1H NMR spectrum for the ratio determination.  
All the allylic azides showed very strong stretching absorption at 2100 cm-1 in the IR 
spectra. For HRMS, its exact MS peak is not always shown; sometimes, 2M–N2 is the major 
ionization peak.  
Substrate-dependent ratio. Most of γ- and δ- substituted allylic azides have a 
similar pattern of composition, which contains 48–67% of trans isomer, 5–13% of cis isomer, 
and 24–44% of internal isomer (Figure 52). The effect of solvents in the allylic azide 
rearrangement is negligible, the ratio difference being under the error margin of 
determination method. A similar result has been reported by Winstein and coworkers.88 Based 
on the correlation between energy difference and ratio (Table 8), the cis isomer is ~1.0–1.3 
kcal/mol higher than trans isomer, and internal isomer is only ~0.2-0.5 kcal/mol higher than 
trans isomer.   
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Figure 52. γ- or δ- substituted allylic azides. 
 
Table 8. Correlation between energy difference and ratio.  
 
 
Energy difference 
(kcal/mol) 
% more stable isomer % less stable isomer K 
0 50 50 1 
0.119 55 45 1.22 
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0.239 60 40 1.50 
0.365 65 35 1.86 
0.501 70 30 2.33 
0.649 75 25 3 
0.819 80 20 4 
1.03 85 15 5.67 
1.30 90 10 9 
1.74 95 5 19 
2.72 99 1 99 
 
For γ- or δ- substituted allylic azides, the substituent has no discernible effect on the 
equilibration of allylic azides. In the cis isomer, there is a strong repulsive force between Hb3 
and Hb2. In comparison, the repulsive force between N3 and Hc2 is much smaller due to the 
flexible orientation of N2
+ ion. But, it is still bigger than the steric hindrance between Ha1 and 
Ha2. This greatly explains why the internal isomer is ~0.2–0.5 kcal/mol higher and the cis 
isomer is ~1.0–1.3 kcal/mol higher representively than the trans isomer. 
 
Figure 53. Steric interaction existed in the γ- or δ- substituted allylic azides.  
For β-substituted allylic azides, di- and tri-substituted allylic ones have different 
composition pattern (Figure 54). In comparison to γ-substituted allylic azides, all the β-
substituted allylic azides have a smaller population of internal isomers, and tri-substituted 
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compounds having an even smaller population only up to 3%. The internal isomer of di-
substituted allylic azides is 10–18%, which is about half of γ-substituted allylic azides. Cis 
isomer’s population does not have any difference with γ-substituted allylic azides.   
 
Figure 54. β-substituted allylic azides.  
The steric hindrance of trans and cis isomers for γ- and β-substituted allylic azides is 
similar (Figure 55). The syn-pentane interaction between R1 and Ha1 or Hb1 confers these 
molecules higher ground state energy. If R1 ≠ H, the same interaction between R1 and N3 
group endows very high energy to the internal isomer. This is why internal isomer’s 
population is so low for the tri-substituted case. For di-substituted case, the interaction is 
dramatically lessened, although it is still worse than γ- substituted allylic azides.  
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Figure 55. Steric interaction existed in the β - substituted allylic azides. 
The interaction pattern of inter-substituted allylic azides changed when a methyl 
group was added to the middle carbon of the allyl group (Figure 56). Here, the internal 
isomer became the major isomer, occupying half of the population. The ratio between trans 
and cis isomers remained constant.  
Comparing trans isomer to internal isomer, there is a strong repulsive force between 
Ha5 and Ha4 of trans isomer; However, this interaction is smaller for internal isomer due to 
the rotating allylic bond. But, the interaction between Hc2 and N group is bigger than trans 
isomer. This compromise only makes the internal isomer’s population is slightly bigger than 
that of trans isomer. In addition, the energy difference between trans isomer and cis isomer 
remained the same.  
 
Figure 56. Steric interaction existed in the inter-substituted allylic azides. 
Hydroxyl allylic azide rearrangement may be different from those discussed 
previously due to the existence of H-bonding (Figure 57). For allylic azides 2-181 and 2-185, 
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trans isomer and internal isomer have the same percentage, due to 5-membered H-bonding. 
So the composition pattern is changed for the alkylated allylic azides 2-183 and 2-184. But, 
allylic azides 2-182 have a different composition pattern although it has 6-membered H-
bonding. It indicated that 6-memebered intramolecular H-bonding is relatively weak, and 
intermolecular H-bonding might be the major contribution here.  
 
Figure 57. Hydroxyl allylic azide rearrangement.   
H-bonding effect also clearly existed for cyclic allylic azides (Figure 58). The large 
population of 2-186a over 2-186b showed that intramolecular H-bonding is relatively strong 
in comparison with 2-187a and 2-187b. Furthermore, conformational analysis indicated that 
2-187a and 2-187b, both with half-chair conformations, have similar energies. Although the 
azide group and OR group of 2-187a have a gauche interaction, it is still slightly more stable 
than 2-187b.  
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Figure 58. Cyclic allylic azide rearrangement. 
For allylic azides 2-188, A1,3 strain results in higher population of trans azide 2-188c 
than cis 2-188b (Figure 59). Currently, it remains unclear why half-chair azide 2-188a is 
more stable than chair azide 2-188c and 2-188b. But A1,3 strain of H1 and H2, lying in the 
same plane, still could be one of reasons although the molecule with chair conformation is 
usually ~10 kcal/mol more stable than the one with half-chair conformation.  
 
Figure 59. Cyclic allylic azide rearrangement.  
Allylic azide is an excellent example to study molecular conformation, because of 
their interconverting isomers. The higher population of the isomer indicates that the 
conformation of this isomer is more stable than others.  
Time-dependent study. Although allylic azide is an interconverting mixture of three 
or four isomers, two mixtures, with trans and internal isomers predominant respectively, can 
be obtained after careful column separation due to their slow interconverting rate. The ratio of 
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them changes with time until an equilibration is reached. We utilized the NMR technique to 
track these changes (Figure 60).  
 
Figure 60. Time-dependent study of allylic azide 2-144. 
The numerical data is shown in Table 9. These data showed that the equilibration was 
reached after 10–15 h. Theoretically, the kp/ks value is equal to 2-144a/(2-144c+2-144d): 
66/30 = 2.2. Although there are not enough data, the current data still indicated that kp is 
much faster than ks (Figure 61).  
Table 9. Time-dependent study of allylic azides 2-144. 
 
Time 
Ratio 
(a:b:(c+d)) 
Time 
Ratio 
(a:b:(c+d)) 
0 h 26:2:72 0 h 81:6:13 
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3 h 44:2:54 3.5 h 73:7:20 
7.5 h 60:3:37 8 h 67:7:26 
14.5 h 65:4:31 15 h 66:6:28 
19 h 66:4:30 19 h 65:6:29 
 
 
Figure 61. The comparison of ks and kp for azides 2-144.  
 
We also did a time-dependent study with azides 2-181a, 2-181b, and 2-181c (Table 
10). Their equilibration was reached after 1–2 days, which indicated their interconverting 
transition state energy is higher than the one for 2-144. Its kp is similar to ks (Figure 62), 
which matched their percentage difference (51:48).  
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Table 10. Time-dependent study of allylic azides 2-181. 
 
Time 
Ratio 
(a:b:c) 
Time 
Ratio 
(a:b:c) 
0 min 93:3:4 0 min 7:0:93 
84 min 85:3:12 86 min 13:0:87 
148 min 82:2:16 151 min 17:0:83 
228 min 77:2:21 231 min 22:0:78 
276 min 74:2:24 279 min 24:0:76 
364 min 70:2:28 365 min 28:0:72 
475 min 66:2:32 478 min 32:0:68 
589 min 62:2:36 590 min 35:0:65 
707 min 60:2:38 709 min 37:0:63 
21 h 52:2:46 21 h 43:2:55 
27 h 50:2:48 27 h 44:2:54 
38 h 49:1:50 38 h 46:2:52 
56 h 48:1:51 56 h 47:2:51 
23 d 48:1:51 23 d 46:3:51 
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Figure 62. The comparison of ks and kp for azides 2-181. 
 
Isomeric azides 2-182a, 2-182b and 2-182c reached their equilibration in about 10-15 
h (Table 11), which is similar to 2-144. From the initial changes within 4 h, it can be found 
that kp is much faster than ks, which matched with the theoretical kp/ks value (74/18 = 4) 
(Figure 63).  
Table 11. Time-dependent study of allylic azides 2-182. 
 
Time 
Ratio 
(a:b:c) 
Time 
Ratio 
(a:b:c) 
0 h 82:9:9 0 h 3:0:97 
2.5 h 78:9:13 2 h 41:1:58 
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4.5 h 75:9:16 4 h 58:2:40 
11.5 h 74:8:18 11 h 72:4:24 
20 h 74:8:18 20 h 72:4:24 
35 h 74:8:18 35 h 76:5:19 
43 h 75:8:17 43 h 76:5:19 
68 h 75:8:17 68 h 74:6:20 
 
 
Figure 63. The comparison of ks and kp for azides 2-182. 
 
We also did the time-dependent study of azides 2-186a and 2-186b (Table 12). It 
took about 5–10 days to reach their equilibration (Figure 64), meaning that the energy of their 
interconverting transition state was relatively high.  
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Table 12. Time-dependent study of allylic azide 2-186. 
 
Time 
Ratio 
(a:b) 
Time 
Ratio 
(a:b) 
0 h 100:0 0 h 6:94 
15 h 94:6 14 h 30:70 
39 h 91:9 38 h 50:50 
3.5 d 87:13 3.5 d 67:33 
13 d 83:17 13 d 82:18 
20 d 83:17 20 d 82:18 
 
 
Figure 64. The comparison of ks and kp for azides 2-186. 
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Variable-temperature experiment. We are also interested at the change of ratio at 
the difference temperatures. When variable temperature NMR experiments were used to track 
the change, the ratio was slightly changed at higher temperature (Table 13). The change 
occurred between trans and cis isomers, while the amount of the internal isomer almost kept 
constant.  
Table 13. Temperature-variable study of allylic azides 2-150. 
 
Temperature (°C) Ratio (a: b: c) 
25 70:10:20 
55 70:11:19 
85 68:14:18 
115 66:15:19 
135 65:16:19 
 
Following the reported procedure,94 allylic azides 2-189 were prepared and variable-
temperature experiments were carried out (Table 14). As the temperature increased, the 
conjugate system of styrene was lost, and the ratio changed from 8.9:1 to 3.0:1. But the ratio 
went back when the temperature returned to room temperature. It was interesting to find that 
when the set temperature in the NMR instrument was reached and stablized, usually taking 
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several minutes, the equilibration also was also reached. Even though the temperature was 
kept for 1 h, the ratio did not have a slight variation. It indicated that the equilibrating process 
was very fast though at the different temperatures.  
Table 14. Temperature-variable study of allylic azides 2-189.  
 
Temperature (°C) 
(2-189a+2-189b):( 2-
189c+2-189d) 
2-189a: 2-
189b 
25 8.9 : 1 2.5 : 1 
45 5.9 : 1 nd 
65 4.5 : 1 nd 
85 3.4 : 1 nd 
95 3.2 : 1 nd 
105 3.0 : 1 nd 
 
Lewis acid-promoted study. Because the combination reaction was to be carried out 
under the promotion of Lewis acid, we tried to determine if Lewis acid can accelerate the 
allylic azide rearrangement. We tried several Lewis acids, such as TiCl4, SnCl4, BF3·Et2O; 
however, allylic azide was decomposed under these conditions. When allylic azides 2-181 
were treated with TFA, acetylated allylic azides 2-190 were obtained. Their time-dependent 
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variation was recorded (Table 15). The acetylation was not finished even after 2–3 days. It 
was hard to conclude if TFA promotes this reaction at the current stage.  
Table 15. TFA-promoted allylic azide rearrangement. 
 
Time 
 
Ratio 
(2-181c: 2-181a: 2-181b: 
2-190c: 2-190a: 2-190b) 
Time 
 
Ratio 
(2-181c: 2-181a: 2-181b: 
2-190c: 2-190a: 2-190b) 
0 h 45:52:3:0:0:0 0 h 40:57:2:0:1:0 
0.15 h 46:51:3:0:0:0 1 h 38:52:2:1:7:0 
10 h 38:39:0:4:18:1 9 h 25:31:1:10:32:1 
14 h 34:36:0:5:24:1 13 h 21:26:1:13:39:0 
25 h 27:30:0:8:35:1 24 h 16:18:1:14:51:0 
42 h 21:22:0:11:44:2 42 h 10:13:0:16:62:0 
23 d 11:12:0:5:68:4 23 d 6:9:0:10:75:0 
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2.5 Combined allylic azide rearrangement and intramolecular Schmidt reaction 
Initial study. The allylic azide 2-200, whose 1,3-transposed azide is the same as 
itself, was first used to know if allylic azides were stable under the necessary Lewis acid 
conditions per the Schmidt reaction (Table 16). The conversion of azide 2-200 to lactam 2-
201 was achieved in two conditions with 82–83% yield.   
Table 16. The intramolecular Schmidt reaction of allylic azide 2-200.  
 
Entry Condition Yield 
1 TFA, rt 82% 
2 1.5 eq SnCl4, DCM, reflux 83% 
 
When azide 2-203 was treated with the same conditions, the yield obtained was only 
20–24%. The low yielding may be resulted from the torsional strain of five-membered 
cyclopentanone.  
Table 17. The intramolecular Schmidt reaction of allylic azide 2-203. 
 
Entry Condition Yield 
1 TFA, rt 20% 
2 1.5 eq SnCl4, DCM, reflux 24% 
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Condition-screening. Based on our hypothesis shown in Figure 42 and the 
successful initial studies, a high diastereoseletivity was expected for the combination of 
allylic azide rearrangement and intramolecular Schmidt reaction.  
Various conditions were tested for this combination (Table 18). The best result was 
obtained with 1.5 eq of tin chloride in refluxing dichloroethane to afford amides 2-66a and 2-
66b in 68% yield. However, only 1.2:1 ratio was obtained, which was below our expectations. 
Beside the traditional amides, alcohols 2-66f and 2-66g were also obtained with 1.3:0.5 ratio 
when allylic azide was treated with titanium chloride.   
Table 18. Condition-screening for the combination of allylic azides 2-65.  
 
Entry Condition 
Ratio 
(2-66a: 2-66b) 
Yield 
(2-66a + 
2-66b) 
Yield 
(2-66f + 2-
66g) 
1 1.2 eq TiCl4, DCM, rt 1.1:1   
2 1.5 eq TiCl4, DCM, rt 1.1:1 23% 
16% 
(1.3:0.5) 
3 1.5 eq SnCl4, DCM, rt 1.1:1 55%  
4 1.5 eq BF3·OEt2, DCM, rt 1:1 34%  
5 TFA, DCM, rt 1:1 34%  
 156 
6 1.5 eq SnCl4, DCM, 0 °C 1.1:1 36%  
7 1.5 eq SnCl4, DCM, reflux 1.2:1 60%  
8 1.5 eq SnCl4, DCE, reflux 1.3:1 54%  
9 1.5 eq SnCl4, DCM, rt 1.2:1 56%  
10 
1.5 eq SnCl4, DCM, reflux 
(500 mg scale-up) 
1.2:1 
66% 
(68%) 
 
11 3 eq TMSOTf, DCM, rt 1:1 28%  
12 3 eq MeAlCl2, DCM rt 2.4:1 21%  
 
Mechanistic analysis. Based on the mechanistic study in the traditional 
intramolecular Schmidt reaction shown in Figure 36, there are two reactive conformers eq-2-
65d and ax-2-65d for cyclohexanone substituted allylic azide 2-65d (Figure 65). For 
equatorial conformer eq-2-65d, azide can possibly attack the carbonyl group from axial and 
equatorial positions to produce 2-205 and 2-206, respectively. Both intermediates lead to the 
formation of the same lactam 2-66b. However, for axial conformer ax-2-65d, two 
intermediates 2-207 and 2-208 can be formed due to the orientation of N2
+ group, although 
azide can only attack the carbonyl from the equatorial position. Azidohydrin 2-207 can lead 
to the formation of lactam 2-66b; and 2-208 to the formation of twisted amide 2-66e.   
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Figure 65. Proposed mechanism for the synthesis of 2-66b. 
The same analysis was applied to azide 2-65c, where four intermediates 2-209, 2-210, 
2-211, and 2-212 can lead to the formation of normal amide 2-66a and twisted amide 2-66d, 
respectively (Figure 66).  
 
Figure 66. Mechanistic analysis for the combination.  
Conformational analysis. Based on the Curtin-Hammett princinple, the ratio of 
products is determined by the relative heights of the highest energy barriers leading to the 
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products. Because the intramolecular Schmidt reaction is strongly exothermic, the transition 
state is very close to azidohydrin intermediate (early transition state). We could have a basic 
image how this reaction goes by analyzing all the azidohydrin intermediates. All the 
intermediates were compared to find that azidohydrins 2-209 and 2-206 are the major 
contributors for the production of lactams 2-66a and 2-66b due to less steric interactions. 
Because both vinyl groups are in the equatorial positions, the major difference between both 
intermediates is the switched azidohydrin center, one of which is with axial OLA group and 
the other with equatorial OLA group.  
Before further conformational analysis, basic knowledge of stereochemistry was 
summarized in Figure 67. cis-Decalin has three butane-gauche interactions and is 2.7 
kcal/mol higher in energy than trans-decalin.100 So, butane-gauche interaction in the decalin 
system is around 0.9 kcal/mol. Depending on the method, cis-decalin 2-213 is only 0.55 or 
1.39 kcal/mol higher, than trans-decalin 2-214 or 2-215 if a methyl group was put on the 
bridgehead carbon of decalin system.100 cis-Decalin 2-213 has four Me-H synaxial 
interacations, which are equal to 3.4 kcal/mol if A value of methyl group is 1.7 kcal/mol 
(equal to two synaxial intereactions); trans-decalin 2-214 has two Me-H synaxial interactions 
and three butane-gauche interactions totaling to 4.4 kcal/mol (1.7 + (3*0.9) = 4.4). This 
means that 2-214 is 1 kcal/mol higher than 2-213, which matches with the experimental result. 
If nitrogen replaced one of carbons near to bridgehead carbon, 2-216 and 2-217 become 
different compounds, unlike 2-214 and 2-215, which have the enantiomeric relationship. The 
9:1 ratio of 2-216 and 2-217 indicated that their energy difference is 1.30 kcal/mol.100 
Compound 2-216 has one butane-gauche interaction and two propylamine interactions; and 2-
217 has three butane-gauche interactions. So we can induce that the propylamine interaction 
is around 0.25 kcal/mol ((3*0.9-1.3-0.9)/2=0.25). The low interaction energy of propylamine 
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interaction is due to the small interaction between lone pair electron of nitrogen and hydrogen 
atom (Figure 68). The energy difference of 2-218 and 2-219 is not found yet.   
 
Figure 67. Steric interactions in the decalin system. 
 
Figure 68. Steric interaction of 2-216 and 2-217.  
With the basic knowledge of stereochemistry in mind, the energies of 2-209 and 2-
206 were compared. Intermediate 2-209 has four OLA-H synaxial interactions, and 2-206 has 
two OLA-H interactions, one butane-gauche interaction and two propylamine-gauche 
interactions. Here the propylamine interaction with attached N2
+ group, may be different from 
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2-218; and it may be little higher than 0.25 kcal/mol. The difference of 2-209 and 2-206 is if 
two OLA-H interactions (A value of OLA group) compete with one butane-gauche and two 
propylamine-gauche interactions (0.9 + 2*0.25 = 1.4 kcal/mol). If OH (1 kcal/mol) was used 
to replace OLA group here, 2-209 is about 0.4 kcal/mol more stable than 2-206. Because the 
OLA group is bigger than OH group, this greatly matched with the result of 1.2:1 
diastereoselectivity.   
 
Figure 69. The most stable intermediate in the combination.  
Computational calculation. Computational calculation could assist our deeper 
understanding of the mechanism. Osvaldo Gutierrez and Prof. Dean J. Tantillo from 
University of California–Davis conducted the computational calculations for us (Figure 70).  
All stationary points were calculated using B3LYP with the 6-31G(d,p) basis set 
(SDD was used for Sn) in DCE (CPCM; UA0) as implemented in GAUSSIAN09. As shown 
in Figure 70, the relative energies show that all transition states with an axial vinyl group are 
5-8 kcal/mol higher in energy than the corresponding transition states with an equatorial vinyl 
group. Although the vinyl group has an A value around 1.6-2 kcal/mol, the much larger 
energy difference is attributed to butane-gauche interaction. Therefore, fused lactam 2-66a 
arises predominately from 2-209, although 2-211 certainly contributes, and 2-66b arises from 
2-206. For this system, the transition state leading to the bridged lactam is too high in energy 
and is not expected to produce any significant product. Furthermore, the overall barrier from 
the lowest energy reactant (complexed to SnCl3) to the lowest energy transition state structure 
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2-209 is 28.7 kcal/mol, which is much higher than that calculated for the allylic azide 
rearrangement (ca. 22 kcal/mol) and therefore the overall regio- and diasteroselectivity is 
controlled by the alkyl migration/N2 loss transition state structures. 
 
Figure 70. Relative enthalpies (free energies in brackets; 298.15 K) of transition state 
structures calculated using  B3LYP/6-31G(d,p)-[SDD for Sn] in DCE (CPCM;UA0). 
 
Based on the above data, a reaction coordinate diagram can be generated (Figure 71). 
Based on the Curtin-Hammett principel, the ratio of products 2-66a and 2-66b is determined 
by the difference of the highest energy barriers leading to the products, which are the 
transition states from 2-209 to 2-66a, or from 2-206 to 2-66b. The energy of transition state 
in the allylic azide rearrangement is relatively lower than that.  
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Figure 71. Reaction coordinate diagram of this combination.  
Halo-Prins reaction. Coates and coworkers reported the halo-Prins cyclizations of δ-
unsaturated ketones to synthesize 1,3-halo hydrins (Scheme 61).101,102 Under the promotion of 
TiCl4, a high selectivity for syn products was obtained. However, when SnCl4 was used, anti-
product with high selectivity was obtained. However, with Me-substituted olefin, anti-product 
is a major product although TiCl4 was used to promote this reaction.  
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Scheme 61. Selective halo-Prins reaction.  
They also proposed a mechanism to explain the competition between syn- and anti-
selective reactions for the halo-Prins cyclization (Figure 72). For syn-selectivity, the chloride 
from titanium chloride intramolecularly attacked the carbocation 2-226, generated from the 
Prins reaction of olefin 2-225, to produce syn-product 2-230. The anti-product 2-228 was 
formed from the corresponding intermolecular attack. The preference of syn-addition product 
by TiCl4 was explained by its strong Lewis acidicity. The relatively weaker Lewis acid, SnCl4, 
results in slow rate of ion pair collapse to syn-product, and then favors the formation of trans-
product.  
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Figure 72. Proposed mechanism for competing syn- and anti-selective halo-Prins cyclizations.  
With this in mind, a chloro-Prins reaction can in principle occur in the combination 
of allylic azide rearrangement and intramolecular Schmidt reaction (Figure 73). These 
products have been observed in a limited number of cases.  
 
Figure 73. Competitions between Schmidt and Prins reactions.  
Based on the mechanistic analysis, five stereoisomers are possible halo-Prins adducts 
(Figure 74). As mentioned above, carbocation 2-231, generated from eq-attack of eq-2-65a, 
can make ion pair association intramolecularely or intermolecularly to give 2-66f and 2-66g, 
respectively. The same sequence can occur for ax-attack of eq-2-65a to afford 2-66h and 2-
66i, respectively. For ax-2-65a, there is only one product 2-66j from the intermolecular ion 
pair association. When allylic azides 2-65 were treated with TiCl4, a mixture of 2-66f and 2-
66g was obtained in a 16% yield with 1.3:0.5 ratio (entry 2 in Table 18). Their relative 
stereochemistry was determined by the combination of 2D NMR and coupling patterns. The 
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diagnostic peaks are the hydrogen atoms marked in green, one with td pattern and the other 
with q pattern (Figure 74).    
 
Figure 74. Chloro-Prins reaction of allylic azides.  
 
2.6 Stereocontrol in the combination of allylic azide rearrangement and 
intramolecular Schmidt reaction  
In this section, the influence of substituents in the ketone on the diastereoselectivity 
is to be discussed. In this section and the rest of this chapter, only trans isomer of isomeric 
allylic azides is shown to represent the whole allylic azides mixture and the term, allylic 
azides XXX, was used to refer a mixture of azides XXXa, XXXb, XXXc, and XXXd.  
4-tert-Butylcyclohexanone is an extreme type of cyclohexanone. The existence of 
bulky tert-butyl group, which is always at the equatorial position, can force the 2-alkyl chain 
to either equatorial or axial position. cis-Allylic azides 2-128 were treated with SnCl4 to give 
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lactams 2-129a and 2-129b in a 68% yield with 3:1 ratio (Table 19). The ratio was slightly 
higher than lactam 2-66’s (1.2:1), which may result from no contribution of intermediate 2-
237 (Figure 75). Furthermore, trace amount of lactam 2-131a was obtained, which may be 
resulted from the α-center epimerization of ketone 2-128 to 2-130. The Prins reaction is to be 
discussed in a separate section and this is also applied for the next examples.  
Table 19. Condition-screening for allylic azides 2-128.  
 
Entry Condition 
Ratio 
(2-129a: 2-129b: 
2-129c: 2-129d: 2-
131a) 
Yield 
(2-129a+2-
129b) 
Yield 
(2-129c+2-
129d) 
1 1.5 eq SnCl4, DCM, reflux 10:3:0:0:0 63%  
2 1.5 eq SnCl4, DCM, reflux 3:1:0:0:0.05 68%  
3 1.5 eq TiCl4, DCM, rt 0.66:0.6:1.0:0.35:0 34% 24% 
4 1.5 eq TiCl4, DCM,  rt; M.S. 0.72:0.55:1.0:0.4:0.17 34% 34% 
5 
10 eq amberlyst 15, DCM, 
reflux, 3 days 
1.8:1:0:0:0.2 68%  
6 
1.5 eq SnCl4, DCM,  reflux; 
M. S. 
4:1:0.05:0:0:2.2(SM) 45%  
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Figure 75. Proposed intermediates to 2-129a and 2-129b.  
When azide 2-130 was treated with SnCl4, lactam 2-131a was obtained, along with 2-
131b and 2-131c, in a 63% yield with >25:1:1 ratio (Scheme 62). The instability of 
intermediate 2-241 due to the axial tert-butyl group is the reason high selectivity was 
obtained. For the production of 2-131a, most contributions are from intermediate 2-240, 
instead of 2-239. Trace amount of twisted amide 2-131c was obtained due to the axial 
orientation of N2
+ group.   
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Scheme 62. Generation of lactam 2-129.  
After the understanding of tert-butyl group’s impact on the diastereoselectivity, we 
tried to understand the impact of other substituents around the six-membered ring on the 
diastereoselectivity. The 4,4-Dimethyl substituted cyclohexanone was tested for this 
combination (Table 20). A similar selectivity (1.6:1~1.7:1) to unsubstituted cyclohexanone 
was obtained in modest yield (Figure 76). 
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Table 20. Condition-screening for allylic azides 2-122. 
 
Entry Condition 
Ratio 
(2-123a: 2-123b) 
Yield 
(2-123a+2-123b) 
1 1.5 eq SnCl4, DCM, reflux 1.7:1 74% 
2 1.5 eq SnCl4, DCM, reflux 1.7:1 66% 
3 1.5 eq TiCl4, DCE,  reflux 1.6:1 64% 
 
 
Figure 76. Proposed intermediates to 2-123a and 2-123b. 
Unfortunately, tin chloride did not work for the transformation from allylic azides 2-
126 to lactams 2-127a and 2-127b (Table 21). Titanium chloride afforded the desired latams 
with 10:1 ratio in a 50% yield. The OLA group of intermediate 2-248 has the gauche 
interaction with both methyl groups, and this may confer this intermediate with higher energy 
(Figure 77). The existence of two methyl groups do not bring large hindrance to intermediate 
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2-246. Hence, 10:1 selectivity may be produced due to the energy difference between 2-246 
and 2-248.   
Table 21. Condition-screening for allylic azides 2-126. 
 
Entry Condition 
Ratio 
(2-127a: 2-127b) 
Yield 
(2-127a+2-127b) 
1 1.5 eq SnCl4, DCM, reflux 
SM and CHO 
(20%) 
nd 
2 3 eq SnCl4, DCE, reflux messy nd 
3 3 eq TiCl4, DCM, reflux 2:1: 0.4 (sm) nd 
4 1.5 eq TiCl4, DCE, reflux 10:1 50% 
 
 
Figure 77. Proposed intermediates to 2-127a and 2-127b. 
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For allylic azides 2-120 containing 3,3-dimethyl substituted cyclohexanone, a very 
interesting result was obtained (Table 22). When the temperature treating allylic azides 2-120 
with TiCl4 was changed from 0 °C to refluxing in DCE, the ratio of lactams 2-121a and 2-
121b changed from 1:1.1 to 1.4:1. However, the ratio changed from 4:1 to 35:1 when 
carrying out this experiment with SnCl4.  
Table 22. Condition-screening for allylic azides 2-120. 
 
Entry Condition 
Ratio 
[2-121a: 2-
121b (:2-121c: 
2-121d)] 
Yield 
(2-121a+2-
121b) 
Yield 
(2-121c+2-
121d) 
1 1.5 eq TiCl4, DCM, 0 °C 1.0:1.1:0.4:0.1 25% 8% 
2 1.5 eq TiCl4, DCM, reflux 1:1.1 61%  
3 1.5 eq TiCl4, DCE, reflux 1.4:1 77%  
4 1.5 eq SnCl4, DCM, 0 °C 4:1 
14% 
22%(brsm) 
 
5 1.5 eq SnCl4, DCM, reflux 30:1 57%  
6 1.5 eq SnCl4, DCE,  reflux 35:1 55%  
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Due to the relatively weaker Lewis acidity of tin chloride, O-Sn bond is 2.30 Å; but 
O-Ti bond is 2.14 Å.102 This bond length difference may contribute to the difference of 
selectivity. The syn-axial interaction between axial methyl group and axial O-SnCl3 group in 
the intermediate 2-249-Sn may be relatively smaller in comparison with the syn-pentane 
interaction between axial methyl group and alkyl side-chain in the intermediate 2-251-Sn 
(Figure 78). This could be the reason why SnCl4 can afford high diastereoselectivity. 
However, this might be not true for TiCl4 due to short O-Ti bond, and the syn-axial 
interaction in 2-249-Ti may be matchable with the syn-pentane interaction in 2-251-Ti.  
 
Figure 78. Proposed intermediates to 2-121a and 2-122b.  
When allylic azides 2-124 were treated with SnCl4, lactams 2-125a and 2-125b were 
obtained in a 54% yield with 9:1 diastereoselectivity (Scheme 63). This reaction under the 
promotion of TiCl4 under different temperatures should also be investigated.  
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Scheme 63. Generation of lactams 2-125a and 2-125b.  
Although the population of internal isomers 2-166c and 2-166d is much lower (~2%; 
not shown), lactams 2-167a and 2-167b were obtained in the modest yield with the ratio 
ranged from 1:1.7 to 1.6:1 (Table 23). The success of this reaction demonstrated the power of 
this combination. Like the conversion from azides 2-120 to lactams 2-121, TiCl4 and SnCl4 
provided the different selectivity pattern. Titanium favored the generation of lactam 2-167b; 
however, tin favored the production of 2-167a. Right now, it remains unclear why different 
metal plays so important of a role in the energy difference between 2-255 and 2-257 (Figure 
79).  
 174 
Table 23. Condition-screening for allylic azides 2-166. 
 
 
Condition Yield 
Ratio (2-167a: 2-167b: 
2-167c: 2-167d) 
1 1.5 eq TiCl4, DCM, rt 64% (2-167c+2-167d) 0:0:15:1 
2 1.5 eq TiCl4, DCM, reflux 
10% (2-167a+2-167b) 
57% (2-167c+2-167d) 
1:1.2:11:1 
3 1.5 eq TiCl4, DCE, reflux 
33% (2-167a+2-167b) 
33% (2-167c+2-
167d+2-167e) 
1:1.7:2.2:0.1:0.2 
 (167e) 
4 1.5 eq SnCl4, DCM, reflux 63% (2-167a+2-167b) 1.3:1:0:0 
5 1.5 eq SnCl4, DCE, reflux 50% (2-167a+2-167b) 1.6:1:0:0 
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Figure 79. Proposed intermediates to 2-167a and 2-167b. 
TiCl4 and SnCl4 also provided the different selectivity pattern for the conversion of 
azides 2-164 to lactams 2-165a and 2-165b (Table 24 and Figure 80). The ratio for titanium 
ranged from 1:4 to 1:2.5; however, it was from 4:1 to 7:1 for tin.  
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Table 24. Condition-screening for allylic azides 2-164. 
 
 
Condition Yield 
Ratio 
(2-165a: 2-165b: 2-165c: 
2-165d: 2-165e: 2-165f: 
2-165g: 2-165h) 
1 1.5 eq TiCl4, DCM, reflux 
30%(2-165a+2-165b) 
21% (2-165c+2-165d+2-
165e) 
3% (2-165f) 
2% (2-165g+2-165h) 
0.24:1 
14:1:0.9 
 
2.5: 1 
2 1.5 eq TiCl4, DCE, reflux 54% 1:2.5 
3 1.5 eq SnCl4, DCM, reflux 56% 4:1 
4 1.5 eq SnCl4, DCE, reflux 47% 7:1 
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Figure 80. Proposed intermediates to 2-165a and 2-165b. 
After the studies of substituents around the six-membered ring, we focused our 
attentions on the α-substituent of the ketone (Figure 81). Through the above cases, we have 
learned that low selectivity was obtained due to the possible attacks of azide, of the equatorial 
side chain, on both faces of ketone. If the side chain is forced to the axial position, only one 
face of ketone is accessible, and then high selectivity can be obtained. We tried to put the 
substituents on the α-positon of ketone and then to force the side chain to the axial position.  
 
Figure 81. Selectivity pattern of two conformers.  
Because methyl group and alkyl side chain have a similar A value, a comparative 
percentage of equatorial and axial conformers are expected. Then, the more contribution from 
2-262 is expected due to the more population of axial conformer ax-2-134c, and hence high 
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ratio of 2-135a and 2-135b was expected (Figure 82). Methyl-substituted azides 2-134 were 
treated with TiCl4 or SnCl4 to afford lactams 2-135a and 2-135b in a modest yield with 1.1:1 
ratio (Table 25). That indicated that the flipping of axial and equatorial conformers, which 
may have the lower energy barrier, is much faster than the combination, as the allylic azide 
rearrangement is.  
Table 25. Condition-screening for allylic azides 2-134. 
 
Entry Condition 
Ratio 
(2-135a: 2-135b) 
Yield 
(2-135a+2-135b) 
1 1.5 eq SnCl4, DCM, reflux 1.1:1 57% 
2 1.5 eq TiCl4, DCE,  reflux 1.1:1 75% 
 
 
Figure 82. Proposed intermediates to 2-135a and 2-135b. 
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If an additional carbonyl group is added to 3-position of cyclohexanone, the azide 
can have two attacking options; and the probability of this reaction going through the most 
stable conformation is greatly increased. Several conditions were screened for azides 2-85, 
and lactams 2-86a and 2-86b were obtained in a 1:5 ratio (Table 26). This indicated that 
intermediate 2-266 is most stable (Figure 83).  
Table 26. Condition-screening for allylic azides 2-85. 
 
 
Condition Yield Ratio (2-86a: 2-86b) 
1 3 eq SnCl4, DCM, reflux 26% 1:5 
2 2.1 eq TiCl4, DIEA, DCM, rt 
 
No reaction 
3 2.1 eq TiCl4, pyridine, DCM, rt 
 
No reaction 
4 
1.5 eq SnCl4, DCM, reflux 
(after 15 h, no solvent) 
43% 1:5 
5 
1.5 eq SnCl4, DCM, reflux, 3 
days 
17% 
(20% 
brsm) 
1:3 
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Figure 83. Proposed intermediates to 2-86a and 2-86b. 
The bigger the group at the α-position of ketone, the higher population of axial 
conformers. This also increased the flipping energy barrier of chair conformation in the 
cyclohexane system. When phenyl-substituted ketone 2-132 was treated with TiCl4, lactams 
2-133a and 2-133b were obtained in a 75% yield with 5:1 ratio (Table 27 and Figure 85).  
Table 27. Condition-screening for allylic azides 2-132. 
 
Entry Condition 
Ratio 
(2-133a: 2-133b) 
Yield 
(2-133a+2-133b) 
1 1.5 eq SnCl4, DCM, reflux  No reaction 
2 1.5 eq TiCl4, DCE,  reflux 5:1 75% 
 
The equilibration between two conformers of 2-270 provided the deeper 
understanding of this combination (Figure 84). For 1-phenyl 1-methylcyclohexane, it is not 
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like what we expected eq-2-270 to be the predominant conform, based on the A value 
difference (A value of phenyl is 3.0 kcal/mol; A value of Me is 1.70 kcal/mol). Actually, ax-
2-270 is 0.34 kcal/mol more stable than eq-2-270.103 For eq-2-270, the rotation of phenyl ring 
cause different steric hindrance. When phenyl ring is in the bisector of cyclohexane, two 
hydrogens of methyl group and equatorial phenyl group have great repulsive force. If phenyl 
ring is perpendicular to the bisector of cyclohexane, there are still some interactions between 
methylenene hydrogens and hydrogens in the phenyl ring. Hence, ax-2-270 is of lowest 
energy. But there is one carbonyl group for 2-271 in one side of 1,1-disubstituted 
cyclohexane system. We tried to detect the energy difference between eq-2-271 and ax-2-271 
using NMR technique. Even although the sample was cooled to -100 °C, no difference in the 
13C NMR was detected.  
 
Figure 84. Confomational analysis of phenyl-substituted cyclohexanes.  
Because phenyl group is preferred to be at the axial position of cyclohexane, 
intermediate 2-267 may be slightly favored due to the phenyl group in the axial positions of 
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both 6-membered ring systems (Figure 85). This is the reason why only 5:1 ratio was 
obtained for this substrate.  
 
Figure 85. Proposed intermediates to 2-133a and 2-133b. 
 
α-Keto ester 2-136 was tested for this combination, and only 1.7:1 ratio was obtained 
(Table 28). Because there are two carbonyl groups in this molecule, it is suspected that metal 
can coordinate two carbonyl groups to form an intramolecular bond (2-273 and 2-274), and 
then this make the intermediate with lower energy than the molecule with two metals 
coordinating two carbonyl groups (Figure 86). This may be the reason why poor selectivity 
was obtained.  
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Table 28. Condition-screening for allylic azides 2-136. 
 
Entry Condition 
Ratio 
(2-137a: 2-137b) 
Yield 
(2-137a+2-137b) 
1 3 eq TiCl4, DCE, reflux 1.7:1  55% 
2 1.5 eq TiCl4, DCE,  reflux 1.6:1  45% 
 
 
Figure 86. Proposed intermediates to 2-137a and 2-137b.  
Allylic azides 2-142 were expected to afford lactams 2-143a and 2-143b with high 
selectivity due to the facial attack only from one face (Table 29). 15:1 ratio was obtained 
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when treating allylic azides 2-142 with TiCl4 in refluxing dichloroethane. Azide in the endo-
side chain can not reach the carbonyl group from exo face (Figure 87). Vinyl group is in the 
pseudo-equatorial position of boat conformation 2-275; however, it is at the pseudo-axial 
position for 2-276. Hence, lactam 2-143a was the major product.  
Table 29. Condition-screening for allylic azides 2-142. 
 
 
Condition Yield Ratio 
1 1.5 eq SnCl4, DCM, reflux 
 
No reaction (15% CHO) 
2 1.5 eq SnCl4, DCE, reflux 
 
Messy; no product 
3 1.5 eq TiCl4, DCM, reflux 48% 9:1 
4 1.5 eq TiCl4, DCE, reflux 65% 15:1 
 
 
Figure 87. Proposed intermediates to 2-143a and 2-143b. 
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Allylic azides 2-140, like 2-142, provided high selectivity (>20:1) of lactams 2-141a 
and 2-141b for the combination (Table 30). The similar mechanistic analysis was also applied 
here (Figure 88).  
Table 30. Condition-screening for allylic azides 2-140. 
 
 
Condition Yield Ratio 
1 
1.5 eq SnCl4, DCM, 
reflux  
No reaction (20% CHO) 
2 
1.5 eq SnCl4, DCE, 
reflux  
Messy; no product 
3 
1.5 eq TiCl4, DCM, 
reflux 
60%(schmidt) 
8% (prins) 
5.6:0.24:0.86:1:0.05:0.4 
4 1.5 eq TiCl4, DCE, reflux 
70%(schmidt) 
4% (prins) 
14.2:0.16:0.84:0.47:0.05:0.1 
 
 186 
 
Figure 88. Proposed intermediates to 2-141a and 2-141b. 
Another strategy to increase selectivity would be to increase the bulkiness of the 
vinyl group. Then allylic azides 2-178 were prepared and tested for this combination; and a 
5:1 ratio was obtained (Table 31 and Figure 89).  
Table 31. Condition-screening for allylic azides 2-178. 
 
 
Condition Yield Ratio (2-179a: 2-179b) 
1 1.5 eq SnCl4, DCM, rt 
 
messy 
2 1.5 eq SnCl4, DCM, reflux 19% 7:1 
3 1.5 eq SnCl4, DCM, reflux 26% 5:1 
4 1.5 eq SnCl4, DCM, reflux 24% 5:1 
5 1.5 eq SnCl4, DCE, reflux 
 
messy 
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Figure 89. Proposed intermediates to 2-179a and 2-179b.  
In addition to the six-membered cyclohexanones, cyclopentanone allylic azides 2-148 
were also tested for this combination (Table 32). However, only a 1.7:1 ratio of lactams 2-
149a and 2-149b was obtained. The energy difference between 2-282, 2-283 and 2-284 
remains unclear at this stage (Figure 90).  
Table 32. Condition-screening for allylic azides 2-148. 
 
 
Condition Ratio Yield 
1 3 eq SnCl4, DCM, r.t. 5:3 39% 
2 1.5 eq SnCl4, DCM, reflux 5:3 28% 
3 3 eq SnCl4, DCM, reflux 5:3 29% 
4 3 eq TiCl4, DCM, r.t. 5:4 30% 
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Figure 90. Proposed intermediates to 2-149a and 2-149b. 
This combination was also carried out on the ethyl ester substituted allylic azides 2-
150, and a reversed 1:3.5 ratio was obtained. As mentioned in Figure 86, there may be mutual 
chelation between two carbonyl groups. This could stabilize intermediate 2-287, thus 
producing lactam 2-151b as the major product (Table 33 and Figure 91).   
Table 33. Condition-screening for allylic azides 2-150. 
 
 
Condition Result Ratio 
1 3 eq TiCl4, DCM, -78 °C mixture 
 
2 3 eq TiCl4, DCM, 0 °C 
 
1:2 
3 3 eq TiCl4, toulene, 100 °C 
 
1:5 
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4 3 eq TiCl4·2THF, DCM, rt, Conv. 50% 1:3 
5 3 eq TiCl4·2THF, DCM, reflux, Conv. 60% 1:2 
6 3 eq TiCl4·2THF, tolene, reflux, 
 
1:2 
7 3 eq TiCl4·2THF, DCE, reflux 16% 3:5 
8 TfOH, DCM, r.t. messy 
 
9 TFA, DCM, r.t. 26% 1:3.5 
10 3 eq SnCl4, DCM, r.t. 
 
1:4 
11 3 eq BF3·OEt2, DCM, r.t. 
 
1:7 
12 0.9 eq TiCl4, DCM, 0 °C 
 
4:5 
 
 190 
 
Figure 91. Proposed intermediates to 2-151a and 2-151b. 
Allylic azides on linear ketones were also prepared and tested for this combination. 
Allylic azides 2-172 were prepared and tested for this combination, and a 2:1 ratio was 
obtained (Table 34). Depending on the orientation of carbonyl group, its attack to azide of 2-
172c produced two intermediates 2-288 and 2-289 (Figure 92). Likewise, reaction of 2-172d 
produces the corresponding 2-290 and 2-291. In 2-290 and 2-291, there is a strong repulsive 
force between the syn axial methyl group and the OLA or methyl group from the methyl 
ketone. Right now, it remains unclear why only 2:1 ratio was obtained. 
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Table 34. Condition-screening for allylic azides 2-172. 
 
 
Condition Yield Ratio 
1 1.5 eq TiCl4, DCM, reflux 33% 2:1 
2 1.5 eq SnCl4, toluene, reflux messy  
3 1.5 eq SnCl4, CHCl3, reflux 16% 2:1 
4 1.5 eq SnCl4, DCE, reflux 31% 2:1 
 
 
Figure 92. Proposed intermediates to 2-173a and 2-173b. 
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Lactams 2-159 were prepared from linear ketones 2-158 in the modest yields 
although the existence of bulky carbonyl groups (Table 35). However, a 25% yield of lactam 
2-157 was obtained for azides 2-156 (Table 36), possibly resulting from the poor 
electrophilicity of the carbonyl group here.  
Table 35. Condition-screening for allylic azides 2-158. 
 
 
Condition Yield 
1 1.5 eq TiCl4, DCM, r.t. 47% 
2 1.5 eq SnCl4, DCM, 0 °C 44% 
3 1.5 eq SnCl4, DCM, r.t. 51% 
4 1.5 eq SnCl4, DCM, reflux 54% 
 
Table 36. Condition-screening for allylic azides 2-156. 
 
 
Condition Yield 
1 3 eq TiCl4, DCM, r.t. 25% 
2 3 eq SnCl4, DCE, reflux messy 
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3 3 eq SnCl4, toluene, reflux messy 
4 1.5 eq SnCl4, DCM, reflux aldehyde 
 
Various conditions were screened for the preparation of lactam 2-169; however, no 
one was successful (Scheme 64). The formation of intermediate 2-292 could block the way 
azide attacks the carbonyl group.   
 
Scheme 64. Attempts to prepare lactam 2-169.  
 
2.7 Dihedral angle discussion 
In Section 2.6, high diastereoselectivity was obtained on two impressive examples 
due to the facial selectivity of carbonyl groups (Figure 93). In each case, only one face of 
ketone is accessible for the attack by the azide. The first example is the conversion of 2-130 
to 2-131a through the chair conformation intermediate 2-240. Because of the axial side chain, 
the azide can only attack the carbonyl group from its equatorial face. Hence, the syn lactam 
2-131a is the major product, resulting from the competition between equatorial and axial 
vinyl group. The opposite diastereoselectivity is observed in the conversion of 2-140 to 2-141 
through the boat conformation intermediate 2-277. Because of the exo side chain, the azide 
can only attack the carbonyl group from exo direction. Hence, the anti lactam 2-141a is the 
major product. In the above two cases, one is with syn major product arising from a chair 
conformation intermediate; and the other is with anti major product from boat conformation 
 194 
intermediate. This result forced us to consider which parameter can determine the 6-
membered conformation is chair or boat in this system.  
In contrast, for most cyclohexanone examples with the side chain at the equatorial 
position, both faces of the carbonyl group can be accessed by the azide; and the formed two 
intermediates (e.g. 2-206 and 2-209), with the similar energy (less than 0.5 kcal/mol), 
produced both lactams with low selectivity.  
 
Figure 93. Selectivity comparison.  
The dihedral angle between the side chain and ketone plane is considered. For the 
cyclohexanone system, the equatorial side chain has a dihedral angle of 9.8° with carbonyl 
group. If the side chain is switched to the axial position, this dihedral angle becomes 107.1°. 
For the norcamphor system, the dihedral angle is around 60° regardless of the exo- or endo-
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orientation. But the dihedral angle for exo-side chain is slightly larger, and this may be the 
reason why higher selectivity is obtained for endo-azides 2-140.  
 
Figure 94. Dihedral angles of cyclohexanone and norcamphor systems.  
If the connection between dihedral angle and selectivity is made, the relationship 
curve should be like what is shown in Figure 95. For the allylic azides with cyclic ketones, 
the formed six-membered intermediate, upon the treatment of Lewis acid, can adopt any of 
the possible conformations cyclohexane can have, such as chair, boat and half-chair 
conformations (Figure 96). When dihedral angle is at 0°, there are two stable chair-
conformation intermediates with equal energies, which can produce equal amounts of both 
lactams. When dihedral angel is around 60°, only one face of ketone is accessible and the anti 
lactam is produced through boat conformation intermediate as the major product. When 
dihedral angle is around 90°, the intermediate with half-chair conformation may be formed, 
leading to the syn lactam as the major product. When dihedral angle is around 110°, only one 
face of ketone is accessible and the syn lactam is produced as the major product through chair 
conformation intermediate. If the dihedral angle is above 120°, the azide of side chain can not 
reach the carbonyl group to form a six-membered ring.  
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Figure 95. The relationship between selectivity and dihedral angle.  
 
Figure 96. General scheme for the selectivity.  
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Definitely, the above analysis is purely theoretical, and the impact of substitutents on 
the ketone part were not taken into consideration.  
More examples should be tested to confirm this hypothesis. We re-examined the 
result of cyclopentanone 2-148, which produce lactams 2-149a and 2-149b with 1.7:1 ratio, 
and found that it matched with our hypothesis. The carbonyl group of cyclopentanone, whose 
conformation is to be discussed in detail in chapter 3, resides on the least puckered carbon in 
the five-membered ring in order to produce the most stable [5,6]-fused intermediate. The 
dihedral angle between side chain of 2-149 and the ketone plane is less than 20°, so a 1.7:1 
ratio fits our analysis. High selectivity would be expected due to the dihedral angle of 
cyclobutanone, bicyclo[2.2.2]octan-2-one, and tropinone.    
 
Figure 97. Novel cyclic ketones with different dihedral angles.  
The utilization of chair or boat conformation to analyze the stereochemical outcomes 
of organic reactions is very common for fused bicyclic system, in which one cycle has the 
definite conformation.  To the best of our knowledge, there is no general pricinple on why 
chair or boat conformation is used. Herein, the analysis of dihedral angle could provide some 
illustrations about this question.  
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2.8 Carbocation-mediated allylic azide preparation 
Most examples we have tested so far have the vinyl group at the end. Because there is 
no substituent at the end of the double bond, the chiral center in the allylic azide can be 
reversed, such as the conversion of 2-107c to 2-107d, as discussed in Figure 48 (Figure 98). 
But, the chiral center of 2-112d can not be reversed to 2-113, based on a concerted 
sigmatropic rearrangement as dicussed in Figure 49.   
 
Figure 98. Reversing the chiral center in allylic azides.  
Based on the sigmatropic rearrangement, if allylic azides 2-91a and 2-91b, whose 
stereochemistry is arbitrarily assigned, were treated with SnCl4, lactams 2-95a and 2-95b 
should be obtained with the same ratio as the ratio of 2-91a and 2-91b. However, when 
different ratios of azides 2-91a and 2-91b were activated, similar ratio of lactams 2-95a and 
2-95b were obtained, with the syn lactam 2-95a as the major product.  
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Scheme 65. The combination of azides 2-95a and 2-95b.  
The result suggested that this allylic azide rearrangement is not proceeding via a fully 
concerted sigmatropic rearrangement. An alternative mechanism consistent with this could 
involve with carbocation 2-297 (Scheme 66). Ion pair collapse and re-association allows the 
equilibration between 2-91a and 2-91b, hence providing a reasonable mechanism for the 
selective production of lactam 2-95a.  
 
Scheme 66. Carbocation-involved allylic azide rearrangement.  
In order to further examine this allylic azide rearrangement under the thermal 
conditions, a mixture of azides 2-91a and 2-91b having a 3:1 ratio was heated at 100 °C for 7 
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h; however, no ratio change was observed. When higher temperature was attempted, azides 
were decomposed in 1,2-dichlorobenzene (160 °C for 2 h) and DMSO (120 °C for 2 h). The 
decomposition in DMSO may result from the nucleophilicity of DMSO.  
A mixture of azides 2-189a, 2-189b, 2-189c, and 2-189d was prepared, and treated 
with SnCl4 to confirm wether carbocation-mediated allylic azide rearrangement exists or not 
(Scheme 67). However, this study did not give any positive results even though the reaction 
was run at -78 °C. From the spectrum of crude product, it seemed that the reorganization of 
allylic azide, which is to be discussed in Chapter 5, may have occurred here due to the 
presence of phenyl group.  
 
Scheme 67. Testing carbocation-mediated allylic azide rearrangement.  
To rule this out, when the methyl substituted allylic azdes 2-298a and 2-298b were 
treated with SnCl4 at -40 °C for 2 h, the ratio changed from 3:1 to 5:4 with a 90% recovery 
yield (Scheme 68). This indicated that carbocation-mediated allylic azide rearrangement 
actually occurred in this aliphatic case.  
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Scheme 68. Testing carbocation-mediated allylic azide rearrangement.  
 
2.9 Prins reaction 
In Section 2.5, a chloro-Prins reaction was mentioned as a competing side-reaction in 
the conditions screened for the combination of allylic azide rearrangement and the 
intramolecular Schmidt reaction. Most Prins side products were obtained in low yield when 
allylic azides were treated with TiCl4 at various temperatures (Scheme 69). If the temperature 
was too high, the Schmidt reaction dominated the combination. If the temperature was too 
low, no reaction occurred, including a Schmidt reaction. 
As explained in Figure 74, the anti Prins adduct is the major isomer with modest 
selectivity over syn isomer. Most ratios are ranged from 2.5:1 to 4:1. Only two examples 
were obtained in high ratio, 2-166 and 2-140. If the temperature was increased, the chlorine-
eliminated product was observed, for example 2-167e and 2-141f.  
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Scheme 69. The summary of halo-Prins reaction.  
For the Prins reaction of azide 2-164, there are three other Prins adducts, 2-165f, 2-
165g and 2-165h, besides normal Prins adducts 2-165c and 2-165d. They are speculated to 
come from an eqitorial attack of equatorial azide eq-2-164b and the eq attack from axial 
azides ax-2-164a and ax-2-164b, respectively (Figure 99).  
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Figure 99. Proposed mechanism for Prins adduct of azide 2-164.  
 
2.10 Twisted amide 
After understanding the stereocontrol in the combination of allylic azide 
rearrangement and intramolecular Schmidt reaction, we focused on the stereocontrol in the 
generation of twisted amides.  
A variety of products were obtained when treating allylic azides 2-154 with various 
conditions (Table 37). Traditional fused amides 2-155a and 2-155b, the former being 
confirmed by X-ray (Figure 100), were obtained in most conditions, where the ratio ranged 
from 5:1 to 50:1 and the yield ranged from 6% to 47%. In principle, two twisted amides 2-
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155c and 2-155d should be generated in this reaction. However, only one isomer 2-155c was 
observed, in 5%–18% yield, whose structure was confirmed by X-ray (Figure 101). Twisted 
amide 2-155c has similar physical and spectral data to amides 2-16 and 2-17 (Table 38).  
Besides traditional and twisted amides, amides 2-155e and 2-155d were also obtained 
when more than 1 equiv of Lewis acid was used in the Schmidt reaction. Due to the quality of 
crystal, only partial data was collected, but it was enough to confirm the structure of amide 2-
155e (Figure 102). Excess Lewis acid can associate to the basic nitrogen of twisted amide, 
thus generating an allylic carbocation species (Figure 103). This subsequently reacted with 
electron-rich methoxy substituted aromatic ring (Friedel-Crafts reaction) to form bicyclic 
amides 2-155e and 2-155f. This further explained why no significant diastereoselectivity was 
observed.  
Allylic azides 2-154 were treated with tin tetrachloride to afford ketones 2-155g and 
2-155h in 31% yield, in addition to traditional amides (entry 6 in Table 37). We hypothesized 
that tin chloride may be not a strong enough acid to promote the Schmidt reaction in the full 
conversion to amide 2-155a and 2-155b and retard the Friedel-Crafts reaction of allylic 
azides 2-154 to 2-155g and 2-155h at the same time. Allylic carbocation 2-303, generated 
from allylic azides 2-154, directly reacted with electron-rich methoxy substituted aromatic 
ring to generate the corresponding ketones 2-155g and 2-155h (Figure 103).  
 206 
Table 37. The generation of twisted amide. 
 
 
 
Condition Yield Ratio (crude) 
1 1.5 eq TiCl4, DCM, rt 
23% (2-155a+2-155b) 
18% (2-155e+2-155f) 
1:0.2:0.9:0.9 (a:b:e:f) 
2 1.5 eq TiCl4, DCE, reflux 
47% (2-155a+2-155b) 
39% (2-155e+2-155f) 
1:0.02:0.25:0.25 (a:b:e:f) 
3 1.05 eq TiCl4, DCE, reflux 
40%(2-155a+2-155c) 
18%(2-155c) 
9%(2-155e+2-155f) 
1:0.04:0.5:0:0.1:0.1 
(a:b:c:d:e:f) 
4 1.5 eq MeAlCl2, DCM, rt 
8% (2-155a+2-155b) 
5% (2-155c) 
1:0.1:1.0:0:2.2 
(a:b:c:d:sm) 
5 
1.5 eq MeAlCl2, DCE, 
reflux 
6% (2-155a) 
14% (2-155c) 
1:0:1.3:0(a:b:c:d) 
6 1.5 eq SnCl4, DCE, reflux 
20% (2-155a+2-155b) 
31% (2-155g+2-155h) 
1:0.03:2:1 (a:b:g:h)) 
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Figure 100. ORTEP representation of amide 2-155a.  
 
Figure 101. ORTEP representation of amide 2-155c.  
 
Table 38. Physical and spectral parameters of 2-155c.  
Substrate τ/o χN/
o χC/
o 
N-C(O) 
/Ǻ 
C=O 
/Ǻ 
υC=O 
/cm-1 
13C(C=O) 
/ppm 
Kirby (2-13) 90.5 60.0 0.0 1.475 1.196 1732 200 
Aubé (2-16) 51.5 36.1 12.8 1.387 1.218 1697 188 
Aubé (2-17) 43.2 33.8 16.3 1.363 1.234 1685 185 
2-155c 41.8 36.8 16.1 1.378 1.221 1670 184.3 
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Figure 102. ORTEP representation (partial data) of amide 2-155e.  
 
Figure 103. Proposed mechanism leading to 2-155e,f and 2-155g,h.  
 
The formation of bicyclic amides 2-155e and 2-155f further confirmed the proposed 
mechanism; however, no reaction occurred for traditional fused amide 2-155a under the same 
condition (Scheme 70).   
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Scheme 70. Friedel-Crafts reaction of twisted amide.  
Methyl sulfide group was reported to have good cation-n intereaction capability, 
which can be utilized to produce twisted amides.73 When azides 2-138 were treated with 
TiCl4, only lactam 2-139e was obtained in 12% yield, without any twisted amide (Table 39). 
Its formation is supposed to be from the elimination of methyl sulfide group of normal amide 
2-139a (Figure 104). Twisted amide 2-139c was obtained in 7% yield, along with 10% of 2-
139e, when treating with MeAlCl2.  
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Table 39. Condition-screening for allylic azides 2-138.  
 
 
Condition Yield Ratio 
1 1.5 eq TiCl4, DCE, reflux 12% (2-139e) 
 
2 1.5 eq MeAlCl2, DCE, reflux 
7%(2-139c) 
10%(2-139e) 
1.1:1 (c:e) 
 
 
Figure 104. The elimination of lactam 2-139a to 2-139e.  
 
2.11 The combination of allylic azide rearrangement and 2C Schmidt reaction 
With the successful experience of the combination of allylic azide rearrangement and 
3C intramolecular Schmidt reaction, we tried to know the result of this combination on a 2C 
Schmidt reaction (Scheme 71). When treating azides 2-174 with TiCl4, a mixture of lactams 
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2-175c, and 2-175a (two isomers) was obtained with 5:3:1 ratio. This confirmed the 
possibility of the combination on 2C Schmidt substrate.   
 
Scheme 71. The combination with one carbon-less side chain.  
However, when more substrates were tested on this combination, no positive results 
were obtained; the azides were either nor reactive or decomposed under the tested conditions 
(Figure 105).  
 
Figure 105. More 2C Schmidt substrates on the combination. 
 
2.12 The combination of allylic azide rearrangement and carbocation-mediated 
Schmidt reaction 
Pearson and coworkers reported the carbocation-mediated Schmidt reaction,104 in 
which carbocations such as 2-308, generated from alcohol 2-307 or olefin (not shown) under 
the activation of Lewis acid, undergo migration to carbocation 2-309 in order to facilitate the 
next five-membered ring closure to 2-310. Two possible bond migrations provide two 
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iminium ion intermediates 2-311 and 2-312; and the following reduction provides bicycle 2-
313 and 2-314.   
 
Scheme 72. Carbocation-mediated intramolecular Schmidt reaction.  
We speculated if allylic azides can undergo the similar transformations to generate 
disubstituted bicycles. Azides 2-315 were tested for this combination to afford a mixture of 
compounds 2-316a and 2-316b in 30% yield, whose ratio was not determined due to the 
existence of many possible isomers (Scheme 73). However, azides 2-152 did not provide any 
positive results.  
 
Scheme 73. Carbocation-mediated Schmidt reaction of allylic azides.  
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2.13 Conclusion  
In this chapter, the combination of allylic azide rearrangement and intramolecular 
Schmidt reaction was reported and its stereocontrol results were discussed. 
Isomeric allylic azides were prepared by two methods: allylic bromination-azide 
displacement, and one- or two-pot cross-metathesis-azide displacement. Most of γ- and δ- 
substituted allylic azides contain 48–67% of trans isomer, 5–13% of cis isomer, and 24–44% 
of internal isomer. Trans and internal isomers can be obtained after careful column isolation. 
Their ratio changes were studied based on the substrate, time, temperature and Lewis acid.  
Only 1.2:1 ratio was obtained for azide 2-65 in the combination of allylic azide 
rearrangement and intramolecular Schmidt reaction; which was below our expectation. 
Conformational analysis and computational calculation assisted in deeply understanding its 
mechanism. The next step was to study the impact of substituents of the cyclohexanone on 
the stereocontrol. High diastereoselectivity was obtained from azides 2-130, 2-140 and 2-142. 
For azide 2-130, the side chain was forced to the axial position due to the equatorial bulky t-
butyl group. This resulted in the formation of only one stable intermediate 2-240. For azides 
2-140 and 2-142, the boat-conformation intermediates were generated to afford lactams with 
high dr. Dihedral angle between side chain and ketone was used to rationalize the 
diastereoselectivity of different substrates in the combination.  
Carbocation-mediated allylic azide rearrangement was discovered when phenyl-
substituted allylic azides were used in this combination. It was further confirmed using the 
known allylic azides.  
The Prins reaction is the major side reactions in this combination. Most Prins adducts 
were generated when treating allylic azides with TiCl4, which are usually not obtained from 
SnCl4.  
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During the preparation of twisted amide from this combination, allylic twisted amide 
can undergo further Friedel-Crafts reaction when treating allylic azides with more than 1 
equivalent of Lewis acid.  
Initial studies were conducted for the combination of allylic azide rearrangement and 
2C or carbocation Schmidt reaction.  
 
2.14 Experimental data 
 
General procedure I: To a solution of Hoveyda-Grubbs catalyst 2nd generation (HG-
2, 0.16 mmol) in dichloromethane (12 mL) under N2 atmosphere at room temperature was 
added a solution of olefin 2-71 (6.3 mmol) and allyl bromide (15 – 30 mmol) in 
dichloromethane (5 mL) slowly. The reaction mixture was stirred overnight. The solvent was 
concentrated in vacuum and the residue was purified by chromatography to afford colorless 
oil bromide 2-68. 
 
General procedure II: A suspension of bromides 2-68 (1.1 mmol) and sodum azide 
(3.3 mmol) in DMF (6 mL) at room temperature was stirred overnight. Diethyl ether and 
water were added and the aqueous layer was washed three times with diethyl ether. The 
combined organic layers were washed with brine, dried over anhydrous sodium sulfate. The 
concentrated residue was purified by chromatography to afford a mixture of azides 2-69 and 
2-70. 
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General procedure III: To a solution of Hoveyda-Grubbs 2nd generation catalyst 
(HG-2, 0.450 mmol) in dichloromethane (20 mL) under N2 atmosphere at room temperature 
was slowly added a solution of olefin 2-71 (8.9 mmol) and allyl bromide (45 mmol) in 
dichloromethane (10 mL). The resulting reaction mixture was stirred overnight (as specified). 
The solvent was concentrated in vacuum and the residue was dissolved in DMSO (10 mL) 
and DMF (20 mL), followed by the addition of sodium azide (50.0 mmol) at room 
temperature. After being allowed to stir overnight, diethyl ether and water were added and the 
aqueous layer was washed three times with diethyl ether. The combined organic layers were 
washed with brine, dried over anhydrous sodium sulfate. The concentrated residue was 
purified by chromatography  to afford a mixture of azides 2-69 and 2-70. 
 
General procedure IV: A solution of ketone 2-72 (46 mmol), 1,1-
dimethylhydrazine (150 mmol), and p-toluenesulfonic acid monohydrate (2.0 mmol) in 
benzene (70 mL) was refluxed using a Dean-Stark apparatus for 20 h. The reaction was 
cooled to rt, and the solvent was removed in vacuum. Diethyl ether and saturated aqueous 
sodium bicarbonate were added and the aqueous layer was washed three times with diethyl 
ether. The combined organic layers were washed with saturated aqueous sodium bicarbonate 
and brine, and then dried over anhydrous sodium sulfate. The concentration afforded 
hydrazone 2-73, which was usually used directly in the next step without further purification. 
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General procedure V: To a solution of diisopropylamine (4.33 g, 42.8 mmol) in 
anhydrous THF (50 mL) under N2 atmosphere at 0 °C was slowly added n-BuLi (16.4 mL, 
2.4 M in hexane, 39.3 mmol). The ice bath was removed after 10 min and the reaction stirred 
for another 20 min. The reaction mixture was cooled to 0 °C and ketone dimethylhydrazone 
(35.7 mmol) was slowly added. After the addition, the ice bath was removed and the reaction 
stirred for another 3 h. The reaction mixture was cooled to 0 °C, bromide (42.8 mmol) was 
slowly added, and the resulting mixture was stirred overnight. The solution was poured into a 
mixture of cold 2 M H2SO4 solution (80 mL) and diethyl ether (80 mL), and was vigorously 
stirred for 1 h at room temperature. After separation, the aqueous layer was extracted twice 
with diethyl ether. The combined organic layers were washed with brine, dried over 
anhydrous sodium sulfate, and concentrated. The residue was purified by chromatography to 
afford 2-74. 
 
General procedure VI: To a refluxing solution of azides 2-65a, 2-65b, 2-65c and 2-
65d (0.57 mmol) in anhydrous dichloromethane (8 mL) under N2 atmosphere was added tin 
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tetrachloride (0.86 mmol). After refluxing for 15 h, saturated aqueous ammonium chloride 
was added to the cooled reaction mixture. After separation, the aqueous layer was washed 
with dichloromethane. The aqueous layer was neutralized by saturated aqueous sodium 
bicarbonate, and washed twice with dichloromethane. The combined organic layers were 
washed with saturated aqueous sodium bicarbonate, brine, dried over anhydrous sodium 
sulfate. The concentrated residue was purified by chromatography to afford lactams 2-66a 
and 2-66b.  
 
 
2-(2-(Chloromethyl)allyl)cyclohexanone and 2,2'-(2-methylenepropane-1,3-
diyl)dicyclohexanone. According to the general procedure V, cyclohexanone 
dimethylhydrazone (5.00 g, 35.7 mmol) and 3-chloro-2-chloromethyl-1-propene (5.35 g, 42.8 
mmol) afforded 2-(2-(chloromethyl)allyl)cyclohexanone (1.10 g, 17%) as a colorless oil and 
2,2'-(2-methylenepropane-1,3-diyl)dicyclohexanone (colorless oil, 0.72 g, 16% and white 
solid, 0.95 g,  21%) after chromatography (1-30% EtOAc/hexanes). 2-(2-
(Chloromethyl)allyl)cyclohexanone: Rf = 0.35 (20% EtOAc/hexanes); IR (neat) 2937, 1710, 
1148 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.34-1.43 (m, 1H), 1.65-1.75 (m, 2H), 1.86-1.93 (m, 
1H), 2.03-2.20 (m, 3H), 2.31-2.38 (m, 1H), 2.41-2.48 (m, 1H), 2.53-2.62 (m, 1H), 2.75 (dd, J 
=5.6 Hz, 14.8 Hz, 1H), 4.05 (s, 2H), 4.95 (q, J =1.2 Hz, 1H), 5.20 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ 25.0 (CH2), 28.1 (CH2), 33.2 (CH2), 33.9 (CH2), 42.1 (CH2), 48.4 (CH2), 48.8 
(CH), 116.1 (CH2), 143.0 (C), 212.2 (C). 2,2'-(2-Methylenepropane-1,3-diyl)dicyclohexanone 
(colorless oil): IR (neat): 2934, 1709, 1128, 886 cm-1; HRMS (ESI) m/z calculated for 
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(M+H)+ (C16H25O2) 249.1855, found: 249.1864; 
1H NMR (400 MHz, CDCl3) δ 1.27-1.34 (m, 
2H),  1.65-1.73 (m, 4H), 1.78-1.89 (m, 4H), 2.06-2.11 (m, 2H), 2.13-2.19 (m, 2H), 2.30-2.43 
(m, 4H), 2.52-2.58 (m, 4H), 4.74 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 25.0 (CH2), 28.1 
(CH2), 33.8 (CH2), 35.8 (CH2), 42.1 (CH2), 48.7 (CH), 111.6 (CH2), 145.0 (C), 212.8 (C). 
2,2'-(2-Methylenepropane-1,3-diyl)dicyclohexanone (white solid): IR (neat): 2937, 1699, 
1130, 901 cm-1; HRMS (ESI) m/z calculated for (M+Na)+ (C16H24O2Na) 271.1674, found: 
271.1635; 1H NMR (400 MHz, CDCl3) δ 1.21-1.31 (m, 2H), 1.62-1.68 (m, 4H), 1.82-1.88 (m, 
4H), 2.06-2.16 (m, 4H), 2.29-2.38 (m, 2H), 2.38-2.45 (m, 4H), 2.56 (dd, J =4.0 Hz, 14.8 Hz, 
2H),  4.76 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 25.0 (CH2), 28.0 (CH2), 33.2 (CH2), 34.9 
(CH2), 42.1 (CH2), 48.0 (CH), 113.5 (CH2), 144.4 (C), 212.8 (C). 
 
2-(2-(Azidomethyl)allyl)cyclohexanone (2-200). A suspension of 2-(2-
(chloromethyl)allyl)cyclohexanone (1.10 g, 5.90 mmol), sodium azide (1.15 g, 17.7 mmol), 
and sodium iodide (44 mg, 0.30 mmol) in DMF (10 mL) was stirred overnight at room 
temperature. Diethyl ether and water were added and the aqueous layer was washed three 
times with diethyl ether. The combined organic layers were washed with brine, dried over 
anhydrous sodium sulfate, and concentrated. The residue was purified by chromatography 
(0.5-8% EtOAc/hexanes) to afford 2-200 (1.0 g, 89%) as a colorless oil. Rf = 0.5 (20% 
EtOAc/hexanes); IR (neat) 2937, 2100, 1710 cm-1; HRMS (ESI) m/z calculated for 
(C10H15N3O+Na)
+ 216.1113, found: 216.1148; 1H NMR (400 MHz, CDCl3) δ 1.31-1.41 (m, 
1H), 1.63-1.75 (m, 2H), 1.84-1.93 (m, 1H), 2.06 (dd, J =7.6 Hz, 14.8 Hz, 1H), 2.04-2.18 (m, 
2H), 2.30-2.39 (m, 1H), 2.40-2.47 (m, 1H), 2.49-2.56 (m, 1H), 2.65 (dd, J =6.0 Hz, 14.8 Hz, 
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1H), 3.47 (dd, J =14.0 Hz, 18.4 Hz, 2H), 4.97 (s, 1H), 5.10 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 25.0 (CH2), 28.0 (CH2), 33.7 (CH2), 33.9 (CH2), 42.1 (CH2), 48.8 (CH), 56.2 (CH2), 
115.1 (CH), 141.3 (C), 212.0 (C). 
 
2-Methylene-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-201). According 
to the general procedure VI, azide 2-200 (0.11 g, 0.57 mmol) and tin tetrachloride (0.86 mL, 
1 M in dichloromethane, 0.86 mmol) afforded lactam 2-201 (78 mg, 83%) as a colorless oil 
after column chromatography (1-75% EtOAc/hexanes). Lactam 2-201: Rf = 0.40 (100% 
EtOAc/hexanes); IR (neat) 2930, 1626, 1445 cm-1; HRMS (ESI) m/z calculated for 
(C10H16NO+H)
+ 166.1232, found: 166.1227; 1H NMR (400 MHz, CDCl3) δ 1.45-1.58 (m, 
3H), 1.76-1.97 (m, 3H), 2.35 (dd, J =3.6 Hz, 15.6 Hz, 1H), 2.43 (dd, J =11.6 Hz, 12.8 Hz, 
1H), 2.54 (dd, J =6.8 Hz, 14.0 Hz, 1H), 2.93 (dd, J =8.8 Hz, 14.4 Hz, 1H), 3.88 (sextet, J 
=5.6 Hz, 1H), 4.10 (dd, J =16.0 Hz, 38.8 Hz, 2H), 4.96 (q, J =1.6 Hz, 2H); 13C NMR (100 
MHz, CDCl3) δ 23.3 (CH2), 29.6 (CH2), 35.9 (CH2), 37.8 (CH2), 40.8 (CH2), 51.5 (CH2), 59.0 
(CH), 107.1 (CH2), 143.0 (C), 174.2 (C).  
 
2-Cyclopentylidene-1,1-dimethylhydrazine.
105 According to the general procedure 
IV, cyclopentanone (26.5 mL, 0.30 mol) and 1,1-dimethylhydrazine (45.6 mL, 0.60 mmol) 
afforded 2-cyclopentylidene-1,1-dimethylhydrazine (24.9 g, 66%) as a colorless oil. 1H NMR 
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(400 MHz, CDCl3) δ 1.68-1.77 (m, 4H), 2.31-2.39 (m, 4H), 2.45 (s, 6H); 
13C NMR (100 MHz, 
CDCl3) δ 24.1 (CH2), 24.9 (CH2), 29.3 (CH2), 33.5 (CH2), 47.0 (CH3), 175.8 (C). 
 
2-(2-(Chloromethyl)allyl)cyclopentanone and 2,2'-(2-methylenepropane-1,3-
diyl)dicyclopentanone. According to the general procedure V, 2-cyclopentylidene-1,1-
dimethylhydrazine (5.04 g, 40.0 mmol) and 3-chloro-2-chloromethyl-1-propene (6.0 g, 48.0 
mmol) afforded 2-(2-(chloromethyl)allyl)cyclopentanone (colorless oil, 280 mg, 4%) and 
2,2'-(2-methylenepropane-1,3-diyl)dicyclopentanone (two isomers with ratio 2:3, colorless oil, 
190 mg, 9%) after column chromatography (1-30% EtOAc/hexanes). 2-(2-
(Chloromethyl)allyl)cyclopentanone: Rf = 0.55 (20% EtOAc/hexanes); IR (neat): 2963, 1738, 
1155 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.48-1.58 (m, 1H), 1.73-1.87 (m, 1H), 2.01-2.38 (m, 
6H), 2.72 (dd, J = 3.6 Hz, 14.8 Hz, 1H), 4.05 (s, 2H), 5.00 (s, 1H), 5.20 (s, 1H); 
13
C NMR 
(100 MHz, CDCl3) δ 20.5 (CH2), 29.7 (CH2), 33.6 (CH2), 37.9 (CH2), 47.4 (CH), 48.0 (CH2), 
115.9 (CH2), 143.1 (C), 220.0 (C). 2,2'-(2-methylenepropane-1,3-diyl)dicyclopentanone 
(colorless oil): Rf = 0.25 (20% EtOAc/hexanes); IR (neat): 2962, 1736, 1156 cm
-1; HRMS 
(ESI) m/z calculated for C14H20O2Na (M+Na)
+ 243.1361, found: 243.1353; 1H NMR (400 
MHz, CDCl3) δ 1.43-1.54 (m, 2H), 1.73-1.90 (m, 4H), 1.98-2.04 (m, 2H), 2.08-2.36 (m, 8H), 
2.54 (t, J = 14.4 Hz, 2H), 4.78-4.80 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 20.5 (CH2), 20.6 
(CH2), 29.4 (CH2), 29.7 (CH2), 35.6 (CH2), 36.2 (CH2), 37.95 (CH2), 38.04 (CH2), 47.2 (CH), 
47.6 (CH), 111.8 (CH2), 112.8 (CH2), 144.9 (C), 145.2 (C), 220.7 (C), 220.8 (C).  
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2-(2-(Azidomethyl)allyl)cyclopentanone (2-203). A suspension of 2-(2-
(chloromethyl)allyl)cyclopentanone (280 mg, 1.63 mmol), soidum azide (325 mg, 4.9 mmol) 
and sodium iodide (30 mg, 0.2 mmol) in DMF (3 mL) at room temperature was stirred 
overnight. Diethyl ether and water were added and the aqueous layer was washed with diehtyl 
ether three times. The combined organic layers were washed with brine, dried over anhydrous 
sodium sulfate. The concentration afforded a residue, which was purified by column 
chromatography (1-3% EtOAc/hexanes) to afford azide 2-203 (202 mg, 69%) as a colorless 
oil. Azide 2-203: Rf = 0.45 (20% EtOAc/hexanes); IR (neat): 2962, 2100, 1739 cm
-1; 1H 
NMR (400 MHz, CDCl3) δ 1.50-1.60 (m, 1H), 1.77-1.88 (m, 1H), 1.96-2.04 (m, 2H), 2.10-
2.40 (m, 4H), 2.63 (dd, J = 2.8 Hz, 14.8 Hz, 1H), 3.76 (dd, J = 2.0 Hz, 16.8 Hz, 2H), 5.04 (s, 
1H), 5.12 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 20.5 (CH2), 29.7 (CH2), 34.2 (CH2), 37.9 
(CH2), 47.5 (CH), 55.9 (CH2), 115.1 (CH2), 141.3 (C), 220.0 (C).  
 
2-Methylenehexahydroindolizin-5(1H)-one (2-204). According to the general 
procedure VI, azide 2-203 (74 mg, 0.41 mmol) and tin tetrachloride (0.62 mL, 1 M in 
dichloromethane, 0.62 mmol) afforded lactam 2-204 (15 mg, 24%) as a colorless oil after 
column chromatography (15-75% EtOAc/hexanes). Lactam 2-204: Rf = 0.15 (20% 
EtOAc/hexanes); IR (neat): 2924, 1625, 1451 cm-1; HRMS (ESI) m/z calculated for 
C9H13NONa (M+Na)
+ 174.0895, found: 174.0909; 1H NMR (400 MHz, CDCl3) δ 1.34-1.44 
(m, 1H), 1.67-1.80 (m, 1H), 1.95-2.01 (m, 1H), 2.13-2.18 (m, 1H), 2.28-2.37 (m, 2H), 2.48 
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(dd, J = 6.4 Hz, 18 Hz, 1H), 2.69 (ddd, J = 1.2 Hz, 5.6 Hz, 14.8 Hz, 1H), 3.57-3.63 (m, 1H), 
3.88 (d, J = 16.8 Hz, 1H), 4.43 (d, J = 16.8 Hz, 1H), 5.03-5.06 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ 20.9 (CH2), 29.4 (CH2), 31.0 (CH2), 40.8 (CH2), 49.5 (CH2), 59.2 (CH), 107.5 
(CH2), 142.9 (C), 168.6 (C).  
 
2-(But-3-enyl)cyclohexanone.106 According to the general procedure V, the reaction 
of 2-cyclohexylidene-1,1-dimethylhydrazine (5.0 g, 36 mmol) afforded the title ketone 2-
(but-3-enyl)cyclohexanone (5.2 g, 96%) as a colorless oil. Rf = 0.70 (20% EtOAc/hexanes); 
IR (neat): 2935, 1710, 1449 cm-1; HRMS (EI) m/z calculated for (C10H16O)
+ 152.1201, found: 
152.1189; 1H NMR (400 MHz, CDCl3) δ 1.23-1.32 (m, 1H), 1.34-1.44 (m, 1H), 1.62-1.73 (m, 
2H), 1.82-1.97 (m, 2H), 2.03-2.14 (m, 4H), 2.28-2.33 (m, 2H), 2.37-2.42 (m, 1H), 4.94-5.04 
(m, 2H), 5.74-5.84 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 25.0 (CH2), 28.0 (CH2), 28.5 
(CH2), 31.2 (CH2), 33.9 (CH2), 42.1 (CH2), 49.8 (CH), 114.7 (CH2), 138.5 (CH), 213.2 (C). 
 
2-(Pent-4-en-1-yl)cyclohexanone. According to the general procedure V, 2-
cyclohexylidene-1,1-dimethylhydrazine (7.0 g, 50 mmol) and 5-bromo-1-petene (10.6 g, 65.0 
mmol) afforded the title ketone 2-(pent-4-en-1-yl)cyclohexanone (8.7 g, 100%) as a colorless 
oil after column chromatography (3% EtOAc/hexanes). Rf = 0.65 (20% EtOAc/hexanes); IR 
(neat): 2933 1711, 1449, 1127 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.14-1.23 (m, 1H), 1.31-
1.42 (m, 3H), 1.60-1.69 (m, 2H), 1.72-1.85 (m, 2H), 2.00-2.11 (m, 4H), 2.24-2.29 (m, 2H), 
2.35-2.41 (m, 1H), 4.92-5.01 (m, 2H), 5.74-5.81 (m, 1H); 
13
C NMR (100 MHz, CDCl3) δ 
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24.9 (CH2), 26.5 (CH2), 28.0 (CH2), 28.9 (CH2), 33.86 (CH2), 33.88 (CH2), 42.0 (CH2), 50.6 
(CH), 114.4 (CH2), 138.7 (CH), 213.3 (C).  
 
2-(5-Bromopent-3-enyl)cyclohexanone. According to the general procedure I, 2-
(but-3-enyl)cyclohexanone (0.61 g, 4.0 mmol), HG-2 (50 mg, 0.080 0mmol, 2 mol%) and 
allyl boromide (0.68 mL, 8.0 mmol) afforded a mixture of the title bromide 2-(5-bromopent-
3-enyl)cyclohexanone (320 mg, 33%, E/Z: 5:1 ratio) as colorless oil after column 
chromatography (3% EtOAc/hexanes). Rf = 0.50 (20% EtOAc/hexanes); IR (neat): 2934, 
1709, 1448 cm-1. E isomer: 1H NMR (400 MHz, CDCl3) δ 1.25-1.32 (m, 1H), 1.34-1.43 (m, 
1H), 1.64-1.72 (m, 2H), 1.85-1.96 (m, 2H), 2.04-2.14 (m, 4H), 2.26-2.42 (m, 3H), 3.96 (d, J 
=6.4 Hz, 2H), 5.68-5.78 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 25.0 (CH2), 28.0 (CH2), 
28.4 (CH2), 29.6 (CH2), 33.4 (CH2), 34.0 (CH2), 42.1 (CH2), 49.8 (CH), 126.7 (CH), 136.1 
(CH), 213.0 (C). Z isomer (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) 4.00 (d, J 
=8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 25.0 (CH2), 28.1 (CH2), 34.2 (CH2), 125.9 
(CH), 135.4 (CH), 213.1 (C). 
 
(2R*,E)-2-(5-Azidopent-3-enyl)cyclohexanone (2-65a), (2R*,Z)-2-(5-azidopent-3-
enyl) cyclohex-anone (2-65b), (2R*)-2-( (3`S*)-3-azidopent-4-enyl)cyclohexanone (2-65c), 
and (2R*)-2-( (3`R*)-3-azidopent-4-enyl)cyclohexanone (2-65d). According to the general 
procedure II, 2-(5-bromopent-3-enyl)cyclohexanone (0.27 g, 1.1 mmol) and sodium azide 
 224 
(0.22 g, 3.3 mmol) afforded a mixture of azides 2-65a, 2-65b, 2-65c, and 2-65d (225 mg, 
99%, 62:8:15:15 ratio from 1H NMR in acetone; 64:6:15:15 from 1H NMR in CDCl3) as a 
colorless oil after chromatography (1-5% EtOAc/hexanes). Azides 2-65a, 2-65b, 2-65c, and 
2-65d: Rf = 0.50 (20% EtOAc/hexanes); IR (neat): 2935, 2098, 1709 cm
-1; HRMS (ESI) m/z 
calculated for (C22H34N4O2+H)
+ 387.2760 (corresponding to (2M-N2+H)
+), found: 387.2719. 
Azide 2-65a: 1H NMR (400 MHz, acetone) δ 1.19-1.30 (m, 1H), 1.30-1.41 (m, 1H), 1.53-
1.78 (m, 3H), 1.82-1.90 (m, 2H), 2.03-2.16 (m, 3H), 2.25-2.28 (m, 1H), 2.31-2.42 (m, 2H), 
3.77 (d, J =6.4 Hz, 2H), 5.55-5.62 (m, 1H), 5.76-5.86 (m, 1H); 13C NMR (100 MHz, acetone) 
δ 24.8 (CH2), 27.8 (CH2), 28.8 (CH2), 29.6 (CH2), 33.8 (CH2), 41.6 (CH2), 49.3 (CH), 52.3 
(CH2), 123.33 (CH), 136.5 (CH), 210.9 (C). Azide 2-65b (diagnostic peaks only): 
1H NMR 
(400 MHz, acetone) δ 3.89 (d, J =7.2 Hz, 2H); 13C NMR (100 MHz, acetone) δ 49.4 (CH), 
122.5 (CH), 135.7 (CH), 211.0 (C). Azides 2-65c and 2-65d (diagnostic peaks only): 1H 
NMR (400 MHz, acetone) δ 3.97 (q, J =7.2 Hz, 1H), 5.27-5.36 (m, 2H), 5.76-5.86 (m, 1H); 
13C NMR (100 MHz, acetone) δ 25.7 (CH2), 25.8 (CH2), 31.6 (CH2), 31.7 (CH2), 49.7 (CH), 
49.7 (CH), 65.0 (CH), 65.1 (CH), 117.49 (CH2), 117.51 (CH2), 136.12 (CH), 136.16 (CH), 
210.82 (C), 210.84 (C).  
 
 (3S*,9aR*)-3-Vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-66a) and 
(3R*,9aR*)-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-66b). According to 
the general procedure VI, azides 2-65a, 2-65b, 2-65c, and 2-65d (500 mg, 2.41 mmol) and tin 
tetrachloride (3.8 mL, 1 M in dichloromethane, 3.8 mmol) afforded lactam 2-66a (161 mg, 
37%) as a colorless oil and 2-66b (134 mg, 31%) as a colorless oil after column 
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chromatography (10-100% EtOAc/hexanes). Lactam 2-66a: Rf = 0.7 (100% EtOAc, twice); 
IR (neat): 2928, 1635, 1447, 1415 cm-1; HRMS (ESI) m/z calculated for (C11H17NO+H)
+ 
180.1388, found: 180.1380; 1H NMR (400 MHz, CDCl3) δ 1.45-1.68 (m, 6H), 1.79-1.83 (m, 
1H), 1.92-1.97 (m, 1H), 1.97-2.04 (m, 1H), 2.19-2.24 (m, 1H), 2.47-2.50 (m, 2H), 3.83 (t, J 
=9.2 Hz, 1H), 4.66 (dd, J =5.6 Hz, 6.8 Hz, 1H), 4.95-5.05 (m, 2H), 5.69-5.77 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 23.4 (CH2), 28.3 (CH2), 29.8 (CH2), 31.8 (CH2), 35.9 (CH2), 38.5 
(CH2), 59.2 (CH), 59.6 (CH), 113.6 (CH2), 137.2 (CH), 173.7 (C). Lactam 2-66b: Rf = 0.65 
(100% EtOAc, twice); IR (neat): 2927, 1636, 1446 cm-1; HRMS (ESI) m/z calculated for 
(C11H17NO+H)
+ 180.1388, found: 180.1376; 1H NMR (400 MHz, CDCl3) δ 1.35-1.46 (m, 
1H), 1.47-1.55 (m, 2H), 1.68-1.75 (m, 2H), 1.79-1.97 (m, 4H), 2.08-2.13 (m, 1H), 2.41 (dd, J 
=12.0 Hz, 14.0 Hz, 1H), 2.59 (dd, J =7.2 Hz, 14.4 Hz, 1H), 3.69 (dd, J =9.2 Hz, 16.4 Hz, 
1H), 4.75 (t, J =6.0 Hz, 1H), 5.08-5.16 (m, 2H), 5.75-5.81 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 23.5 (CH2), 29.0 (CH2), 29.8 (CH2), 32.6 (CH2), 36.0 (CH2), 38.4 (CH2), 59.6 (CH), 
59.9 (CH), 114.2 (CH2), 137.9 (CH), 174.3 (C). The following data and NOE correlations 
were used to assign lactams 2-66a and 2-66b. 
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(3R*,4R*,4aR*,8aR*)-4-(Azidomethyl)-3-chlorodecahydronaphthalen-4a-ol (2-
66f) and (3S*,4R*,4aR*,8aR*)-4-(azidomethyl)-3-chlorodecahydronaphthalen-4a-ol (2-
66g). According to the general procedure VI, azides 2-65a, 2-65b, 2-65c, and 2-65d (75 mg, 
0.36 mmol) and titanium tetrachloride (0.54 mL, 1 M in dichloromethane, 0.54 mmol) 
afforded lactam 2-66a (7 mg, 11%) as a colorless oil, 2-66b (8 mg, 12%) as a colorless oil, 
and a mixture of alcohols 66f and 66g (5:2 ratio, 14 mg, 16%) after column chromatography 
(1-100% EtOAc/hexanes). Alcohol 66f: Rf = 0.55 (20% EtOAc, twice); 
1H NMR (400 MHz, 
CDCl3) δ 1.21-1.30 (m, 3H), 1.31-1.42 (m, 3H), 1.49-1.56 (m, 2H), 1.57-1.67 (m, 2H), 1.67-
1.84 (m, 2H), 1.87-1.96 (m, 1H), 2.30 (d, J = 1.0 Hz, 1H), 2.37 (dq, J = 11.0, 3.4 Hz, 1H), 
3.85 (dd, J = 13.0, 2.5 Hz, 1H), 4.04 (dd, J = 13.0, 3.2 Hz, 1H), 4.37 (td, J = 11.4, 4.6 Hz, 
1H). Alcohol 66g (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 2.25 (dq, J = 14.5, 
3.0 Hz, 1H), 2.53 (d, J = 2.5 Hz, 1H), 3.69 (dd, J = 12.4, 10.2 Hz, 1H), 3.80 (dd, J = 12.4, 4.7 
Hz, 1H), 4.69 (q, J = 2.9 Hz, 1H).  
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(2S*,4S*)-2-(But-3-enyl)-4-tert-butylcyclohexanone and (2S*,4R*)-2-(but-3-enyl)-
4-tert-butylcyclohexanone.107 According to the general procedure V, 2-(4-(tert-
butyl)cyclohexylidene)-1,1-dimethylhydrazine (7.85 g, 40.0 mmol) afforded (2S*,4S*)-2-
(but-3-enyl)-4-tert-butylcyclohexanone (3.6 g, 43%) as a colorless oil and (2S*,4R*)-2-(but-
3-enyl)-4-tert-butylcyclohexanone (3.5 g, 42%) as a colorless oil. (2S*,4S*)-2-(But-3-enyl)-
4-tert-butylcyclohexanone: Rf = 0.45 (10% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 
0.91 (s, 9H), 1.08-1.26 (m, 2H), 1.43 (dq, J = 4.8 Hz, 12.8 Hz, 1H), 1.58 (tt, J = 3.0 Hz, 12.0 
Hz, 1H), 1.88-1.97 (m, 1H), 2.07-2.15 (m, 4H), 2.26-2.40 (m, 3H), 4.93-5.02 (m, 2H), 5.74-
5.81 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 27.6 (3CH3), 28.4 (CH2), 28.8 (CH2), 31.3 
(CH2), 32.4 (C), 35.1 (CH2), 41.7 (CH2), 47.1 (CH), 48.8 (CH), 114.6 (CH2), 138.6 (CH), 
213.3 (C). (2S*,4R*)-2-(But-3-enyl)-4-tert-butylcyclohexanone: Rf = 0.4 (10% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 0.90 (s, 9H), 1.40-1.68 (m, 4H), 1.77-1.86 
(m, 2H), 1.94-2.12 (m, 3H), 2.26-2.32 (m, 1H), 2.36-2.45 (m, 2H), 4.96-5.04 (m, 2H), 5.73-
5.83 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 26.9 (CH2), 27.4 (3CH3), 30.6 (CH2), 31.3 
(CH2), 31.4 (CH2), 32.4 (C), 38.4 (CH2), 41.3 (CH2), 48.5 (CH2), 115.2 (CH2), 137.8 (CH), 
215.6 (C). 
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(2S*,4S*,E)-2-(5-Bromopent-3-enyl)-4-tert-butylcyclohexanone and (2S*,4S*,Z)-
2-(5-bromopent-3-enyl)-4-tert-butylcyclohexanone. According to the procedure I, 
(2S*,4S*)-2-(but-3-enyl)-4-tert-butylcyclohexanone (2.38 g, 11.4 mmol) afforded a mixture 
of (2S*,4S*,E)-2-(5-bromopent-3-enyl)-4-tert-butylcyclohexanone and (2S*,4S*,Z)-2-(5-
bromopent-3-enyl)-4-tert-butylcyclohexanone (1.3 g, 38%, E/Z 10:1 ratio) as a colorless oil. 
(2S*,4S*,E)-2-(5-Bromopent-3-enyl)-4-tert-butylcyclohexanone and (2S*,4S*,Z)-2-(5-
bromopent-3-enyl)-4-tert-butylcyclohexanone: Rf = 0.30 (10% EtOAc/hexanes); IR (neat) 
2954, 2868, 1712 cm-1; HRMS (ESI) m/z calculated for (C30H49BrO2+Na)
+ 543.2814 
(corresponding to (2M-HBr+Na)+), found: 543.2808. E isomer: 1H NMR (400 MHz, CDCl3) 
δ 0.93 (s, 9H), 1.08-1.29 (m, 2H), 1.45 (dq, J = 4.8 Hz, 12.4 Hz, 1H), 1.60 (tt, J = 2.8 Hz, 
12.0 Hz, 1H), 1.88-1.98 (m, 1H), 2.07-2.18 (m, 4H), 2.26-2.43 (m, 3H), 3.96 (d, J = 6.6 Hz, 
1H), 5.66-5.80 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 27.7 (3CH3), 28.4 (CH2), 28.8 (CH2), 
29.6 (CH2), 32.5 (C), 33.5 (CH2), 35.1 (CH2), 41.7 (CH2), 47.1 (CH), 48.8 (CH), 126.7 (CH), 
136.2 (CH), 213.2 (C). Z isomer (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) 4.00-
4.03 (m, 2H); 13C NMR (100 MHz, CDCl3) 27.4 (3CH3). 
 
(2S*,4S*,E)-2-(5-Azidopent-3-enyl)-4-tert-butylcyclohexanone (2-128a), 
(2S*,4S*,Z)-2-(5-azido-pent-3-enyl)-4-tert-butylcyclohexanone (2-128b), (2S*,4S*)-2-
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((S*)-3-azidopent-4-enyl)-4-tert-butylcyclohexanone (2-128c), and (2S*,4S*)-2-((R*)-3-
azidopent-4-enyl)-4-tert-butylcyclo hexan-one (2-128d). According to the procedure II, the 
mixture of (2S*,4S*,E)-2-(5-bromopent-3-enyl)-4-tert-butylcyclohexanone and (2S*,4S*,Z)-
2-(5-bromopent-3-enyl)-4-tert-butylcyclohexanone (1.23 g, 4.10 mmol) afforded after 
chromatography (0.25-1.2% EtOAc/hexanes) a mixture of azides 2-128a, 2-128b, 2-128c, 
and 2-128d (0.90 g, 84%, 67:7:13:13 from 1H NMR in acetone; 60:6:17:17 from 1H NMR in 
CDCl3) as a colorless oil. Azides 2-128a, 2-128b, 2-128c, and 2-128d: Rf = 0.45 (10% 
EtOAc/hexanes); IR (neat) 2953, 2093, 1711 cm-1; HRMS (ESI) m/z calculated for 
(C30H50N6O2+Na)
+ 549.3893 (corresponding to (2M+Na)+), found: 549.3894. Azide 2-128a: 
1H NMR (400 MHz, acetone) δ 0.94 (s, 9H), 1.11-1.32 (m, 3H), 1.36-1.45 (m, 1H), 1.65-1.73 
(m, 1H), 1.85-1.93 (m, 1H), 2.05-2.28 (m, 4H), 2.36-2.45 (m, 2H), 3.77 (d, J = 6.4 Hz, 2H), 
5.54-5.62 (m, 1H), 5.77-5.86 (m, 1H); 13C NMR (100 MHz, acetone) δ 27.1 (3CH3), 28.5 
(CH2), 28.8 (CH2), 29.6 (CH2), 32.1 (C), 34.9 (CH2), 41.2 (CH2), 46.9 (CH), 48.3 (CH), 52.3 
(CH2), 123.3 (CH), 136.6 (CH), 211.05 (C). Azide 2-128b (diagnostic peaks only): 
1H NMR 
(400 MHz, acetone) δ 3.90 (d, J = 7.2 Hz, 2H); 13C NMR (100 MHz, acetone) δ 122.5 (CH), 
135.8 (CH), 211.17 (C). Azides 2-128c and 2-128d (diagnostic peaks only): 1H NMR (400 
MHz, acetone) δ 3.96 (q, J = 7.2 Hz, 1H), 5.28-5.36 (m, 2H), 5.79-5.86 (m, 1H); 13C NMR 
(100 MHz, acetone) δ 48.8 (CH), 48.9 (CH), 65.1 (CH), 65.2 (CH), 117.4 (CH2), 117.5 (CH2), 
136.2 (CH), 136.2 (CH), 210.97 (C), 211.00 (C).  
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(3R*,8S*,9aS*)-8-tert-Butyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-
one (2-129a) and (3S*,8S*,9aS*)-8-tert-butyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-
a]azepin-5(6H)-one (2-129b). According to the procedure VI, azides 2-128a, 2-128b, 2-128c, 
and 2-128d (86 mg, 0.33 mmol) afforded after chromatography (10-100% EtOAc/hexanes) 
lactam 2-129a (39 mg, 51%) as a colorless oil and lactam 2-129b (13 mg, 17%) as a colorless 
oil. Lactam 2-129a: Rf = 0.55 (100% EtOAc); IR (neat) 2951, 1637, 1416 cm
-1; HRMS (ESI) 
m/z calculated for (C15H25NO+H)
+ 236.2014, found: 236.2002; 1H NMR (400 MHz, CDCl3) δ 
0.88 (s, 9H), 1.23-1.37 (m, 3H), 1.63-1.71 (m, 2H), 1.74-1.82 (m, 1H), 1.95-2.02 (m, 1H), 
2.03-2.13 (m, 1H), 2.25-2.35 (m, 1H), 2.42-2.48 (m, 1H), 2.53-2.59 (m, 1H), 3.83 (t, J = 8.8 
Hz, 1H), 4.70 (t, J = 6.0 Hz, 1H), 4.99-5.10 (m, 2H), 5.74-5.82 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 24.2 (CH2), 27.7 (3CH3), 28.5 (CH2), 32.5 (CH2), 33.2 (C), 37.4 (CH2), 37.7 (CH2), 
51.7 (CH), 58.6 (CH), 59.5 (CH), 113.7 (CH2), 137.2 (CH), 173.6 (C). Lactam 2-129b: Rf = 
0.65 (100% EtOAc); IR (neat) 2960, 1637, 1416 cm-1; HRMS (ESI) m/z calculated for 
(C15H25NO+H)
+ 236.2014, found: 236.2006; 1H NMR (400 MHz, CDCl3) δ 0.90 (s, 9H), 
1.13-1.36 (m, 3H), 1.70-1.79 (m, 2H), 1.81-1.90 (m, 1H), 1.98-2.05 (m, 2H), 2.11-2.19 (m, 
1H), 2.40 (dd, J = 12.0 Hz, 14.0 Hz, 1H), 2.64 (dd, J = 8.0 Hz, 14.0 Hz, 1H), 3.65-3.71 (m, 
1H), 4.77 (t, J = 6.0 Hz, 1H), 5.10-5.17 (m, 2H), 5.78-5.86 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 24.3 (CH2), 27.6 (3CH3), 29.1 (CH2), 33.09 (CH2), 33.11 (C), 37.2 (CH2), 37.6 
(CH2), 51.5 (CH), 59.1 (CH), 59.7 (CH), 114.3 (CH2), 137.9 (CH), 174.4 (C). The following 
data and NOE correlations were used to assign lactams 2-129a and 2-129b.  
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(2S*,4aR*,5R*,6R*,8aS*)-5-(Azidomethyl)-2-(tert-butyl)-6-chlorodecahydro-
naphthalen-4a-ol (2-129c) and (2S*,4aR*,5R*,6S*,8aS*)-5-(azidomethyl)-2-(tert-butyl)-6-
chlorodecahydronaphthalen-4a-ol (2-129d). According to the procedure VI, azides 2-128a, 
2-128b, 2-128c, and 2-128d (79 mg, 0.30 mmol), titanium tetrachloride (0.48 mL, 1 M in 
dichloromethane, 0.48 mmol) and molecular sieves (1 g) at room temperature afforded after 
chromatography (3-100% EtOAc/hexanes) a mixture of lactams 2-129a and 2-129b (24 mg, 
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34%) and a mixture of alcohols 2-129c and 2-129d (2.5:1 ratio, 31 mg, 34%) as a colorless 
oil. Alcohol 2-129c and 2-129d (2.5:1 ratio): Rf = 0.60 (20% EtOAc/hexanes); IR (neat) 3533, 
2940, 2101 cm-1. Alchol 2-129c: 1H NMR (400 MHz, CDCl3) δ 0.87 (s, 9H), 0.98-1.10 (m, 
1H), 1.12 (q, J = 12.0 Hz, 1H), 1.21-1.32 (m, 2H), 1.33-1.45 (m, 3H), 1.49 (dt, J = 11.2, 3.0 
Hz, 1H), 1.54-1.73 (m, 2H), 1.76 (qd, J = 13.4, 4.3 Hz, 1H), 1.96 (qt, J = 13.1, 3.2 Hz, 1H), 
2.28 (d, J = 1.3 Hz, 1H), 2.37 (dq, J = 13.1, 3.2 Hz, 1H), 3.85 (dd, J = 13.0, 2.5 Hz, 1H), 4.04 
(dd, J = 13.0, 3.3 Hz, 1H), 4.37 (td, J = 11.4, 4.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
22.0 (CH2), 27.51 (3CH3), 28.4 (CH2), 28.8 (CH2), 32.31 (C), 37.41 (CH2), 37.44 (CH2), 45.0 
(CH), 47.4 (CH), 48.8 (CH2), 53.0 (CH), 59.9 (CH), 73.1 (C). Alcohol 2-129d (diagnostic 
peaks only): 1H NMR (400 MHz, CDCl3) δ 2.24 (q, J = 3.0 Hz, 1H), 2.51 (d, J = 2.5 Hz, 1H), 
3.70 (dd, J = 12.5, 10.2 Hz, 1H), 3.80 (dd, J = 5.8, 10.4 Hz, 1H), 4.69 (q, J = 3.0 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 21.9 (CH2), 22.9 (CH2), 27.49 (3CH3), 29.0 (CH2), 32.36 (C), 
34.3 (CH2), 36.6 (CH2), 45.4 (CH), 47.7 (CH), 48.2(CH), 49.5 (CH2), 61.9 (CH), 71.9 (C). 
The following data and NOE correlations were used to assign alcohols 2-129c and 2-129d.  
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(2S*,4R*,E)-2-(5-Azidopent-3-enyl)-4-tert-butylcyclohexanone (2-130a), 
(2S*,4R*,Z)-2-(5-azido-pent-3-enyl)-4-tert-butylcyclohexanone (2-130b), (2S*,4R*)-2-
((S*)-3-azidopent-4-enyl)-4-tert-butylcyclohexanone (2-130c), and (2S*,4R*)-2-((R*)-3-
azidopent-4-enyl)-4-tert-butylcyclo hexan-one (2-130d). According to the general 
procedure III, (2S*,4R*)-2-(but-3-enyl)-4-tert-butylcyclohexanone (63 mg, 0.30 mmol), HG-
2 (11 mg, 0.020 mmol), and allyl bromide (125 mg, 1.03 mmol) afforded a mixture of azides 
2-130a, 2-130b, 2-130c, and 2-130d (53 mg, 67%, 63:9:14:14 ratio from 1H NMR in acetone) 
as a colorless oil after column chromatography (0.3-1.6% EtOAc/hexanes). Azides 2-130a, 2-
130b, 2-130c, and 2-130d: Rf = 0.25 (10% EtOAc/hexanes); IR (neat) 2952, 2095, 1709 cm
-1; 
HRMS (ESI) m/z calculated for (C30H50N6O2+Na)
+ 549.3893 (corresponding to (2M+Na)+), 
found: 549.3893. Azide 2-130a: 1H NMR (400 MHz, acetone) δ 0.94 (s, 9H), 1.46-1.62 (m, 
2H), 1.66-1.75 (m, 2H), 1.80-1.90 (m, 2H), 1.95-2.13 (m, 3H), 2.15-2.25 (m, 1H), 2.36-2.50 
(m, 2H), 3.78 (d, J = 6.4 Hz, 2H), 5.58-5.65 (m, 1H), 5.79-5.86 (m, 1H); 13C NMR (100 MHz, 
acetone) δ 26.4 (CH2), 26.8 (3CH3), 29.6 (CH2), 30.5 (CH2), 31.1 (CH2), 32.0 (C), 38.0 (CH2), 
41.2 (CH), 47.9 (CH), 52.3 (CH2), 123.9 (CH), 135.7 (CH), 212.9 (C). Azide 2-130b 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.91 (d, J = 7.2 Hz, 2H); 13C NMR 
(100 MHz, acetone) δ 122.9 (CH), 135.0 (CH), 212.97 (C). Azides 2-130c and 2-130d 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.97-4.04 (m, 1H), 5.28-5.36 (m, 
2H), 5.79-5.86 (m, 1H); 13C NMR (100 MHz, acetone) δ 48.26 (CH), 48.32 (CH), 64.54 (CH), 
64.63 (CH), 117.7 (CH2), 136.0 (CH), 212.87 (C), 212.90 (C).  
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(3S*,8R*,9aS*)-8-tert-Butyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-
one (2-131a), (3R*,8R*,9aS*)-8-tert-butyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-
5(6H)-one (2-131b), and (4S*,6S*,9S*)-4-tert-butyl-9-vinyl-1-azabicyclo[4.3.1]decan-10-
one (2-131c). According to the procedure VI, the mixture of azides 2-130a, 2-130b, 2-130c, 
and 2-130d (48 mg, 0.18 mmol) afforded after chromatography (1/4-3/1 EtOAc/hexanes) 
lactam 2-131a (24 mg, 56%) as a colorless oil and a mixture of lactams 2-131a, 2-131b, and 
2-131c (3 mg, 7%, 1:1:1 ratio) as a colorless oil. Lactam 2-131a: Rf = 0.50 (100% EtOAc); IR 
(neat) 2950, 1632, 1408 cm-1; HRMS (ESI) m/z calculated for (C15H25NO+H)
+ 236.2014, 
found: 236.1981; 1H NMR (500 MHz, CDCl3) δ 0.79 (s, 9H), 1.23-1.27 (m, 1H), 1.32-1.40 
(m, 1H), 1.41-1.48 (m, 1H), 1.50-1.62 (m, 3H), 1.70-1.78 (m, 1H), 1.96-2.08 (m, 2H), 2.37-
2.44 (m, 1H), 2.62-2.68 (m, 1H), 3.92-3.97 (m, 1H), 4.54-4.63 (m, 1H), 4.94-5.02 (m, 2H), 
5.67-5.74 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 22.0 (CH2), 27.2 (3CH3), 28.2 (CH2), 31.4 
(CH2), 33.0 (C), 34.0 (CH2), 35.5 (CH2), 43.2 (CH), 55.5 (CH), 59.4 (CH), 113.7 (CH2), 
137.7 (CH), 171.0 (C). Lactams 2-131b and 2-131c: Rf = 0.45 (100% EtOAc); IR (neat): 
2925, 1635, 1413 cm-1; HRMS (ESI) m/z calculated for (C15H25NO+Na)
+ 258.1834, found: 
258.1811; 1H NMR (500 MHz, CDCl3) (diagnostic peaks only) δ 0.80 (s, 9H), 0.82 (s, 9H), 
3.55-3.63 (m, 1H), 3.85-3.91 (m, 1H), 4.54-4.63 (m, 1H), 4.67-4.73 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 22.5 (CH2), 24.3 (CH2), 27.2 (3CH3), 27.6 (3CH3), 29.1 (CH2), 29.7 (CH2), 
32.4 (CH2), 33.0 (C), 33.09 (CH2), 33.12 (C), 34.3 (CH2), 35.5 (CH2), 37.2 (CH2), 37.6 (CH2), 
43.5 (CH), 51.5 (CH), 55.9 (CH), 59.1 (CH), 59.7 (CH), 59.8 (CH), 114.3 (CH2), 114.5 (CH2), 
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137.9 (CH), 138.4 (CH), 171.4 (C), 174.4 (C). The following data and NOE correlation were 
used to assign lactam 2-131a. 
 
 
 
 
2-(4,4-Dimethylcyclohexylidene)-1,1-dimethylhydrazine.108 According to the 
general procedure IV, 4,4-dimethylcyclohexanone (2.0 g, 0.16 mmol) afforded 2-(4,4-
dimethylcyclohexylidene)-1,1-dimethylhydrazine (2.7 g, 100%) as a colorless oil. IR (neat) 
2951, 1636 cm-1; HRMS (ESI) m/z calculated for C10H21N2 (M+H)
+ 169.1705, found: 
169.1709; 1H NMR (400 MHz, CDCl3) δ 1.00 (s, 6H), 1.43 (t, J =6.4 Hz, 2H), 1.49 (t, J =6.4 
Hz, 2H), 2.26 (t, J =6.4 Hz, 2H), 2.43 (s, 6H), 2.52 (t, J =6.4 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 24.6, 27.7, 30.3, 31.8, 38.8, 39.6, 47.5, 169.9. 
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2-(But-3-enyl)-4,4-dimethylcyclohexanone.109 According to the general procedure 
V, 2-(4,4-dimethylcyclohexylidene)-1,1-dimethylhydrazine (2.5 g, 15 mmol) afforded 2-(but-
3-enyl)-4,4-dimethylcyclohexanone (1.75 g, 65%) as a colorless oil after chromatography 
(0.6-2% EtOAc/hexanes). Rf = 0.50 (10% EtOAc/hexanes); IR (neat) 2924, 1711 cm
-1; 
HRMS (ESI) m/z calculated for C12H20ONa (M+Na)
+ 203.1412, found: 203.1457; 1H NMR 
(400 MHz, CDCl3) δ 1.02 (s, 3H), 1.14-1.23 (m, 1H), 1.21 (s, 3H), 1.32 (t, J =13.2 Hz, 1H), 
1.63 (dt, J =4.6, 13.6 Hz, 1H), 1.70-1.82 (m, 2H), 1.88-1.98 (m, 1H), 2.03-2.10 (m, 2H), 2.25 
(ddd, J =2.8, 4.6, 14.0 Hz, 1H), 2.39-2.52 (m, 2H), 4.94-5.04 (m, 2H), 5.74-5.82 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 24.5 (CH3), 28.0 (CH2), 30.8 (C), 31.1 (CH2), 31.5 (CH3), 38.5 
(CH2), 40.1 (CH2), 45.1 (CH), 46.7 (CH2), 114.7 (CH2), 138.5 (CH), 213.6 (C). 
 
 (S*,E)-2-(5-Azidopent-3-enyl)-4,4-dimethylcyclohexanone (2-122a), (S*,Z)-2-(5-
azido pent-3-enyl)-4,4-dimethylcyclohex-anone (2-122b), (S*)-2-((S*)-3-azidopent-4-
enyl)-4,4-dimethyl cyclohexanone (2-122c), and (S*)-2-((R*)-3-azidopent-4-enyl)-4,4-
dimethylcyclohexanone (2-122d). According to the general procedure III, 2-(but-3-enyl)-
4,4-dimethylcyclohexanone (1.7 g, 9.4 mmol) and (HG-2, 2 mol%) afforded azides 2-122a, 
2-122b, 2-122c, and 2-122d (1.43 g, 65%, 63:7:15:15 ratio from 1H NMR in CDCl3) as a 
colorless oil after chromatography (0.3-1.8% EtOAc/hexanes). Azides 2-122a, 2-122b, 2-
122c, and 2-122d: Rf = 0.30 (10% EtOAc/hexanes); IR (neat) 2955, 2093, 1709, 1238 cm
-1; 
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HRMS (ESI) m/z calculated for C26H43N6O2 (2M+H)
+ 471.3447, found: 471.3436. Azide 2-
122a: 1H NMR (400 MHz, CDCl3) δ 1.01 (s, 3H), 1.16-1.38 (m, 3H), 1.21 (s, 3H), 1.56-1.68 
(m, 1H), 1.70-1.80 (m, 2H), 1.88-1.96 (m, 1H), 2.11 (q, J =7.2 Hz, 1H), 2.22-2.27 (m, 1H), 
2.35-2.52 (m, 2H), 3.69 (d, J =6.6 Hz, 2H), 5.49-5.56 (m, 1H), 5.69-5.77 (m, 1H); 1H NMR 
(400 MHz, acetone) δ 1.02 (s, 3H), 1.10-1.38 (m, 2H), 1.26 (s, 3H), 1.53-1.65 (m, 1H), 1.71-
1.86 (m, 3H), 2.03-2.15 (m, 3H), 2.45-2.55 (m, 2H), 3.70 (d, J =4.8 Hz, 2H), 5.53-5.62 (m, 
1H), 5.72-5.83 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 24.5 (CH3), 28.3 (CH2), 29.7 (CH2), 
30.8 (C), 31.4 (CH3), 38.5 (CH2), 40.1 (CH2), 45.0 (CH), 46.8 (CH2), 52.8 (CH2), 123.2 (CH), 
136.6 (CH), 213.35(C); 13C NMR (100 MHz, acetone) δ 23.8 (CH3), 28.6 (CH2), 29.5 (CH2), 
30.6 (C), 30.9 (CH3), 38.0 (CH2), 39.8 (CH2), 44.6 (CH), 46.5 (CH2), 52.3 (CH2), 123.3 (CH), 
136.5 (CH), 211.3 (C). Azide 2-122b (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 
3.79-3.82 (m, 2H); 1H NMR (400 MHz, acetone) δ 3.89 (br, 2H); 13C NMR (100 MHz, 
CDCl3) δ 122.5 (CH), 135.72 (CH), 213.29 (C); 
13C NMR (100 MHz, acetone) δ 122.5 (CH), 
135.7 (CH). Azides 2-122c and 2-122d (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) 
δ 3.79-3.82 (m, 1H); 5.26-5.31 (m, 2H), 5.69-5.77 (m, 1H); 1H NMR (400 MHz, acetone) δ 
3.96 (q, J =6.4 Hz, 1H), 5.27-5.36 (m, 2H), 5.76-5.86 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 65.21 (CH), 65.36 (CH), 118.11 (CH2), 118.23 (CH2), 135.60 (CH), 135.69 (CH), 212.96 
(C), 213.04 (C); 13C NMR (100 MHz, acetone) δ 65.11 (CH), 65.14 (CH), 117.5 (CH2), 
136.15 (CH), 136.18 (CH). 
 
(3S*,9aS*)-8,8-Dimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one 
(2-123a) and (3R*,9aS*)-8,8-dimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-
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5(6H)-one (2-123b). According to general procedure VI, azides 2-122a, 2-122b, 2-122c, and 
2-122d (215 mg, 0.915 mmol) afforded lactam 2-123a (88 mg, 47%) as a colorless oil and 
lactam 2-123b (52 mg, 28%) as a colorless oil after chromatography (5-15% EtOAc/hexanes). 
Lactam 2-123a: Rf = 0.50 (100% EtOAc); IR (neat) 2951, 1632, 1416 cm
-1; HRMS (ESI) m/z 
calculated for C13H21NONa (M+Na)
+ 230.1521, found: 230.1521; 1H NMR (400 MHz, CDCl3) 
δ 0.93 (s, 3H), 1.03 (s, 3H), 1.31 (d, J =14.0 Hz, 1H), 1.49-1.59 (m, 4H), 1.63-1.68 (m, 1H), 
1.99-2.11 (m, 1H), 2.19-2.29 (m, 1H), 2.31-2.38 (m, 1H), 2.57-2.65 (m, 1H), 3.95 (t, J =9.6 
Hz, 1H), 4.68 (t, J =7.0 Hz, 1H), 4.98-5.08 (m, 2H), 5.72-5.80 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 24.9 (CH3), 28.5 (CH2), 32.1 (CH2), 32.6 (C), 33.1 (CH3), 33.5 (CH2), 35.9 (CH2), 
48.5 (CH2), 54.1 (CH), 59.6 (CH), 113.7 (CH2), 137.3 (CH), 173.3 (C). Lactam 2-123b: Rf = 
0.42 (100% EtOAc); IR (neat) 2954, 1635, 1414 cm-1; HRMS (ESI) m/z calculated for 
C13H22NO (M+H)
+ 208.1701, found: 208.1704; 1H NMR (400 MHz, CDCl3) δ 0.97 (s, 3H), 
1.02 (s, 3H), 1.38 (dd, J =2.6, 14.2 Hz, 1H), 1.49-1.59 (m, 3H), 1.62-1.78 (m, 2H), 1.83-1.92 
(m, 1H), 2.05-2.12 (m, 1H), 2.40 (ddd, J =1.8, 7.2, 14.8 Hz, 1H), 2.54-2.61 (m, 1H), 3.77-
3.84 (m, 1H), 4.75 (t, J =6.0 Hz, 1H), 5.10-5.16 (m, 2H), 5.77-5.85 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 24.3 (CH3), 29.1 (CH2), 32.4 (C), 32.7 (CH2), 33.2 (CH2), 33.3 (CH3), 36.2 
(CH2), 49.0 (CH2), 54.7 (CH), 59.8 (CH), 114.3 (CH2), 137.9 (CH), 174.2 (C). The following 
data and NOE correlations were used to assign lactams 2-123a and 2-123b. 
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2,2-Dimethylcyclohexanone.110 To a mixture of sodium amide (50% w/w in toluene, 
16.4 g, 0.21 mol) in THF (90 mL) was added dropwise 2-methylcyclohexanone (22.5 g, 0.20 
mol) at room temperature under nitrogen atmosphere with the accompanying gas emission. 
The resulting mixture was refluxed for 2 h. After the mixture was cooled to to 0 oC, methyl 
iodide (31.2 g, 0.22 mol) was added dropwise and the resulting mixture was refluxed for 
another 2 h. The reaction mixture was filtered, and the filtrate was washed with water, dried 
over anhydrous sodium sulfate and evaporated. The residue oil was distilled under reduced 
pressure (40 °C/15 mmHg) to afford the title ketone 2,2-dimethylcyclohexanone (11.5 g, 46%) 
as a colorless oil.  
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2-(2,2-Dimethylcyclohexylidene)-1,1-dimethylhydrazine. According to the general 
procedure IV, 2,2-dimethylcyclohexanone (5.8 g, 46 mmol), and 1,1-dimethylhydrazine (11.5 
mL, 150 mmol) afforded 2-(2,2-dimethylcyclohexylidene)-1,1-dimethylhydrazine (6.80 g, 
88%) as a colorless oil. IR (neat) 2929, 1709, 1449 cm-1; HRMS (ESI) m/z calculated for 
C10H21N2 (M+H)
+ 169.1705, found: 169.1737; 1H NMR (400 MHz, CDCl3) δ 1.10 (s, 6H), 
1.48-1.53 (m, 2H), 1.58-1.62 (m, 2H), 2.39 (s, 6H), 2.40-2.43 (m, 2H), 2.52-2.55 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 21.8, 24.5, 26.9, 27.1, 41.3, 47.4, 47.6, 173.9. 
 
6-(But-3-enyl)-2,2-dimethylcyclohexanone. According to the general procedure V, 
2-(2,2-dimethylcyclohexylidene)-1,1-dimethylhydrazine (6.80 g, 40 mmol) and 4-
bromobutene (6.48 g, 48.0 mmol) afforded 6-(but-3-enyl)-2,2-dimethylcyclohexanone (1.10 g, 
15%) as a colorless oil after column chromatography (0.5-1.2% EtOAc/hexanes). Rf = 0.60 
(10% EtOAc/hexanes); IR (neat) 2929, 1703, 1452 cm-1; HRMS (ESI) m/z calculated for 
C12H21O (M+H)
+ 181.1592, found: 181.1628; 1H NMR (400 MHz, CDCl3) δ 1.05 (s, 3H), 
1.18 (s, 3H), 1.19-1.23 (m, 1H), 1.30 (dq, J =4.0, 13.2 Hz, 1H), 1.55 (dt, J =4.0, 13.2 Hz, 
1H), 1.65-1.72 (m, 1H), 1.75-1.82 (m, 1H), 1.83-1.95 (m, 2H), 2.03-2.10 (m, 3H), 2.56 
(sextet, J =6.4 Hz, 1H), 4.94-5.04 (m, 2H), 5.74-5.82 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 21.6 (CH2), 25.1 (CH3), 25.6 (CH3), 28.5 (CH2), 31.4 (CH2), 34.6 (CH2), 41.9 (CH2), 45.1 
(CH), 45.5 (C), 114.6 (CH2), 138.7 (CH), 216.8 (C). 
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(R*,E)-6-(5-Azidopent-3-enyl)-2,2-dimethylcyclohexanone (2-126a), (R*,Z)-6-(5-
azido pent-3-enyl)-2,2-dimethylcyclohex-anone (2-126b), (R*)-6-((S*)-3-azidopent-4-
enyl)-2,2-dimethyl cyclohexanone (2-126c), and (R*)-6-((R*)-3-azidopent-4-enyl)-2,2-
dimethylcyclohexanone (2-126d). According to the general procedure III, 6-(but-3-enyl)-
2,2-dimethylcyclohexanone (1.10 g, 6.10 mmol), HG-2 (77 mg, 0.12 mmol) and allyl 
bromide (1.7 mL, 20 mmol) afforded a mixture of azides 2-126a, 2-126b, 2-126c, and 2-126d 
(0.63 g, 44%, 65:5:15:15 ratio from 1H NMR in acetone) as a colorless oil after column 
chromatography (0.3-1% EtOAc/hexanes). Azides 2-126a, 2-126b, 2-126c, and 2-126d: Rf = 
0.35 (10% EtOAc/hexanes); IR (neat) 2930, 2093, 1702 cm-1; HRMS (ESI) m/z calculated for 
C26H43N6O2 (2M+H)
+ 471.3447, found: 471.3424. Azide 2-126a: 1H NMR (400 MHz, 
acetone) δ 0.99 (s, 3H), 1.18 (s, 3H), 1.18-1.35 (m, 2H), 1.53 (dt, J =4.0, 13.2 Hz, 1H), 1.62-
1.70 (m, 1H), 1.75-1.82 (m, 1H), 1.83-1.99 (m, 2H), 2.05-2.15 (m, 3H), 2.63-2.71 (m, 1H), 
3.76 (d, J =6.6 Hz, 2H), 5.53-5.61 (m, 1H), 5.76-5.86 (m, 1H); 13C NMR (100 MHz, acetone) 
δ 21.3 (CH2), 24.3 (CH3), 25.2 (CH3), 28.9 (CH2), 29.7 (CH2), 34.4 (CH2), 41.6 (CH2), 44.7 
(CH), 45.0 (C), 52.3 (CH2), 123.3 (CH), 136.6 (CH), 214.80 (C). Azide 2-126b (diagnostic 
peaks only): 1H NMR (400 MHz, acetone) δ 3.90 (d, J =7.2 Hz, 2H); 13C NMR (100 MHz, 
acetone) δ 122.5 (CH), 135.8 (CH), 214.86 (C). Azides 2-126c and 2-126d (diagnostic peaks 
only): 1H NMR (400 MHz, acetone) δ 3.96 (q, J =6.8 Hz, 1H), 5.27-5.36 (m, 2H), 5.76-5.86 
(m, 1H); 13C NMR (100 MHz, acetone) δ 65.12 (CH), 65.18 (CH), 117.40 (CH2), 117.44 
(CH2), 136.16 (CH), 136.22 (CH), 214.71 (C), 214.74 (C). 
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(3S*,9aR*)-6,6-Dimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one 
(2-127a) and (3R*,9aR*)-6,6-dimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-
5(6H)-one (2-127b). According to general procedure VI, azides 2-126a, 2-126b, 2-126c, and 
2-126d (54 mg, 0.23 mmol) afforded a mixture of lactams 2-127a and 2-127b (24 mg, 50%, 
10:1 ratio) as a colorless oil after chromatography (5-30% EtOAc/hexanes). Lactam 2-127a 
and 2-127b: Rf = 0.55 (50% EtOAc/hexanes); IR (neat) 2925, 1619, 1398 cm
-1; HRMS (ESI) 
m/z calculated for C13H22NO (M+H)
+ 208.1701, found: 208.1700. Lactam 2-127a: 1H NMR 
(400 MHz, CDCl3) δ 1.23 (s, 3H), 1.28 (s, 3H), 1.48-1.67 (m, 4H), 1.70-1.83 (m, 4H), 1.90-
2.00 (m, 1H), 2.18-2.28 (m, 1H), 3.97-4.02 (m, 1H), 4.75-4.78 (m, 1H), 5.01-5.08 (m, 2H), 
5.70-5.77 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 23.9 (CH2), 24.3 (CH3), 27.8 (CH2), 29.5 
(CH3), 32.4 (CH2), 35.5 (CH2), 37.0 (CH2), 42.5 (C), 57.4 (CH), 61.6 (CH), 113.2 (CH2), 
138.1 (CH), 177.1 (C). Lactam 2-127b (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) 
δ 1.24 (s, 3H), 1.27 (s, 3H), 3.80-3.86 (m, 1H), 5.00-5.13 (m, 2H), 5.75-5.80 (m, 1H); 13C 
NMR (125 MHz, CDCl3) δ 28.4 (CH2), 30.6 (CH3), 33.2 (CH2), 35.9 (CH2), 37.7 (CH2), 42.2 
(C), 58.6 (CH), 61.9 (CH), 113.9 (CH2), 138.5 (CH), 176.9 (C). The following NOE 
correlations were used to assign lactam 2-127a.  
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Ethyl 3-(but-3-en-1-yl)-2-methyl-4-oxocyclohex-2-enecarboxylate (2-80).111 
Hagemann’s ester (90% purity, 20.4 g, 0.100 mol) was rapidly added to a stirred solution of 
potassium tert-butoxide (12.1 g, 0.110 mol) in dry tert-butanol (60 mL). The red solution so 
formed turned into a straw-yellow suspension a few minutes after the addition. The mixture 
was stirred for 15 min before 4-bromo-1-butene (14.6 g, 0.110 mol) was added in a single 
portion. The mixture was allowed to reflux overnight. The mixture was allowed to cool to 
room temperature then was partitioned between 0.5 M aqueous HCl and dichloromethane. 
The combined organic layer was dried over anhydrous sodium sulfate and concentrated to 
afford ester 2-80 (24.5 g, 104%), which was used without further purification. Ester 2-80: 1H 
NMR (400 MHz, CDCl3) δ 1.28 (t, J = 7.2 Hz, 3H), 1.96-2.10 (m, 2H), 1.99 (s, 3H), 2.15-
2.30 (m, 2H), 2.32-2.42 (m, 3H), 2.52-2.65 (m, 1H), 3.29 (t, J = 4.8 Hz, 1H), 4.20 (q, J = 7.2 
Hz, 2H), 4.91-5.02 (m, 2H), 5.76-5.86 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.2 (CH), 
20.5 (CH), 24.9 (CH2), 25.6 (CH2), 32.9 (CH2), 34.7 (CH2), 47.7 (CH), 61.2 (CH2), 114.7 
(CH2), 136.9 (C), 138.2 (CH), 150.3 (C), 172.2 (C), 197.4 (C).  
 
2-(But-3-enyl)-3-methylcyclohex-2-enone (2-81).111 Ester 2-80 (8.1g, 34 mmol) was 
dissolved in a 1/1 mixture of ethanol and water (40 mL) and LiOH·H2O (2.86 g, 68.0 mmol) 
was added as a powder. The mixture was stirred overnight, concentrated, and the residue 
partitioned between water and diethyl ether. The aqueous phase was acidified with 6 M 
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aqueous HCl and extracted with dichloromethane. The organic extracts were dried over 
anhydrous sodium sulfate and concentrated. The residue was dissolved in a mixture of 
concentrated HCl (3 mL) in THF (50 mL) and heated for 24 h at 90 °C. The mixture was 
concentrated. The residue was partitioned between water and dichloromethane. The 
combined organic layer was dried over anhydrous sodium sulfate and concentrated. The 
residue was chromatographed (2.5-5% EtOAc/hexanes) to yield ketone 2-81 as a dark-yellow 
oil (3.08 g, 50% two steps). Ketone 2-81: Rf = 0.40 (20% EtOAc/hexanes); IR (neat) 2927, 
1660, 1379 cm-1; HRMS (ESI) m/z calculated for (C11H16O+H)
+ 165.1279, found: 165.1270; 
1H NMR (400 MHz, CDCl3) δ 1.94 (s, 3H), 1.90-1.96 (m, 2H), 2.04-2.10 (m, 2H), 2.33-2.41 
(m, 6H), 4.91-5.02 (m, 2H), 5.77-5.87 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.3 (CH3), 
22.3 (CH2), 24.7 (CH2), 32.9 (CH2), 33.2 (CH2), 37.9 (CH2), 114.5 (CH2), 135.0 (C), 138.5 
(CH), 155.6 (C), 198.7 (C). 
 
2-(But-3-enyl)-3,3-dimethylcyclohexanone (2-82).111 Lithium chloride (158 mg, 
37.5 mmol, flame-dried) and copper(I) iodide were dissolved in anhydrous THF (120 mL) 
under argon at rt. The resulting solution was cooled to -40 °C using a dry ice/acetonitrile bath, 
ketone 2-81 (3.08 g, 18.8 mmol) and chlorotrimethylsilane (2.24 g, 20.6 mmol) were added, 
and the solution stirred for 10 min. MeMgCl (3 M in THF, 9.4 mL, 28.1 mmol) was added 
dropwise and left stirring at -40 °C for 1.5 h. The reaction mixture was then poured into 150 
mL of saturated aqueous ammonium chloride and 150 mL of diethyl ether, and the aqueous 
layer was extracted with diethyl ether. The combined organic extracts were dried with 
anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to afford (2-(but-
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3-enyl)-3,3-dimethylcyclohex-1-enyloxy)trimethylsilane (4.42 g), which was used without 
further purification. IR (neat) 2934, 1252, 1196 cm-1; HRMS (ESI) m/z calculated for 
(C15H28OSi+H)
+ 253.1988, found: 253.1913; 1H NMR (400 MHz, CDCl3) δ 0.20 (s, 9H), 1.02 
(s, 6H), 1.39-1.42 (m, 2H), 1.63-1.69 (m, 2H), 1.99-2.06 (m, 4H), 2.14-2.20 (m, 2H), 4.92-
5.06 (m, 2H), 5.83-5.93 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 0.8 (CH2), 19.4 (CH2), 26.2 
(CH2), 28.5 (2CH3), 30.8 (CH2), 33.9 (CH2), 34.5 (C), 39.2 (CH2), 113.5 (CH2), 123.1 (C), 
139.9 (CH), 144.3 (C). The silyl enol ether was dissolved in THF (40 mL) and stirred with 
TBAF (1 M in THF, 28.1 mL, 28.1 mmol) at rt for 30 min under N2 atmosphere. The mixture 
was poured into water and diethyl ether, and the aqueous layer extracted with diethyl ether. 
The combined organic extracts were dried with anhydrous sodium sulfate, filtered, and 
concentrated to yield a residue, which was purified by chromatography (1.5% EtOAc/hexanes) 
to afford ketone 2-82 (2.60 g, 77% for two steps). Ketone 2-82: Rf = 0.30 (5% 
EtOAc/hexanes); IR (neat) 2962, 1708 cm-1; HRMS (ESI) m/z calculated for (C24H40O2+Na)
+ 
383.2926 (corresponding to (2M+Na)+), found: 383.2923; 1H NMR (400 MHz, CDCl3) δ 0.78 
(s, 3H), 1.05 (s, 3H), 1.34-1.42 (m, 1H), 1.58-1.69 (m, 2H), 1.77-1.94 (m, 4H), 2.06-2.15 (m, 
2H), 2.23-2.38 (m, 2H), 4.94-5.01 (m, 2H), 5.72-5.83 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 22.1 (CH3), 23.2 (CH2), 29.4 (CH3), 32.8 (CH2), 39.2 (CH2), 39.7 (C), 41.3 (CH2), 60.1 
(CH), 114.7 (CH2), 138.7 (CH), 213.3 (C). The following data were used to assign ketone 2-
82. 
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(S*,E)-2-(5-Azidopent-3-enyl)-3,3-dimethylcyclohexanone (2-120a), (S*,Z)-2-(5-
azido pent-3-enyl)-3,3-dimethylcyclohexanone (2-120b), (R*)-2-((S*)-3-azidopent-4-
enyl)-3,3-dimethyl cyclo-hexanone (2-120c), and (R*)-2-((R*)-3-azidopent-4-enyl)-3,3-
dimethylcyclo hexanone (2-120d). According to the general procedure III, ketone 2-82 (1.6 
g, 8.9 mmol), HG-2 (179 mg, 0.450 mmol) and allyl bromide (3.8 mL, 45 mmol) afforded a 
mixture of azides 2-120a, 2-120b, 2-120c, and 2-120d (1.60 g, 77%, 67:9:12:12 ratio from 1H 
NMR in CDCl3) as a colorless oil after column chromatography (0.6-4.0% EtOAc/hexanes). 
Azides 2-120a, 2-120b, 2-120c, and 2-120d: Rf = 0.15 (5% EtOAc/hexanes); IR (neat) 2954, 
2094, 1706 cm-1; HRMS (ESI) m/z calculated for (C26H42N6O2+H)
+ 471.3447 (corresponding 
to (2M+H)+), found: 471.3417. Azide 2-120a: 1H NMR (500 MHz, CDCl3) δ 0.76 (s, 3H), 
1.04 (s, 3H), 1.22-1.38 (m, 1H), 1.55-1.68 (m, 2H), 1.76-1.93 (m, 4H), 2.07-2.18 (m, 2H), 
2.23-2.35 (m, 2H), 3.67-3.72 (m, 2H), 5.46-5.54 (m, 1H), 5.68-5.76 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 21.9 (CH3), 23.16 (CH2), 23.18 (CH2), 29.5 (CH3), 31.3 (CH2), 39.3 (CH2), 
39.8 (C), 41.4 (CH2), 52.8 (CH2), 59.8 (CH), 123.3 (CH), 136.7 (CH), 213.09 (C); 
1H NMR 
(500 MHz, acetone) δ 0.76 (s, 3H), 1.06 (s, 3H), 1.28-1.43 (m, 1H), 1.55-1.62 (m, 1H), 1.69-
1.95 (m, 5H), 2.08-2.18 (m, 1H), 2.21-2.28 (m, 2H), 2.29-2.39 (m, 1H), 3.76 (m, 2H), 5.54-
5.58 (m, 1H), 5.79-5.86 (m, 1H); 13C NMR (125 MHz, acetone) δ 26.3 (CH3), 28.1 (CH2), 
28.2 (CH2), 34.2 (CH3), 36.4 (CH2), 44.4 (CH2), 44.5 (C), 46.2 (CH2), 57.6 (CH2), 64.5 (CH), 
128.6 (CH), 141.7 (CH), 216.2 (C). Azide 2-120b (diagnostic peaks only): 1H NMR (500 
MHz, CDCl3) δ 0.767 (s, 3H), 1.055 (s, 3H), 3.65-3.75 (m, 2H);
 13C NMR (125 MHz, CDCl3) 
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δ 122.7 (CH), 135.7 (CH), 213.07 (C); 1H NMR (500 MHz, acetone) δ 3.83-3.88 (m, 2H); 13C 
NMR (125 MHz, acetone) δ 64.7 (CH), 127.8 (CH), 140.9 (CH). Azides 2-120c and 2-120d 
(diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 0.753 (s, 3H), 1.04 (s, 3H), 3.77-3.84 
(m, 1H); 5.25-5.29 (m, 2H), 5.68-5.76 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 64.8 (CH), 
65.4 (CH), 118.1 (CH2), 118.2 (CH2), 135.6 (CH), 135.7 (CH), 212.91 (C), 212.94 (C); 
1H 
NMR (500 MHz, acetone) δ 3.92-4.00 (m, 1H), 5.25-5.38 (m, 2H), 5.79-5.86 (m, 1H); 13C 
NMR (125 MHz, acetone) δ 67.0 (CH), 70.4 (CH), 122.6 (CH2), 122.8 (CH2), 141.3 (CH), 
141.4 (CH).  
 
(3S*,9aR*)-9,9-Dimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one 
(2-121a) and (3S*,9aR*)-9,9-dimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-
5(6H)-one (2-121b). According to the procedure VI, azides 2-120a, 2-120b, 2-120c, and 2-
120d (130 mg, 0.550 mmol) and tin tetrachloride (1 M in chloromethane, 0.83 mL, 0.83 
mmol) afforded a mixture of lactams 2-121a and 2-112b (65 mg, 57%, 30:1 ratio) as a 
colorless oil after chromatography (15-25% EtOAc/hexanes). Lactams 2-121a and 2-121b: Rf 
= 0.35 (100% EtOAc/hexanes); IR (neat) 2966, 2927, 1634, 1408 cm-1; HRMS (ESI) m/z 
calculated for (C13H21NO+Na)
+ 230.1521, found: 230.1449. Lactam 2-121a: 1H NMR (400 
MHz, CDCl3) δ 0.84 (s, 3H), 0.94 (s, 3H), 1.42-1.70 (m, 5H), 1.91-2.08 (m, 3H), 2.35-2.42 
(m, 1H), 2.48-2.53 (m, 1H), 3.73 (dd, J = 2.4, 8.0 Hz, 1H), 4.60 (t, J = 5.2 Hz, 1H), 4.94-5.05 
(m, 2H), 5.72-5.81 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 19.7 (CH2), 20.3 (CH3), 26.1 
(CH2), 29.5 (CH2), 29.8 (CH3), 36.0 (C), 38.6 (CH2), 46.5 (CH2), 60.5 (CH), 66.2 (CH), 113.0 
(CH2), 138.1 (CH), 173.7 (C). Lactam 2-121b (diagnostic peaks only): 
1H NMR (400 MHz, 
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CDCl3) δ 0.79 (s, 3H), 0.87 (s, 3H), 3.58 (dd, J = 6.4 Hz, 9.6 Hz, 1H), 4.79 (t, J = 6.2 Hz, 1H), 
5.05-5.21 (m, 2H), 5.72-5.82 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 19.0 (CH3), 19.5 (CH2), 
27.9 (CH2), 28.0 (CH2), 28.7 (CH3), 34.6 (C), 38.2 (CH2), 46.0 (CH2), 60.0 (CH), 66.9 (CH), 
115.0 (CH2), 138.1 (CH), 174.5 (C). The following data and NOE correlations were used to 
assign lactams 2-121a and 2-121b. 
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(4aR*,5R*,6R*,8aS*)-5-(Azidomethyl)-6-chloro-1,1-dimethyldecahydro-
naphthalen-4a-ol (2-121c) and (4aR*,5R*,6S*,8aS*)-5-(azidomethyl)-6-chloro-1,1-
dimethyldecahydronaphthalen-4a-ol (2-121d). According to the procedure VI, azides 2-
120a, 2-120b, 2-120c, and 2-120d (92 mg, 0.39 mmol) and titanium tetrachloride (1 M in 
chloromethane, 0.60 mL, 0.60 mmol) afforded a mixture of lactams 2-121a and 2-112b (20 
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mg, 25%, 1:1.1 ratio) as a colorless oil and a mixture of alcohols 2-121c and 2-121d (8 mg, 
8%, 4:1 ratio) after chromatography (1-25% EtOAc/hexanes) as a colorless oil. Alcohols 2-
121c and 2-121d: Rf = 0.70 (20% EtOAc/hexanes). Alcohol 2-121c: 
1H NMR (500 MHz, 
CDCl3) δ 0.79 (s, 3H), 0.86 (s, 3H), 0.86-0.96 (m, 1H), 1.09 (qd, J = 13.4, 3.3 Hz, 1H), 1.17 
(dd, J = 14.0, 3.1 Hz, 1H), 1.30-1.44 (m, 3H), 1.56-1.67 (m, 3H), 1.75 (dt, J = 13.5, 3.4 Hz, 
1H), 1.78-1.82 (m, 1H), 2.28 (d, J = 1.7 Hz, 1H), 2.31-2.41 (m, 1H), 3.75 (dd, J = 13.0, 2.6 
Hz, 1H), 3.98 (dd, J = 13.0, 2.9 Hz, 1H), 4.31 (td, J = 11.2, 4.8 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 16.9 (CH2), 20.7 (CH3), 20.8 (CH2), 31.1 (CH3), 32.1 (C), 36.8 (CH2), 37.0 (CH2), 
40.4 (CH2), 47.8 (CH2), 51.5 (CH), 52.9 (CH), 58.9 (CH), 74.0 (C). Alcohol 2-121d 
(diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 0.82 (s, 3H), 0.92 (s, 3H), 1.86 (dq, J 
= 11.5, 1.5 Hz, 1H), 2.24 (dq, J = 14.3, 2.9 Hz, 1H), 2.49 (d, J = 2.7 Hz, 1H), 3.56 (dd, J = 
12.4, 10.1 Hz, 1H), 3.70 (dd, J = 12.4, 4.8 Hz, 1H), 4.59 (q, J = 2.9 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 14.9 (CH2), 16.6 (CH2), 20.5 (CH3), 31.2 (CH3), 32.3 (C), 33.9 (CH2), 36.1 
(CH2), 40.5 (CH2), 48.2 (CH), 48.4 (CH2), 51.7 (CH), 60.8 (CH), 72.7 (C). The following 
data and NOE correlations were used to assign alcohol 2-121c. 
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2-(3,3-Dimethylcyclohexylidene)-1,1-dimethylhydrazine. According to the general 
procedure IV, 3,3-dimethylcyclohexanone (10.0 g, 79.2 mmol) and 1,1-dimethylhydrazine 
(18.3 mL, 240 mmol) afforded 2-(3,3-dimethylcyclohexylidene)-1,1-dimethylhydrazine (12.3 
g, 92%, 1:1 ratio) as a colorless oil, which was used directly in the next step without further 
purification. 1H NMR (400 MHz, CDCl3) δ 0.93 (s, 3H), 0.94 (s, 3H), 1.42-1.47 (m, 2H), 
1.63-1.75 (m, 2H), 2.03 (s, 1H), 2.19 (t, J = 6.4 Hz, 1H), 2.35 (s, 1H), 2.40 (s, 3H), 2.45 (s, 
3H), 2.45 (t, J = 6.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 22.1 (CH2), 22.8 (CH2), 27.8 
(CH2), 28.2 (CH3), 28.6 (CH3), 33.2 (C), 34.2 (C), 35.2 (CH2), 39.0 (CH2), 39.2 (CH2), 41.2 
(CH2), 47.4 (CH3), 47.7 (CH3), 48.6 (CH2), 169.4 (C), 170.3 (C). 
 
2-(But-3-enyl)-5,5-dimethylcyclohexanone. According to the general procedure V, 
2-(3,3-dimethylcyclohexylidene)-1,1-dimethylhydrazine (5.05 g, 30.0 mmol) afforded 2-(but-
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3-enyl)-5,5-dimethylcyclohexanone (3.91 g, 72%) as a colorless oil after chromatography 
(0.5-2.5% EtOAc/hexanes). Rf = 0.50 (10% EtOAc/hexanes); IR (neat) 2954, 1710 cm
-1; 
HRMS (ESI) m/z calculated for (C12H20O+H)
+ 181.1592, found: 181.1606; 1H NMR (400 
MHz, CDCl3) δ 0.88 (s, 3H), 1.05 (s, 3H), 1.24-1.33 (m, 1H), 1.45-1.55 (m, 1H), 1.56-1.70 
(m, 2H), 1.86-1.95 (m, 1H), 1.98-2.15 (m, 4H), 2.18-2.27 (m, 2H), 4.94-5.04 (m, 2H), 5.74-
5.84 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 25.7 (CH3), 28.3 (CH2), 29.4 (CH2), 31.2 (CH2), 
31.3 (CH3), 37.0 (C), 38.0 (CH2), 48.7 (CH), 54.9 (CH2), 114.7 (CH2), 138.5 (CH), 212.8 (C). 
 
(S*,E)-2-(5-Azidopent-3-enyl)-5,5-dimethylcyclohexanone (2-124a), (S*,Z)-2-(5-
azido pent-3-enyl)-5,5-dimethylcyclohexanone (2-124b), (R*)-2-((S*)-3-azidopent-4-
enyl)-5,5-dimethyl cyclohexanone (2-124c), and (R*)-2-((R*)-3-azidopent-4-enyl)-5,5-
dimethylcyclo hexanone (2-124d). According to the general procedure III, 2-(but-3-enyl)-
5,5-dimethylcyclohexanone (1.28 g, 7.10 mmol), HG-2 (89 mg, 0.14 mmol) and allyl 
boromide (1.80 mL, 21.3 mmol) afforded a mixture of azides 2-124a, 2-124b, 2-124c, and 2-
124d (872 mg, 52%, 63:7:15:15 ratio) as colorless oil after column chromatography (0.1-1.6% 
EtOAc/hexanes). Azides 2-124a, 2-124b, 2-124c, and 2-124d: Rf = 0.30 (10% 
EtOAc/hexanes); IR (neat) 2952, 2093, 1708, 1236 cm-1; HRMS (ESI) m/z calculated 
(C26H42N6O2+H)
+ 471.3447 (corresponding to (2M+H)+), found: 471.3432. Azide 2-124a: 1H 
NMR (400 MHz, acetone) δ 0.85 (s, 3H), 1.05 (s, 3H), 1.22-1.31 (m, 1H), 1.42-1.62 (m, 3H), 
1.69-1.79 (m, 1H), 1.81-1.92 (m, 1H), 1.99-2.08 (m, 2H), 2.09-2.19 (m, 1H), 2.28-2.36 (m, 
2H), 3.77 (d, J = 6.4 Hz, 2H), 5.55-5.62 (m, 1H), 5.77-5.86 (m, 1H); 13C NMR (100 MHz, 
acetone) δ 24.9 (CH2), 28.6 (CH3), 29.3 (CH2), 29.6 (CH2), 30.8 (CH3), 36.4 (C), 37.7 (CH2), 
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48.1 (CH), 52.3 (CH2), 54.5 (CH2), 123.3 (CH), 136.5 (CH), 210.65 (C). Azide 2-124b 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.90 (d, J = 7.2 Hz, 2H); 13C NMR 
(100 MHz, acetone) δ 122.6 (CH), 135.7 (CH), 210.75 (C). Azides 2-124c and 2-124d 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.97 (q, J = 7.0 Hz, 1H); 5.28-5.36 
(m, 2H), 5.77-5.86 (m, 1H); 13C NMR (100 MHz, acetone) δ 48.55 (CH2), 48.62 (CH2), 65.0 
(CH), 65.1 (CH), 117.52 (CH2), 117.54 (CH2), 136.12 (CH), 136.16 (CH), 210.58 (C).  
 
(3S*,9aR*)-7,7-Dimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one 
(2-125a) and (3S*,9aR*)-7,7-dimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-
5(6H)-one (2-125b). According to the general procedure VI, azides 2-124a, 2-124b, 2-124c, 
and 2-124d (125 mg, 0.530 mmol) afforded lactam 2-125a (53 mg, 48%) as a colorless oil 
and lactam 2-125b (7 mg, 6%) as a colorless oil after column chromatography (10-50% 
EtOAc/hexanes). Lactam 2-125a: Rf = 0.60 (100% EtOAc); IR (neat) 2956, 1631, 1414 cm
-1; 
HRMS (ESI) m/z calculated for (C13H21NO+H)
+ 208.1701, found: 208.1701; 1H NMR (400 
MHz, CDCl3) δ 1.00 (s, 6H), 1.53-1.70 (m, 5H), 1.71-1.82 (m, 1H), 1.98-2.10 (m, 1H), 2.20-
2.31 (m, 1H), 2.24 (d, J = 13.2 Hz, 1H), 2.62 (d, J = 13.2 Hz, 1H), 3.81 (t, J = 9.6 Hz, 1H), 
4.71 (t, J = 6.0 Hz, 1H), 4.99-5.08 (m, 2H), 5.71-5.80 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 23.7 (CH3), 28.5 (CH2), 30.3 (C), 31.8 (CH2), 32.3 (CH2), 33.6 (CH3), 43.6 (CH2), 50.7 
(CH2), 59.0 (CH), 59.5 (CH), 113.8 (CH2), 137.3 (CH), 171.3 (C). Lactam 2-125b: Rf = 0.52 
(100% EtOAc); IR (neat) 2956, 2925, 1635, 1415 cm-1; HRMS (ESI) m/z calculated for 
(C13H21NO+H)
+ 208.1701, found: 208.1712; 1H NMR (500 MHz, CDCl3) δ 0.93 (s, 3H), 0.97 
(s, 3H), 1.41 (dt, J = 4.0 Hz, 13.5 Hz, 1H), 1.51-1.28 (m, 2H), 1.65-1.80 (m, 4H), 2.01-2.07 
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(m, 1H), 2.22 (dd, J = 2.0 Hz, 13.5 Hz, 1H), 2.46 (d, J = 13.5 Hz, 1H), 3.55 (dd, J = 9.0 Hz, 
16.0 Hz, 1H), 4.65 (t, J = 6.0 Hz, 1H), 5.02-5.16 (m, 2H), 5.72-5.80 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 22.6 (CH3), 27.9 (CH2), 29.5 (C), 31.43 (CH2), 31.47 (CH2), 32.8 (CH3), 42.2 
(CH2), 49.5 (CH2), 58.4 (CH), 59.0 (CH), 113.5 (CH2), 137.0 (CH), 170.9 (C). The following 
NOE correlations were used to assign lactams 2-125a and 2-125b. 
 
 
 
(1R,2S,5R)-5-Methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol, (1S,2S,5R)-5-
methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol, (1R,2R,5R)-5-methyl-2-(2-methyl-pent-
4-en-2-yl)cyclohexanol and (1S,2R,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol. 
A solution of (R)-(+)-pulegone (85% purity, 12.5 g, 70.0 mmol) in dichloromethane
 
(150 mL) 
was stirred at -78 °C as titanium tetrachloride
 
(neat, 8.4 mL, 77 mmol) was added dropwise 
over 5 min to form a red solution. After stirring 10 min, a solution of allyltrimethylsilane 
(10.4 g, 91.0 mmol) in dichloromethane
 
(30 mL) was added dropwise over 5 min. The 
resulting purple solution was stirred at –78 °C for 10 min and at 0 °C for an additional 10 min. 
A solution of triethylamine (70 mL) and methanol (22 mL) was added dropwise over 5 min, 
forming a white heterogeneous mixture that was diluted with diethyl ether (300 mL) and 
filtered. The mixture was washed with 10% HCl, saturated aqueous sodium bicarbonate, and 
brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to give 
N
O
H
N
O
H
Me
Me Me
Me
H
H
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a crude product, which was purified by chromatography (0.6-5% EtOAc/hexanes) to afford a 
mixture of (2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone and (2R,5R)-5-
methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone (15.3 g, 96%, 1.3:1 ratio) as a colorless oil. 
To a solution of (2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone and (2R,5R)-5-
methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone (11.5 g, 59.0 mmol) in methanol (110 mL) 
at 0 °C was added portionwise sodium borohydride (3.37 g, 88.7 mmol). After being allowed 
to stir overnight, water was added slowly to quench the reaction. Diethyl ether was used to 
extract the product, and the aqueous layer was washed with diethyl ether three times. The 
combined organic layers were washed with brine, dried over anhydrous sodium sulfate, and 
concentrated. The residue was purified by chromatography (0.6-5% EtOAc/hexanes) to 
afford a mixture of (1R,2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol and 
(1S,2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol (2.50 g, 22%, 2:5 ratio) as a 
colorless oil, a mixture of alcohols (1R,2S,5R)-5-methyl-2-(2-methylpent-4-en-2-
yl)cyclohexanol, (1S,2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol, (1R,2R,5R)-
5-methyl-2-(2-methyl-pent-4-en-2-yl)cyclohexanol and (1S,2R,5R)-5-methyl-2-(2-
methylpent-4-en-2-yl)cyclohexanol (3.80 g, 33%) as a colorless oil, and a mixture of 
(1R,2R,5R)-5-methyl-2-(2-methyl-pent-4-en-2-yl)cyclohexanol and (1S,2R,5R)-5-methyl-2-
(2-methylpent-4-en-2-yl)cyclohexanol (3.68 g, 32%, 25:1 ratio) as a colorless oil. (1R,2S,5R)-
5-Methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol and (1S,2S,5R)-5-methyl-2-(2-methylpent-
4-en-2-yl)cyclohexanol (2:5 ratio): Rf = 0.25 (10% EtOAc/hexanes); IR (neat) 3424, 2916, 
1638, 1455 cm-1; HRMS (ESI) m/z calculated for C13H24ONa (M+Na)
+ 219.1725, found: 
219.1772; (1S,2S,5R)-5-Methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol: 1H NMR (400 
MHz, CDCl3) δ 0.89 (d, J =6.2 Hz, 3H), 0.95 (s, 3H), 0.98 (s, 3H), 0.88-1.02 (m, 1H), 1.07-
1.20 (m, 2H), 1.47-1.60 (m, 2H), 1.71-1.82 (m, 3H), 2.03-2.15 (m, 2H), 4.25 (br, 1H), 5.00-
 255 
5.06 (m, 2H), 5.80-5.90 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 20.9 (CH2), 22.3 (CH3), 25.4 
(CH3), 25.98 (CH3), 26.2 (CH), 35.4 (C), 35.6 (CH2), 44.0 (CH2), 45.8 (CH2), 48.6 (CH), 68.3 
(CH), 116.8 (CH2), 136.0 (CH). (1R,2S,5R)-5-Methyl-2-(2-methylpent-4-en-2-
yl)cyclohexanol (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 0.91 (d, J =6.4 Hz, 
3H), 0.97 (s, 3H), 1.03 (s, 3H), 1.37-1.45 (m, 1H), 1.63-1.68 (m, 1H), 1.89-1.96 (m, 1H), 
2.15-2.30 (m, 2H), 3.58 (dt, J =4.0, 10.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 22.0 (CH3), 
26.04 (CH2), 26.4 (CH3), 26.6 (CH3), 31.7 (CH), 34.9 (CH2), 35.7 (CH2), 46.7 (CH2), 46.9 
(CH2), 50.9 (CH), 73.1 (CH), 116.5 (CH2), 136.5 (CH). (1R,2R,5R)-5-Methyl-2-(2-methyl-
pent-4-en-2-yl)cyclohexanol and (1S,2R,5R)-5-methyl-2-(2-methylpent-4-en-2-
yl)cyclohexanol (25:1 ratio): Rf = 0.30 (10% EtOAc/hexanes); IR (neat) 3506, 2910, 1638 
cm-1; HRMS (ESI) m/z calculated for C13H24ONa (M+Na)
+ 219.1725, found: 219.1728; 
(1R,2R,5R)-5-Methyl-2-(2-methyl-pent-4-en-2-yl)cyclohexanol: 1H NMR (400 MHz, CDCl3) 
δ 0.96 (s, 3H), 0.98 (s, 3H), 1.08-1.18 (m, 2H), 1.19 (d, J =7.4 Hz, 3H), 1.27-1.33 (m, 1H), 
1.37-1.44 (m, 1H), 1.51-1.60 (m, 1H), 1.62-1.77 (m, 2H), 1.89-1.97 (m, 1H), 2.03-2.17 (m, 
2H), 4.26 (br, 1H), 5.00-5.06 (m, 2H), 5.80-5.90 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 
15.9 (CH2), 21.3 (CH or CH3), 25.2 (CH or CH3), 25.9 (CH or CH3), 26.5 (CH or CH3), 32.6 
(CH2), 35.6 (C), 40.7 (CH2), 45.7 (CH2), 49.1 (CH), 69.2 (CH), 116.7 (CH2), 136.1 (CH). 
(1S,2R,5R)-5-Methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol (diagnostic peaks only): 1H 
NMR (400 MHz, CDCl3) δ 1.00 (s, 3H), 3.83 (br, 1H).  
 
(2S,5R)-5-Methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone. To a solution of 
(1R,2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanol and (1S,2S,5R)-5-methyl-2-(2-
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methylpent-4-en-2-yl)cyclohexanol (2.50 g, 12.7 mmol) in dichloromethane (40 mL) at room 
temperature was added silica gel (7.50 g) and pyridinium chlorochromate (PCC, 5.50 g, 25.5 
mmol) slowly. After being allowed to stir overnight, the reaction mixture was concentrated, 
purified by chromatography (0.6-3% EtOAc/hexanes) to afford ketone (2S,5R)-5-methyl-2-
(2-methylpent-4-en-2-yl)cyclohexanone (2.20 g, 88%) as a colorless oil. Its spectral data 
matched reported data.102  
 
(2S,5R,E)-2-(6-Azido-2-methylhex-4-en-2-yl)-5-methylcyclohexanone (2-166a), 
(2S,5R,Z)-2-(6-azido-2-methylhex-4-en-2-yl)-5-methylcyclohexanone (2-166b), (2S,5R)-2-
((S)-4-azido-2-methylhex-5-en-2-yl)-5-methylcyclohexanone (2-166c), and (2S,5R)-2-((R)-
4-azido-2-methylhex-5-en-2-yl)-5-methylcyclohexanone (2-166d). According to the 
general procedure III, (2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone (1.55 g, 
8.0 mmol), HG-2 (250 mg, 0.400 mmol) and allyl bromide (2.0 mL, 24 mmol) afforded a 
mixture of azides 2-166a, 2-166b, 2-166c, and 2-166d (1.41 g, 71%, 89:9:1:1 from 13C NMR 
in CDCl3, 90:8:1:1 from 
13C NMR in acetone) as a colorless oil after column chromatography 
(0.6-4.0% EtOAc/hexanes). Azides 2-166a, 2-166b, 2-166c, and 2-166d: Rf = 0.35 (5% 
EtOAc/hexanes); IR (neat) 2954, 2094, 1708 cm-1; HRMS (ESI) m/z calculated for 
C28H47N4O2 (2M-N2+H)
+ 471.3699, found: 471.3673. Azide 2-166a: 1H NMR (500 MHz, 
CDCl3) δ 0.89 (s, 3H), 0.93 (dd, J =1.0, 6.2 Hz, 3H), 0.95 (s, 3H), 1.22-1.32 (m, 1H), 1.35-
1.45 (m, 1H), 1.76-1.86 (m, 2H), 1.94 (t, J =12.5 Hz, 1H), 1.96-2.04 (m, 2H), 2.11 (dd, J 
=4.7, 13.0 Hz, 1H), 2.18 (td, J =2.0, 10.0 Hz, 1H), 2.33 (dd, J =8.5, 13.5 Hz, 1H), 3.63 (d, J 
=6.5 Hz, 2H), 5.40-5.47 (m, 1H), 5.62-5.68 (m, 1H); 1H NMR (500 MHz, acetone) δ 0.91 (s, 
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3H), 0.93 (d, J =6.5 Hz, 3H), 0.97 (s, 3H), 1.28-1.43 (m, 2H), 1.73-1.81 (m, 1H), 1.82-1.87 
(m, 1H), 1.96-2.04 (m, 1H), 2.05-2.12 (m, 3H), 2.18 (ddd, J =1.0, 4.5, 13.0 Hz, 1H), 2.33 (dd, 
J =7.5, 13.5 Hz, 1H), 3.72 (d, J =6.7 Hz, 2H), 5.46-5.52 (m, 1H), 5.76-5.80 (m, 1H); 13C 
NMR (125 MHz, CDCl3) δ 22.3 (CH3), 24.2 (CH3), 25.4 (CH3), 28.2 (CH2), 34.5 (C), 34.62 
(CH2), 36.4 (CH), 43.1 (CH2), 52.4 (CH2), 52.9 (CH2), 56.7 (CH), 125.4 (CH), 133.6 (CH), 
212.1 (C); 13C NMR (125 MHz, acetone) δ 22.6 (CH3), 24.5 (CH3), 25.5 (CH3), 28.8 (CH2), 
35.1 (C), 35.3 (CH2), 37.1 (CH), 43.8 (CH2), 52.7 (CH2), 53.3 (CH2), 57.1 (CH), 126.6 (CH2), 
134.3 (CH), 211.6 (C). Azide 2-166b (diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 
2.43 (dd, J =8.7, 14.0 Hz, 1H), 3.70-3.78 (m, 2H); 1H NMR (500 MHz, acetone) δ 2.43 (dd, J 
=8.7, 14.0 Hz, 1H), 3.81-3.87 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 124.4 (CH), 132.1 
(CH), 211.98 (C); 13C NMR (125 MHz, acetone) δ 125.3 (CH), 132.9 (CH), 211.8 (C). 
Azides 2-166c and 2-166d (diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 3.70-3.78 
(m, 1H); 1H NMR (500 MHz, acetone) δ 3.85-3.88 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 
61.97 (CH), 62.03 (CH), 117.1 (CH2), 117.2, (CH2) 136.7 (CH), 136.9 (CH); 
13C NMR (125 
MHz, acetone) δ 62.60 (CH), 62.74 (CH), 117.42 (CH2), 117.57 (CH2), 138.14 (CH), 138.21 
(CH). 
 
(3R,7R,9aS)-1,1,7-Trimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-
one (2-167a) and (3S,7R,9aS)-1,1,7-trimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-
a]azepin-5(6H)-one (2-167b). According to the general procedure VI, azides 2-166a, 2-166b, 
2-166c, and 2-166d (63 mg, 0.25 mmol) and tin tetrachloride (0.38 mL, 1 M in 
dichloromethane, 0.38 mmol) afforded lactam 2-167a (17 mg, 30%) as a colorless oil and 2-
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167b (11 mg, 20%) as a colorless oil after column chromatography (10-18% EtOAc/hexanes). 
Lactam 2-167a: Rf = 0.5 (100% EtOAc/hexanes); [α]
546
25
 -48.0 (c 3.75, dichloromethane); IR 
(neat) 2954, 1638, 1408 cm-1; HRMS (ESI) m/z calculated for C14H23NONa (M+Na)
+ 
244.1677, found: 244.1708; 1H NMR (500 MHz, CDCl3) δ 0.93 (s, 3H), 0.96 (d, J =6.5 Hz, 
3H), 1.07 (s, 3H), 1.13-1.27 (m, 2H), 1.54 (dd, J =6.0, 12.5 Hz, 1H), 1.68-1.75 (m, 1H), 1.77-
1.82 (m, 1H), 1.87 (dd, J =8.0, 12.5 Hz, 1H), 1.90-1.95 (m, 1H), 2.27-2.37 (m, 2H), 3.31 (d, J 
=10.0 Hz, 1H), 4.45 (dd, J =6.5, 14.0 Hz, 1H), 5.03 (td, J =1.0, 9.0 Hz, 1H), 5.08 (td, J =1.0, 
17.0 Hz, 1H), 5.79-5.86 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 23.7 (CH3), 24.2 (CH3), 
28.5 (CH3), 29.9 (CH), 30.1 (CH2), 38.5 (CH2), 41.2 (C), 45.0 (CH2), 46.8 (CH2), 59.6 (CH), 
69.0 (CH), 113.7 (CH2), 140.5 (CH), 173.4 (C). Lactam 2-167b: Rf = 0.4 (100% 
EtOAc/hexanes); [α]
546
25
 -25.6 (c 2.35, dichloromethane); IR (neat) 2954, 1638, 1406 cm-1; 
HRMS (ESI) m/z calculated for C14H23NONa (M+Na)
+ 244.1677, found: 244.1676; 1H NMR 
(500 MHz, CDCl3) δ 0.92 (d, J =6.5 Hz, 3H), 0.94 (s, 3H), 1.03 (s, 3H), 1.13-1.32 (m, 2H), 
1.55 (dd, J =6.5, 12.5 Hz, 1H), 1.68-1.75 (m, 1H), 1.77-1.82 (m, 2H), 1.88-1.94 (m, 1H), 
2.26-2.35 (m, 2H), 3.22 (d, J =10.5 Hz, 1H), 4.39-4.45 (m, 1H), 5.00 (td, J =1.3, 10.0 Hz, 
1H), 5.06 (td, J =1.3, 17.0 Hz, 1H), 5.73-5.81 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 24.0 
(CH3), 24.6 (CH3), 29.0 (CH3), 30.23 (CH2), 30.26 (CH), 39.0 (CH2), 41.3 (C), 44.4 (CH2), 
46.6 (CH2), 59.0 (CH), 69.2 (CH), 113.8 (CH2), 140.0 (CH), 174.0 (C). The following NOE 
correlations were used to assign lactams 2-167a and 2-167b. 
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(3S*,4S*,4aS*,6R*,8aS*)-4-(Azidomethyl)-3-chloro-1,1,6-trimethyldecahydro-
naphthalen-4a-ol (2-167c) and (3R*,4S*,4aS*,6R*,8aS*)-4-(azidomethyl)-3-chloro-1,1,6-
trimethyldecahydronaphthalen-4a-ol (2-167d). According to the general procedure VI, 
azides 2-166a, 2-166b, 2-166c, and 2-166d (19 mg, 0.076 mmol) and titanium tetrachloride 
(1 M in dichloromethane, 0.12 mL, 0.12 mmol) at room temperature afforded a mixture of 
alcohols 2-167c and 2-167d (20:1 ratio, 14 mg, 64%) as a colorless oil after column 
chromatography (0.5-1% EtOAc/hexanes). Alcohol 2-167c: Rf = 0.70 (20% EtOAc/hexanes); 
IR (neat) 3531, 2948, 2103, 1456 cm-1; HRMS (EI) m/z calculated for C14H24ClN3O (M)
+ 
285.1608, found: 285.1613; 1H NMR (500 MHz, CDCl3) δ 0.75-0.87 (m, 3H), 0.83 (d, J =7.5 
Hz, 3H), 0.84 (s, 3H), 0.95 (s, 3H), 1.35-1.43 (m, 2H), 1.47-1.53 (m, 1H), 1.61 (t, J =12.5 Hz, 
1H), 1.67-1.77 (m, 3H), 2.05 (dd, J =4.0, 13.0 Hz, 1H), 2.19 (d, J =1.1 Hz, 1H), 3.77 (dd, J 
=2.5, 13.0 Hz, 1H), 3.96 (dd, J =3.5, 13.0 Hz, 1H), 4.38 (dt, J =3.8, 12.0 Hz, 1H); 13C NMR 
(125 MHz, CDCl3) δ 20.5 (CH2), 21.30 (CH3), 21.31 (CH3), 26.6 (CH), 30.9 (CH3), 33.8 
(CH2), 34.4(C), 46.3 (CH2), 47.6 (CH2), 51.2 (CH), 51.8 (CH2), 52.8 (CH), 57.0 (CH), 74.5 
(C). Alcohol 2-167d (diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 2.12 (dd, J =2.7, 
15.3 Hz, 1H), 2.33 (d, J =2.0 Hz, 1H), 3.67 (dd, J =10.2, 12.5 Hz, 1H), 3.80 (dd, J =4.7, 12.5 
Hz, 1H), 4.60 (q, J =3.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 20.6 (CH2), 23.0 (CH or 
CH3), 26.2 (CH or CH3), 31.5(C), 32.7 (CH or CH3), 34.2 (CH2), 45.8 (CH2), 45.9 (CH2), 
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47.2 (CH), 48.5 (CH2), 51.3 (CH), 58.7 (CH), 72.4 (C). The following data and NOE 
correlations were used to assign alcohol 2-167c.  
 
 
 
 
(3R*,4aS*,5S*,8aS*)-5-(Azidomethyl)-3,8,8-trimethyl-1,2,3,4,4a,5,8,8a-octa-
hydronaphthalen-4a-ol (2-167e). According to the general procedure VI, azides 2-166a, 2-
166b, 2-166c, and 2-166d (69 mg, 0.28 mmol) and titanium tetrachloride (1 M in 
dichloromethane, 0.42 mL, 0.42 mmol) at room temperature afforded a mixture of alcohol 2-
167c, 2-167d and 2-167e (22:1:2 ratio, 26 mg, 33%) as a colorless oil, and a mixture of 
lactams 2-167a and 2-167b (20 mg, 33%, 1:1.7 ratio) after column chromatography (0.5-40% 
EtOAc/hexanes). Alcohol 2-167e (diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 3.24 
(dd, J = 12.3, 8.4 Hz, 1H), 3.63 (dd, J = 12.3, 4.6 Hz, 1H), 5.36 (dd, J = 10.2, 1.7 Hz, 1H), 
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5.54 (dd, J = 10.2, 2.8 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 22.4 (CH or CH3), 22.6 (CH2), 
24.7 (CH or CH3), 28.0 (CH or CH3), 30.6 (CH or CH3), 34.9 (CH2), 45.6 (CH), 46.0 (CH2), 
48.9 (CH), 51.7 (CH2), 71.9 (C), 121.6 (CH), 140.2 (CH).  
 
(2R,5R)-5-Methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone. To a solution of 
(1R,2R,5R)-5-Methyl-2-(2-methyl-pent-4-en-2-yl)cyclohexanol and (1S,2R,5R)-5-methyl-2-
(2-methylpent-4-en-2-yl)cyclohexanol (3.68 g, 18.8 mmol) in dichloromethane (40 mL) at 
room temperature was added silica gel (10 g) and pyridinium chlorochromate (PCC, 8.08 g, 
37.5 mmol) slowly. After stirring overnight, the reaction mixture was concentrated, purified 
by chromatography (0.6-3% EtOAc/hexanes) to afford (2R,5R)-5-methyl-2-(2-methylpent-4-
en-2-yl)cyclohexanone (2.23 g, 61%) as a colorless oil. Its spectral data matched reported 
data. 102  
 
(2R,5R,E)-2-(6-Azido-2-methylhex-4-en-2-yl)-5-methylcyclohexanone (2-164a), 
(2R,5R,Z)-2-(6-azido-2-methylhex-4-en-2-yl)-5-methylcyclohexanone (2-164b), (2R,5R)-
2-((S)-4-azido-2-methylhex-5-en-2-yl)-5-methylcyclohexanone (2-164c), and (2R,5R)-2-
((R)-4-azido-2-methylhex-5-en-2-yl)-5-methylcyclohexanone (2-164d). According to the 
general procedure III, (2R,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone (2.23 g, 
11.5 mmol). HG-2 (360 mg, 0.570 mmol) and allyl bromide (2.0 mL, 24 mmol) afforded a 
mixture of azides 2-164a, 2-164b, 2-164c, and 2-164d (1.97 g, 69%, 94:5:0.5:0.5 ratio from 
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13C NMR in CDCl3, 94:5:0.5:0.5 from 
13C NMR in acetone) as a colorless oil after column 
chromatography (0.6-4.0% EtOAc/hexanes). Azides 2-164a, 2-164b, 2-164c, and 2-164d: Rf 
= 0.5 (5% EtOAc/hexanes); IR (neat) 2957, 2094, 1707 cm-1; HRMS (ESI) m/z calculated for 
C28H47N6O2 (2M+H)
+ 499.3760, found: 499.3738. Azide 2-164a: 1H NMR (500 MHz, CDCl3) 
δ 0.95 (d, J =7.0 Hz, 3H), 0.98 (s, 3H), 1.03 (s, 3H), 1.58-1.65 (m, 1H), 1.76 (dq, J =3.5, 
12.0 Hz, 1H), 1.82-1.90 (m, 1H), 1.93-1.98 (m, 1H), 2.03-2.12 (m, 2H), 2.22 (dd, J =5.5, 
11.5 Hz, 1H), 2.33-2.39 (m, 2H), 2.50 (dd, J =5.5, 12.8 Hz, 1H), 3.71 (d, J =6.6 Hz, 2H), 
5.49-5.57 (m, 1H), 5.72-5.78 (m, 1H); 1H NMR (500 MHz, acetone) δ 0.91 (d, J =7.1 Hz, 
3H), 0.97 (s, 3H), 1.02 (s, 3H), 1.58-1.45 (m, 1H), 1.67-1.78 (m, 1H), 1.88-1.97 (m, 3H), 2.10 
(dd, J =7.5, 13.5 Hz, 1H), 2.28-2.38 (m, 3H), 2.55 (dd, J =6.8, 12.5 Hz, 1H), 3.76 (d, J =6.6 
Hz, 2H), 5.51-5.57 (m, 1H), 5.70-5.86 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 19.1 (CH or 
CH3), 24.0 (CH2), 24.5 (CH or CH3), 25.4 (CH or CH3), 31.4 (CH2), 32.3 (CH or CH3), 34.9 
(C), 43.3 (CH2), 50.3 (CH2), 52.9 (CH2), 57.0 (CH), 125.5 (CH), 133.6 (CH), 212.8 (CH2); 
13C NMR (125 MHz, acetone) δ 19.1 (CH or CH3), 24.6 (CH2), 24.72 (CH or CH3), 25.5 (CH 
or CH3), 32.0 (CH2), 33.0 (CH or CH3), 35.4 (C), 43.9 (CH2), 50.8 (CH2), 53.3 (CH2), 57.5 
(CH), 126.6 (CH), 134.2 (CH), 212.06 (C). Azide 2-164b (diagnostic peaks only): 1H NMR 
(500 MHz, CDCl3) δ 3.79-3.84 (m, 2H); 
1H NMR (500 MHz, acetone) δ 2.45 (dd, J =8.7, 
14.0 Hz, 1H), 3.83-3.91 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 57.2 (CH), 124.5 (CH2), 
132.0 (CH2), 212.7 (CH2); 
13C NMR (125 MHz, acetone) δ 57.7 (CH), 125.3 (CH), 132.8 
(CH), 212.28 (C). Azides 2-164c and 2-164d (diagnostic peaks only): 1H NMR (500 MHz, 
CDCl3) δ 3.79-3.84 (m, 1H); 
1H NMR (500 MHz, acetone) δ 3.83-3.91 (m, 1H); 13C NMR 
(125 MHz, CDCl3) δ 62.02 (CH), 62.05 (CH), 117.13 (CH2), 117.19 (CH2), 136.77 (CH), 
136.91 (CH),. 212.12 (C), 212.42 (C); 13C NMR (125 MHz, acetone) δ 62.63 (CH), 62.73 
(CH), 117.43 (CH2), 117.53 (CH2), 138.16 (CH), 138.22 (CH), 211.8 (C), 212.14 (C). 
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(3S,7R,9aR)-1,1,7-Trimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-
one (2-165a) and (3R,7R,9aR)-1,1,7-trimethyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-
a]azepin-5(6H)-one (2-165b). According to the general procedure VI, azides 2-164a, 2-164b, 
2-164c, and 2-164d (50 mg, 0.20 mmol) afforded lactam 2-165a (19 mg, 43%) as a colorless 
oil and 2-165b (2 mg, 5%) as a colorless oil after column chromatography (11-25% 
EtOAc/hexanes). Lactam 2-165a: Rf = 0.5 (100% EtOAc/hexanes); [α]
546
25
 +12.7 (c 0.75, 
dichloromethane); IR (neat) 2955, 1629, 1410 cm-1; HRMS (ESI) m/z calculated for 
C14H23NONa (M+Na)
+ 244.1677, found: 244.1632; 1H NMR (500 MHz, CDCl3) δ 0.78 (s, 
3H), 0.94 (d, J =6.8 Hz, 3H), 0.98 (s, 3H), 1.31-1.37 (m, 2H), 1.41 (dd, J =9.8, 12.5 Hz, 1H), 
1.48-1.55 (m, 1H), 1.65-1.73 (m, 2H), 1.85 (dd, J =7.5, 12.5 Hz, 1H), 2.03-2.10 (m, 1H), 
2.34-2.45 (m, 2H), 3.21 (d, J =10.5 Hz, 1H), 4.49 (dd, J =7.2, 16.0 Hz, 1H), 5.03 (td, J =1.0, 
10.0 Hz, 1H), 5.09 (td, J =1.0, 17.0 Hz, 1H), 5.71-5.78 (m, 1H); 13C NMR (125 MHz, CDCl3) 
δ 21.0 (CH3), 21.6 (CH3), 25.2 (CH2), 25.4 (CH3), 27.0 (CH), 34.0 (CH2), 41.1 (C), 43.2 
(CH2), 45.1 (CH2), 58.7 (CH), 67.4 (CH), 113.9 (CH2), 139.5 (CH), 172.7 (C). Lactam 2-
165b: Rf = 0.35 (100% EtOAc/hexanes); [α]
546
25
 +20.8 (c 0.75, dichloromethane); IR (neat) 
2959, 1644, 1412 cm-1; HRMS (ESI) m/z calculated for C14H23NONa (M+Na)
+ 244.1677, 
found: 244.1641; 1H NMR (500 MHz, CDCl3) δ 0.98 (s, 3H), 1.01 (s, 3H), 1.02 (d, J =7.0 Hz, 
3H), 1.43-1.53 (m, 1H), 1.58-1.70 (m, 3H), 1.75-1.82 (m, 2H), 2.03-2.12 (m, 1H), 2.39 (ddd, 
J =1.0, 6.5, 14.5 Hz, 1H), 2.69 (dd, J =2.5, 14.5 Hz, 1H), 3.25 (d, J =11.5 Hz, 1H), 4.45 (dd, 
J =6.5, 14.0 Hz, 1H), 5.05 (td, J =1.3, 10.5 Hz, 1H), 5.13 (td, J =1.3, 17.0 Hz, 1H), 5.79-5.86 
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(m, 1H); 13C NMR (125 MHz, CDCl3) δ 17.2 (CH3), 23.9 (CH3), 25.4 (CH2), 27.1 (CH), 28.8 
(CH3), 35.5 (CH2), 41.0 (C), 44.1 (CH2), 44.3 (CH2), 59.3 (CH), 69.4 (CH), 114.3 (CH2), 
140.2 (CH), 173.0 (C). The following NOE correlations were used to assign lactams 2-165a 
and 2-165b. 
 
 
 
(3R*,4R*,4aR*,6R*,8aR*)-4-(Azidomethyl)-3-chloro-1,1,6-trimethyl-deca-
hydronaphthalen-4a-ol (2-165c), (3S*,4R*,4aR*,6R*,8aR*)-4-(azidomethyl)-3-chloro-
1,1,6-trimethyldecahydronaphthalen-4a-ol (2-165d), and (3R*,4aR*,5R*,8aR*)-5-
(azidomethyl)-3,8,8-trimethyl-1,2,3,4,4a,5,8,8a-octahydronaphthalen-4a-ol (2-165e). 
According to the general procedure VI, azides 2-164a, 2-164b, 2-164c, and 2-164d (52 mg, 
0.21 mmol) afforded a mixture of lactams 2-165a and 2-165b (14 mg, 30%, 1:4.7 ratio) as a 
colorless oil, a mixture of alcohols 2-165c, 2-165d and 2-165e (12 mg, 21%, 14:1:0.9 ratio) 
as a colorless oil, alcohol 2-165f (2 mg, 3%) as a colorless oil, and a mixture of alcohols 2-
165g and 2-165h (1 mg, 2%, 2.5:1 ratio) as a colorless oil after column chromatography (1-
25% EtOAc/hexanes). Alcohols 2-165c, 2-165d and 2-165e (14:1:0.9 ratio): Rf = 0.70 (5% 
EtOAc/hexanes); IR (neat) 3526, 2944, 2106 cm-1; HRMS (EI) m/z calculated for 
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C14H24ClN3O (M
+) 285.1608, found: 285.1602. Alchol 2-165c: 1H NMR (500 MHz, CDCl3) δ 
0.85 (s, 3H), 0.86-0.91 (m, 1H), 0.97 (s, 3H), 1.10 (d, J = 7.5 Hz, 3H), 1.27-1.40 (m, 3H), 
1.44 (ddd, J = 13.2, 5.0, 4.5 Hz, 1H), 1.51-1.66 (m, 4H), 1.95-2.01 (m, 1H), 2.05 (dd, J = 
12.9, 3.9 Hz, 1H), 2.18 (d, J = 1.5 Hz, 1H), 3.76 (dd, J = 13.1, 2.5 Hz, 1H), 3.98 (dd, J = 13.1, 
3.2 Hz, 1H), 4.38 (td, J = 11.9, 4.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 15.6 (CH2), 20.0 
(CH3), 21.4 (CH3), 26.4 (CH), 30.96 (CH3), 30.98 (CH2), 34.7 (C), 42.9 (CH2), 47.5 (CH2), 
51.9 (CH2), 52.1 (CH), 53.3 (CH), 56.9 (CH), 75.3 (C). Alcohol 2-165d (diagnostic peaks 
only): 1H NMR (500 MHz, CDCl3) δ 2.33 (d, J = 2.5 Hz, 1H), 3.61 (dd, J = 12.6, 5.1 Hz, 1H), 
3.68 (dd, J = 12.6, 10.0 Hz, 1H), 4.58 (q, J = 3.5 Hz, 1H). Alcohol 2-165e (diagnostic peaks 
only): 1H NMR (500 MHz, CDCl3) δ 3.19 (dd, J = 12.5, 8.5 Hz, 1H), 4.15 (dd, J = 8.5, 6.0 Hz, 
1H), 5.32 (dd, J = 10.0, 1.2 Hz, 1H), 5.55 (dd, J = 10.0, 2.8 Hz, 1H). The following data and 
NOE correlations were used to assign alcohol 2-165c. 
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(3R*,4S*,4aR*,6R*,8aR*)-4-(Azidomethyl)-3-chloro-1,1,6-trimethyl deca-
hydronaphthalen-4a-ol (2-165f). Alcohol 2-165f: Rf = 0.45 (50% EtOAc/hexanes); IR (neat) 
3350, 2951, 2099 cm-1; 1H NMR (500 MHz, CDCl3) δ 0.83 (d, J = 6.6 Hz, 3H), 0.95 (s, 3H), 
0.96 (s, 3H), 0.98-1.08 (m, 1H), 1.37-1.48 (m, 4H), 1.52 (d, J = 12.8 Hz, 1H), 1.56 (ddd, J = 
13.5, 4.5, 1.4 Hz, 1H), 1.64 (dm, J = 14.8 Hz, 1H), 1.75 (s, 1H), 1.75-1.82 (m, 1H), 1.83-1.92 
(m, 1H), 1.97 (td, J = 4.6, 2.1 Hz, 1H), 3.59 (dd, J = 12.4, 6.6 Hz, 1H), 3.68 (dd, J = 12.4, 2.1 
Hz, 1H), 4.22 (dt, J = 12.5, 4.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 21.1 (CH2), 22.4 
(CH3), 26.5 (CH3), 26.6 (CH), 30.7 (CH2), 33.1 (CH3), 36.1 (C), 43.9 (CH), 45.0 (CH2), 47.3 
(CH2), 47.7 (CH2), 54.7 (CH), 57.0 (CH), 75.0 (C). The following data and NOE correlations 
were used to assign alcohol 2-165f. 
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(3R*,4R*,4aS*,6R*,8aR*)-4-(Azidomethyl)-3-chloro-1,1,6-trimethyl-decahydro-
naphthalen-4a-ol (2-165g) and (3R*,4S*,4aS*,6R*,8aR*)-4-(azidomethyl)-3-chloro-1,1,6-
trimethyldecahydronaphthalen-4a-ol (2-165h). Alcohol 2-165g and 2-165h: Rf = 0.40 (50% 
EtOAc/hexanes); IR (neat) 3480, 2928, 2101, 1456 cm-1. Alcohol 2-165g: 1H NMR (500 
MHz, CDCl3) δ 0.85 (d, J = 6.5 Hz, 3H), 0.95 (s, 3H), 0.96 (s, 3H), 0.99-1.11 (m, 2H), 1.25 
(dm, J = 6.5 Hz, 1H), 1.37-1.45 (m, 1H), 1.53-1.59 (m, 1H), 1.63-1.73 (m, 2H), 1.74-1.83 (m, 
3H), 1.88 (dd, J = 13.0, 3.6 Hz, 1H), 2.27 (s, 1H), 3.65 (dd, J = 12.7, 8.0 Hz, 1H), 3.83 (td, J 
= 12.1, 3.6 Hz, 1H), 3.92 (dd, J = 12.7, 3.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 21.3 
(CH2), 22.7 (CH3), 26.1 (CH3), 26.4 (CH), 30.5 (CH2), 33.0 (CH3), 36.1 (C), 38.2 (CH2), 49.8 
(CH), 50.0 (CH2), 53.4 (CH2), 56.1 (CH), 57.0 (CH), 75.7 (C). Alcohol 2-165h (diagnostic 
peaks only): 1H NMR (500 MHz, CDCl3) δ 0.83 (d, J = 6.5 Hz, 3H), 1.94-1.99 (m, 1H), 3.59 
(dd, J = 12.5, 6.7 Hz, 1H), 3.64-3.69 (m, 1H), 4.21 (dt, J = 12.5, 4.3 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 21.1 (CH2), 22.4 (CH3), 26.54 (CH or CH3), 26.57 (CH or CH3), 30.7 (CH2), 
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33.1 (CH3), 36.1 (C), 43.9 (CH), 45.0 (CH2), 47.3 (CH2), 47.7 (CH2), 54.7 (CH), 57.0 (CH), 
75.0 (C). The following data were used to assign alcohol 2-165g. 
 
 
 
2-(But-3-enyl)-2-methylcyclohexanol. To a mixture of sodium hydride (60% in 
mineral oil, 880 mg, 22.0 mmol) and HMPA (5.40 g, 30.0 mmol) in THF (50 mL) at 0 oC was 
slowly added a solution of 2-(but-3-enyl)cyclohexanone (3.04 g, 20.0 mmol) in THF (10 mL). 
After 1 h, the mixture was heated to reflux for 2 h. After cooling down to 0 oC, methyl iodide 
(14.2 g, 100 mmol) was added slowly and then heated to reflux overnight. Diethyl ether and 
water were added and then the aqueous layer was extracted with diethyl ether three times. 
The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, 
and concentrated. The residue was purified by chromatography (0.3-0.6% EtOAc/hexanes) to 
afford 2-(but-3-enyl)-2-methylcyclohexanone (1.7 g, 51%, 74% brsm, 90% purity) as a 
colorless oil and 2-(but-3-enyl)cyclohexanone (0.94 g) as a colorless oil. According to the 
procedure described for the reduction of (2S,5R)-5-methyl-2-(2-methylpent-4-en-2-
yl)cyclohexanone, 2-(but-3-enyl)-2-methyl-cyclohexanone (2.07 g, 12.5 mmol) afforded 2-
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(but-3-enyl)-2-methylcyclohexanol (1.10 g, 52%, 1.2:1.0 ratio) as a colorless oil after column 
chromatography (5-7% EtOAc/hexanes). Rf = 0.15 (10% EtOAc/hexanes); IR (neat) 3368, 
2929, 1640, 1450 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.90 (s, 1.4H), 0.97 (s, 1.6H), 1.02-
1.21 (m, 1H), 1.25-1.63 (m, 7H), 1.67-1.77 (m, 2H), 1.98-2.09 (m, 2H), 3.40 (td, J =4.0, 10.0 
Hz, 1H), 4.94 (td, J =0.8, 10.0 Hz, 1H), 5.01 (dd, J =1.2, 17.2 Hz, 1H), 5.80-5.90 (m, 1H); 
13C NMR (100 MHz, CDCl3) δ 17.1 (CH3), 21.2 (CH2), 21.3 (CH2), 23.3 (CH2), 24.0 (CH3), 
24.3 (CH2), 27.5 (CH2), 27.7 (CH2), 29.7 (CH2), 30.5 (CH2), 32.4 (CH2), 34.2 (CH2), 35.0 
(CH2), 37.3 (C), 37.8 (C), 40.0 (CH2), 75.8 (CH), 76.8 (CH), 113.90 (CH2), 113.93 (CH2), 
139.7 (CH), 139.8 (CH). 
 
2-(But-3-enyl)-2-methylcyclohexanone. According to the general procedure for the 
synthesis of (2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone, 2-(but-3-enyl)-2-
methylcyclohexanol (1.10 g, 6.54 mmol) afforded 2-(but-3-enyl)-2-methylcyclohexanone 
(0.91 g, 84%) as a colorless oil after column chromatography (0.6-1.8% EtOAc/hexanes). Rf 
= 0.60 (10% EtOAc/hexanes); IR (neat) 2934, 1703 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.07 
(s, 3H), 1.47-1.62 (m, 2H), 1.67-1.83 (m, 6H), 1.87-1.93 (m, 2H), 1.98-2.09 (m, 1H), 2.30-
2.45 (m, 2H), 4.94 (dd, J =0.8, 10.0 Hz, 1H), 5.01 (dd, J =1.6, 17.2 Hz, 1H), 5.74-5.85 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 21.1 (CH2), 22.5 (CH3), 27.5 (CH2), 28.2 (CH2), 36.8 
(CH2), 38.8 (CH2), 39.4 (CH2), 48.4 (C), 114.5 (CH2), 138.6 (CH), 215.8 (C). 
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(R*,E)-2-(5-Azidopent-3-enyl)-2-methylcyclohexanone (2-134a), (R*,Z)-2-(5-
azidopent-3-enyl)-2-methylcyclohexanone (2-134b), (R*)-2-((S*)-3-azidopent-4-enyl)-2-
methylcyclo- hexanone (2-134c), and (R*)-2-((R*)-3-azidopent-4-enyl)-2-
methylcyclohexanone (2-134d). According to general procedure III, 2-(but-3-enyl)-2-
methylcyclohexanone (900 mg, 5.41 mmol) afforded azides 2-134a, 2-134b, 2-134c, and 2-
134d (710 mg, 60%, 55:7:19:19 ratio from 1H NMR in acetone; 55:9:18:18 ratio from 1H 
NMR in CDCl3) as a colorless oil after column chromatography (0.6-2.5% EtOAc/hexanes). 
Azides 2-134a, 2-134b, 2-134c, and 2-134d: Rf = 0.40 (10% EtOAc/hexanes); IR (neat) 2935, 
2094, 1702, 1240 cm-1; HRMS (ESI) m/z calculated for C24H38N6O2Na (2M+Na)
+ 465.2954, 
found: 469.2984. Azide 2-134a: 1H NMR (400 MHz, CDCl3) δ 1.09 (s, 3H), 1.46-1.65 (m, 
3H), 1.66-1.81 (m, 4H), 1.82-1.95 (m, 2H), 2.04-2.12 (m, 1H), 2.35-2.41 (m, 2H), 3.71 (d, J 
=6.4 Hz, 2H), 5.51-5.57 (m, 1H), 5.69-5.79 (m, 1H); 1H NMR (400 MHz, acetone) δ 1.06 (s, 
3H), 1.46-1.65 (m, 3H), 1.68-1.91 (m, 7H), 2.27-2.33 (m, 1H), 2.35-2.45 (m, 1H), 3.77 (d, J 
=6.6 Hz, 2H), 5.56-5.63 (m, 1H), 5.77-5.86 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.0, 
22.6, 26.7, 27.5, 37.1, 38.8, 39.3, 48.4, 52.7, 123.1 (CH), 136.5 (CH), 215.52 (C); 13C NMR 
(100 MHz, acetone) δ 20.8 (CH2), 22.1 (CH3), 26.6 (CH2), 27.3 (CH2), 37.0 (CH2), 38.4 
(CH2), 39.0 (CH2), 48.0 (C), 52.3 (CH2), 123.2 (CH), 136.4 (CH), 213.4 (C). Azide 2-134b 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.10 (s, 3H), 3.77-3.82 (m, 2H); 
1H 
NMR (400 MHz, acetone) δ 1.08 (s, 3H), 3.90 (d, J =7.2 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 47.1, 122.3 (CH), 135.7 (CH); 
13C NMR (100 MHz, acetone) δ 46.7 (CH2), 122.3 
(CH), 135.7 (CH). Azides 2-134c and 2-134d (diagnostic peaks only): 1H NMR (400 MHz, 
CDCl3) δ 1.066 (s, 3H), 1.068 (s, 3H), 3.77-3.82 (m, 1H); 5.26-5.31 (m, 2H), 5.69-5.79 (m, 
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1H); 1H NMR (400 MHz, acetone) δ 1.03 (s, 3H), 3.96 (q, J =6.8 Hz, 1H), 5.29-5.36 (m, 2H), 
5.77-5.86 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 65.29 (CH), 65.39 (CH), 118.31 (CH2), 
118.37 (CH2), 135.48 (CH), 135.52 (CH), 215.40 (C), 215.47 (C); 
13C NMR (100 MHz, 
acetone) δ 21.96 (CH3), 47.78 (C), 47.81 (C), 65.21 (CH), 65.25 (CH), 117.6 (CH2), 136.0 
(CH). 
 
(3S*,9aR*)-9a-Methyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-
135a) and (3R*,9aR*)-9a-methyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one 
(2-135b). According to the general procedure VI, azides 2-134a, 2-134b, 2-134c, and 2-134d 
(176 mg, 0.79 mmol) afforded a mixture of lactam 2-135a and lactam 2-135b (115 mg, 75%, 
1.1:1 ratio) as a colorless oil after column chromatography (5-35% EtOAc/hexanes). Lactams 
2-135a and 2-135b: Rf = 0.50 (100% EtOAc); IR (neat) 2930, 1625, 1407 cm
-1; HRMS (ESI) 
m/z calculated for C12H20NO (M+H)
+ 194.1545, found: 194.1546; 1H NMR (400 MHz, 
CDCl3) δ 1.37 (s, 1.4H), 1.47 (s, 1.6H), 1.58-1.92 (m, 8H), 1.93-2.10 (m, 2H), 2.50-2.65 (m, 
2H), 4.75-4.78 (m, 1H), 5.07-5.14 (m, 2H), 5.77-5.83 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 23.7 (CH3), 23.9 (CH2), 24.3 (CH2), 25.0 (CH2), 25.2 (CH3), 26.7 (CH2), 27.6 (CH2), 37.4 
(CH2), 38.4 (CH2), 40.3 (CH2), 41.6 (CH2), 42.6 (CH2), 61.2 (CH), 62.2 (CH), 62.3 (2C), 
113.5 (CH2), 113.9 (CH2), 138.0 (CH), 138.9 (CH), 173.3 (C), 173.5 (C). The following NOE 
correlations were used to assign lactams 2-135a and 2-135b. 
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(2R*,4aS*,8aR*)-8a-Hydroxy-4a-methyl-2-vinyl-octahydrochromen-5-one (2-84). 
To a solution of aldehyde 83 (5.5 g, 30 mmol) in THF (50 mL) under N2 atmosphere at -
78 °C was slowly added vinyl magnesium bromide (36 mL, 1 M in THF, 36 mmol). After the 
addition, the mixture was stirred and allowed naturally to raise the temperature to -20 °C. 
Saturated aqueous ammonium chloride was added and the temperature was raised to rt. The 
reaction mixture extracted with ethyl acetate four times. The combined organic layers were 
washed with brine, dried over anhydrous sodium sulfate, and concentrated. The residue was 
purified by chromatography (6-20% EtOAc/hexanes) to afford ketone 2-84 (0.90 g, 14%) as a 
colorless oil. Ketone 2-84: Rf = 0.55 (50% EtOAc/hexanes); IR (neat): 3422, 2944, 1701 cm
-1; 
HRMS (ESI) m/z calculated for C12H18O3Na (M+Na)
+ 233.1154, found: 233.1130; 1H NMR 
(400 MHz, CDCl3) δ 1.19 (s, 3H), 1.46-1.50 (m, 2H), 1.65-1.72 (m, 1H), 1.75-1.82 (m, 2H), 
1.88-2.02 (m, 1H), 2.13-2.37 (m, 4H), 2.48-2.55 (m, 1H), 4.38-4.47 (m, 1H), 5.05 (dt, J =1.2 
Hz, 10.2 Hz, 1H), 5.19 (dt, J =1.6 Hz, 17.2 Hz, 1H), 5.74-5.82 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 19.0 (CH2), 23.7 (CH3), 26.7 (CH2), 28.5 (CH2), 35.2 (CH2), 36.8 (CH2), 51.9 (CH2), 
70.9 (CH), 99.4 (C), 114.6 (CH2), 139.1 (CH), 212.8 (C). The following data and NOE 
correlations were used to assign alcohol 2-84. 
 273 
 
 
 
 
(E)-2-(5-Azidopent-3-enyl)-2-methylcyclohexane-1,3-dione (2-85a), (Z)-2-(5-
azidopent-3-enyl)-2-methylcyclohexane-1,3-dione (2-85b), and 2-(3-azidopent-4-enyl)-2-
methylcyclohexane-1,3-dione (2-85c). Method A: To a suspension of ketone 2-84 (370 mg, 
1.76 mmol), PPh3 (924 mg, 3.52 mmol), and Zn(N3)2·2Pyr (541 mmol, 1.76 mmol) in 
benzene (20 mL) at rt under N2 atmosphere was slowly added DEAD (1.53 g, 40% in toluene, 
3.52 mmol). The resulting mixture was heated to reflux for 24 h. The reaction was cooled to 
rt and the solvent was removed in vacuo. The residue was purified by chromatography (6-25% 
EtOAc/hexanes) to afford a mixture of azides 2-85a, 2-85b, and 2-85c (270 mg, 65%, ratio: 
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63:6:31 from 1H NMR in acetone; 64:6:30 from 1H NMR in CDCl3) as a yellow oil. Azides 
2-85a, 2-85b, and 2-85c: Rf = 0.60 (50% EtOAc/hexanes); IR (neat): 2934, 2100, 1726, 1695, 
1245, 1026 cm-1; HRMS (ESI) m/z calculated for C24H35N4O4 (2M-N2+H)
+ 443.2658, found: 
443.2612. Azide 2-85a: 1H NMR (400 MHz, acetone) δ 1.21 (s, 3H), 1.30-1.38 (m, 1H), 
1.76-2.07 (m, 5H), 2.62-2.81 (m, 4H), 3.76 (d, J =6.4 Hz, 2H), 5.54-5.61 (m, 1H), 5.73-5.83 
(m, 1H); 13C NMR (100 MHz, acetone) δ 17.5 (CH2), 19.4 (CH3), 27.4 (CH2), 35.9 (CH2), 
37.4 (CH2), 37.5 (CH2), 52.2 (CH2), 64.7 (C), 123.9 (CH), 135.3 (CH), 209.5 (C). Azide 2-
85b (diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 1.20 (s, 3H), 3.87 (d, J =7.2 Hz, 
2H); 13C NMR (100 MHz, acetone) 64.8 (C), 123.1 (CH), 134.6 (CH). Azide 2-85c 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 1.22 (s, 3H), 3.94 (q, J =6.8 Hz, 1H), 
5.28-5.36 (m, 2H), 5.73-5.83 (m, 1H); 13C NMR (100 MHz, acetone) 64.8 (CH), 117.9 (CH2), 
135.7 (CH), 209.4 (C). 
Method B: To a solution of sodium azide (650 mg, 10 mmol) in deionized water (2 mL) was 
added benzene (10 mL). After cooling to 0 °C, concentrated sulfuric acid (510 mg, 5 mmol, 
95%) was added slowly. After stirring for 15 min, the ice bath was removed. After warming 
to room temperature, the organic layer was dried over anhydrous sodium sulfate. To a 
solution of ketone 2-84 (205 mg, 1 mmol) and triphenylphosphine (524 mg, 2 mmol) in 
benzene (10 mL) at 0 °C under N2 atmosphere was added the above solution (2 mL, 2 mmol) 
and DEAD (870 mg, 40% w/w in toluene, 2 mmol) simultaneously. The reaction mixture was 
allowed naturally to room temperature. The solvent was removed in vacuo. The residue was 
purified by chromatography to afford a mixture of azides 2-85a, 2-85b, and 2-85c (173 mg, 
74%, ratio: 63:6:31) as a yellow oil.  
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(3S*,9aR*)-9a-Methyl-3-vinyl-tetrahydro-1H-pyrrolo[1,2-a]azepine-5,9(6H,9aH) 
-dione (2-86a) and (3R*,9aR*)-9a-methyl-3-vinyl-tetrahydro-1H-pyrrolo[1,2-a]azepine-
5,9(6H,9aH)-dione (2-86b) According to the general procedure VI, the reaction of azide 2-
85a, 2-85b, and 2-85c (33 mg, 0.14 mmol) and tin tetrachloride (0.21 mL, 1 M in 
dichloromethane, 0.21 mmol) in anhydrous dichloromethane (3 mL) for 3 d afforded lactam 
2-86a (11 mg, 34%) as a colorless oil and lactam 2-86b (2 mg, 7%) as a colorless oil after 
column chromatography (10-100% EtOAc/hexanes). Lactam 2-86a: Rf = 0.25 (100% 
EtOAc/hexanes); IR (neat): 2979, 1715, 1652, 1399 cm-1; HRMS (ESI) m/z calculated for 
C12H18NO2 (M+H)
+ 208.1338, found: 208.1342; 1H NMR (400 MHz, CDCl3) δ 1.51 (s, 1H), 
1.79 (dd, J =6.0 Hz, 12.0 Hz, 1H), 1.93 (dd, J =6.4 Hz, 12.4 Hz, 1H), 1.99-2.13 (m, 2H), 
2.14-2.30 (m, 2H), 2.34-2.54 (m, 3H), 3.12 (dd, J =7.2 Hz, 20.8 Hz, 1H), 4.77 (t, J =7.2 Hz, 
1H), 5.19-5.30 (m, 2H), 5.89-5.97 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.4 (CH3), 22.2 
(CH2), 27.6 (CH2), 33.7 (CH2), 35.5 (CH2), 36.5 (CH2), 60.2 (CH), 72.2 (C), 116.0 (CH2), 
136.6 (CH), 170.4 (C), 213.3 (C). Lactam 2-86b: Rf = 0.20 (100% EtOAc/hexanes); IR (neat): 
2972, 1716, 1657, 1400 cm-1; HRMS (ESI) m/z calculated for C12H18NO2 (M+H)
+ 208.1338, 
found: 208.1311; 1H NMR (400 MHz, CDCl3) δ 1.52 (s, 3H), 1.83-2.03 (m, 4H), 2.20-2.27 
(m, 2H), 2.36-2.46 (m, 3H), 2.91-2.96 (m, 1H), 4.72 (q, J =6.8 Hz, 1H), 5.16-5.25 (m, 2H), 
5.84-5.92 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.5 (CH3), 22.7 (CH2), 29.1 (CH2), 33.5 
(CH2), 35.2 (CH2), 37.5 (CH2), 61.4 (CH), 72.3 (C), 115.0 (CH2), 138.9 (CH), 170.2 (C), 
211.9 (C). The following data and NOE correlations were used to assign lactam 2-86a. 
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2-(But-3-enyl)-2-phenylcyclohexanone. To a mixture of sodium hydride (60% in 
mineral oil, 880 mg, 22.0 mmol) in THF (80 mL) at 0 oC was slowly added a solution of 2-
phenylcyclohexanone (3.04 g, 20.0 mmol) in THF (15 mL). After 6 h, 4-bromobutene (10.8 g, 
80.0 mmol) was added slowly at room temperature and the resulting mixture was stirred 
overnight. Diethyl ether and water were added and then the aqueous layer was extracted with 
diethyl ether three times. The combined organic layers were washed with brine, dried over 
anhydrous sodium sulfate, and concentrated. The residue was purified by chromatography 
(0.3-3% EtOAc/hexanes) to afford 2-(but-3-enyl)-2-phenylcyclohexanone (1.04 g, 23%, 74% 
brsm) as a colorless oil and recovered 2-phenylcyclohexanone (2.42 g). Rf = 0.50 (20% 
EtOAc/hexanes); IR (neat) 2939, 1707, 1448 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.60-1.85 
(m, 7H), 1.88-1.98 (m, 2H), 2.27-2.41 (m, 2H), 2.77 (ddd, J =2.4, 5.6, 13.6 Hz, 1H), 4.85-
4.95 (m, 2H), 5.65-5.76 (m, 1H), 7.16-7.19 (m, 2H), 7.25-7.29 (m, 1H), 7.34-7.39 (m, 2H); 
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13C NMR (100 MHz, CDCl3) δ 21.7 (CH2), 28.1 (CH2), 28.4 (CH2), 35.2 (CH2), 39.3 (CH2), 
40.2 (CH2), 57.2 (C), 114.1 (CH2), 126.7 (CH2), 127.0 (CH2), 128.8 (CH2), 138.9 (CH), 140.7 
(C), 213.5 (C). 
 
(R*,E)-2-(5-Azidopent-3-enyl)-2-phenylcyclohexanone (2-132a), (R*,Z)-2-(5-
azidopent-3-enyl)-2-phenylcyclohexanone (2-132b), (R*)-2-((S*)-3-azidopent-4-enyl)-2-
phenylcyclo-hexanone (2-132c), and (R*)-2-((R*)-3-azidopent-4-enyl)-2-
phenylcyclohexanone (2-132d). According to the general procedure III, 2-(but-3-enyl)-2-
phenylcyclohexanone (1.04 g, 4.60 mmol) afforded azides 2-132a, 2-132b, 2-132c, and 2-
132d (680 mg, 53%, 48:8:22:22 ratio from 1H NMR in acetone) as a colorless oil after 
column chromatography (0.3-1.2% EtOAc/hexanes). Azides 2-132a, 2-132b, 2-132c, and 2-
132d: Rf = 0.45 (10% EtOAc/hexanes); IR (neat) 2939, 2093, 1705 cm
-1; HRMS (ESI) m/z 
calculated for C34H43N6O2 (2M+H)
+ 567.3447, found: 567.3425. Azide 2-132a: 1H NMR (400 
MHz, CDCl3) δ 1.60-1.82 (m, 7H), 1.82-1.90 (m, 1H), 1.92-2.02 (m, 1H), 2.28-2.40 (m, 2H), 
2.71-2.80 (m, 1H), 3.61-3.68 (m, 2H), 5.39-5.47 (m, 1H), 5.53-5.67 (m, 1H), 7.15-7.20 (m, 
2H), 7.25-7.30 (m, 1H), 7.36-7.41 (m, 2H); 1H NMR (400 MHz, acetone) δ 1.60-1.80 (m, 
7H), 1.82-1.90 (m, 1H), 1.92-1.98 (m, 1H), 2.18-2.21 (m, 1H), 2.28-2.35 (m, 1H), 2.79-2.85 
(m, 1H), 3.69 (d, J =6.6 Hz, 2H), 5.41-5.48 (m, 1H), 5.59-5.73 (m, 1H), 7.20-7.24 (m, 2H), 
7.29 (t, J =7.2 Hz, 1H), 7.41 (t, J =7.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 21.7 (CH2), 
26.7 (CH2), 28.4 (CH2), 35.3 (CH2), 39.5 (CH2), 40.2 (CH2), 52.8 (CH2), 57.2 (C), 122.7 (CH), 
126.8 (CH), 127.0 (CH), 128.9 (CH), 136.9 (CH), 140.50 (C), 213.4 (C); 13C NMR (100 MHz, 
acetone) δ 26.6 (CH2), 28.0 (CH2), 34.9 (CH2), 39.79 (CH2), 39.85 (CH2), 52.3 (CH2), 57.0 
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(C), 122.9 (CH), 126.7 (CH), 126.9 (CH), 128.8 (CH), 136.7 (CH), 140.9 (C), 211.51 (C). 
Azide 2-132b (diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.71-3.73 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 122.1 (CH), 135.9 (CH); 
13C NMR (100 MHz, acetone) δ 122.2 
(CH), 135.8 (CH), 211.58 (C). Azides 2-132c and 2-132d (diagnostic peaks only): 1H NMR 
(400 MHz, CDCl3) δ 3.61-3.68 (m, 1H); 5.16-5.25 (m, 2H), 5.53-5.67 (m, 1H); 
1H NMR (400 
MHz, acetone) δ 3.78 (q, J =7.2 Hz, 1H), 5.19-5.27 (m, 2H), 5.59-5.73 (m, 1H); 13C NMR 
(100 MHz, CDCl3) δ 65.39 (CH), 118.21 (CH2), 118.33 (CH2), 135.5 (CH), 140.35 (C), 
140.47 (C), 213.25 (C), 213.32 (C); 13C NMR (100 MHz, acetone) δ 65.23 (CH), 65.24 (CH), 
117.48 (CH2), 117.53 (CH2), 135.98 (CH), 136.01 (CH), 211.47 (C). 
 
(3S*,9aR*)-9a-Phenyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-
133a) and (3R*,9aR*)-9a-phenyl-3-vinyl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one 
(2-133b). According to the general procedure VI, azides 2-132a, 2-132b, 2-132c, and 2-132d 
(67 mg, 0.24 mmol) and titanium tetrachloride (1 M in dichloromethane, 0.36 mL, 0.36 mmol) 
in refluxing dichloromethane afforded lactam 2-133a (38 mg, 63%) as a colorless oil and 
lactam 2-133b (7.5 mg, 12%) as a colorless oil after column chromatography (3-8% 
EtOAc/hexanes). Lactam 2-133a: Rf = 0.30 (50% EtOAc/hexanes); IR (neat) 2932, 1626, 
1401 cm-1; HRMS (ESI) m/z calculated for C17H22NO (M+H)
+ 256.1701, found: 256.1711; 
1H NMR (400 MHz, CDCl3) δ 1.48-1.57 (m, 2H), 1.60-1.68 (m, 2H), 1.69-1.75 (m, 1H), 
1.97-2.10 (m, 2H), 2.11-2.19 (m, 2H), 2.19-2.27 (m, 1H), 2.34-2.39 (m, 1H), 2.56-2.61 (m, 
1H), 4.86 (dd, J =6.8, 12.8 Hz, 1H), 5.18 (td, J =1.2, 10.4 Hz, 1H), 5.32 (td, J =1.2, 17.2 Hz, 
1H), 6.05 (ddd, J =6.8, 10.4, 17.2 Hz, 1H), 7.25-7.29 (m, 2H), 7.31-7.34 (m, 1H), 7.37-7.41 
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(m, 2H); 13C NMR (100 MHz, CDCl3) δ 23.3 (CH2), 24.6 (CH2), 27.9 (CH2), 37.7 (CH2), 39.7 
(CH2), 45.7 (CH2), 62.7 (CH), 69.6 (C), 115.5 (CH2), 125.8 (CH), 126.5 (CH), 128.7 (CH), 
138.2 (CH), 144.6 (C), 174.8 (C). Lactam 2-133b: Rf = 0.35 (50% EtOAc/hexanes); IR (neat) 
2929, 1628, 1397 cm-1; HRMS (ESI) m/z calculated for C17H22NO (M+H)
+ 256.1701, found: 
256.1707; 1H NMR (400 MHz, CDCl3) δ 1.50-1.60 (m, 3H), 1.66-1.73 (m, 1H), 1.77-1.83 (m, 
1H), 1.87-1.93 (m, 3H), 2.05-2.13 (m, 1H), 2.24-2.33 (m, 1H), 2.44 (dd, J =6.8, 14.8 Hz, 1H), 
2.84-2.88 (m, 1H), 5.01 (t, J =5.6 Hz, 1H), 5.18-5.26 (m, 2H), 5.94 (ddd, J =4.8, 10.4, 17.2 
Hz, 1H), 7.19 (d, J =7.2 Hz, 2H), 7.28 (t, J =7.2 Hz, 1H), 7.39 (t, J =7.2 Hz, 2H); 13C NMR 
(100 MHz, CDCl3) δ 23.6 (CH2), 25.2 (CH2), 25.7 (CH2), 38.3 (CH2), 40.1 (CH2), 44.5 (CH2), 
61.9 (CH2), 69.3 (C), 113.8 (CH2), 126.0 (CH), 126.7 (CH), 128.7 (CH), 137.9 (CH), 143.9 
(C), 174.9 (C). The following data and NOE correlations were used to assign lactams 2-133a 
and 2-133b. 
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Ethyl 1-(but-3-enyl)-2-oxocyclohexanecarboxylate and ethyl 2-(but-3-
enyloxy)cyclohex-1-enecarboxylate. To a stirred solution of t-BuOK (3.42 g, 30.5 mmol) in 
dry DMSO (100 mL) was slowly added ethyl 2-oxocyclohexanecarboxylate (5.16 g, 30.3 
mmol) at room temperature. After 5 h, 4-bromobutene (6.03 g, 44.5 mmol) was slowly added 
at room temperature. After being allowed to stir overnight, diethyl ether and water were 
added and the aqueous layer was washed with diethyl ether three times. The combined 
organic layers were washed with brine, dried over anhydrous sodium sulfate and concentrated. 
The residue was purified by chromatography (1.2-5% EtOAc/hexanes) to afford ethyl 1-(but-
3-enyl)-2-oxocyclohexanecarboxylate (3.44 g, 51%) as a colorless oil and ethyl 2-(but-3-
enyloxy)cyclohex-1-enecarboxylate (650 mg, 10%) as a colorless oil. Ethyl 1-(but-3-enyl)-2-
oxocyclohexanecarboxylate: Rf = 0.20 (5% EtOAc/hexanes); IR (neat) 2939, 1710 cm
-1; 
HRMS (ESI) m/z calculated for C13H20O3Na (M+Na)
+ 247.1310, found: 247.1316; 1H NMR 
(400 MHz, CDCl3) δ 1.26 (t, J =7.2 Hz, 3H), 1.44 (dt, J =4.4, 12.0 Hz, 1H), 1.57-1.78 (m, 
4H), 1.92-2.08 (m, 4H), 2.38-2.53 (m, 3H), 4.19 (q, J =7.2 Hz, 2H), 4.93 (d, J =10.0 Hz, 1H), 
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5.00 (d, J =17.2 Hz, 1H), 5.72-5.81 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1 (CH3), 22.6 
(CH2), 27.6 (CH2), 28.6 (CH2), 33.9 (CH2), 36.1 (CH2), 41.1 (CH2), 60.5 (C), 61.1 (CH2), 
114.7 (CH2), 138.0 (CH), 171.9 (C), 207.7 (C). Ethyl 2-(but-3-enyloxy)cyclohex-1-
enecarboxylate: Rf = 0.15 (5% EtOAc/hexanes); IR (neat) 2936 cm
-1; HRMS (ESI) m/z 
calculated for C13H21O3 (M+H)
+ 225.1491, found: 225.1482; 1H NMR (400 MHz, CDCl3) δ 
1.29 (t, J =7.2 Hz, 3H), 1.55-1.61 (m, 2H), 1.66-1.72 (m, 2H), 2.26-2.33 (m, 4H), 2.43 (q, J 
=6.8 Hz, 2H), 3.90 (t, J =6.8 Hz, 2H), 4.19 (q, J =7.2 Hz, 2H), 5.07 (d, J =10.4 Hz, 1H), 
5.12 (dd, J =1.2, 17.2 Hz, 1H), 5.84-5.92 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.4 (CH3), 
22.1 (CH2), 22.5 (CH2), 25.4 (CH2), 26.7 (CH2), 34.3 (CH2), 59.8 (CH2), 67.7 (CH2), 108.8 
(C), 116.8 (CH2), 134.6 (CH), 161.3 (C), 168.1 (C). 
 
(S*,E)-Ethyl 1-(5-azidopent-3-enyl)-2-oxocyclohexanecarboxylate (2-136a), 
(S*,Z)-ethyl 1-(5-azidopent-3-enyl)-2-oxocyclohexanecarboxylate (2-136b), (S*)-ehtyl 1-
((S*)-3-azidopent-4-enyl)-2-oxocyclohexanecarboxylate (2-136c), and (S*)-ehtyl 1-((R*)-
3-azidopent-4-enyl)-2- oxocyclohexanecarboxylate (2-136d). According to the general 
procedure III, ethyl 1-(but-3-enyl)-2-oxocyclohexanecarboxylate (2.24 g, 10.0 mmol) 
afforded azides 2-136a, 2-136b, 2-136c, and 2-136d (1.33 g, 48%, 68% brsm, 59:7:17:17 
from 1H NMR in acetone; 63:7:15:15 from 1H NMR in CDCl3) as a colorless oil and ethyl 1-
(but-3-enyl)-2-oxocyclohexanecarboxylate (650 mg) after column chromatography (0.6-3% 
EtOAc/hexanes). Azides 2-136a, 2-136b, 2-136c, and 2-136d: Rf = 0.20 (10% 
EtOAc/hexanes); IR (neat) 2940, 2095, 1709 cm-1; HRMS (ESI) m/z calculated for 
C28H42N6O6Na (2M+Na)
+ 581.3064, found: 581.3050. Azide 2-136a: 1H NMR (500 MHz, 
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CDCl3) δ 1.29 (t, J =7.0 Hz, 3H), 1.41-1.51 (m, 1H), 1.58-1.72 (m, 4H), 1.73-1.82 (m, 1H), 
1.92-2.13 (m, 3H), 2.43-2.57 (m, 3H), 3.71 (d, J =6.5 Hz, 2H), 4.20-4.25 (m, 2H), 5.51-5.59 
(m, 1H), 5.70-5.79 (m, 1H); 1H NMR (500 MHz, acetone) δ 1.24-1.28 (m, 3H), 1.47-1.58 (m, 
1H), 1.58-1.78 (m, 4H), 1.82-2.11 (m, 4H), 2.31-2.36 (m, 1H), 2.47-2.55 (m, 2H), 3.77 (d, J 
=6.5 Hz, 2H), 4.20-4.25 (m, 2H), 5.56-5.62 (m, 1H), 5.76-5.85 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 14.2 (CH3), 22.6 (CH2), 27.2 (CH2), 27.6 (CH2), 34.2 (CH2), 36.3 (CH2), 41.1 (CH2), 
52.7 (CH2), 60.53 (C), 61.3 (CH2), 123.3 (CH), 135.9 (CH), 171.87 (C), 207.82 (C); 
13C 
NMR (125 MHz, acetone) δ 14.4 (CH3), 23.3 (CH2), 28.0 (CH2), 28.2 (CH2), 35.1 (CH2), 
36.85 (CH2), 41.6 (CH2), 53.1 (CH2), 61.16 (C), 61.77 (CH2), 124.4 (CH), 136.76 (CH), 
172.41 (C), 207.24 (C). Azide 2-136b (diagnostic peaks only): 1H NMR (500 MHz, acetone) 
δ 3.90 (d, J =7.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 60.56 (C), 122.8 (CH), 135.0 (CH), 
171.92 (C), 207.89 (C); 13C NMR (125 MHz, acetone) δ 61.22 (C), 123.7 (CH), 136.0 (CH), 
172.45 (C), 207.38 (C). Azides 2-136c and 2-136d (diagnostic peaks only): 1H NMR (500 
MHz, CDCl3) δ 3.79-3.84 (m, 1H); 5.28-5.31 (m, 2H), 5.70-5.77 (m, 1H); 
1H NMR (500 
MHz, acetone) δ 3.97 (q, J =7.0 Hz, 1H), 5.30 (d, J =10.2 Hz, 1H), 5.35 (d, J =17.1 Hz, 1H), 
5.77-5.85 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 60.36 (C), 60.40 (C), 65.06 (CH), 65.11 
(CH), 118.51 (CH2), 118.56 (CH2), 135.29 (CH), 135.33 (CH2), 171.84 (C), 207.69 (C); 
13C 
NMR (125 MHz, acetone) δ 61.0 (C), 65.83 (CH), 65.86 (CH), 118.7 (CH2), 136.71 (CH), 
136.76 (CH), 207.18 (C), 207.27 (C). 
 
(3S*,9aR*)-Ethyl 5-oxo-3-vinyl-octahydro-1H-pyrrolo[1,2-a]azepine-9a-
carboxylate (2-137a) and (3R*,9aR*)-Ethyl 5-oxo-3-vinyl-octahydro-1H-pyrrolo[1,2-
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a]azepine-9a-carboxylate (2-137b). According to the general procedure VI, azides 2-136a, 
2-136b, 2-136c, and 2-136d (185 mg, 0.66 mmol) and titanium chloride in refluxing 
dichloroethane afforded lactam 2-137a (57 mg, 36%) as a colorless oil and lactam 2-137b (34 
mg, 20%) as a colorless oil after column chromatography (10-40% EtOAc/hexanes). Lactam 
2-137a: Rf = 0.20 (50% EtOAc/hexanes); IR (neat) 2934, 1734, 1638, 1400 cm
-1; HRMS (ESI) 
m/z calculated for C14H21NO3Na (M+Na)
+ 274.1419, found: 274.1419; 1H NMR (400 MHz, 
CDCl3) δ 1.31 (t, J =7.2 Hz, 3H), 1.42-1.62 (m, 2H), 1.63-1.78 (m, 3H), 1.82-1.90 (m, 1H), 
1.98-2.10 (m, 2H), 2.32-2.45 (m, 3H), 2.53 (dd, J =6.8, 14.4 Hz, 1H), 4.20-4.31 (m, 2H), 
4.80 (br, 1H), 5.10 (td, J =1.2, 10.4 Hz, 1H), 5.29 (td, J =1.2, 17.2 Hz, 1H), 5.84 (ddd, J =5.6, 
10.4, 17.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 14.2 (CH3), 22.9 (CH2), 26.6 (CH2), 28.2 
(CH2), 38.0 (CH2), 38.2 (CH2), 40.2 (CH2), 61.5 (CH2), 62.4 (CH), 69.3 (C), 114.8 (CH2), 
137.7 (CH), 173.5 (C), 174.2 (C). Lactam 2-137b: Rf = 0.26 (50% EtOAc/hexanes); IR (neat) 
2933, 1730, 1638, 1394 cm-1; HRMS (ESI) m/z calculated for C14H21NO3Na (M+Na)
+ 
274.1419, found: 274.1400; 1H NMR (400 MHz, CDCl3) δ 1.31 (t, J =7.2 Hz, 3H), 1.48-1.60 
(m, 3H), 1.63 (dd, J =6.0, 12.4 Hz, 1H), 1.76-1.83 (m, 1H), 1.86-1.92 (m, 1H), 1.93-2.02 (m, 
1H), 2.13 (dt, J =6.0, 13.2 Hz, 1H), 2.22-2.30 (m, 2H), 2.57-2.65 (m, 2H), 4.20-4.32 (m, 2H), 
4.90 (dd, J =4.8, 8.0 Hz, 1H), 5.10-5.15 (m, 2H), 5.84 (ddd, J =4.6, 10.0, 17.4 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 14.3 (CH3), 23.0 (CH2), 26.8 (CH2), 26.9 (CH2), 38.2 (CH2), 38.5 
(CH2), 40.1 (CH2), 61.4 (CH), 61.7 (CH2), 69.7 (C), 113.8 (CH2), 137.8 (CH), 173.3 (C), 
174.4 (C). The following NOE correlation was used to assign lactams 2-137a. 
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(1S*,3R*,4R*)-3-(But-3-enyl)bicyclo[2.2.1]heptan-2-one. A solution of 3-
methylene-2-norbornanone (2.45 g, 20.0 mmol) in dichloromethane
 
(60 mL) was stirred at -
78 °C as titanium tetrachloride
 
(neat, 20 mL, 1 M in dichloromethane, 20 mmol) was added 
dropwise over 5 min to form a gray solution. After stirring 40 min, a solution of 
allyltrimethylsilane (2.97 g, 26.0 mmol) in dichloromethane
 
(30 mL) was added dropwise 
over 5 min. The resulting purple solution was stirred at –78 °C for 30 min and at 0 °C for an 
additional 20 min. A solution of triethylamine (15 mL) and methanol (5 mL) was added 
dropwise over 5 min, forming a white heterogeneous mixture that was diluted with diethyl 
ether (100 mL) and filtered. The mixture was washed with 10% HCl, saturated aqueous 
sodium bicarbonate, and brine, dried over anhydrous sodium sulfate, and concentrated under 
reduced pressure to give a crude product, which was purified by chromatography (0.6-5% 
EtOAc/hexanes) to afford (1S*,3R*,4R*)-3-(but-3-enyl)bicyclo[2.2.1]heptan-2-one (1.20 g, 
36%) as a colorless oil. Rf = 0.3 (10% EtOAc/hexanes); IR (neat) 2961, 1740 cm
-1; HRMS 
(ESI) m/z calculated for C11H16ONa (M+Na)
+ 187.1099, found: 187.1122; 1H NMR (400 
MHz, CDCl3) δ 1.25-1.35 (m, 1H), 1.36-1.45 (m, 1H), 1.57-1.62 (m, 3H), 1.67 (d, J =10.0 Hz, 
1H), 1.75-1.87 (m, 2H), 2.00-2.21 (m, 3H), 2.60 (br, 2H), 4.98 (td, J =0.8, 10.4 Hz, 1H), 5.04 
(qd, J =1.6, 17.2 Hz, 1H), 5.79 (tdd, J =6.6, 10.4, 17.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
δ 21.1 (CH2), 25.3 (CH2), 25.5 (CH2), 32.0 (CH2), 37.0 (CH2), 38.1 (CH), 50.5 (CH), 52.8 
(CH), 115.1 (CH2), 137.9 (CH), 219.9 (C). The following data were used to assign the title 
ketone.  
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219.92
52.85
25.49
31.98
137.95
115.12
38.14
37.02
50.54
23.31
21.21
2.04
5.80
5.05
4.98
2.10 2.15
2.58
1.60
1.60
1.40
1.82
1.58 1.68
2.62
1.28
1.82
 
 
 
(1S*,3R*,4R*,E)-3-(5-Azidopent-3-enyl)bicyclo[2.2.1]heptan-2-one (2-142a), 
(1S*,3R*,4R*,Z)-3-(5-azidopent-3-enyl)bicyclo[2.2.1]heptan-2-one (2-142b), 
(1S*,3R*,4R*)-3-((S*)-3-azidopent-4-enyl)bicyclo[2.2.1]heptan-2-one (2-142c) and 
(1S*,3R*,4R*)-3-((R*)-3-azidopent-4-enyl)bicyclo[2.2.1]heptan-2-one (2-142d). 
According to the general procedure III, (1S*,3R*,4R*)-3-(but-3-enyl)bicyclo[2.2.1]heptan-2-
one (1.10 g, 6.70 mmol) afforded azides 2-142a, 2-142b, 2-142c, and 2-142d (1.30 g, 89%, 
63:7:15:15 ratio from 1H NMR in acetone; 68:8:12:12 from 1H NMR in CDCl3) as a colorless 
oil after column chromatography (0.6-5% EtOAc/hexanes). Azides 2-142a, 2-142b, 2-142c, 
and 2-142d: Rf = 0.3 (10% EtOAc/hexanes); IR (neat) 2957, 2093, 1739 cm
-1; HRMS (ESI) 
m/z calculated for C12H17N3ONa (M +Na)
+ 242.1269, found: 242.1299. Azide 2-142a: 1H 
NMR (500 MHz, CDCl3) δ 1.28-1.49 (m, 5H), 1.52-1.68 (m, 2H), 1.70-1.80 (m, 3H), 2.10-
2.22 (m, 1H), 2.34 (br, 1H), 2.47 (br, 1H), 3.63 (d, J =6.5 Hz, 2H), 5.46-5.52 (m, 1H), 5.64-
5.70 (m, 1H); 1H NMR (500 MHz, acetone) δ 1.28-1.47 (m, 3H), 1.49 (d, J =11.5 Hz, 1H), 
1.55-1.65 (m, 1H), 1.67-1.73 (m, 2H), 1.77-1.88 (m, 3H), 2.18-2.32 (m, 1H), 2.42 (br, 1H), 
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2.46 (br, 1H), 3.78 (d, J =6.5 Hz, 2H), 5.59-5.65 (m, 1H), 5.78-5.86 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 24.0 (CH2), 27.9 (CH2), 28.5 (CH2), 30.7 (CH2), 34.84 (CH2), 39.2 (CH), 
49.6 (CH), 52.7 (CH2), 53.0 (CH), 123.8 (CH), 135.8 (CH), 220.1 (C); 
13C NMR (125 MHz, 
acetone) δ 24.5 (CH2), 28.6 (CH2), 29.4 (CH2), 31.3 (CH2), 35.19 (CH2), 40.0 (CH), 50.15 
(CH), 53.2 (CH2), 53.5 (CH), 124.8 (CH), 136.7 (CH), 218.6 (C). Azide 2-142b (diagnostic 
peaks only): 1H NMR (500 MHz, CDCl3) δ 3.71-3.82 (m, 2H); 
1H NMR (500 MHz, acetone) 
δ 3.88-3.97 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 123.1 (CH), 135.0 (CH), 219.9 (C); 
13C 
NMR (125 MHz, acetone) δ 124.0 (CH), 136.0 (CH). Azides 2-142c and 2-142d (diagnostic 
peaks only): 1H NMR (500 MHz, CDCl3) δ 3.71-3.82 (m, 1H), 5.18-5.23 (m, 2H), 5.64-5.70 
(m, 1H); 1H NMR (500 MHz, acetone) δ 4.01 (d, J =7.0 Hz, 1H), 5.30 (d, J =10.0 Hz, 1H), 
5.34 (d, J =17.0 Hz, 1H), 5.74-5.85 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 64.8 (CH), 65.0 
(CH), 118.4 (CH2), 118.5 (CH2), 135.3 (CH), 135.5 (CH), 219.56 (C), 219.64 (C); 
13C NMR 
(125 MHz, acetone) δ 65.60 (CH), 65.63 (CH), 118.58 (CH2), 118.63 (CH2), 136.85 (CH), 
136.93 (CH), 218.33 (C), 218.30 (C). 
 
(1S*,2S*,5R*,8S*)-5-Vinyl-6-azatricyclo[6.1.2.0
2,6
]undecan-7-one (2-143a) and 
(1S*,2S*,5S*,8S*)-5-vinyl-6-azatricyclo[6.1.2.0
2,6
]undecan-7-one (2-143b). According to 
the general procedure VI, azides 2-142a, 2-142b, 2-142c, and 2-142d (130 mg, 0.593 mmol) 
afforded lactam 2-143a (69 mg, 61%) as a colorless oil and 2-143b (5 mg, 4%) as a colorless 
oil after column chromatography (11-35% EtOAc/hexanes). Lactam 2-143a: Rf = 0.15 (100% 
EtOAc/hexanes); IR (neat) 2946, 1644, 1418 cm-1; HRMS (ESI) m/z calculated for 
C12H17NONa (M+Na)
+ 214.1208, found: 214.1232; 1H NMR (500 MHz, CDCl3) δ 1.55-1.65 
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(m, 4H), 1.67-1.73 (m, 2H), 1.73-1.83 (m, 2H), 1.87-1.93 (m, 1H), 1.95 (dd, J =1.0, 11.5 Hz, 
1H), 2.38 (br, 1H), 2.54 (dt, J =0.8, 4.5 Hz, 1H), 3.52-3.56 (m, 1H), 4.27 (t, J =7.5 Hz, 1H), 
5.00 (td, J =1.0, 10.5 Hz, 1H), 5.05 (td, J =1.0, 17.0 Hz, 1H), 5.65 (ddd, J =6.5, 10.5, 17.0 
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 21.4 (CH2), 26.5 (CH2), 30.4 (CH2), 32.0 (CH2), 
35.4 (CH2), 36.0 (CH), 43.3 (CH), 56.9 (CH), 65.9 (CH), 114.3 (CH2), 138.0 (CH), 172.8 (C). 
Lactam 2-143b: Rf = 0.2 (100% EtOAc/hexanes); IR (neat) 2950, 1645, 1428 cm
-1; HRMS 
(ESI) m/z calculated for C12H17NONa (M+Na)
+ 214.1208, found: 214.1233; 1H NMR (500 
MHz, CDCl3) δ 1.45-1.62 (m, 4H), 1.65-1.71 (m, 2H), 1.72-1.85 (m, 2H), 1.95 (d, J =11.5 Hz, 
1H), 2.07-2.11 (m, 1H), 2.39 (br, 1H), 2.61 (t, J =4.5 Hz, 1H), 3.57-3.62 (m, 1H), 4.38 (dd, J 
=6.5, 13.5 Hz, 1H), 5.00 (td, J =1.5, 10.0 Hz, 1H), 5.05 (td, J =1.3, 17.0 Hz, 1H), 5.73 (ddd, 
J =5.5, 10.5, 17.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 21.1 (CH2), 27.7 (CH2), 29.7 
(CH2), 31.5 (CH2), 34.9 (CH2), 35.8 (CH), 42.9 (CH), 57.2 (CH), 63.1 (CH), 113.7 (CH2), 
138.4 (CH), 173.3 (C). The following data and NOE correlations were used to assign lactams 
2-143a and 2-143b. 
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2-(Bicyclo[2.2.1]heptan-2-ylidene)-1,1-dimethylhydrazine. According to the 
general procedure IV, 2-norbornanone (6.6 g, 60 mmol) and 1,1-dimethylhydrazine (12 g, 
0.18 mol) afforded 2-(bicyclo[2.2.1]heptan-2-ylidene)-1,1-dimethylhydrazine (27.3 g, 100%, 
E/Z: 4:1), which was used without purification. IR (neat) 2952, 1669, 1466 cm
-1
; HRMS (ESI) 
m/z calculated for C9H17N2 (M+H)
+ 153.1392, found: 153.1382. Major isomer: 1H NMR (400 
MHz, CDCl3) δ 1.25-1.50 (m, 4H), 1.62-1.78 (m, 2H), 2.05 (dd, J =3.0, 17.2 Hz, 1H), 2.25 (d, 
J =17.2 Hz, 1H), 2.44 (s, 6H), 2.47-2.50 (m, 1H), 2.78 (br, 1H); 13C NMR (100 MHz, CDCl3) 
δ 26.9 (CH2), 27.73 (CH2), 35.7 (CH), 36.9 (CH2), 38.2 (CH2), 44.9 (CH), 47.1 (CH3), 176.5 
(C). Minor isomer (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.94 (dd, J =3.0, 
16.4 Hz, 1H), 3.36 (br, 1H); 13C NMR (100 MHz, CDCl3) δ 26.2 (CH2), 27.67 (CH2), 34.9 
(CH), 38.4 (CH2), 39.5 (CH2), 40.8 (CH), 48.0 (CH3), 176.1 (C). 
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(1S*,3S*,4R*)-3-(But-3-enyl)bicyclo[2.2.1]heptan-2-one. According to the general 
procedure V, 2-(bicyclo[2.2.1]heptan-2-ylidene)-1,1-dimethylhydrazine (4.56 g, 30.0 mmol), 
n-BuLi (12 mL, 2.5 M in hexane, 30 mmol) and 4-bromo-1-butene (4.5 g, 33 mmol) afforded 
(1S*,3S*,4R*)-3-(but-3-enyl)bicyclo[2.2.1]heptan-2-one (3.68 g, 75%) as a colorless oil after 
column chromatography (0.6-11% EtOAc/hexanes). Rf = 0.60 (10% EtOAc/hexanes); IR 
(neat) 2958, 1740 cm-1; HRMS (ESI) m/z calculated for C11H17O (M+H)
+ 165.1279, found: 
165.1242; 1H NMR (400 MHz, CDCl3) δ 1.28-1.38 (m, 1H), 1.38-1.53 (m, 3H), 1.60-1.68 (m, 
1H), 1.68-1.75 (m, 1H), 1.78-1.87 (m, 3H), 2.08-2.25 (m, 2H), 2.42 (br, 1H), 2.53 (br, 1H), 
4.97 (td, J =0.8, 10.0 Hz, 1H), 5.03 (qd, J =1.6, 17.2 Hz, 1H), 5.78 (tdd, J =6.6, 10.4, 17.2 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 24.0 (CH2), 27.9 (CH2), 28.3 (CH2), 32.2 (CH2), 
34.8 (CH2), 39.1 (CH), 49.6 (CH), 53.2 (CH), 115.2 (CH2), 137.9 (CH), 220.2 (C). The 
following data were used to assign the title ketone.  
O O
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4.97
5.02
2.18
2.18
1.35
1.65
1.722.42
2.52
1.861.48
1.82
1.51
1.82
1.42
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(1S*,3S*,4R*,E)-3-(5-Azidopent-3-enyl)bicyclo[2.2.1]heptan-2-one (2-140a), 
(1S*,3S*,4R*,Z)-3-(5-azidopent-3-enyl)bicyclo[2.2.1]heptan-2-one (2-140b), 
(1S*,3S*,4R*)-3-((S*)-3-azidopent-4-enyl)bicyclo[2.2.1]heptan-2-one (2-140c) and 
(1S*,3S*,4R*)-3-((R*)-3-azidopent-4-enyl)bicyclo[2.2.1]heptan-2-one (2-140d). 
According to the general procedure III, (1S*,3S*,4R*)-3-(but-3-enyl)bicyclo[2.2.1]heptan-2-
one (1.50 g, 9.10 mmol), HG-2 (285 mg, 0.450 mmol) and allyl bromide (3.9 mL, 45.5 mmol) 
afforded a mixture of azides 2-140a, 2-140b, 2-140c, and 2-140d (1.77 g, 84%, 64:8:14:14 
ratio from 1H NMR in acetone; 68:8:12:12 from 1H NMR in CDCl3) as a colorless oil after 
column chromatography (0.6-6% EtOAc/hexanes). Azides 2-140a, 2-140b, 2-140c, and 2-
140d: Rf = 0.25 (10% EtOAc/hexanes); IR (neat) 2959, 2093, 1739, 1239 cm
-1; HRMS (ESI) 
m/z calculated for C12H17N3ONa (M +Na)
+ 242.1269, found: 242.1295. Azide 2-140a: 1H 
NMR (500 MHz, CDCl3) δ 1.27-1.35 (m, 1H), 1.37-1.43 (m, 1H), 1.52-1.63 (m, 3H), 1.67 
(dd, J =1.0, 10.0 Hz, 1H), 1.75-1.85 (m, 2H), 1.95-2.05 (m, 1H), 2.08-2.23 (m, 2H), 2.60 (br, 
2H), 3.70 (d, J =6.5 Hz, 2H), 5.53-5.59 (m, 1H), 5.69-5.76 (m, 1H); 1H NMR (500 MHz, 
acetone) δ 1.23-1.32 (m, 2H), 1.53-1.60 (m, 4H), 1.62-1.72 (m, 2H), 1.75-1.82 (m, 1H), 1.97-
2.03 (m, 1H), 2.08-2.22 (m, 1H), 2.43 (d, J =5.0 Hz, 1H), 2.59 (br, 1H), 3.73 (d, J =5.5 Hz, 
2H), 5.56-5.62 (m, 1H), 5.73-5.83 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 21.1 (CH2), 25.3 
(CH2), 25.6 (CH2), 30.5 (CH2), 37.0 (CH2), 38.2 (CH), 50.5 (CH), 52.69 (CH), 52.74 (CH2), 
123.7 (CH), 135.9 (CH), 219.8 (C); 13C NMR (125 MHz, acetone) δ 21.7 (CH2), 25.9 (CH2), 
26.7 (CH2), 31.2 (CH2), 37.4 (CH2), 39.0 (CH), 51.1 (CH), 53.17 (CH2), 53.20 (CH), 124.7 
(CH), 136.83 (CH), 218.3 (C). Azide 2-140b (diagnostic peaks only): 1H NMR (500 MHz, 
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CDCl3) δ 3.79-3.86 (m, 2H); 
1H NMR (500 MHz, acetone) δ 3.88 (d, J =7.5 Hz, 2H), 5.50-
5.56 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 123.0 (CH), 135.2 (CH), 219.6 (C); 
13C NMR 
(125 MHz, acetone) δ 123.8 (CH), 136.1 (CH). Azides 2-140c and 2-140d (diagnostic peaks 
only): 1H NMR (500 MHz, CDCl3) δ 3.79-3.86 (m, 1H), 5.26-5.29 (m, 2H), 5.70-5.77 (m, 
1H); 1H NMR (500 MHz, acetone) δ 3.96-4.01 (m, 1H), 5.25 (ddd, J =0.7, 1.3, 11.0 Hz, 1H), 
5.31 (td, J =1.1, 17.0 Hz, 1H), 5.72-5.82 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 64.9 (CH), 
65.0 (CH), 118.4 (CH2), 118.7 (CH2), 135.3 (CH), 135.5 (CH), 219.26 (C), 219.35 (C); 
13C 
NMR (125 MHz, acetone) δ 65.65 (CH), 65.70 (CH), 118.55 (CH2), 118.69 (CH2), 136.85 
(CH), 136.99 (CH), 218.00 (C), 218.05 (C). 
 
(1S*,2R*,5S*,8S*)-5-Vinyl-6-azatricyclo[6.1.2.0
2,6
]undecan-7-one (2-141a), 
(1S*,2R*,10S*)-8-aza-tricyclo[8.1.2.0
2,8
]-5-tridecen-9-one (2-141c) and 
(1S*,2R*,5R*,8S*)-5-vinyl-6-azatricyclo[6.1.2.0
2,6
]undecan-7-one (2-141b). According to 
the general procedure VI, azides 2-140a, 2-140b, 2-140c, and 2-140d (98 mg, 0.45 mmol) 
and titanium tetrachloride (0.67 mL, 1 M in dichloromethane, 0.67 mmol) afforded lactam 2-
141a (53 mg, 62%) as a colorless oil, a mixture of lactams 2-141b and 2-141c (5 mg, 6%, 1:7 
ratio) as a colorless oil, and a mixture of alcohols 2-141d, 2-141e, and 2-141f (5 mg, 4%, 
4.3:0.3:1 ratio) as a colorless oil after column chromatography (2-30% EtOAc/hexanes). 
Lactam 2-141a: Rf = 0.2 (100% EtOAc/hexanes); IR (neat) 2946, 1649, 1415 cm
-1; HRMS 
(ESI) m/z calculated for C12H17NONa (M+Na)
+ 214.1208, found: 214.1204; 1H NMR (500 
MHz, CDCl3) δ 1.41-1.47 (m, 1H), 1.48-1.59 (m, 2H), 1.62 (d, J =11.5 Hz, 1H), 1.69-1.82 (m, 
4H), 1.91-1.99 (m, 1H), 2.01-2.11 (m, 1H), 2.37 (br, 1H), 2.70 (t, J =4.0 Hz, 1H), 3.11 (td, J 
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=2.0, 12.0 Hz, 1H), 4.19 (t, J =8.5 Hz, 1H), 5.05 (td, J =0.8, 10.0 Hz, 1H), 5.13 (td, J =0.8, 
17.0 Hz, 1H), 5.73-5.80 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 27.2 (CH2), 29.5 (CH2), 
30.1 (CH2), 31.6 (CH2), 33.2 (CH2), 36.5 (CH), 43.8 (CH), 57.8 (CH), 66.2 (CH), 114.3 
(CH2), 138.9 (CH), 175.6 (C). Mixture of lactams 2-141b and 2-141c: Rf = 0.25 (100% 
EtOAc/hexanes); IR (neat) 2941, 1639, 1450 cm-1; HRMS (ESI) m/z calculated for 
C12H17NONa (M+Na)
+ 214.1208, found: 214.1218. Lactam 2-141c: 1H NMR (500 MHz, 
CDCl3) δ 1.38-1.43 (m, 1H), 1.49-1.59 (m, 2H), 1.65-1.78 (m, 2H), 1.82-1.92 (m, 2H), 1.98 
(d, J =11.5 Hz, 1H), 2.19 (t, J =6.0 Hz, 1H), 2.23-2.26 (m, 2H), 2.65 (t, J =5.0 Hz, 1H), 
3.00-3.04 (m, 1H), 3.18 (d, J =9.5 Hz, 1H), 4.60 (dd, J =7.0, 15.0 Hz, 1H), 5.84-5.89 (m, 1H), 
5.90-5.95 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 26.4 (CH2), 29.3 (CH2), 29.7 (CH2), 30.8 
(CH2), 34.5 (CH2), 40.6 (CH), 43.7 (CH2), 43.8 (CH), 69.5 (CH), 129.8 (CH), 134.0 (CH), 
175.3 (C). Lactam 2-141b (diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 2.10 (dtd, J 
=1.0, 8.5, 13.0 Hz, 1H), 2.36 (t, J =4.5 Hz, 1H), 2.68-2.71 (m, 1H), 3.13 (dd, J =4.5, 11.5 Hz, 
1H), 4.55-4.60 (m, 1H), 4.95 (td, J =1.5, 10.5 Hz, 1H), 4.99 (td, J =1.5, 17.0 Hz, 1H), 5.72 
(ddd, J =5.0, 10.5, 17.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 28.4 (CH2), 29.19 (CH2), 
29.24 (CH2), 30.7 (CH2), 31.8 (CH2), 36.2 (CH), 43.5 (CH), 56.3 (CH), 64.8 (CH), 112.8 
(CH2), 138.7 (CH), 175.0 (C). The following data and NOE correlations were used to assign 
lactam 2-141a, 2-141b and 2-141c.  
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(1R*,4S*,4aS*,5S*,6S*,8aS*)-5-(Azidomethyl)-6-chlorodecahydro-1,4-methano-
naphthalen-4a-ol (2-141d), (1R*,4S*,4aS*,5S*,6R*,8aS*)-5-(azidomethyl)-6-
chlorodecahydro-1,4-methanonaphthalen-4a-ol (2-141e), and (1R*,4S*,4aS*,5S*,8aS*)-
5-(azidomethyl)-1,2,3,4,4a,5,8,8a-octahydro-1,4-methanonaphthalen-4a-ol (2-141f). 
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Alcohol 2-141d, 2-141e, and 2-141f: Rf = 0.25 (10% EtOAc/hexanes); IR (neat) 3502, 2945, 
2101 cm-1. Alcohol 2-141d: 1H NMR (500 MHz, CDCl3) δ 1.09 (ddd, J =2.3, 6.5, 12.5 Hz, 
1H), 1.17-1.26 (m, 2H), 1.27-1.32 (m, 1H), 1.33-1.40 (m, 1H), 1.47-1.55 (m, 3H), 1.81-1.86 
(m, 2H), 1.87-1.95 (m, 1H), 2.06-2.15 (m, 2H), 2.17-2.23 (m, 1H), 2.43 (s, 1H), 3.76 (dd, J 
=3.0, 13.0 Hz, 1H), 3.89 (dd, J =3.8, 13.0 Hz, 1H), 4.31 (ddd, J =2.0, 7.0, 10.0 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 21.2 (CH2), 22.2 (CH2), 29.9 (CH2), 32.3 (CH2), 36.0 (CH2), 42.1 
(CH), 45.0 (CH), 45.1 (CH), 50.0 (CH2), 53.8 (CH), 57.6 (CH), 82.1 (C). Alcohol 2-141e 
(diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 3.17 (dd, J =3.8, 12.5 Hz, 1H), 3.53 
(dd, J =4.0, 12.5 Hz, 1H), 4.47 (ddd, J =3.5, 7.0, 10.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
δ 79.3 (C). Alochol 2-141f (diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 1.13 (ddd, 
J =2.3, 7.0, 11.0 Hz, 1H), 2.29 (d, J =3.2 Hz, 1H), 3.39 (dd, J =9.0, 12.5 Hz, 1H), 3.60 (dd, J 
=4.0, 12.5 Hz, 1H), 5.68 (td, J =3.0, 9.0 Hz, 1H), 5.96-6.01 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 22.4 (CH2), 27.9 (CH2), 29.3 (CH2), 36.7 (CH2), 42.0 (CH), 43.5 (CH), 45.4 (CH), 
52.5 (CH2), 56.0 (CH), 84.1 (C), 129.1 (CH), 130.1 (CH). The following data and NOE 
correlations were used to assign lactam 2-141d. 
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6-(3-Hydroxy-4-methylpent-4-enyl)-1,4-dioxaspiro(4.5)decane. To a stirred 
solution of isopropenylmagnesium bromide (40 mL, 0.5 M in THF, 20.0 mmol) in THF (20 
mL) at -78 °C under N2 atmosphere was added slowly a solution of 2-88 (2.0 g, 10.1 mmol) 
in anhydrous THF (5 mL). After stirring overnight and warmed to rt, saturated NH4Cl was 
added. The aqueous layer was washed three times with ethyl acetate. The combined organic 
layers were washed with brine, dried over Na2SO4. The concentrated residue was purified by 
chromatography (6-25% EtOAc/hexanes) to afford 6-(3-hydroxy-4-methylpent-4-enyl)-1,4-
dioxaspiro(4.5)decane (1.6 g, 66%, 1:1 ratio) as a colorless oil. Rf = 0.45 (50% 
EtOAc/hexanes); IR (neat): 3436, 2932 cm-1; HRMS (ESI) m/z calculated for C28H48O6Na 
(2M+Na)+ 503.3349, found: 503.3332; 1H NMR (400 MHz, CDCl3, both isomers) δ 1.10-
1.40 (m, 4H), 1.43-1.53 (m, 2H), 1.57-1.70 (m, 4H), 1.72 (s, 3H), 1.73-1.95 (m, 3H), 3.90-
3.98 (m, 4H), 4.00-4.05 (m, 1H), 4.81-4.83 (m, 1H), 4.91-4.95 (m, 1H); 13C NMR (100 MHz, 
CDCl3, both isomers) δ 17.3 (CH3), 17.8 (CH3), 23.8 (CH2), 24.2 (CH2), 24.3 (CH2), 24.5 
(CH2), 29.2 (CH2), 29.3 (CH2), 33.0 (CH2), 33.1 (CH2), 34.6 (CH2), 44.3 (CH), 44.6 (CH), 
64.6 (CH2), 64.7 (CH2), 75.8 (CH), 76.6 (CH), 110.6 (CH2), 110.87 (C), 110.90 (C), 111.2 
(CH2), 147.5 (C), 147.8 (C). 
 
(R*,E)-6-(5-Azido-4-methylpent-3-enyl)-1,4-dioxaspiro(4.5)decane (2-180a), 
(R*,Z)-6-(5-azido-4-methylpent-3-enyl)-1,4-dioxaspiro(4.5)decane (2-180b), (R*)-6-((S*)-
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3-azido-4-methylpent-4-enyl)-1,4-dioxaspiro(4.5)decane (2-180c), and (R*)-6-((R*)-3-
azido-4-methylpent-4-enyl)-1,4-dioxaspiro(4.5)decane (2-180d) According to the 
procedure described for the synthesis of azides 85 (Method A), the reaction of 6-(3-hydroxy-
4-methylpent-4-enyl)-1,4-dioxaspiro(4.5)decane (1.12 g, 5.0 mmol), PPh3 (2.62 g, 10.0 
mmol), Zn(N3)2·2Pyr (1.53 g, 5.0 mmol), and DEAD (4.35 g, 40% in toluene, 10.0 mmol) in 
benzene (40 mL) afforded a mixture of azides 2-180a, 2-180b, 2-180c, and 2-180d (1.12 g, 
85%, ratio: 38:12:25:25 from 1H NMR in CDCl3) as a colorless oil after column 
chromatography (0.5-3% EtOAc/hexanes). Azides 2-180a, 2-180b, 2-180c, and 2-180d: Rf = 
0.45 (10% EtOAc/hexanes); IR (neat): 2934, 2094 cm-1; HRMS (ESI) m/z calculated for 
C28H46N6O4Na (2M+Na)
+ 553.3478, found: 553.3474. Azide 2-180a: 1H NMR (400 MHz, 
CDCl3) δ 1.10-2.20 (m, 13H), 3.67 (s, 2H), 3.90-4.00 (m, 4H), 5.44 (dt, J = 1.0 Hz, 7.2 Hz, 
1H). Azide 2-180b (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.78 (s, 2H). 
Azides 2-180c and 2-180d (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.79-3.84 
(m, 1H), 4.96 (s, 1H), 4.98 (dt, J = 1.6 Hz, 4.8 Hz, 1H). Azides 2-180a, 2-180b, 2-180c, and 
2-180d: 13C NMR (100 MHz, CDCl3) δ 14.6 (CH3), 17.5 (CH3), 17.8 (CH3), 22.3 (CH3), 23.8 
(CH2), 23.9 (CH2), 24.49 (CH2), 24.52 (CH2), 24.9 (CH2), 25.0 (CH2), 25.7 (CH2), 25.9 (CH2), 
27.8 (CH2), 28.6 (CH2), 29.0 (CH2), 29.1 (CH2), 29.23 (CH2), 29.27 (CH2), 30.4 (CH2), 30.7 
(CH2), 34.6 (CH2), 34.7 (CH2), 44.1 (CH), 44.4 (CH), 44.5 (CH), 51.2 (CH2), 59.5 (CH2), 
64.62 (CH2), 64.64 (CH2), 64.68 (CH2), 64.74 (CH2), 64.76 (CH2), 64.77 (CH2), 69.0 (CH), 
69.1 (CH), 110.66 (C), 110.69 (C), 110.79 (C), 110.83 (C), 114.2 (CH2), 114.7 (CH2), 128.8 
(C), 129.4 (C), 131.1 (CH), 131.7 (CH), 142.2 (C), 142.6 (C).  
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(R*,E)-2-(5-Azido-4-methylpent-3-enyl)cyclohexanone (2-178a), (R*,Z)-2-(5-
azido-4-methylpent-3-enyl)cyclohexanone (2-178b), (R*)-2-((S*)-3-azido-4-methylpent-
4-enyl)cyclohexanone (2-178c), and (R*)-2-((R*)-3-azido-4-methylpent-4-
enyl)cyclohexanone (2-178d). According to the first procedure described for azide 91a and 
91b, the reaction of ketal 2-180a, 2-180b, 2-180c, and 2-180d (724 mg, 2.73 mmol) and I2 
(70 mg, 0.27 mmol) in acetone (20 mL) afforded a mixture of azide 2-178a, 2-178b, 2-178c, 
and 2-178d (500 mg, 83%, ratio: 40:8:26:26 from 1H NMR in CDCl3) as a colorless oil after 
chromatography (0.6-2% EtOAc/hexanes). Azide 2-178a, 2-178b, 2-178c, and 2-178d: Rf = 
0.55 (10% EtOAc/hexanes); IR (neat): 2935, 2095, 1710, 1449, 1243 cm-1; HRMS (ESI) m/z 
calculated for C12H19N3ONa (M+Na)
+ 244.1426, found: 244.1439. Azide 2-178a: 1H NMR 
(400 MHz, CDCl3) δ 1.18-1.31 (m, 1H), 1.36-1.45 (m, 1H), 1.48-1.63 (m, 1H), 1.64-1.78 (m, 
2H), 1.71 (s, 3H), 1.80-1.93 (m, 2H), 2.04-2.15 (m, 3H), 2.26-2.36 (m, 2H), 2.38-2.43 (m, 
1H), 3.67 (s, 2H), 5.41-5.42 (dt, J = 1.2 Hz, 7.2 Hz, 1H). Azide 2-178b (diagnostic peaks 
only): 1H NMR (400 MHz, CDCl3) δ 1.61 (s, 3H), 3.79 (d, J = 6.8 Hz, 2H), 5.47 (t, J = 7.6 Hz, 
1H). Azides 2-178c and 2-178d (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.74-
1.76 (m, 3H), 3.85 (q, J = 7.2 Hz, 1H), 4.98 (s, 1H), 5.00 (qintet, J = 1.6 Hz, 1H). Azides 2-
178a, 2-178b, 2-178c, and 2-178d: 13C NMR (100 MHz, CDCl3, all isomers) δ 14.6 (CH3), 
17.6 (CH3), 20.9 (CH3), 22.3 (CH3), 25.0 (CH2), 25.1 (CH2), 25.4 (CH2), 25.6 (CH2), 25.8 
(CH2), 25.9 (CH2), 26.4 (CH2), 27.8 (CH2), 28.05 (CH2), 28.08 (CH2), 29.1 (CH2), 29.5 (CH2), 
29.7 (CH2), 29.8 (CH2), 30.2 (CH2), 33.9 (CH2), 34.09 (CH2), 34.15 (CH2), 38.3 (CH2), 39.3 
(CH2), 42.13 (CH2), 42.17 (CH2), 42.9 (CH2), 49.0 (CH2), 49.9 (CH), 50.2 (CH), 50.5 (CH), 
51.1 (CH2), 59.4 (CH2), 68.6 (CH), 68.9 (CH), 114.7 (CH2), 114.8 (CH2), 129.6 (C), 130.1 
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(C), 130.2 (CH2), 130.9 (CH2), 142.0 (C), 142.2 (C), 212.7 (C), 212.8 (C), 213.1 (C), 213.2 
(C). 
 
(3S*,9aR*)-3-(Prop-1-en-2-yl)-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-
179a) and (3R*, 9aR*)-3-(prop-1-en-2-yl)-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one 
(2-179b) According to the general procedure VI, the reaction of azide 2-178a, 2-178b, 2-
178c and 2-178d (108 mg, 0.49 mmol) and tin chloride (0.73 mL, 1 M in dichloromethane, 
0.73 mmol) in anhydrous dichloromethane (17 mL) afforded lactam 2-179a (20 mg, 21%) as 
a colorless oil and lactam 2-179b (4 mg, 4%) as a colorless oil after column chromatography 
(12-35% EtOAc/hexanes). Lactam 2-179a: Rf = 0.45 (100% EtOAc/hexanes); IR (neat): 2924, 
1639, 1447, 1413 cm-1; HRMS (ESI) m/z calculated for C12H20NO (M+H)
+ 194.1545, found: 
194.1550; 1H NMR (400 MHz, CDCl3) δ 1.52-1.81 (m, 6H), 1.75 (s, 3H), 1.83-1.90 (m, 1H), 
1.97-2.08 (m, 2H), 2.21-2.31 (m, 1H), 2.48-2.54 (m, 2H), 3.91 (t, J = 9.2 Hz, 1H), 4.53 (d, J 
= 8.2 Hz, 1H), 4.59 (s, 1H), 4.80 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 20.1 (CH3), 23.5 
(CH2), 27.5 (CH2), 29.9 (CH2), 31.9 (CH2), 36.0 (CH2), 38.4 (CH2), 59.4 (CH), 62.9 (CH), 
108.7 (CH2), 144.1 (C), 173.4 (C). Lactam 2-179b: Rf = 0.40 (100% EtOAc/hexanes); IR 
(neat): 2924, 1639, 1412 cm-1; HRMS (ESI) m/z calculated for C12H20NO (M+H)
+ 194.1545, 
found: 194.1546; 1H NMR (500 MHz, CDCl3) δ 1.42-1.55 (m, 3H), 1.57-1.65 (m, 1H), 1.68-
1.75 (m, 2H), 1.69 (s, 3H), 1.79-1.88 (m, 2H), 1.89-1.95 (m, 1H), 1.96-2.03 (m, 1H), 2.31-
2.38 (m, 1H), 2.54 (dd, J = 8.0 Hz, 15.0 Hz, 1H), 3.63 (dd, J = 9.2 Hz, 16.5 Hz, 1H), 4.48-
4.52 (m, 1H), 4.75-4.77 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 20.3 (CH3), 23.5 (CH2), 27.8 
(CH2), 29.9 (CH2), 32.6 (CH2), 35.4 (CH2), 38.6 (CH2), 59.9 (CH), 63.5 (CH), 109.8 (CH2), 
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144.0 (C), 174.5 (C). The following data and NOE correlations were used to assign lactams 
2-179a and 2-179b.  
 
 
 
 
 
2-(But-3-en-1-yl)cyclopentanone.
112 According to the general procedure V, 2-
cyclopentylidene-1,1-dimethylhydrazine (3.16 g, 25.0 mmol) and 4-bromo-1-butene (4.46 g, 
33.0 mmol) afforded 2-(but-3-en-1-yl)cyclopentanone (colorless oil, 1.38 g, 40%) as a 
colorless oil after column chromatography (2-5% EtOAc/hexanes). Rf = 0.70 (20% 
EtOAc/hexanes); IR (neat): 2962, 1736 cm-1; HRMS (EI) m/z calculated for C9H14O (M
+) 
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138.1045, found: 138.1058; 1H NMR (400 MHz, CDCl3) δ 1.31-1.38 (m, 1H), 1.49-1.56 (m, 
1H), 1.75-1.81 (m, 1H), 1.86-1.92 (m, 1H), 1.98-2.32 (m, 7H), 4.95-5.05 (m, 2H), 5.74-5.81 
(m, 1H); 13C NMR (100 MHz, CDCl3) δ 20.7 (CH2), 28.8 (CH2), 29.6 (CH2), 31.6 (CH2), 38.1 
(CH2), 48.4 (CH), 115.0 (CH2), 138.0 (CH), 221.3 (C).  
 
2-(5-Bromopent-3-en-1-yl)cyclopentanone. According to the general procedure I, 
2-(but-3-en-1-yl)cyclopentanone (1.30 g, 9.4 mmol), HG-2 (118 mg, 0.19 mmol, 2 mol%) 
and allyl boromide (1.6 mL, 18.8 mmol) afforded 2-(5-bromopent-3-en-1-yl)cyclopentanone 
(colorless oil, 900 mg, 42%, E/Z: 6:1 ratio) as a colorless oil after column chromatography (2% 
EtOAc/hexanes). Rf = 0.55 (20% EtOAc/hexanes); IR (neat): 2961, 1736, 1205, 1155 cm
-1. 
Trans isomer: 1H NMR (400 MHz, CDCl3) δ 1.32-1.41 (m, 1H), 1.45-1.56 (m, 1H), 1.76-1.92 
(m, 2H), 2.01-2.33 (m, 7H), 3.93 (d, J = 6.4 Hz, 2H), 5.71-5.75 (m, 2H). 13C NMR (100 MHz, 
CDCl3) δ 20.7 (CH2), 28.8 (CH2), 29.5 (CH2), 29.9 (CH2), 33.2 (CH2), 38.1 (CH2), 48.4 (CH), 
127.1 (CH), 135.5 (CH), 221.05 (C). Cis isomer (diagnostic peaks only): 1H NMR (400 MHz, 
CDCl3) δ 3.99 (d, J = 8.4 Hz, 2H), 5.55-5.61 (m, 1H), 5.71-5.75 (m, 1H); 
13C NMR (100 
MHz, CDCl3) δ 24.9 (CH2), 27.1 (CH2), 29.1 (CH2), 29.7 (CH2), 126.1 (CH), 134.9 (CH), 
221.01 (C).  
 
(R*,E)-2-(5-Azidopent-3-en-1-yl)cyclopentanone (2-148a), (R*,Z)-2-(5-azidopent-
3-en-1-yl)cyclopentanone (2-148b), (R*)-2-((S*)-3-azidopent-4-en-1-yl)cyclopentanone 
(2-148c), and (R*)-2-((R*)-3-azidopent-4-en-1-yl)cyclopentanone (2-148d). According to 
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the general procedure II, 2-(5-bromopent-3-en-1-yl)cyclopentanone (900 mg, 3.9 mmol) and 
soidum azide (760 mg, 11.7 mmol) afforded a mixture of azides 2-148a, 2-148b, 2-148c, and 
2-148d (colorless oil, 590 mg, 80%, 67:7:13:13 from 1H NMR in acetone; 66:8:13:13 from 
1H NMR in CDCl3) after column chromatography (1-6% EtOAc/hexanes). Azides 2-148, 2-
148b, 2-148c, and 2-148d: Rf = 0.45 (20% EtOAc/hexanes); IR (neat): 2962, 2098, 1738 cm
-1; 
HRMS (ESI) m/z calculated for C20H30N6O2Na (2M+Na)
+ 409.2328, found: 409.2321. Azide 
2-148a: 1H NMR (400 MHz, acetone) δ 1.30-1.40 (m, 1H), 1.52-1.61 (m, 1H), 1.72-1.87 (m, 
2H), 1.96-2.25 (m, 7H), 3.78 (d, J = 6.4 Hz, 2H), 5.54-5.66 (m, 1H), 5.75-5.87 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 20.7 (CH2), 29.0 (CH2), 29.7 (CH2), 30.1 (CH2), 38.1 (CH2), 48.3 
(CH), 52.7 (CH2), 123.7 (CH), 136.0 (CH), 221.0 (C). Azide 2-148b (diagnostic peaks only): 
1H NMR (400 MHz, acetone) δ 3.92 (d, J = 7.2 Hz, 2H). Azides 2-148c and 2-148d 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 4.00 (q, J = 7.2 Hz, 1H), 5.28-5.37 
(m, 2H), 5.75-5.87 (m, 1H). Azides 2-148b, 2-148c, and 2-148d (diagnostic peaks only): 13C 
NMR (100 MHz, CDCl3) δ 65.01 (CH), 65.06 (CH), 118.38 (CH2), 118.46 (CH2), 122.92 
(CH), 135.20 (CH), 135.41 (CH), 135.50 (CH), 220.6(C), 220.9 (C).  
 
(3S*,8aR*)-3-Vinylhexahydroindolizin-5(1H)-one (2-149a) and (3R*,8aR*)-3-
vinylhexahydroindolizin-5(1H)-one (2-149b). According to the general procedure VI, 
azides 2-148, 2-148b, 2-148c, and 2-148d (101 mg, 0.52 mmol) and tin tetrachloride (1.57 
mL, 1 M in dichloromethane, 1.57 mmol) at room temperature afforded lactam 2-149a 
(colorless oil, 21 mg, 24%) as a colorless oil and lactam 2-149b (colorless oil, 12.5 mg, 15%) 
after column chromatography (3-100% EtOAc/hexanes). Lactam 2-149a: Rf = 0.35 (100% 
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EtOAc); IR (neat): 2944, 1635, 1412 cm-1; HRMS (ESI) m/z calculated for C10H16NO 
(M+H)+ 166.1232, found: 166.1212; 1H NMR (400 MHz, CDCl3) δ 1.21-1.31 (m, 1H), 1.36-
1.47 (m, 1H), 1.55-1.65 (m, 1H), 1.65-1.75 (m, 1H), 1.89-1.93 (m, 1H), 2.04-2.18 (m, 3H), 
2.22-2.31 (m, 1H), 2.47 (dd, J = 6.0 Hz, 18.0 Hz, 1H), 3.50 (septet, J = 4.8 Hz, 1H), 4.64 (q, 
J = 6.8 Hz, 1H), 5.07-5.16 (m, 2H), 5.79-5.88 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 20.9 
(CH2), 29.3 (CH2), 29.4 (CH2), 31.6 (CH2), 32.9 (CH2), 58.5 (CH), 58.9 (CH), 114.0 (CH2), 
138.4 (CH), 169.0 (C). Lactam 2-149b: Rf = 0.30 (100% EtOAc);  IR (neat): 2943, 1634, 
1447 cm-1; HRMS (ESI) m/z calculated for C10H16NO (M+H)
+ 166.1232, found: 166.1218; 1H 
NMR (400 MHz, CDCl3) δ 1.35-1.46 (m, 1H), 1.58-1.65 (m, 1H), 1.71-1.81(m, 3H), 1.92-
2.03 (m, 3H), 2.06-2.12 (m, 1H), 2.30-2.42 (m, 1H), 3.46 (tdd, J = 3.2 Hz, 4.4 Hz, 11.2 Hz, 
1H), 4.58 (t, J = 6.8 Hz, 1H), 5.03-5.11 (m, 2H), 5.77-5.85 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 21.2 (CH2), 29.0 (CH2), 29.7 (CH2), 30.5 (CH2), 31.2 (CH2), 58.1 (CH), 60.1 (CH), 
114.0 (CH2), 137.9 (CH), 169.4 (C). The following data and NOE correlations were used to 
assign lactam 2-149a.  
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Ethyl 2-oxo-1-(pent-4-en-1-yl)cyclopentanecarboxylate and ethyl 2-(pent-4-en-1-
yloxy)cyclopent-1-enecarboxylate. A suspension of ethyl 2-oxocyclopentanecarboxylate 
(15.62 g, 0.1 mol), 5-bromo-1-pentene (14.9 g, 0.1 mol) and potassium carbonate (27.6 g, 0.2 
mol) in acetone (120 mL) under N2 atmosphere was refluxed for about 36 h. After cooling 
down to room temperature, the reaction mixture was filatrated and the filtrate was 
concentrated. The residue was purified by chromatography (5-20% EtOAc/hexanes) to afford 
ethyl 2-oxo-1-(pent-4-en-1-yl)cyclopentanecarboxylate (colorless oil, 19.3 g, 86%) and ethyl 
2-(pent-4-en-1-yloxy)cyclopent-1-enecarboxylate (colorless oil, 2.1 g, 9%). Ethyl 2-oxo-1-
(pent-4-en-1-yl)cyclopentanecarboxylate: Rf = 0.45 (20% EtOAc/hexanes); IR (neat): 2978, 
1750, 1723 cm-1; HRMS (ESI) m/z calculated for C13H21O3 (M+H)
+ 225.1491, found: 
225.1475; 1H NMR (400 MHz, CDCl3) δ 1.24 (t, J = 7.2 Hz, 3H), 1.26-1.34 (m, 1H), 1.46-
1.48 (m, 1H), 1.56 (dt, J = 4.4 Hz, 12.4 Hz 1H), 1.88-2.07 (m, 6H), 2.20-2.29 (m, 1H), 2.36-
2.41 (m, 1H), 2.49-2.54 (m, 1H), 4.15 (dq, J = 2.4 Hz, 7.2 Hz, 2H), 4.94-5.02 (m, 2H), 5.73-
5.80 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1 (CH3), 19.6 (CH2), 24.1 (CH2), 32.8 (CH2), 
33.3 (CH2), 33.9 (CH2), 37.9 (CH2), 60.4 (C), 61.3 (CH2), 114.9 (CH2), 138.1 (CH), 171.0 (C), 
214.9 (C). Ethyl 2-(pent-4-en-1-yloxy)cyclopent-1-enecarboxylate: Rf = 0.40 (20% 
EtOAc/hexanes); IR (neat): 2977, 1683, 1227, 1057 cm-1; HRMS (ESI) m/z calculated for 
C13H20O3Na (M+Na)
+ 247.1310, found: 247.1299; 1H NMR (400 MHz, CDCl3) δ 1.25 (t, J = 
7.2 Hz, 3H), 1.74-1.85 (m, 4H), 2.16-2.21 (m, 1H), 2.50-2.62 (m, 4H), 3.99 (t, J = 6.4 Hz, 
2H), 4.13 (q, J = 7.2 Hz, 2H), 4.94-5.04 (m, 2H), 5.75-5.82 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 14.4 (CH3), 19.3 (CH2), 28.8 (CH2), 29.2 (CH2), 29.7 (CH2), 31.6 (CH2), 59.2 (CH2), 
69.6 (CH2), 104.2 (C), 115.2 (CH2), 137.6 (CH), 165.3 (C), 168.4 (C).  
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Ethyl 1-(5-bromopent-3-en-1-yl)-2-oxocyclopentanecarboxylate. To a refluxing 
suspension of ethyl 2-oxo-1-(pent-4-en-1-yl)cyclopentanecarboxylate (1.7 g, 7.6 mmol) and 
NBS (1.5 g, 8.4 mmol) in CCl4 (50 mL) under N2 atmosphere was added catalytic amount of 
benzoyl peroxide. After refluxing for 1.5 h, the solvent was removed in vacuo. The residue 
was purified by chromatography (4-20% EtOAc/hexanes) to afford ethyl 1-(5-bromopent-3-
en-1-yl)-2-oxocyclopentanecarboxylate (colorless oil, 1.75 g, 76%). Rf = 0.45 (20% 
EtOAc/hexanes); IR (neat): 2974, 1749, 1723 cm-1; HRMS (ESI) m/z calculated for 
C13H19BrO3Na (M+Na)
+ 325.0415, found: 325.0389; 1H NMR (400 MHz, CDCl3) δ 1.24 (t, J 
= 7.2 Hz, 3H), 1.64-1.67 (m, 1H), 1.88-2.02 (m, 5H), 2.10-2.16 (m, 1H), 2.20-2.27 (m, 1H), 
2.37-2.44 (m, 1H), 2.48-2.53 (m, 1H), 3.90 (d, J = 6.4 Hz, 2H), 4.15 (q, J = 7.2 Hz, 2H), 
5.68-5.72 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 14.1 (CH3), 19.6 (CH2), 27.5 (CH2), 32.8 
(CH2), 32.9 (CH2), 33.1 (CH2), 37.9 (CH2), 60.0 (C), 61.4 (CH2), 127.0 (CH), 135.1 (CH), 
170.8 (C), 214.6 (C).  
 
(S*,E)-Ethyl 1-(5-azidopent-3-en-1-yl)-2-oxocyclopentanecarboxylate (2-150a), 
(S*,Z)-ethyl 1-(5-azidopent-3-en-1-yl)-2-oxocyclopentanecarboxylate (2-150b), (R*)-
ethyl 1-((S*)-4-azidohex-5-en-1-yl)-2-oxocyclopentanecarboxylate (2-150c), and (R*)-
ethyl 1-((R*)-4-azidohex-5-en-1-yl)-2-oxocyclopentanecarboxylate (2-150d). According to 
the general procedure II, ethyl 1-(5-bromopent-3-en-1-yl)-2-oxocyclopentanecarboxylate 
(1.75 g, 5.75 mmol) and sodium azide (1.63 g, 25 mmol) afforded a mixture of azides 2-150a, 
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2-150b, 2-150c, and 2-150d (colorless oil, 900 mg, 59%, 61:9:15:15 from 1H NMR in DMSO; 
64:6:15:15 from 1H NMR in CDCl3) after column chromatography (2-10% EtOAc/hexanes). 
Azides 2-150a, 2-150b, 2-150c, and 2-150d: Rf = 0.65 (20% EtOAc/hexanes); IR (neat): 
2977, 2098, 1750, 1723 cm-1; HRMS (ESI) m/z calculated for C13H19N3O3Na (M+Na)
+ 
288.1324, found: 288.1294. Azide 2-150a: 1H NMR (400 MHz, CDCl3) δ 1.18 (t, J = 7.2 Hz, 
3H), 1.53-1.64 (m, 1H), 1.78-2.00 (m, 5H), 2.07-2.21 (m, 2H), 2.31-2.48 (m, 2H), 3.63 (d, J 
= 6.4 Hz, 2H), 4.11 (q, J = 7.2 Hz, 2H), 5.44-5.49 (m, 1H), 5.61-5.69 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 14.0 (CH3), 19.5 (CH2), 27.6 (CH2), 32.9 (CH2), 33.1 (CH2), 37.8 (CH2), 52.5 
(CH2), 60.0 (CH2), 61.3 (CH2), 123.6 (CH), 135.4 (CH), 170.7 (C), 214.4 (C). Azide 2-150b 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.73-3.76 (m, 2H). Azide 2-150c and 
2-150d (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.73-3.76 (m, 1H), 5.20-5.24 
(m, 2H), 5.61-5.69 (m, 1H). Azide 2-150b, 2-150c, and 2-150d (diagnostic peaks only): 13C 
NMR (100 MHz, CDCl3) δ 64.87 (CH), 64.91 (CH), 118.49 (CH2), 118.53 (CH2), 122.9 (CH), 
134.6 (CH), 135.1 (CH), 135.2 (CH), 170.76 (C), 170.79 (C), 214.37 (C).  
 
(3S*,8aR*)-Ethyl 5-oxo-3-Vinyloctahydroindolizine-8a-carboxylate (2-151a) and 
(3S*,8aR*)-ethyl 5-oxo-3-vinyloctahydroindolizine-8a-carboxylate (2-151b). According 
to the general procedure VI, azides 2-150a, 2-150b, 2-150c, and 2-150d (265 mg, 1 mmol) in 
TFA (2 mL) at room temperature afforded azides 2-150a, 2-150b, 2-150c, and 2-150d (72 mg, 
27%), compound 2-151b (35 mg, 15%) as a colorless oil and compound 2-151a (10 mg, 4%) 
as a colorless oil after column chromatography (50-200% EtOAc/hexanes). Lactam 2-151a: 
Rf = 0.45 (100% EtOAc); IR (neat): 2981, 1732, 1626 cm
-1; HRMS (ESI) m/z calculated for 
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C13H20O3N (M+H)
+ 238.1443, found: 238.1354; 1H NMR (400 MHz, CDCl3) δ 1.29 (t, J = 
7.2 Hz, 3H), 1.45-1.76 (m, 4H), 1.78-1.86 (m, 1H), 2.09-2.16 (m, 1H), 2.27-2.36 (m, 1H), 
2.47-2.55 (m, 3H), 4.21 (dq, J = 2.8 Hz, 7.2 Hz, 2H), 4.61 (q, J = 7.6 Hz, 1H), 5.11-5.27 (m, 
2H), 5.93-6.01 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.2 (CH3), 18.5 (CH2), 28.5 (CH2), 
30.9 (CH2), 33.0 (CH2), 37.6 (CH2), 60.6 (CH), 61.8 (CH2), 70.4 (C), 115.1 (CH2), 139.1 
(CH), 169.6 (C), 173.7 (C). Lactam 2-151b: Rf = 0.40 (100% EtOAc); IR (neat): 2938, 1732, 
1655, 1400, 1185 cm-1; HRMS (ESI) m/z calculated for C13H20O3N (M+H)
+ 238.1443, found: 
238.1422; 1H NMR (400 MHz, acetone) δ 1.26 (t, J = 7.2 Hz, 3H), 1.54-1.76 (m, 3H), 1.83-
1.95 (m, 3H), 2.21-2.27 (m, 2H), 2.30-2.36 (m, 1H), 2.44 (dt, J = 4.0 Hz, 12.8 Hz, 1H), 4.21 
(q, J = 7.2 Hz, 1H), 4.51 (t, J = 7.2 Hz, 1H), 4.95-5.04 (m, 2H), 5.77-5.86 (m, 1H); 13C NMR 
(100 MHz, acetone) δ 13.6 (CH3), 18.8 (CH2), 27.6 (CH2), 30.3 (CH2), 31.8 (CH2), 34.9 
(CH2), 58.1 (CH), 61.3 (CH2), 70.4 (C), 112.8 (CH2), 138.6 (CH), 168.0 (C), 173.6 (C). The 
following data and NOE correlations were used to assign lactams 2-151a and 2-151b.  
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4-Methylhept-6-en-2-one.
113 To a solution of (E)-pent-3-en-2-one (2.78 g, 33.1 
mmol) in dichloromethane (75 mL) at -78 °C under N2 atmosphere was added slowly 
titanium tetrachloride (1 M in dichloromethane, 35 mL, 35 mmol). After stirring for 30 min, 
allyltrimethylsilane (4.57 g, 40.0 mmol) was added to the resulting mixture over 20 min. 
After 4 h, the reaction was quenched by aqueous saturated ammonium chloride at 0 °C and 
extracted with diethyl ether. The combined organic extracts were washed with aqueous 
sodium bicarbonate and brine, and then dried over anhydrous sodium sulfate. The 
concentrated residue was purified by column chromatography (2-10% EtOAc/hexanes) to 
afford 4-methylhept-6-en-2-one (colorless oil, 1.43 g, 11.3 mmol). Rf = 0.45 (10% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 0.90 (d, J = 6.4 Hz, 3H), 1.93-2.01 (m, 2H), 
2.04-2.14 (m, 1H), 2.11 (s, 3H), 2.16-2.23 (m, 1H), 2.45 (dd, J = 2.8 Hz, 16 Hz, 1H), 4.97-
5.02 (m, 2H), 5.68-5.78 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 19.7 (CH or CH3), 28.9 (CH 
or CH3), 30.4 (CH or CH3), 41.1 (CH2), 50.2 (CH2), 116.4 (CH2), 136.6 (CH), 208.7 (C). 
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8-Bromo-4-methyloct-6-en-2-one. According to the general procedure I, 4-
methylhept-6-en-2-one (1.43 g, 11.3 mmol), HG-2 (71 mg, 0.11 mmol, 1 mol%) and allyl 
bromide (2.9 mL, 34 mmol) afforded 8-bromo-4-methyloct-6-en-2-one (colorless oil, 1.48 g, 
60%, E/Z: 5:1) afte column chromatography (2-10% EtOAc/hexanes). E isomer: Rf = 0.30 (10% 
EtOAc/hexanes); IR (neat): 2958, 1714, 1205 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.92 (d, J 
= 6.4 Hz, 3H), 1.99-2.05 (m, 1H), 2.08-2.15 (m, 2H), 2.13 (s, 3H), 2.22-2.27 (m, 1H), 2.40-
2.46 (m, 1H), 3.95 (d, J = 3.6 Hz, 2H), 5.66-5.77 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
19.7, 29.0, 30.5, 33.0, 39.1, 50.1, 128.4, 134.1, 208.3. Z isomer (diagnostic peaks only): 1H 
NMR (400 MHz, CDCl3) δ 0.95 (d, J = 6.8 Hz, 3H), 3.99 (d, J = 8.4 Hz, 2H); 
13C NMR (100 
MHz, CDCl3) δ 19.8, 27.1, 29.1, 33.7, 50.2, 126.9, 133.3.  
 
(E)-8-Azido-4-methyloct-6-en-2-one (2-172a), (Z)-8-azido-4-methyloct-6-en-2-
one (2-172b), (4S*,6S*)-6-azido-4-methyloct-7-en-2-one (2-172c), and (4S*,6R*)-6-azido-
4-methyloct-7-en-2-one (2-172d). According to the general procedure II, 8-bromo-4-
methyloct-6-en-2-one (1.40 g, 6.38 mmol) and sodium azide (1.25 g, 19.2 mmol) afforded a 
mixture of azides 2-172a, 2-172b, 2-172c, and 2-172d (colorless oil, 865 mg, 75%, 79:11:5:5 
from 1H NMR in CDCl3) after column chromatography (3-10% EtOAc/hexanes). Azides 2-
172a, 2-172b, 2-172c, and 2-172d: Rf = 0.35 (10% EtOAc/hexanes); IR (neat): 2999, 2099, 
1715 cm-1; HRMS (ESI) m/z calculated for C18H31N6O2 (2M+H)
+ 363.2508, found: 363.2509. 
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Azide 2-172a: 1H NMR (400 MHz, CDCl3) δ 0.93 (d, J = 6.4 Hz, 3H), 1.99-2.14 (m, 3H), 
2.13 (s, 3H), 2.25 (dd, J = 7.6 Hz, 16.4Hz, 1H), 2.45 (dd, J = 5.6 Hz, 16.4Hz, 1H), 3.71 (d, J 
= 6.8 Hz, 2H), 5.49-5.54 (m, 1H), 5.65-5.76 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 19.7 
(CH or CH3), 28.8 (CH or CH3), 30.4 (CH or CH3), 39.3 (CH2), 50.1 (CH2), 52.7 (CH2), 
125.0 (CH), 134.5 (CH), 208.3 (C). Azide 2-172b (diagnostic peaks only): 1H NMR (400 
MHz, CDCl3) δ 3.81 (d, J = 7.2 Hz, 2H). Azides 2-172c and 2-172d (diagnostic peaks only): 
1H NMR (400 MHz, CDCl3) δ 3.84-3.92 (m, 1H), 5.26-5.32 (m, 2H), 5.57-5.65 (m, 1H). 
Azides 2-172b, 2-172c, and 2-172d (diagnostic peaks only): 13C NMR (100 MHz, CDCl3) δ 
29.2 (CH or CH3), 34.2 (CH2), 47.2 (CH2), 50.1 (CH2), 118.0 (CH2), 118.7 (CH2), 123.9 (CH), 
133.6 (CH).  
 
1-((2R*,4R*)-4-Methyl-2-vinylpyrrolidin-1-yl)ethanone (2-173a) and 1-
((2S*,4R*)-4-methyl-2-vinylpyrrolidin-1-yl)ethanone (2-173b). According to the general 
procedure VI, azides 2-172a, 2-172b, 2-172c, and 2-172d (54 mg, 0.30 mmol) and tin 
tetrachloride (0.45 mL, 1 M in dichloromethane, 0.45 mmol) afforded a mixture of lactams 2-
173a and 2-173b (colorless oil, 14 mg, 31%) by chromatography (5-100% EtOAc/hexanes). 
Lactams 2-173a and 2-173b: Rf = 0.35 (100% EtOAc); IR (neat): 2960, 1646, 1416 cm
-1; 
HRMS (ESI) m/z calculated for C9H16NO (M+H)
+ 154.1232, found: 154.1229. Lactam 2-
173a: 1H NMR (400 MHz, CDCl3) δ 1.08 (d, J = 6.8 Hz, 3H), 1.40-1.47 (m, 1H), 2.01 (s, 3H), 
2.10-2.21 (m, 1H), 2.34-2.43 (m, 1H), 2.83 (t, J = 10.4 Hz, 1H), 4.10 (ddd, J = 0.8 Hz, 6.8 Hz, 
10.8Hz, 1H), 4.24 (q, J = 7.6 Hz, 1H), 5.13-5.18 (m, 2H), 5.73-5.83 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 17.5 (CH or CH3), 22.3 (CH or CH3), 31.7 (CH or CH3), 42.6 (CH2), 53.3 
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(CH2), 61.6 (CH), 114.9 (CH2), 140.0 (CH), 170.2 (C). Lactam 2-173b: 
1H NMR (400 MHz, 
CDCl3) δ 1.09 (d, J = 6.4 Hz, 3H), 1.34-1.43 (m, 1H), 2.08 (s, 3H), 2.21-2.33 (m, 2H), 3.04 (t, 
J = 6.0 Hz, 1H), 3.67 (ddd, J = 0.8 Hz, 8.0 Hz, 10.0Hz, 1H), 4.49 (q, J = 7.2 Hz, 1H), 5.08-
5.14 (m, 2H), 5.80-5.89 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 17.5 (CH or CH3), 23.2 (CH 
or CH3), 33.1 (CH or CH3), 40.3 (CH2), 55.4 (CH2), 59.5 (CH), 113.9 (CH2), 139.2 (CH), 
169.0 (C). 
 
1,1-Dimethyl-2-(2-methyl-1-phenylpropylidene)hydrazine.114 To a solution of 
isobutyrophenone (22.6 mL, 0.150 mol) and 1,1-dimethylhydrazine (34.2 mL, 0.450 mol) in 
40 mL toluene was added p-toluenesulfonic acid monohydrate (0.29 g, 1.5 mmol). The 
reaction mixture was heated to reflux using a Dean-Stark apparatus for one day before the 
additional addition of 1,1-dimethylhydrazine (34 mL, 0.45 mol). The reaction mixture was 
allowed to reflux for 5 days. The reaction mixture was concentrated under reduced pressure 
and the residue was distilled under reduced pressure to afford 1,1-dimethyl-2-(2-methyl-1-
phenylpropylidene)hydrazine (27.3 g, 100%, E/Z: 8:1) as a colorless oil. E isomer: 1H NMR 
(400 MHz, CDCl3) δ 1.10 (d, J =6.8 Hz, 6H), 2.36 (s, 6H), 2.79 (septet, J =6.8 Hz, 1H), 7.20-
7.22 (m, 2H), 7.32-7.38 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 20.6 (CH3), 37.1 (CH), 47.3 
(CH3), 127.1 (CH), 127.6 (CH), 128.0 (CH), 137.9 (C), 169.1 (C). Z isomer (diagnostic peaks 
only): 1H NMR (400 MHz, CDCl3) δ 1.16 (d, J =6.8 Hz, 6H), 2.57 (s, 6H), 3.88 (septet, J 
=6.8 Hz, 1H), 7.20-7.22 (m, 2H), 7.32-7.38 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 20.4 
(CH3), 29.1 (CH), 48.1 (CH3), 132.8 (C), 175.8 (C).  
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2-(2,2-Dimethyl-1-phenylhex-5-enylidene)-1,1-dimethylhydrazine. To a solution 
of 1,1-dimethyl-2-(2-methyl-1-phenylpropylidene)hydrazine (11.4 g, 60.0 mmol) in THF 
(100 mL) under N2 atmosphere at 0 °C was added n-BuLi (30 mL, 2.5 M in hexane, 75 
mmol). After stirring for 2 h, 4-bromo-1-butene (10.1 g, 75.0 mmol) was added dropwise at 
0 °C. The reaction mixture was allowed naturally to warm to rt and stirred overnight. The 
reaction mixture was quenched with saturated NH4Cl. After the separation, the aqueous layer 
was washed with diethyl ether three times. The combined organic layers were washed with 
brine, dried over anhydrous magnesium sulfate. After the filtration and concentration, the 
residue was purified by chromatography (0.5-5% EtOAc/hexanes) to afford 2-(2,2-dimethyl-
1-phenylhex-5-enylidene)-1,1-dimethylhydrazine (9.5 g, 65%) as a colorless oil. Rf = 0.40 (20% 
EtOAc/hexanes); IR (neat) 2965, 1640, 1467 cm-1; HRMS (ESI) m/z calculated for 
(C16H24N2+H)
+ 245.2018, found: 245.2010; 1H NMR (400 MHz, CDCl3) δ 1.13 (s, 6H), 1.58-
1.62 (m, 2H), 2.14-2.20 (m, 2H), 2.35 (s, 6H), 4.96-5.09 (m, 2H), 5.82-5.92 (m, 1H), 7.06-
7.09 (m, 2H), 7.32-7.38 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 26.9 (CH3), 29.3 (CH2), 39.7 
(CH2), 41.4 (C), 47.4 (CH3), 114.0 (CH2), 127.2 (CH), 127.3 (CH), 127.8 (CH), 137.9 (C), 
139.3 (CH), 170.7 (C). 
 
2,2-Dimethyl-1-phenylhex-5-en-1-one. A solution of 2-(2,2-dimethyl-1-phenylhex-
5-enylidene)-1,1-dimethylhydrazine (3.9 g, 16 mmol) in a mixed solvent of CCl4 (35 mL) and 
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2 M aqueous H2SO4 (35 mL) was heated to reflux for 10 h. After cooling to room temperature, 
the aqueous layer was separated from organic layer and washed twice with dichloromethane. 
The combined organic layers were washed with brine and dried over anhydrous sodium 
sulfate. The concentrated residue was purified by chromatography (0.5-1.5% EtOAc/hexanes) 
to afford 2,2-dimethyl-1-phenylhex-5-en-1-one (3.0 g, 93%) as a colorless oil. Rf = 0.50 (20% 
EtOAc/hexanes); IR (neat) 2973, 1674 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.35 (s, 6H), 
1.84-1.89 (m, 2H), 2.00-2.06 (m, 2H), 4.92-5.01 (m, 2H), 5.72-5.82 (m, 1H), 7.39-7.49 (m, 
3H), 7.67-7.69 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 26.1 (2CH3), 29.2 (CH2), 40.1 (CH2), 
47.7 (C), 114.6 (CH2), 127.5 (2CH), 128.1 (2CH), 130.8 (CH), 138.4 (CH), 139.1 (C), 209.0 
(C).  
 
(E)-7-Bromo-2,2-dimethyl-1-phenylhept-5-en-1-one and (Z)-7-bromo-2,2-
dimethyl-1-phenylhept-5-en-1-one. According to the general procedure I, 2,2-dimethyl-1-
phenylhex-5-en-1-one (2.03 g, 10.0 mmol), HG-2 (125 mg, 0.20 mmol, 2 mol%) and allyl 
bromide (2.54 mL, 30.0 mmol) afforded a mixture of (E)-7-bromo-2,2-dimethyl-1-
phenylhept-5-en-1-one and (Z)-7-bromo-2,2-dimethyl-1-phenylhept-5-en-1-one (2.44 g, 83%, 
5:1 ratio) as a colorless oil after column chromatography (0.5-1.5% EtOAc/hexanes). Rf = 
0.35 (5% EtOAc/hexanes); IR (neat) 2968, 1672, 1203, 965, 718, 699 cm-1; HRMS (ESI) m/z 
calculated for (C15H19BrO+NH4)
+ 312.0963, found: 312.0968. E isomer: 1H NMR (400 MHz, 
CDCl3) δ 1.34 (s, 3H), 1.82-1.88 (m, 2H), 2.01-2.07 (m, 2H), 3.91 (d, J = 6.8 Hz, 1H), 5.61-
5.78 (m, 2H), 7.39-7.48 (m, 3H), 7.66-7.73 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 26.1 
(2CH3), 27.6 (CH2), 33.3 (CH2), 39.9 (CH2), 47.7 (C), 126.6 (CH), 127.6 (CH), 128.2 (CH), 
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131.0 (CH), 135.8 (CH), 138.9 (C), 208.6 (C). Z isomer (diagnostic peaks only): 1H NMR 
(400 MHz, CDCl3) δ 1.37 (s, 3H), 3.85 (d, J = 8.4 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ 
125.8 (CH), 135.0 (CH), 208.9 (C). 
 
(E)-7-Azido-2,2-dimethyl-1-phenylhept-5-en-1-one (2-158a), (Z)-7-azido-2,2-
dimethyl-1-phenyl-hept-5-en-1-one (2-158b), and 5-azido-2,2-dimethyl-1-phenylhept-6-
en-1-one (2-158c). According to the general procedure II, (E)-7-bromo-2,2-dimethyl-1-
phenylhept-5-en-1-one and (Z)-7-bromo-2,2-dimethyl-1-phenylhept-5-en-1-one (2.44 g, 8.30 
mmol) and sodium azide (1.63 g, 25.0 mmol) afforded a mixture of azides 2-158a, 2-158b 
and 2-158c (1.5 g, 71%, 53:11:36 ratio from 1H NMR in CDCl3) as colorless oil after column 
chromatography (0.25-1.5% EtOAc/hexanes). Azides 2-158a, 2-158b and 2-158c: Rf = 0.45 
(10% EtOAc/hexanes); IR (neat) 2968, 2094, 1671 cm-1; HRMS (ESI) m/z calculated for 
(C30H38N4O2+H)
+ 487.3073 (corresponding to (2 M-N2+H)
+), found: 487.3087. Azide 2-158a: 
1H NMR (400 MHz, CDCl3) δ 1.34 (s, 3H), 1.82-1.89 (m, 2H), 2.01-2.08 (m, 2H), 3.67 (d, J 
= 6.8 Hz, 1H), 5.44-5.51 (m, 1H), 5.61-5.74 (m, 1H), 7.39-7.50 (m, 3H), 7.66-7.69 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 26.1 (2CH3), 27.8 (CH2), 40.4 (CH2), 47.6 (C), 52.7 (CH2), 
123.1 (CH), 127.6 (CH), 128.2 (CH), 131.0 (CH), 136.3 (CH), 138.9 (C), 208.66 (C). Azide 
2-158b (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.36 (s, 3H), 3.64 (d, J = 11.6 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 23.1 (CH2), 26.2 (CH3), 40.9 (CH2), 47.0 (C), 52.1 
(CH2), 122.5 (CH), 127.7 (CH), 131.1 (CH), 135.3 (CH), 208.39 (C). Azide 2-158c 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.33 (s, 3H), 1.45-1.52 (m, 2H), 1.72-
1.89 (m, 2H), 3.76 (q, J = 7.2 Hz, 1H), 5.22-5.27 (m, 2H), 5.61-5.74 (m, 1H); 13C NMR (100 
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MHz, CDCl3) δ 26.2 (CH3), 29.7 (CH2), 36.9 (CH2), 47.4 (C), 65.3 (CH), 118.4 (CH2), 127.6 
(CH), 131.0 (CH), 135.4 (CH), 138.8 (C), 208.47 (C). 
 
(2,2-Dimethyl-5-vinylpyrrolidin-1-yl)phenylmethanone (2-159). According to the 
procedure V, azides 2-158a, 2-158b, and 2-158c (86 mg, 0.33 mmol) afforded after 
chromatography (1-8% EtOAc/hexanes) lactam 2-159 (41 mg, 54%) as a colorless oil. 
Lactam 2-159: Rf = 0.20 (20% EtOAc/hexanes); IR (neat) 2965, 1627 cm
-1; HRMS (ESI) m/z 
calculated for (C15H19NO+Na)
+ 252.1364, found: 252.1343; 1H NMR (400 MHz, CDCl3) δ 
1.58 (br s, 3H), 1.58-1.70 (m, 1H), 1.70 (br s, 3H), 1.78-1.83 (m, 1H), 1.90-1.97 (m, 1H), 
2.06-2.15 (m, 1H), 4.35 (br s, 3H), 4.76 (d, J = 16.4 Hz, 3H), 4.92 (d, J = 10.0 Hz, 3H), 5.58 
(br s, 1H), 7.32 (s, 5H); 13C NMR (100 MHz, CDCl3) δ 25.4 (CH3), 27.2 (CH3), 29.3 (CH2), 
39.7 (CH2), 63.0 (C), 63.5 (CH), 115.0 (CH2), 126.2 (CH), 127.9 (CH), 128.7 (CH), 139.1 
(CH), 170.7 (C).  
 
1-Phenylhex-5-en-1-one.113 According to the general procedure V, 1,1-dimethyl-2-
(1-phenylethylidene)hydrazine (6.5 g, 40.0 mmol) and 4-bromo-1-butene (6.21 g, 46.0 mmol) 
afforded 1-phenylhex-5-en-1-one (colorless oil, 5.4 g, 78%) as a colorless oil after column 
chromatography (1-5% EtOAc/hexanes). Rf = 0.60 (10% EtOAc/hexanes); 
1H NMR (400 
MHz, CDCl3) δ 1.84-1.91 (m, 2H), 2.18 (q, J = 7.2 Hz, 2H), 2.99 (t, J = 7.2 Hz, 2H), 5.00-
5.09 (m, 2H), 5.79-5.89 (m, 1H), 7.45-7.49 (m, 2H), 7.54-7.58 (m, 1H), 7.96-7.98 (m, 2H); 
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13C NMR (100 MHz, CDCl3) δ 23.3 (CH2), 33.2 (CH2), 37.8 (CH2), 115.3 (CH2), 128.0 (CH), 
128.6 (CH), 132.9 (CH), 137.1 (C), 138.0 (CH), 200.2 (C). 
 
7-Bromo-1-phenylhept-5-en-1-one. According to the general procedure I, 1-
phenylhex-5-en-1-one (3.48 g, 20 mmol), HG-2 (125 mg, 0.2 mmol, 1 mol%) and allyl 
bromide (5.1 mL, 60.0 mmol) afforded 7-bromo-1-phenylhept-5-en-1-one (colorless oil, 2.86 
mg, 54%, E/Z: 15:1) as a colorless oil after column chromatography (0.5-3% EtOAc/hexanes). 
E isomer: Rf = 0.30 (5% EtOAc/hexanes); IR (neat): 2937, 1684, 1449 cm
-1; 1H NMR (400 
MHz, CDCl3) δ 1.83-1.90 (m, 2H), 2.18 (q, J = 7.2 Hz, 2H), 2.98 (t, J = 7.2 Hz, 2H), 3.95 (d, 
J = 6.8 Hz, 2H), 5.70-5.83 (m, 2H), 7.46-7.49 (m, 2H), 7.54-7.58 (m, 1H), 7.95-7.97 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 23.2 (CH2), 31.5 (CH2), 33.3 (CH2), 37.5 (CH2), 127.3 (CH), 
128.0 (CH), 128.6 (CH), 133.0 (CH), 135.6 (CH), 137.0 (C), 200.0 (C). Z isomer (diagnostic 
peaks only): 1H NMR (400 MHz, CDCl3) δ 4.01 (d, J = 8.4 Hz, 2H).  
 
(E)-7-Azido-1-phenylhept-5-en-1-one (2-156a), (Z)-7-azido-1-phenylhept-5-en-1-
one (2-156b) and 5-azido-1-phenylhept-6-en-1-one (2-156c). According to the general 
procedure II, 7-bromo-1-phenylhept-5-en-1-one (1.40 g, 5.24 mmol) and sodium azide (1.02 
g, 15.7 mmol) afforded a mixture of azides 2-156a, 2-156b, and 2-156c (colorless oil, 940 mg, 
78%, 68:7:25 from 1H NMR in CDCl3) after column chromatography (0.5-3% 
EtOAc/hexanes). Azides 2-156a, 2-156b, and 2-156c: Rf = 0.35 (10% EtOAc/hexanes); IR 
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(neat): 2938, 2099, 1684 cm-1; HRMS (ESI) m/z calculated for C26H31N4O2 (2M-N2)
+ 
431.2447, found: 431.2445. Azide 2-156a: 1H NMR (400 MHz, CDCl3) δ 1.81-1.92 (m, 2H), 
2.22 (q, J = 6.8 Hz, 2H), 2.99-3.04 (m, 2H), 3.72 (d, J = 6.4 Hz, 2H), 5.56-5.61 (m, 1H), 
5.75-5.82 (m, 1H), 7.46-7.49 (m, 2H), 7.56-7.60 (m, 1H), 7.96-7.98 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 23.3 (CH2), 31.7 (CH2), 37.6 (CH2), 52.8 (CH2), 123.8 (CH), 128.0 (CH), 
128.6 (CH), 133.01 (CH), 136.0 (CH), 137.0 (C), 200.0 (C). Azide 2-156b (diagnostic peaks 
only): 1H NMR (400 MHz, CDCl3) δ 3.83 (d, J = 7.2 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 
23.8 (CH2), 26.8 (CH2), 47.1 (CH2), 123.1 (CH), 135.3 (CH), 136.9 (C), 199.8 (C). Azide 2-
156c (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.62-1.68 (m, 2H), 1.81-1.92 (m, 
2H), 3.90 (q, J = 6.8 Hz, 1H), 5.29-5.34 (m, 2H), 5.75-5.82 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 20.5 (CH2), 33.8 (CH2), 37.9 (CH2), 64.9 (CH), 118.4 (CH2), 128.0 (CH), 128.6 
(CH), 133.08 (CH), 135.5 (CH), 136.87 (CH), 199.6 (CH).  
 
Phenyl(2-vinylpyrrolidin-1-yl)methanone (2-157). According to the general 
procedure VI, azides 2-156a, 2-156b, and 2-156c (91 mg, 0.40 mmol) and titinium 
tetrachloride (1.2 mL, 1 M in dichloromethane, 1.2 mmol) at room temperature afforded 
lactam 2-157 (colorless oil, 20 mg, 25%) after column chromatography (5-30% 
EtOAc/hexanes). Lactam 2-157: Rf = 0.40 (100% EtOAc/hexanes); IR (neat): 2972, 1627, 
1409 cm-1; HRMS (ESI) m/z calculated for C13H16NO (M+H)
+ 202.1232, found: 202.1231; 1H 
NMR (two rotamers with 1:1 ratio, 400 MHz, CDCl3, both rotamers) δ 1.75-2.20 (m, 8H), 
3.40-3.80 (m, 4H), 4.37 (br, 1H), 4.85 (br, 1H), 4.93-5.28 (m, 4H), 5.68 (br, 1H), 5.92 (m, 
1H), 7.35-7.54 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 21.5, 24.7, 31.0, 32.1, 45.9, 50.0, 
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58.8, 61.5, 114.4, 115.3, 126.8, 127.2, 128.0, 128.2, 129.6, 129.8, 137.3, 137.3, 137.7, 138.3, 
169.9, 170.6.  
 
Dimethyl 2-allyl-2-(2-oxopropyl)malonate. To a solution of chloroacetone (1.2 g, 
13 mol) in DMF (10 mL) at room tmeperature was added sodium iodide (2.10 g, 14 mmol). 
The reaction was stirring for 1 h. To a suspension of sodium hydride (480 mg, 60% in 
petroleum oil, 12 mmol) in DMF(10 mL) at 0 °C was added dimethyl 2-allylmalonate (1.72 g, 
10 mmol). The stirring was continued for 1 h, followed by the addition of the above 
suspension. The reaction mixture was stirred overnight. The reaction mixture was quenched 
with saturated NH4Cl. After the separation, the aqueous layer was washed with diethyl ether 
three times. The combined organic layers were washed with brine, dried over anhydrous 
magnesium sulfate. After the filtration and concentration, the residue was purified by column 
chromatography (10-15% EtOAc/hexanes) to afford dimethyl 2-allyl-2-(2-
oxopropyl)malonate (1.77 g, 78%) as a colorless oil. Rf = 0.30 (20% EtOAc/hexanes); IR 
(neat): 2955, 1738, 1723, 1436 cm-1; HRMS (ESI) m/z calculated for C11H16O5Na (M+Na)
+ 
251.0895, found: 251.0860; 1H NMR (400 MHz, CDCl3) δ 2.15 (s, 3H), 2.77 (d, J = 7.2 Hz, 
2H), 3.11 (s, 2H), 3.73 (s, 6H), 5.04-5.12 (m, 2H), 5.58-5.68 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 30.2 (CH3), 37.8 (CH2), 45.7 (CH2), 52.7 (CH3), 54.9 (C), 119.5 (CH2), 132.7 (CH), 
170.8 (C), 205.1 (C).  
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Dimethyl 2-(4-bromobut-2-en-1-yl)-2-(2-oxopropyl)malonate. According to the 
general procedure I, dimethyl 2-allyl-2-(2-oxopropyl)malonate (1.43 g, 6.3 mmol), HG-2 
(100 mg, 0.16 mmol) and allyl bromide (1.7 mL, 15 mmol) afforded dimethyl 2-(4-bromobut-
2-en-1-yl)-2-(2-oxopropyl)malonate (colorless oil, 1.19 g, 59%, E/Z: 15:1) by 
chromatography (3-15% EtOAc/hexanes). Rf = 0.20 (20% EtOAc/hexanes); IR (neat): 2954, 
1738, 1723, 1435 cm-1; HRMS (ESI) m/z calculated for C12H17BrO5Na (M+Na)
+ 343.0157, 
found: 343.0138; 1H NMR (400 MHz, CDCl3) δ 2.14 (s, 3H), 2.75 (d, J = 7.2 Hz, 2H), 3.09 (s, 
2H), 3.71 (s, 6H), 3.87 (d, J = 7.2 Hz, 2H), 5.58-5.74 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
30.2 (CH3), 32.1 (CH2), 35.9 (CH2), 45.8 (CH2), 52.8 (CH3), 55.0 (C), 130.0 (CH), 131.0 
(CH), 170.5 (C), 205.0 (C).  
 
(E)-Dimethyl 2-(4-azidobut-2-en-1-yl)-2-(2-oxopropyl)malonate (2-168a), (Z)-
Dimethyl 2-(4-azidobut-2-en-1-yl)-2-(2-oxopropyl)malonate (2-168b) and dimethyl 2-(2-
azidobut-3-en-1-yl)-2-(2-oxopropyl)malonate (2-168c). According to the general procedure 
II, dimethyl 2-(4-bromobut-2-en-1-yl)-2-(2-oxopropyl)malonate (1.19 g, 3.7 mmol) and 
sodium azide (722 mg, 11.1 mmol) afforded a mixture of azides 2-168a, 2-168b and 2-168c 
(colorless oil, 800 mg, 76%, 64:36:0 from 1H NMR in CDCl3) after column chromatography 
(10-50% EtOAc/hexanes). Azides 2-168a, 2-168b and 2-168c: Rf = 0.50 (50% 
EtOAc/hexanes); IR (neat): 2955, 2102, 1735, 1720 cm-1; HRMS (ESI) m/z calculated for 
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C12H17N3O5Na (M+Na)
+ 306.1066, found: 306.1047. Azide 2-168a: 1H NMR (400 MHz, 
CDCl3) δ 2.17 (s, 3H), 2.83 (d, J = 6.4 Hz, 2H), 3.14 (s, 2H), 3.72 (d, J = 5.2 Hz, 2H), 3.75 (s, 
6H), 5.54-5.66 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 30.2 (CH3), 36.2 (CH2), 45.8 (CH2), 
52.4 (CH2), 52.9 (CH3), 54.8 (C), 127.9 (CH), 130.4 (CH), 170.6 (C), 205.0 (C). Azide 2-
168b: 1H NMR (400 MHz, CDCl3) δ 2.16 (s, 3H), 2.88 (dd, J = 0.9 Hz, 8.0 Hz, 2H), 3.14 (s, 
2H), 3.73 (s, 6H), 3.79 (d, J = 7.2 Hz, 2H), 5.54-5.66 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
30.2 (CH3), 30.9 (CH2), 45.6 (CH2), 47.0 (CH2), 52.9 (CH3), 54.7 (C), 126.9 (CH), 128.8 
(CH), 170.5 (C), 205.2 (C). 
 
6-(But-3-enyl)-1,4-dioxaspiro(4.5)decane (2-87) To a solution of 2-(but-3-
enyl)cyclohexanone (11.4 g, 75.0 mmol) and ethylene glycol (12.6 mL, 225.0 mmol) in 150 
mL benzene was added p-toluenesulfonic acid monohydrate (712 mg, 3.75 mmol). The 
reaction mixture was heated to reflux under Dean-Stark apparatus for one day. After cooling 
to rt, diethyl ether and saturated aqueous sodium bicarbonate were added and the aqueous 
layer was washed three times with diethyl ether. The combined organic layers were washed 
with saturated aqueous sodium bicarbonate, brine, dried over anhydrous sodium sulfate. The 
concentration afforded ketal 2-87 (13.8 g, 94%) as a colorless oil, which was used directly in 
the next step without further purification. Ketal 2-87: 1H NMR (400 MHz, CDCl3) δ 1.15-
1.31 (m, 3H), 1.32-1.40 (m, 1H), 1.45-1.53 (m, 1H), 1.56-1.68 (m, 3H), 1.69-1.87 (m, 3H), 
1.93-2.03 (m, 1H), 2.12-2.21 (m, 1H), 3.94-3.98 (m, 4H), 4.94-5.05 (m, 2H), 5.78-5.89 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 23.9 (CH2), 24.5 (CH2), 27.3 (CH2), 28.9 (CH2), 31.7 
(CH2), 34.7 (CH2), 44.0 (CH), 64.7 (CH2), 64.8 (CH2), 110.9 (C), 114.2 (CH2), 139.3 (CH).  
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6-(3-Oxopropyl)-1,4-dioxaspiro(4.5)decane (2-88). A solution of ketal 2-87 (13.8 g, 
70.3 mmol) in anhydrous dichloromethane (180 mL) was cooled to -78 °C. In-situ generated 
ozone was flushed into the above solution until it turned blue. N2 was used to flush out the 
extra ozone. PPh3 (27.7 g, 105 mmol) was added at -78 °C and the resulting mixture was 
stirred overnight and raised to rt. The solvent was removed in vacuo and the residue was 
applied to filtration. Hexane was used to wash the cake, followed by the washing with 5% 
EtOAc/hexanes. The filtrate was concentrated and the residue was purified by 
chromatography (2.5-20% EtOAc/hexanes) to afford aldehyde 2-88 (11.6 g, 84%) as a 
colorless oil. Aldehyde 2-88: Rf = 0.65 (10% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 
1.23-1.35 (m, 3H), 1.40-1.50 (m, 2H), 1.50-1.63 (m, 3H), 1.71-1.81 (m, 2H), 1.95-2.05 (m, 
1H), 2.38-2.60 (m, 2H), 3.92-4.01 (m, 4H), 9.77 (t, J = 1.8 Hz, 1H); 
13
C NMR (100 MHz, 
CDCl3) δ 20.9 (CH2), 23.7 (CH2), 24.6 (CH2), 29.2 (CH2), 34.5 (CH2), 42.3 (CH2), 44.0 (CH), 
64.6 (CH2), 64.7 (CH2), 110.6 (C), 203.1 (CH).  
 
(E)-6-(3-Hydroxy-5-phenylpent-4-enyl)-1,4-dioxaspiro(4.5)decane (2-89). To a 
stirred solution of (E)-β-styryltributyltin (4.33 g, 11.0 mmol) in anhydrous THF (60 mL) at -
78 °C under N2 atmosphere was slowly added n-BuLi (4.4 mL, 2.5 M in hexane, 11.0 mmol). 
The reaction mixture turned gradually from purple to darkpurple. After stirring at -78 °C for 1 
h, a solution of aldehyde 2-88 (1.60 g, 8.0 mmol) in THF (10 mL) was slowly added. The 
reaction mixture turned gradually yellow. After stirring overnight and warmed to rt, saturated 
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NH4Cl was added. Diethyl ether was used to extract the product and the aqueous layer was 
washed twice with diethyl ether. The combined organic layers were washed with brine, dried 
over Na2SO4. The concentrated residue was purified by chromatography (5-30% 
EtOAc/hexanes) to afford alcohol 2-89 (2.37 g, 98%, ratio: 1:1) as a colorless oil.  
Alcohol 2-89: Rf = 0.55 (100% EtOAc/hexanes); IR (neat): 3413, 2932, 748, 694 cm
-1; 
HRMS (ESI) m/z calculated for C19H26O3Na (M+Na)
+ 325.1780; found: 325.1801; 1H NMR 
(400 MHz, CDCl3) δ 1.11-1.41 (m, 4H), 1.45-1.55 (m, 1H), 1.56-1.69 (m, 4H), 1.70-1.93 (m, 
4H), 3.91-4.01 (m, 4H), 4.25-4.34 (m, 1H), 6.22 (dd, J = 5.2 Hz, 6.4 Hz, 1H), 6.26 (dd, J = 
5.2 Hz, 6.4 Hz, 1H), 6.60 (d, J = 16.0 Hz, 1H), 7.23-7.27 (m, 1H), 7.33 (t, J = 8.0 Hz, 2H), 
7.40 (d, J = 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 23.8 (CH2), 24.1 (CH2), 24.2 (CH2), 
24.5 (CH2), 29.35 (CH2), 29.38 (CH2), 34.52 (CH2), 34.58 (CH2), 35.5 (CH2), 35.6 (CH2), 
44.3 (CH), 44.6 (CH), 64.6 (CH), 64.7 (CH), 73.0 (CH2), 73.6 (CH2), 110.88 (C), 110.92 (C), 
126.45 (CH), 126.46 (CH), 127.54 (CH), 127.57 (CH), 128.6 (CH), 130.0 (CH), 130.2 (CH), 
132.6 (CH), 132.7 (CH), 136.84 (C), 136.86 (C).  
 
(2S*,4aR*,8aS*,E)-2-Styryl-octahydro-2H-chromen-8a-ol (2-92), (2R*,4aR*, 
8aS*,E)-2-styryl-octahydro-2H-chromen-8a-ol (2-93), and (E)-2-styryl-3,4,5,6,7,8-
hexahydro-2H-chromene (2-94). To a solution of ketal 2-89 (2.26 g, 7.47 mmol) in acetone 
(100 mL) at rt was added p-toluenesulfonic acid monohydrate (57 mg, 0.15 mmol). After 
stirring for one day, saturated NaHCO3 was added and acetone was removed in vacuo. The 
aqueous layer was washed three times with ethyl acetate and the combined organic layers 
were washed with brine, dried over anhydrous Na2SO4. The concentrated residue was purified 
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by chromatography (0.3-5% EtOAc/hexanes) to afford alcohol 2-92 (425 mg, 21%) as a 
white semi-solid, alcohol 2-93 (160 mg, 8%) as a white semi-solid, and olefin 2-94 (370 mg, 
18%) as a colorless oil. Alcohol 2-92: Rf = 0.50 (20% EtOAc/hexanes); IR (neat): 3419, 2929, 
944, 748, 692 cm-1; HRMS (ESI) m/z calculated for C17H22O2Na (M+Na)
+ 281.1518, found: 
281.1504; 1H NMR (400 MHz, CDCl3) δ 1.28-1.83 (m, 13H), 4.67-4.72 (m, 1H), 6.24 (dd, J 
= 6.8 Hz, 16.0 Hz, 1H), 6.60 (d, J = 16.0 Hz, 1H), 7.21-7.26 (m, 1H), 7.28-7.33 (m, 2H), 
7.40-7.42 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 23.3 (CH2), 25.2 (CH2), 26.0 (CH2), 29.5 
(CH2), 32.6 (CH2), 39.3 (CH2), 43.1 (CH), 71.0 (CH), 96.9 (C), 126.5 (CH), 127.4 (CH), 
128.5 (CH), 130.2 (CH), 130.9 (CH), 137.0 (C). The following data were used to assign 
alcohol 2-92.  
 
Alcohol 2-93: Rf = 0.45 (20% EtOAc/hexanes); IR (neat): 3443, 2925, 1693, 747, 691 cm
-1; 
HRMS (ESI) m/z calculated for C17H22O2Na (M+Na)
+ 281.1518, found: 281.1520; 1H NMR 
(400 MHz, CDCl3) δ 1.40-1.52 (m, 3H), 1.53-1.80 (m, 6H), 1.81-1.92 (m, 2H), 2.27-2.36 (m, 
2H), 4.67-4.72 (m, 1H), 6.27 (dd, J = 6.4 Hz, 16.0 Hz, 1H), 6.61 (d, J = 16.0 Hz, 1H), 7.21-
7.26 (m, 1H), 7.28-7.33 (m, 2H), 7.40-7.42 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 23.6 
(CH2), 24.0 (CH2), 25.7 (CH2), 26.2 (CH2), 27.7 (CH2), 37.3 (CH), 40.7 (CH2), 71.0 (CH), 
96.5 (C), 126.5 (CH), 127.4 (CH), 128.5 (CH), 129.7 (CH), 131.3 (CH), 137.1 (C).  
Olefin 2-94: Rf = 0.70 (20% EtOAc/hexanes); IR (neat): 2925, 1694, 748, 692 cm
-1; HRMS 
(ESI) m/z calculated for C17H21O (M+H)
+ 241.1592, found: 241.1599; 1H NMR (400 MHz, 
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CDCl3) δ 1.53-1.61 (m, 1H), 1.61-1.72 (m, 2H), 1.73-1.84 (m, 2H), 1.88-2.03 (m, 4H), 2.05-
2.13 (m, 3H), 4.43-4.48 (m, 1H), 6.31 (dd, J = 6.4 Hz, 16.0 Hz, 1H), 6.65 (d, J = 16.0 Hz, 
1H), 7.24-7.28 (m, 1H), 7.32-7.35 (m, 2H), 7.42-7.44 (m, 2H); 13C NMR (100 MHz, CDCl3) 
δ 23.0 (CH2), 23.2 (CH2), 25.2 (CH2), 27.5 (CH2), 28.8 (CH2), 28.9 (CH2), 75.3 (CH), 104.4 
(C), 126.5 (CH), 127.6 (CH), 128.5 (CH), 129.7 (CH), 130.8 (CH), 136.9 (C), 146.3 (C).  
 
(E)-6-(3-Azido-5-phenylpent-4-enyl)-1,4-dioxaspiro(4.5)decane (2-90). To a 
suspension of alcohol 2-89 (700 mg, 2.33 mmol), PPh3 (1220 mg, 4.66 mmol), and 
Zn(N3)2·2Pyr (717 mg, 2.0 mmol) in benzene (70 mL) at rt under N2 atmosphere was slowly 
added DEAD (2.03 g, 40% in toluene, 4.66 mmol). The resulting mixture was heated to 
reflux for 48 h. The reaction was cooled to rt and the solvent was removed in vacuo. The 
residue was purified by chromatography (2-5% EtOAc/hexanes) to afford azide 2-90 (350 mg, 
46%, ratio: 1:1) as a colorless oil. Azide 2-90: Rf = 0.55 (20% EtOAc/hexanes); IR (neat): 
2934, 2093, 749, 694 cm-1; HRMS (ESI) m/z calculated for C19H25N3O2Na (M+Na)
+ 
350.1844, found: 350.1859; 1H NMR (400 MHz, CDCl3) δ 1.11-1.40 (m, 4H), 1.45-1.84 (m, 
9H), 3.90-4.02 (m, 5H), 6.09-6.17 (m, 1H), 6.61-6.65 (m, 1H), 7.27-7.31 (m, 1H), 7.34-7.38 
(m, 2H), 7.41-7.44 (m, 2H); 13C NMR (100 MHz, acetone) δ 23.6 (CH2), 24.4 (CH2), 24.6 
(CH2), 24.7 (CH2), 29.1 (CH2), 29.2 (CH2), 32.87 (CH2), 32.89 (CH2), 34.4 (CH2), 44.30 
(CH), 44.31 (CH), 64.32 (CH2), 64.33 (CH2), 64.5 (CH2), 65.1 (CH), 65.2 (CH), 110.2 (C), 
126.6 (CH), 127.4 (CH), 127.6 (CH), 128.0 (CH), 128.6 (CH), 133.0 (CH), 133.1 (CH), 136.6 
(C). 
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(R*)-2-((S*,E)-3-Azido-5-phenylpent-4-enyl)cyclohexanone (2-91a) and (R*)-2-
((R*,E)-3-azido-5-phenylpent-4-enyl)cyclohexanone (2-91b). Procedure 1: To a solution of 
azide 2-90 (376 mg, 1.15 mmol) in acetone at rt was added I2 (50 mg, 0.2 mmol). After 
stirring for 25 min, 5% aqueous Na2S2O3 was added and acetone was removed in vacuo. 
Diethyl ether was added and the aqueous layer was washed three times with diethyl ether. 
The combined organic layers were washed with 5% aqueous Na2S2O3, brine, dried over 
anhydrous sodium sulfate. The concentrated residue was purified by chromatography (0.6-5% 
EtOAc/hexanes) to afford a mixture of azide 2-91a and 2-91b (220 mg, 68%, 1:1 ratio) as a 
colorless oil. Azide 2-91a and 2-91b: Rf = 0.30 (10% EtOAc/hexanes); IR (neat): 2933, 2093, 
1707, 751, 694 cm-1; HRMS (ESI) m/z calculated for C17H21N3ONa (M+Na)
+ 306.1582, 
found: 306.1580. Azide 2-91a: 1H NMR (400 MHz, CDCl3) δ 1.28-1.47 (m, 2H), 1.57-1.74 
(m, 4H), 1.81-1.93 (m, 2H), 2.05-2.18 (m, 2H), 2.28-2.37 (m, 2H), 2.38-2.45 (m, 1H), 3.99-
4.07 (m, 1H), 6.13 (dd, J = 8.0Hz, 16.0 Hz, 1H); 6.64 (d, J = 16.0 Hz, 1H), 7.27-7.31 (m, 1H), 
7.34-7.38 (m, 2H), 7.41-7.44 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 25.0 (CH2), 25.8 (CH2), 
28.0 (CH2), 32.3 (CH2), 34.1 (CH2), 42.1 (CH2), 50.4 (CH), 65.0 (CH), 126.7 (CH), 126.9 
(CH), 128.1 (CH), 128.6 (CH), 133.4 (CH), 136.0 (C), 212.7 (C). Azide 2-91b (diagnostic 
peaks only): 1H NMR (400 MHz, CDCl3) δ 6.14 (dd, J = 8.0Hz, 16.0 Hz, 1H); 
13C NMR (100 
MHz, CDCl3) δ 25.1 (CH2), 26.1 (CH2), 28.1 (CH2), 32.6 (CH2), 34.3 (CH2), 42.2 (CH2), 50.5 
(CH), 65.1 (CH), 127.0 (CH), 133.4 (CH), 212.8 (C). 
Procedure 2: According to the procedure described for azide 2-90, the reaction of 
alcohol 2-92 (52 mg, 0.2 mmol), PPh3 (105 mg, 0.4 mmol), Zn(N3)2·2Pyr (46 mg, 0.15 mmol), 
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and DEAD (174 mg, 40% in toluene, 0.4 mmol) in benzene (5 mL) after chromatography 
(0.5-2.2% EtOAc/hexanes) afforded a mixture of azide 2-91a and 2-91b (34 mg, 60%, 1:2 
ratio).  
Procedure 3: According to the procedure described for azide 2-90, the reaction of 
alcohol 2-93 (53 mg, 0.2 mmol), PPh3 (105 mg, 0.4 mmol), Zn(N3)2·2Pyr (46 mg, 0.15 mmol), 
and DEAD (174 mg, 40% in toluene, 0.4 mmol) in benzene (5 mL) after chromatography 
(0.5-2.2% EtOAc/hexanes) afforded a mixture of azide 2-91a and 2-91b (31 mg, 53%, 2:1 
ratio).  
 
(3S*,9aR*,E)-3-Styryl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-95a) 
and (3R*,9aR*, E)-3-styryl-hexahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-95b). 
Procedure 1: According to the procedure V, the reaction of azides 2-91a and 2-91b (20 mg, 
0.07 mmol, 2:1 ratio) and tin tetrachloride (0.14 mL, 1 M in dichloromethane, 0.14 mmol) in 
anhydrous dichloromethane (10 mL) after chromatography (15-200% EtOAc/hexanes) 
afforded lactam 2-95a (8 mg, 44%) as a colorless oil and lactam 2-95b (1 mg, 6%) as a 
colorless oil. Lactam 2-95a: Rf = 0.65 (100% EtOAc); IR (neat): 2926, 1630, 1446, 1413, 728, 
694 cm-1; HRMS (ESI) m/z calculated for C17H21NONa (M+Na)
+ 278.1521, found: 278.1490; 
1H NMR (400 MHz, CDCl3) δ 1.54-1.63 (m, 3H), 1.63-1.82 (m, 3H), 1.85-1.92 (m, 1H), 
1.98-2.04 (m, 1H), 2.08-2.19 (m, 1H), 2.29-2.39 (m, 1H), 2.52-2.59 (m, 2H), 3.94 (t, J = 9.2 
Hz, 1H), 4.88 (t, J = 6.8 Hz, 1H), 6.16 (dd, J = 5.6 Hz, 16.0 Hz, 1H), 6.39 (dd, J = 0.8 Hz, 
16.0 Hz, 1H), 7.18-7.22 (m, 1H), 7.26-7.31 (m, 2H), 7.35-7.38 (m, 2H); 13C NMR (100 MHz, 
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CDCl3) δ 23.5 (CH2), 28.8 (CH2), 29.9 (CH2), 32.3 (CH2), 36.1 (CH2), 38.7 (CH2), 59.18 
(CH), 59.24 (CH), 126.5 (CH), 127.2 (CH), 128.4 (CH), 129.17 (CH), 129.25 (CH), 136.9 
(C), 173.7 (C). Lactam 2-95b: Rf = 0.55 (100% EtOAc); IR (neat): 2925, 1636, 1447, 1413, 
693 cm-1; HRMS (ESI) m/z calculated for C17H21NONa (M+Na)
+ 278.1521, found: 278.1501; 
1H NMR (500 MHz, CDCl3) δ 1.35-1.60 (m, 3H), 1.65-1.79 (m, 2H), 1.82-1.95 (m, 4H), 
2.07-2.12 (m, 1H), 2.35-2.40 (m, 1H), 2.56 (dd, J = 7.2 Hz, 14.2 Hz, 1H), 3.64-3.69 (m, 1H), 
4.86 (t, J = 6.5 Hz, 1H), 6.08 (dd, J = 5.0 Hz, 15.5 Hz, 1H), 6.42 (dd, J = 1.5 Hz, 15.5 Hz, 
1H), 7.12-7.16 (m, 1H), 7.20-7.24 (m, 2H), 7.28-7.30 (m, 2H); 13C NMR (125 MHz, CDCl3) 
δ 23.5 (CH2), 29.5 (CH2), 29.9 (CH2), 32.9 (CH2), 36.3 (CH2), 38.5 (CH2), 59.4 (CH), 59.7 
(CH), 126.4 (CH), 127.3 (CH), 128.4 (CH), 129.7 (CH), 129.8 (CH), 137.0 (C), 174.4 (C). 
The following data and NOE correlation were used to assign lactam 2-95a and 2-95b.   
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Procedure 2: According to the general procedure VI, the reaction of azide 2-91a and 2-91b 
(24 mg, 0.08 mmol, 1:2 ratio) and tin chloride (0.16 mL, 1 M in dichloromethane, 0.16 mmol) 
in anhydrous dichloromethane (10 mL) after chromatography (15-200% EtOAc/hexanes) 
afforded lactam 2-95a (9 mg, 42%) as a colorless oil and lactam 2-95b (2 mg, 9%) as a 
colorless oil. 
Procedure 3: According to the general procedure VI, the reaction of azide 2-91a and 2-91b 
(93 mg, 0.33 mmol, 1:1 ratio) and tin chloride (0.49 mL, 1 M in dichloromethane, 0.49 mmol) 
in anhydrous dichloromethane (12 mL) after chromatography (12-36% EtOAc/hexanes) 
afforded lactam 2-95a (35 mg, 42%) as a colorless oil and lactam 2-95b (5 mg, 6%) as a 
colorless oil.  
 
(R,E)-1-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)-3-phenylprop-2-en-1-ol 
and (S,E)-1-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)-3-phenylprop-2-en-1-ol. 
According to the procedure described for alcohol 2-89, (1R,2S,5R)-2-isopropyl-5-
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methylcyclohexanecarbaldehyde (260 mg, 1.55 mmol) and (E)-β-styryltributyltin (865 mg, 
2.20 mmol) afforded (R,E)-1-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)-3-phenylprop-2-
en-1-ol (186 mg, 44%) as a colorless oil and (S,E)-1-((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl)-3-phenylprop-2-en-1-ol (106 mg, 25%) as a colorless oil after column 
chromatography (2.5% EtOAc/hexanes). Their spectral data matched with reported data.94  
 
((S,E)-3-Azido-3-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)prop-1-en-1-
yl)benzene (2-189a), ((R,E)-3-azido-3-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)-
prop-1-en-1-yl)benzene (2-189b), ((R,E)-1-azido-3-((1S,2S,5R)-2-isopropyl-5-methyl-
cyclohexyl)allyl)benzene (2-189c), and ((S,E)-1-azido-3-((1S,2S,5R)-2-isopropyl-5-
methyl-cyclohexyl)allyl)benzene (2-189d). According to the procedure described for azide 
90, (R,E)-1-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)-3-phenylprop-2-en-1-ol (186 mg, 
0.683 mmol) afforded a mixture of azides 2-189a, 2-189b, 2-189c, and 2-189d (120 mg, 59%, 
(2-189a+2-189b):(2-189c+2-189d) = 8.9:1; 2-189a:2-189b = 2.5:1) as a colorless oil after 
column chromatography (0-2.5% EtOAc/hexanes). Their spectral data matched with reported 
data.94  
 
(R,E)-1-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)but-2-en-1-ol (2-320a), 
(R,Z)-1-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)but-2-en-1-ol (2-320b), (S,E)-1-
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((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)but-2-en-1-ol (2-320c) and (S,Z)-1-
((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)but-2-en-1-ol (2-320d). A solution of 
(1R,2S,5R)-2-isopropyl-5-methylcyclohexanecarbaldehyde (890 mg, 5.30 mmol) was slowly 
added to prop-1-en-1-ylmagnesium bromide (0.5 M in THF, 26.5 mL, 13.2 mmol) at -78 °C 
under N2 atmosphere. After warming naturally to the room temperature, the reaction was 
quenched with aqueous saturated ammonium chloride, and extracted with ethyl acetate. The 
combined organic extracts were washed with brine, and then dried ove anhydrous sodium 
sulfate. The concentrated residue was purified by column chromatography (1-5% 
EtOAc/hexanes) to afford a mixture of alcohols 2-320a and 2-320b (100 mg, 9%, 1:0.14 ratio) 
as a colorless oil, a mixture of alcohols 2-320a and 2-320b (150 mg, 13%, 1:10 ratio) as a 
colorless oil, a mixture of alcohols 2-320b, 2-320c and 2-320d (35 mg, 3%, 0.5:1:0.15 ratio) 
as a colorless oil, and a mixture of alcohols 2-320c and 2-320d (25 mg, 2%, 1:0.3 ratio) as a 
colorless oil. Their spectral data matched with reported data.94  
 
(1S,2S,4R)-2-((R,E)-3-Azidobut-1-en-1-yl)-1-isopropyl-4-methylcyclo-hexane (2-
298a), and (1S,2S,4R)-2-((S,E)-3-azidobut-1-en-1-yl)-1-isopropyl-4-methylcyclo-hexane 
(2-298b). According to the procedure described for azide 90, alcohols 2-320a and 2-320b 
(150 mg, 1:10 ratio, 0.71 mmol) afforded a mixture of azides 2-298a and 2-298b (110 mg, 
66%, 3:1 ratio) as a colorless oil after column chromatography (100% hexanes). Their 
spectral data matched with reported data.94   
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(2S*,4R*)-2-(But-3-enyl)-4-tert-butyl-2-(4-methoxyphenyl)cyclohexanone. To a 
suspension of potassium hydride (in mineral oil; washed with hexanes and dried; 1.32 g, 33 
mmol) in anhydrous THF (36 mL) was added dropwise 4-(tert-butyl)-2-(4-
methoxyphenyl)cyclohexanone (3.43 g, 13.2 mmol) in THF (12 mL) at room temperature and 
the resulting solution was stirred for 5 h, before cooling to 0 °C. 4-Iodo-1-butene (4.50 g, 25 
mmol) and 4-bromo-1-butene (4.5 g, 34 mmol) were added slowly, and the resulting mixture 
was stirred for 20 h at room temperature and refluxed for 24 h. After cooling to room 
temperature, the reaction was quenched with saturated sodium bicarbonate and extracted with 
diethyl ether. The combined extracts were washed with brine, and dried over anhydrous 
sodium sulfate. The concentrated residue was purified by column chromatography (1-7% 
EtOAc/hexanes), followed by crystallization (EtOAc/hexanes) to afford (2S*,4R*)-2-(but-3-
enyl)-4-tert-butyl-2-(4-methoxyphenyl)cyclohexanone (750 mg, 18%) as a white solid. Mp = 
79-80 °C; Rf = 0.70 (20% EtOAc/hexanes); IR (neat) 2953, 1709, 1512 cm
-1; HRMS (ESI) 
m/z calculated for C21H31O2 (M+H)
+ 315.2324, found: 315.2340; 1H NMR (400 MHz, acetone) 
δ 0.98 (s, 9H), 1.55-1.70 (m, 2H), 1.76 (tdd, J = 12.0, 4.0, 3.1 Hz, 1H), 1.90-2.19 (m, 6H), 
2.39 (ddd, J = 14.6, 6.5, 4.6 Hz, 1H), 2.54 (ddd, J = 14.6, 9.9, 6.9 Hz, 1H), 3.79 (s, 3H), 4.90 
(ddt, J = 10.2, 2.1, 1.1 Hz, 2H), 4.97 (dq, J = 17.1, 1.6 Hz, 1H), 5.80 (ddt, J = 16.8, 10.2, 6.6 
Hz, 1H), 6.89 (d, J = 9.0 Hz, 2H), 7.24 (d, J = 9.0 Hz, 2H); 13C NMR (100 MHz, acetone) δ 
26.0 (CH2), 26.8 (CH3), 28.2 (CH2), 32.2 (C), 34.9 (CH2), 37.3 (CH2), 37.8 (CH2), 41.6 (CH), 
54.5 (CH3), 55.2 (C), 113.2 (CH), 113.9 (CH2), 128.6 (CH2), 134.4 (C), 138.5 (CH), 158.2 
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(C), 212.2 (C); 1H NMR (500 MHz, CDCl3) δ 0.96 (s, 9H), 1.59-1.73 (m, 3H), 1.91-2.07 (m, 
6H), 2.09-2.17 (m, 2H), 2.45-2.58 (m, 2H), 3.82 (s, 3H), 4.93-4.96 (m, 1H), 4.99 (dt, J = 17.1, 
1.6 Hz, 1H), 5.78 (ddt, J = 16.6, 10.1, 6.4 Hz, 1H), 6.90 (d, J = 8.9 Hz, 1H), 7.20 (d, J = 8.9 
Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 26.5 (CH2), 27.4 (CH3), 28.2 (CH2), 32.6 (C), 34.8 
(CH2), 38.0 (CH2), 38.3 (CH2), 41.9 (CH), 55.2 (CH3), 55.5 (C), 113.5 (CH), 114.6 (CH2), 
128.6 (CH), 134.1 (C), 138.2 (CH), 158.0 (C), 214.2 (C). 
 
(2S*,4R*,E)-2-(5-Azidopent-3-enyl)-4-tert-butyl-2-(4-methoxyphenyl)cyclo-
hexanone (2-154a), (2S*,4R*,Z)-2-(5-Azidopent-3-enyl)-4-tert-butyl-2-(4-methoxyphenyl) 
cyclohexanone (2-154b), (2S*,4R*)-2-((S*)-3-azidopent-4-enyl)-4-tert-butyl-2-(4-
methoxyphenyl)cyclohexanone (2-154c), and (2S*,4R*)-2-((R*)-3-azidopent-4-enyl)-4-
tert-butyl-2-(4-methoxyphenyl)cyclo- hexanone (2-154d). According to the general 
procedure III, (2S*,4R*)-2-(but-3-enyl)-4-tert-butyl-2-(4-methoxyphenyl)cyclohexanone 
(750 mg, 2.40 mmol), HG-2 (75 mg, 0.12 mmol) and allyl bromide (0.61 mL, 7.2 mmol) 
afforded a mixture of azides 2-154a, 2-154b, 2-154c, and 2-154d (510 mg, 58%, 86% brsm, 
61:7:16:16 from 13C NMR in CDCl3) as a semisolid and recovered starting material (260 mg). 
Azides 2-154a, 2-154b, 2-154c, and 2-154d: Rf = 0.45 (20% EtOAc/hexanes); IR (neat) 2954, 
2094, 1708, 1512 cm-1; HRMS (ESI) m/z calculated for C22H31N3O2Na (M+Na)
+ 392.2314, 
found: 392.2312. Azide 2-154a: 1H NMR (400 MHz, acetone) δ 0.98 (s, 9H), 1.59-1.79 (m, 
3H), 1.95-2.19 (m, 6H), 2.35-2.45 (m, 1H), 2.46-2.56 (m, 1H), 3.74 (d, J = 6.0 Hz, 1H), 3.79 
(s, 3H), 5.49-5.56 (m, 1H), 5.72-5.81 (m, 1H), 6.88-6.91 (m, 2H), 7.23-7.26 (m, 2H); 13C 
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NMR (100 MHz, acetone) δ 26.0 (CH2), 26.7 (CH2), 26.8 (CH3), 32.2 (C), 35.1 (CH2), 37.3 
(CH2), 37.8 (CH2), 41.6 (CH), 52.2 (CH2), 54.5 (CH3), 55.2 (C), 113.2 (CH), 123.3 (CH), 
128.6 (CH), 134.3 (C), 136.0 (CH), 158.2 (C), 212.3 (C); 1H NMR (500 MHz, CDCl3) δ 
0.963 (s, 9H), 1.58-1.71 (m, 3H), 1.92-2.19 (m, 6H), 2.45-2.52 (m, 2H), 3.69 (d, J = 6.6 Hz, 
2H), 3.822 (s, 3H), 5.45-5.52 (m, 1H), 5.67-5.74 (m, 1H), 6.87-6.92 (m, 2H), 7.17-7.21 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 26.3 (CH2), 26.8 (CH2), 27.4 (CH3), 32.6 (C), 35.2 (CH2), 
37.8 (CH2), 38.2 (CH2), 41.9 (CH), 52.7 (CH2), 55.2 (CH3), 55.4 (C), 113.6 (CH), 123.2 (CH), 
128.5 (CH), 133.8 (C), 136.0 (CH), 158.1 (C), 214.1 (C). Azide 2-154b (diagnostic peaks 
only): 13C NMR (100 MHz, acetone) δ 122.4 (CH), 134.2 (C), 135.3 (CH); 1H NMR (500 
MHz, CDCl3) δ 0.967 (s, 9H), 3.827 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ 55.5 (C), 122.5 
(CH), 128.4 (CH), 133.7 (C), 135.2 (CH), 158.2 (C), 214.0 (C). Azides 2-154c and 2-154d 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.88-3.99 (m, 1H), 5.24-5.33 (m, 
2H); 13C NMR (100 MHz, acetone) δ 54.9 (C), 64.99 (CH), 65.04 (CH), 113.2 (CH), 117.6 
(CH2), 117.8 (CH2), 128.6 (CH), 134.08 (C), 134.13 (C), 135.87 (CH), 135.90 (CH), 212.3 
(C); 1H NMR (500 MHz, CDCl3) δ 0.956 (s, 9H), 3.72-3.79(m, 1H), 3.818 (s, 3H), 5.21-5.30 
(m, 2H), 5.60-5.66 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 55.1 (C), 65.1 (CH), 65.2 (CH), 
113.59 (CH), 113.62 (CH), 118.4 (CH2), 118.6 (CH2), 128.4 (CH), 128.5 (CH), 133.7 (C), 
135.27 (CH), 135.34 (CH), 158.1 (C), 158.2 (C), 214.13 (C), 214.16 (C).  
 
(3S*,8R*,9aS*)-8-(tert-Butyl)-9a-(4-methoxyphenyl)-3-vinylhexahydro-1H-
pyrrolo[1,2-a]azepin-5(6H)-one (2-155a). According to the general procedure VI, a mixture 
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of azides 2-154a, 2-154b, 2-154c, and 2-154d (55 mg, 0.15 mmol) and MeAlCl2 (1 M in 
hexanes, 0.23 mL, 0.23 mmol) in refluxing dichloroethane afforded a mixture of lactams 2-
155a and 2-155b (3 mg, 6%, 10:1 ratio) as a white solid, and lactam 2-155c (7 mg, 14%)  as a 
white solid after column chromatography (6-30% EtOAc/hexanes). Amide 2-155a: Rf = 0.30 
(50% EtOAc/hexanes); IR (neat) 2959, 1638, 1510 cm-1; HRMS (ESI) m/z calculated for 
C22H32NO2 (M+H)
+ 342.2433, found: 342.2463; 1H NMR (500 MHz, CDCl3) δ 0.81 (s, 9H), 
1.16-1.27 (m, 3H), 1.37 (dd, J = 14.1, 10.0 Hz, 1H), 1.78-1.85 (m, 2H), 1.95-2.02 (m, 1H), 
2.10 (dd, J = 12.1, 6.1 Hz, 1H), 2.16 (dd, J = 12.4, 6.1 Hz, 1H), 2.18-2.26 (m, 2H), 3.74 (s, 
3H), 4.48 (dt, J = 10.0, 7.3 Hz, 1H), 5.04 (dt, J = 10.3, 1.1 Hz, 1H), 5.14 (dt, J = 17.2, 1.1 Hz, 
1H), 5.89 (ddd, J = 17.3, 10.3, 7.1 Hz, 1H), 6.81 (d, J = 8.8 Hz, 2H), 7.18 (d, J = 8.9 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 24.7 (CH2), 27.0 (CH3), 27.6 (CH2), 32.7 (C), 33.6 (CH2), 
40.81 (CH2), 40.82 (CH2), 41.5 (CH), 55.3 (CH3), 62.2 (CH), 69.6 (C), 113.7 (CH), 115.6 
(CH2), 126.3 (CH), 138.9 (C), 139.4 (CH), 158.5 (C), 172.7 (C). The following NOE 
correlation was used to assign lactam 2-155a.  
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(3R*,8R*,9aS*)-8-(tert-Butyl)-9a-(4-methoxyphenyl)-3-vinylhexahydro-1H-
pyrrolo[1,2-a]azepin-5(6H)-one (2-155b). Amide 2-155b (diagnostic peaks only): Rf = 0.25 
(50% EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 0.83 (s, 9H), 1.89 (dd, J = 12.0, 5.5 Hz, 
1H), 2.42 (d, J = 12.8 Hz, 1H), 3.73 (s, 3H), 4.63 (t, J = 7.5 Hz, 1H), 5.10 (dm, J = 10.4 Hz, 
1H), 5.19 (dm, J = 17.3 Hz, 1H), 5.81-5.89 (m, 1H), 6.79 (d, J = 8.8 Hz, 2H), 7.04 (d, J = 8.8 
Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 24.5 (CH2), 27.0 (CH2), 27.2 (CH3), 32.6 (C), 33.7 
(CH2), 39.9 (CH2), 41.9 (CH), 42.1 (CH2), 55.3 (CH3), 60.4 (CH), 68.8 (C), 113.6 (CH), 
115.2 (CH2), 126.1 (CH), 137.8 (CH), 140.2 (C), 158.3 (C), 172.6 (C). 
 
(4S*,6S*,9S*)-4-(tert-Butyl)-6-(4-methoxyphenyl)-9-vinyl-1-azabicyclo[4.3.1]-
decan-10-one (2-155c). Twisted amide 2-155c: Rf = 0.75 (50% EtOAc/hexanes); IR (neat) 
2957, 1670, 1513 cm-1; HRMS (ESI) m/z calculated for C22H32NO2 (M+H)
+ 342.2433, found: 
342.2459; 1H NMR (400 MHz, CDCl3) δ 0.98 (s, 9H), 1.45-1.52 (m, 1H), 1.64 (d, J = 11.6 
Hz, 1H), 1.67-1.79 (m, 1H), 1.81-1.97 (m, 3H), 1.99-2.06 (m, 2H), 2.50 (d, J = 11.2 Hz, 1H), 
2.60 (dt, J = 13.5, 9.2 Hz, 1H), 3.82 (s, 3H), 3.83-3.88 (m, 2H), 5.11 (d, J = 10.2 Hz, 1H), 
5.29 (d, J = 17.0 Hz, 1H), 5.71 (ddd, J = 16.8, 10.1, 6.5 Hz, 1H), 6.90 (d, J = 8.9 Hz, 2H), 
7.28 (d, J = 8.9 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 26.1 (CH2), 28.0 (CH3), 28.9 (CH2), 
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34.1 (C), 35.9 (CH2), 43.2 (CH), 44.4 (CH2), 48.5 (CH2), 55.2 (C), 55.3 (CH3), 67.9 (CH), 
113.9 (CH), 115.0 (CH2), 127.1 (CH), 139.6 (CH), 139.9 (C), 157.9 (C), 184.3 (C). The 
following data and NOE correlations were used to assign lactam 2-155c. 
 
 
 
 
(1S*,4'R*,5R*)-5-(tert-Butyl)-6'-methoxy-4'-vinyl-3',4'-dihydro-2'H-spiro[cyclo-
hexane-1,1'-naphthalen]-2-one (2-155g). According to the general procedure VI, a mixture 
of azides 2-154a, 2-154b, 2-154c, and 2-154d (78 mg, 0.21 mmol) and SnCl4 (1 M in 
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dichloromethane, 0.32 mL, 0.32 mmol) in refluxing dichloroethane afforded a mixture of 
lactams 2-155a and 2-155b (14 mg, 20%, 30:1 ratio), ketone 2-155g (14 mg, 21%) as a 
colorless oil and ketone 2-155h (7 mg, 10%) as a colorless oil after column chromatography 
(1-20% EtOAc/hexanes). Ketone 2-155g: Rf = 0.30 (5% EtOAc/hexanes); 
1H NMR (500 
MHz, CDCl3) δ 0.85 (s, 9H), 1.47-1.57 (m, 2H), 1.71 (tt, J = 2.8, 12.3 Hz, 1H), 1.78-1.89 (m, 
3H), 1.98 (td, J = 3.0, 13.5 Hz, 1H), 2.02-2.13 (m, 2H), 2.38 (ddd, J = 2.7, 4.4, 15.5 Hz, 1H), 
2.61 (ddd, J = 6.1, 14.0, 15.2 Hz, 1H), 3.32 (q, J = 7.0 Hz, 1H), 3.70 (s, 3H), 4.95 (td, J = 1.3, 
17.0 Hz, 1H), 5.02 (dd, J = 1.4, 10.0 Hz, 1H), 5.74-5.81 (m, 1H), 6.62 (d, J = 2.8 Hz, 1H), 
6.72 (dd, J = 2.8, 8.5 Hz, 1H), 6.92 (d, J = 8.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 25.5 
(CH2), 27.56 (CH3), 27.69 (CH2), 30.7 (CH2), 32.3 (C), 38.5 (CH2), 42.0 (CH), 42.2 (CH2), 
44.1 (CH), 53.1 (C), 55.1 (CH), 112.7 (CH), 113.7 (CH), 116.0 (CH2), 130.5 (CH), 131.7 (C), 
140.0 (C), 142.2 (CH), 157.7 (C), 214.7 (C). The following data and NOE correlation were 
used to assign ketone 2-155g. 
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(1S*,4'S*,5R*)-5-(tert-butyl)-6'-methoxy-4'-vinyl-3',4'-dihydro-2'H-spiro[cyclo-
hexane-1,1'-naphthalen]-2-one (2-155h). Ketone 2-155h: Rf = 0.25 (5% EtOAc/hexanes); 
1H NMR (500 MHz, CDCl3) δ 0.85 (s, 9H), 1.50-1.57 (m, 1H), 1.60-1.80 (m, 4H), 1.86 (ddd, 
J = 2.8, 9.5, 10.4 Hz, 1H), 1.98-2.10 (m, 3H), 2.40 (ddd, J = 2.5, 4.5, 15.5 Hz, 1H), 2.60 (ddd, 
J = 6.0, 14.0, 15.5 Hz, 1H), 3.33 (q, J = 7.0 Hz, 1H), 3.70 (s, 3H), 4.97 (td, J = 1.5, 17.0 Hz, 
1H), 5.07 (dd, J = 1.2, 10.0 Hz, 1H), 5.75-5.82 (m, 1H), 6.62 (d, J = 2.5 Hz, 1H), 6.71 (dd, J 
= 2.8, 8.5 Hz, 1H), 6.89 (d, J = 8.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 25.4 (CH2), 
27.47 (CH2), 27.54 (CH3), 30.6 (CH2), 32.3 (C), 38.6 (CH2), 42.02 (CH2), 42.08 (CH), 44.0 
(CH), 53.1 (C), 55.1 (CH), 112.8 (CH), 113.6 (CH), 116.2 (CH2), 130.7 (CH), 131.8 (C), 
139.8 (C), 142.1 (CH), 157.7 (C), 214.9 (C). The following data and NOE correlation were 
used to assign ketone 2-155h. 
OMe
O
H
H
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(1'S*,4'R*,5S*)-5-(tert-Butyl)-6'-methoxy-4'-vinyl-3',4'-dihydro-2'H-spiro[aze-
pane-3,1'-naphthalen]-2-one (2-155e). According to the general procedure VI, a mixture of 
azides 2-154a, 2-154b, 2-154c, and 2-154d (92 mg, 0.25 mmol) and TiCl4 (1 M in 
dichloromethane, 0.38 mL, 0.38 mmol) in refluxing dichloroethane afforded a mixture of 
lactams 2-155a and 2-155b (40 mg, 20%, 50:1 ratio), lactam 2-155e (11 mg, 13%) as a white 
solid, a mixture of lactams 2-155e and 2-155f (12 mg, 14%, 1:1 ratio) as a white solid, and 
lactam 2-155f (10 mg, 12%) as a white solid after column chromatography (1-20% 
EtOAc/hexanes). Amide 2-155e: Rf = 0.35 (100% EtOAc/hexanes); 
1H NMR (500 MHz, 
CDCl3) δ 0.80 (s, 9H), 1.31-1.38 (m, 1H), 1.48-1.55 (m, 1H), 1.66-1.73 (m, 2H), 1.74-1.82 
(m, 2H), 1.83-1.90 (m, 1H), 1.92-1.98 (m, 1H), 2.44 (t, J = 10.5 Hz, 1H), 3.20-3.27 (m, 1H), 
3.33 (q, J = 6.5 Hz, 1H), 3.48-3.55 (m, 1H), 3.69 (s, 3H), 4.98 (dd, J = 0.8, 17.0 Hz, 1H), 
5.02 (dd, J = 1.7, 10.0 Hz, 1H), 5.85-5.93 (m, 2H), 6.60 (d, J = 2.7 Hz, 1H), 6.70 (dd, J = 2.8, 
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8.7 Hz, 1H), 7.09 (d, J = 8.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 25.3 (CH2), 27.38 
(CH3), 27.65 (CH2), 30.1 (CH2), 33.5 (C), 38.4 (CH2), 41.7 (CH2), 43.7 (CH), 44.0 (CH), 49.7 
(C), 55.1 (CH), 113.0 (CH), 113.9 (CH), 115.4 (CH2), 129.2 (CH), 134.7(C), 138.6 (C), 142.6 
(CH), 157.5 (C), 180.2 (C). The following data were used to assign lactam 2-155e. 
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(1'S*,4'S*,5S*)-5-(tert-Butyl)-6'-methoxy-4'-vinyl-3',4'-dihydro-2'H-spiro[aze-
pane-3,1'-naphthalen]-2-one (2-155f). Amide 2-155f: Rf = 0.30 (100% EtOAc/hexanes); 
1H 
NMR (500 MHz, CDCl3) δ 0.80 (s, 9H), 1.33-1.41 (m, 1H), 1.45-1.57 (m, 2H), 1.57-1.66 (m, 
1H), 1.78 (d, J = 6.2 Hz, 1H), 1.85-2.00 (m, 3H), 2.23-2.32 (m, 1H), 3.18-3.26 (m, 1H), 3.42 
(q, J = 8.2 Hz, 1H), 3.55-3.63 (m, 1H), 3.69 (s, 3H), 4.99-5.04 (m, 1H), 5.08 (dd, J = 10.1, 
1.8 Hz, 1H), 5.77 (ddd, J = 17.1, 10.0, 8.2 Hz, 1H), 5.84-5.90 (m, 1H), 6.63 (d, J = 2.7 Hz, 
1H), 6.69 (dd, J = 8.7, 2.9 Hz, 1H), 7.08 (d, J = 8.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
25.5 (CH2), 27.3 (CH3), 28.3 (CH2), 29.9 (CH2), 33.4 (C), 38.2 (CH2), 41.5 (CH2), 43.3 (CH), 
44.1 (CH), 49.9 (C), 55.1 (CH3), 113.0 (CH), 113.7 (CH), 116.1 (CH2), 129.3 (CH), 134.6 (C), 
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138.5 (C), 142.3 (CH), 157.6 (C), 180.5 (C). The following data were used to assign lactam 
2-155f. 
 
2-(But-3-en-1-yl)-2-(methylthio)cyclohexanol. To a suspension of potassium 
hydride (in mineral oil; washed with hexanes and dried; 1.0 g, 25 mmol) in anhydrous THF 
(30 mL) was added dropwise 2-(methylthio)cyclohexanone (1.44 g, 10.0 mmol) in THF (5 
mL) at room temperature and the resulting solution was stirred for 3 h. 4-Iodo-1-butene (5.46 
g, 30 mmol) was added slowly, and the resulting mixture was stirred for 24 h at room 
temperature and refluxed for 24 h. After cooling to room temperature, the reaction was 
quenched with saturated sodium bicarbonate and extracted with diethyl ether. The combined 
extracts were washed with brine, and dried over anhydrous sodium sulfate. The concentrated 
residue was purified by column chromatography (1-5% EtOAc/hexanes) to afford 2-(but-3-
en-1-yl)-2-(methylthio)cyclohexanone (610 mg, 31%, 90% purity). To a solution of 2-(but-3-
en-1-yl)-2-(methylthio)cyclohexanone (610 mg, 3.08 mmol) in methanol (15 mL) at 0 °C was 
added portionwise sodium borohydride (360 mg, 9.47 mmol). The reaction was stirred for 5 h 
at room temperature, followed by the addition of sodium borohydride (120 mg, 3.16 mmol). 
The reaction was stirred overnight, and quenched with water and extracted with diethyl ether. 
The combined organic layers were washed with brine, dried over anhydrous sodium sulfate. 
The concentrated residue was purified by column chromatography (1-5% EtOAc/hexanes) to 
afford 2-(but-3-en-1-yl)-2-(methylthio)cyclohexanol (215 mg, 35%, one isomer) as a 
colorless oil. Rf = 0.45 (10% EtOAc/hexanes); IR (neat) 3454, 2931, 1640 cm
-1; 1H NMR 
(400 MHz, CDCl3) δ 1.36-1.77 (m, 8H), 1.85-1.95 (m, 2H), 1.94 (s, 3H), 2.10-2.21 (m, 1H), 
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2.25-2.35 (m, 1H), 2.88 (s, 1H), 3.53 (d, J = 4.9 Hz, 1H), 4.95-5.04 (m, 1H), 5.08 (dq, J = 
17.1, 1.6 Hz, 1H), 5.88 (ddt, J = 16.8, 10.2, 6.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 9.1 
(CH3), 20.5 (CH2), 21.5 (CH2), 28.0 (CH2), 28.2 (CH2), 29.5 (CH2), 31.8 (CH2), 55.1 (C), 
70.4 (CH), 114.6 (CH2), 138.6 (CH). 
 
2-(But-3-en-1-yl)-2-(methylthio)cyclohexanone. According to the general 
procedure for the synthesis of (2S,5R)-5-methyl-2-(2-methylpent-4-en-2-yl)cyclohexanone, 
2-(but-3-en-1-yl)-2-(methylthio)cyclohexanol (215 mg, 1.1 mmol) afforded 2-(but-3-en-1-
yl)-2-(methylthio)cyclohexanone (63 mg, 29%) as a colorless oil after column 
chromatography (1-5% EtOAc/hexanes). Rf = 0.40 (10% EtOAc/hexanes); IR (neat) 2936, 
1695, 1439 cm-1; HRMS (ESI) m/z calculated for C11H19OS (M+H)
+ 199.1157, found: 
199.1157; 1H NMR (400 MHz, CDCl3) δ 1.57-1.73 (m, 3H), 1.81 (s, 3H), 1.85-1.92 (m, 2H), 
1.95-2.12 (m, 4H), 2.15-2.23 (m, 1H), 2.25 (ddt, J = 15.1, 4.3, 2.3 Hz, 2H), 3.13 (ddd, J = 
15.1, 13.8, 6.1 Hz, 1H), 4.95-5.00 (m, 1H), 5.06 (dq, J = 17.1, 1.6 Hz, 1H), 5.86 (ddt, J = 
16.8, 10.2, 6.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 11.0 (CH3), 21.0 (CH2), 26.3 (CH2), 
27.7 (CH2), 32.3 (CH2), 36.1 (CH2), 36.9 (CH2), 56.4 (C), 114.6 (CH2), 138.5 (CH), 206.6 (C). 
 
(S*,E)-2-(5-Azidopent-3-enyl)-2-(methylthio)cyclohexanone (2-138a), (S*,Z)-2-
(5-azidopent-3-enyl)-2-(methylthio)cyclohexanone (2-138b), (S*)-2-((S*)-3-azidopent-4-
enyl)-2-(methylthio)cyclo-hexanone (2-138c), and (S*)-2-((R*)-3-azidopent-4-enyl)-2-
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(methylthio)cyclohexanone (2-138d). According to the general procedure III, 2-(but-3-en-1-
yl)-2-(methylthio)cyclohexanone (330 mg, 1.65 mmol) afforded a mixture of azides 2-138a, 
2-138b, 2-138c, and 2-138d (33 mg, 8%, 58:10:16:16 ratio from 1H NMR in CDCl3) after 
column chromatography (1-3% EtOAc/hexanes). Azides 2-138a, 2-138b, 2-138c, and 2-138d: 
Rf = 0.40 (10% EtOAc/hexanes); IR (neat) 2924, 2095, 1697 cm
-1; HRMS (ESI) m/z 
calculated for C24H39N4O2S2 (2M-N2+H)
+ 479.2514, found: 479.2478. Azide 2-138a: 1H 
NMR (500 MHz, CDCl3) δ 1.41-1.57 (m, 4H), 1.64 (s, 3H), 1.65-1.73 (m, 2H), 1.78-1.93 (m, 
3H), 2.03-2.11 (m, 2H), 2.96 (td, J = 15.0, 6.0 Hz, 1H), 3.55 (d, J = 6.6 Hz, 2H), 5.37-5.45 
(m, 1H), 5.58-5.67 (m, 1H); 1H NMR (500 MHz, acetone) δ 1.62-1.72 (m, 4H), 1.772 (s, 3H), 
1.80-2.20 (m, 7H), 3.05 (td, J = 14.0, 6.0 Hz, 2H), 3.77 (d, J = 6.6 Hz, 2H), 5.52-5.65 (m, 
1H), 5.79-5.90 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 11.0 (CH3), 21.0 (CH2), 26.30 (CH2), 
26.35 (CH2), 32.6 (CH2), 36.1 (CH2), 36.9 (CH2), 52.8 (CH2), 56.3 (C), 123.2 (CH2), 136.5 
(CH), 206.6 (C); 13C NMR (125 MHz, acetone) δ 10.9 (CH3), 21.8 (CH2), 26.89 (CH2), 26.90 
(CH2), 33.6 (CH2), 36.7 (CH2), 37.5 (CH2), 53.1 (CH2), 57.0 (C), 124.2 (CH), 137.4 (CH). 
Azide 2-138b (diagnostic peaks only): 1H NMR (500 MHz, CDCl3) δ 3.65-3.73 (m, 2H); 
1H 
NMR (500 MHz, acetone) δ 1.779 (s, 3H), 3.91 (d, J = 7.4 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 11.0 (CH3), 56.4 (C), 122.4 (CH), 135.6 (CH); 
13C NMR (125 MHz, acetone) δ 10.9 
(CH3), 56.9 (C), 123.4 (CH), 136.6 (CH). Azides 2-138c and 2-138d (diagnostic peaks only): 
1H NMR (500 MHz, CDCl3) δ 1.62 (s, 3H), 3.65-3.73 (m, 1H), 5.10-5.17 (m, 2H), 5.58-5.67 
(m, 1H); 1H NMR (500 MHz, acetone) δ 1.753 (s, 3H), 1.766 (s, 3H), 3.98-4.06 (m, 1H), 
5.28-5.31 (m, 1H), 5.33-5.38 (m, 1H), 5.79-5.90 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 
10.94 (CH3), 10.96 (CH3), 56.2 (C), 56.3 (C), 65.28 (CH), 65.29 (CH), 118.4 (CH2), 118.7 
(CH2), 135.5 (CH), 135.6 (CH), 206.64 (C), 206.65 (C); 
13C NMR (125 MHz, acetone) δ 
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10.79 (CH3), 10.80 (CH3), 57.0 (C), 66.03 (CH), 66.07 (CH), 118.5 (CH2), 118.7 (CH2), 
136.9 (CH), 137.0 (CH). 
 
3-Vinyl-2,3,7,8-tetrahydro-1H-pyrrolo[1,2-a]azepin-5(6H)-one (2-139e). 
According to the general procedure VI, a mixture of azides 2-138a, 2-138b, 2-138c, and 2-
138d (33 mg, 0.13 mmol) and MeAlCl2 (1 M in hexane, 0.2 mL, 0.2 mmol) in refluxing 
dichloroethane afforded lactam 2-139e (2.5 mg, 11%) as a colorless oil and lactam 2-139c (2 
mg, 7%) as a colorless oil after column chromatography (1-30% EtOAc/hexanes). Lactam 2-
139e: Rf = 0.35 (50% EtOAc/hexanes); IR (neat) 3367, 2931, 1615, 1405 cm
-1; HRMS (ESI) 
m/z calculated for C11H15NONa (M+Na)
+ 200.1051, found: 200.1092; 1H NMR (500 MHz, 
acetone) δ 1.49-1.54 (m, 1H), 1.60-1.68 (m, 1H), 1.73-1.83 (m, 2H), 2.03-2.18 (m, 2H), 2.31 
(ddd, J = 14.7, 10.5, 1.5 Hz, 1H), 2.36-2.52 (m, 3H), 4.67-4.71 (m, 1H), 4.74 (t, J = 4.0 Hz, 
1H), 4.86-4.93 (m, 2H), 5.68 (ddd, J = 17.2, 10.4, 5.1 Hz, 1H); 13C NMR (125 MHz, acetone) 
δ 22.0 (CH2), 27.8 (CH2), 29.5 (CH2), 32.7 (CH2), 38.6 (CH2), 61.7 (CH), 104.1 (CH), 113.9 
(CH2), 138.0 (C), 138.8 (CH), 172.0 (C). The following data were used to assign lactam 2-
139e.  
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(6S*,9S*)-6-(Methylthio)-9-vinyl-1-azabicyclo[4.3.1]decan-10-one (2-139c). 
Twisted amide 2-139c: Rf = 0.55 (50% EtOAc); 
1H NMR (500 MHz, CDCl3) δ 1.43-1.52 (m, 
1H), 1.55-1.78 (m, 4H), 1.83-1.88 (m, 1H), 1.89 (dd, J =5.0, 6.0 Hz, 2H), 2.06 (ddd, J =6.0, 
13.0, 14.0 Hz, 1H), 2.10 (s, 3H), 2.22 (ddd, J =1.8, 6.5, 14.5 Hz, 1H), 2.82 (td, J =5.9, 14.0 
Hz, 1H), 3.67-3.72 (m, 1H), 3.81 (ddd, J =2.7, 7.5, 11.5 Hz, 1H), 5.04 (dd, J =0.5, 10.0 Hz, 
1H), 5.14 (d, J =17.0 Hz, 1H), 5.50 (ddd, J =7.5, 10.0, 17.5 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 12.8 (CH3), 23.7 (CH2), 26.0 (CH2), 29.3 (CH2), 35.1 (CH2), 41.1 (CH2), 47.7 (CH2), 
56.9 (C), 61.8 (CH), 116.3 (CH2), 139.1 (CH), 182.4 (C). The following data and NOE 
correlations were used to assign lactam 2-139c.   
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(E)-2-(4-Bromobut-2-en-1-yl)cyclohexanone and (Z)-2-(4-bromobut-2-en-1-
yl)cyclohexanone. According to the general procedure I, 2-allylcyclohexanone (2.76 g, 20.0 
mmol), HG-2 (63 mg, 0.1 mmol) and allyl bromide (3.4 mL, 40 mmol) afforded a mixture of 
(E)-2-(4-bromobut-2-en-1-yl)cyclohexanone and (Z)-2-(4-bromobut-2-en-1-
yl)cyclohexanone (1.06 g, 23%, 12:1 ratio) as a colorless oil after column chromatography 
(2-10% EtOAc/hexanes). Rf = 0.50 (10% EtOAc/hexanes); IR (neat): 2935, 1708 cm
-1; 
HRMS (ESI) m/z calculated for C20H29BrO2Na (2M-HBr+Na)
+ 403.1249, found: 403.1216. E 
isomer: 1H NMR (400 MHz, CDCl3) δ 1.35-1.43 (m, 1H), 1.63-1.71 (m, 2H), 1.87-1.92 (m, 
1H), 1.99-2.15 (m, 3H), 2.32-2.44 (m, 3H), 2.51-2.57 (m, 1H), 3.94 (d, J = 6.8 Hz, 2H), 5.69-
5.80 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 25.1 (CH2), 27.9 (CH2), 32.1 (CH2), 33.5 (CH2), 
33.7 (CH2), 42.1 (CH2), 50.21 (CH), 128.1 (CH), 134.0 (CH), 212.1 (C). Z isomer (diagnostic 
peaks only): 1H NMR (400 MHz, CDCl3) δ 3.97-4.07 (m, 2H), 5.56-5.62 (m, 1H), 5.69-5.80 
(m, 1H); 13C NMR (100 MHz, CDCl3) δ 25.2 (CH2), 26.9 (CH2), 27.1 (CH2), 33.8 (CH2), 42.1 
(CH2), 50.27 (CH), 126.7 (CH), 133.2 (CH), 212.06 (C). 
 
(R*,E)-2-(4-Azidobut-2-en-1-yl)cyclohexanone (2-174a), (R*,Z)-2-(4-azidobut-2-
en-1-yl)cyclohexanone (2-174b), (R*)-2-((R*)-2-azidobut-3-en-1-yl)cyclohexanone (2-
174c), and (R*)-2-((S*)-2-azidobut-3-en-1-yl)cyclohexanone (2-174d). According to the 
general procedure II, a mixture of (E)-2-(4-bromobut-2-en-1-yl)cyclohexanone and (Z)-2-(4-
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bromobut-2-en-1-yl)cyclohexanone (1.06 g, 4.6 mmol) afforded a mixture of azides 2-174a, 
2-174b, 2-174c, and 2-174d (740 mg, 84%, 68:14:9:9 from 1H NMR in CDCl3) as a colorless 
oil after column chromatography (1-6% EtOAc/hexanes). Azides 2-174a, 2-174b, 2-174c, 
and 2-174d: Rf = 0.45 (20% EtOAc/hexanes); IR (neat): 2936, 2099, 1709 cm
-1; HRMS (ESI) 
m/z calculated for C20H31N6O2 (2M+H)
+ 387.2508, found: 387.2502. Azide 2-174a: 1H NMR 
(400 MHz, CDCl3) δ 1.32-1.43 (m, 1H), 1.63-1.72 (m, 2H), 1.84-1.92 (m, 1H), 2.00-2.15 (m, 
3H), 2.28-2.44 (m, 3H), 2.51-2.57 (m, 1H), 3.69 (d, J = 6.4 Hz, 2H), 5.50-5.60 (m, 1H), 5.69-
5.80 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 25.0 (CH2), 27.9 (CH2), 32.2 (CH2), 33.5 (CH2), 
42.1 (CH2), 50.3 (CH), 52.7 (CH2), 124.7 (CH), 134.5 (CH), 212.1 (C). Azide 2-174b 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.84 (dd, J = 2.4 Hz, 7.2 Hz, 2H). 
Azides 2-174c and 2-174d (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.93-4.02 
(m, 1H), 5.22-5.32 (m, 2H), 5.69-5.80 (m, 1H). Azide 2-174b, 2-174c, and 2-174d 
(diagnostic peaks only): 13C NMR (100 MHz, CDCl3) δ 62.5 (CH), 63.4 (CH), 118.0 (CH2), 
118.6 (CH2), 123.7 (CH), 133.4 (CH), 135.6 (CH), 135.7 (CH), 211.9 (C), 212.4 (C).  
 
2,3,9,9a-tetrahydro-1H-quinolizin-4(6H)-one (2-175c),  and 8-vinyl-1-
azabicyclo[4.2.0]octan-2-one (2-175a). According to the general procedure VI, a mixture of 
azides 2-174a, 2-174b, 2-174c, and 2-174d (57 mg, 0.30 mmol) and TiCl4 (1 M in 
dichloromethane, 0.45 mL, 0.45 mmol) in refluxing dichloromethane afforded lactam 2-175c 
(4 mg, 8%) and lactam 2-175a (9 mg, 18%, 5:1 ratio) after column chromatography (10-100% 
EtOAc/hexanes). Lactam 2-175c: Rf = 0.70 (100% EtOAc); 
1H NMR (400 MHz, CDCl3) δ 
1.60-1.83 (m, 4H), 2.08-2.13 (m, 1H), 2.43-2.50 (m, 1H), 2.53-2.61 (m, 1H), 2.68-2.77 (m, 
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1H), 3.87-4.09 (m, 3H), 5.85-5.94 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 22.1 (CH2), 26.4 
(CH2), 30.8 (CH2), 33.0 (CH2), 35.8 (CH2), 41.1 (CH2), 52.7 (CH), 124.2 (CH), 125.1 (CH), 
175.0 (C). Lactam 2-175a (major isomer): Rf = 0.35 (100% EtOAc); 
1H NMR (400 MHz, 
CDCl3) δ 1.42-1.52 (m, 1H), 1.67-1.72 (m, 1H), 1.81-1.89 (m, 1H), 1.93 (d, J = 13.0 Hz, 1H), 
2.0-2.08 (m, 1H), 2.29-2.37 (m, 1H), 2.47 (dd, J = 15.3, 6.8 Hz, 1H), 2.53-2.63 (m, 1H), 
4.13-4.25 (m, 1H), 4.72 (q, J = 6.8 Hz, 1H), 5.19 (d, J = 10.4 Hz, 1H), 5.28 (d, J = 17.2 Hz, 
1H), 6.05 (ddd, J = 16.8, 10.3, 6.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 24.0, 29.8, 36.5, 
38.0, 58.4, 60.5, 115.4, 138.0, 175.9. Lactam 2-175a (minor isomer): Rf = 0.45 (100% 
EtOAc); 1H NMR (400 MHz, CDCl3) δ 1.42-1.51 (m, 1H), 1.82-1.88 (m, 1H), 1.91-1.97 (m, 
1H), 2.01-2.08 (m, 1H), 2.08-2.14 (m, 1H), 2.16-2.22 (m, 1H), 2.27-2.36 (m, 1H), 2.46 (dd, J 
= 13.9, 7.2 Hz, 1H), 4.23-4.31 (m, 1H), 4.73-4.79 (m, 1H), 5.19 (d, J = 10.3 Hz, 1H), 5.25 (d, 
J = 17.0 Hz, 1H), 6.04 (ddd, J = 16.9, 10.4, 6.0 Hz, 1H).  
 
(E)-Ethyl 1-(4-bromobut-2-en-1-yl)-2-oxocyclopentanecarboxylate and (Z)-ethyl 
1-(4-bromobut-2-en-1-yl)-2-oxocyclopentanecarboxylate. A suspension of ethyl 2-
oxocyclopentanecarboxylate (3.12 g, 20.0 mmol), potassium carbonate (5.53 g, 40 .0 mmol) 
and (E)-1,4-dibromobut-2-ene (4.71 g, 22.0 mmol) in acetone (60 mL) was refluxed for 24 h 
under N2 atmosphere. After cooling to room temperature, the reaction was quenched with 1 
M HCl (80 mL) to adjust pH = 1; and then extracted with diethyl ether. The combined 
extracts were washed with saturated sodium bicarbonate and brine, and then dried over 
anhydrous sodium sulfate. The concentrated residue was purified by column chromatography 
(1-20% EtOAc/hexanes) to afford a mixture of (E)-ethyl 1-(4-bromobut-2-en-1-yl)-2-
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oxocyclopentanecarboxylate and (Z)-ethyl 1-(4-bromobut-2-en-1-yl)-2-
oxocyclopentanecarboxylate (1.1 g, 39%, 10:1 ratio) as a colorless oil. Rf = 0.35 (20% 
EtOAc/hexanes); IR (neat): 2978, 1748, 1728 cm-1; HRMS (ESI) m/z calculated for 
C12H18BrO3 (M+H)
+ 289.0439, found: 289.0409; 1H NMR (400 MHz, CDCl3) δ 1.20 (t, J = 
7.2 Hz, 3H), 1.89-2.00 (m, 3H), 2.16-2.24 (m, 1H), 2.28-2.42 (m, 3H), 2.61 (dd, J = 6.8 Hz, 
14.0 Hz, 1H), 3.86 (d, J = 7.2 Hz, 2H), 4.11 (q, J = 7.2 Hz, 2H), 5.60-5.75 (m, 2H); 13C NMR 
(100 MHz, CDCl3) δ 14.1 (CH3), 19.5 (CH2), 32.3 (CH2), 32.4 (CH2), 35.8 (CH2), 37.9 (CH2), 
59.8 (C), 61.5 (CH2), 130.4 (CH), 130.7 (CH), 170.7 (C), 214.3 (C). 
 
(S*,E)-Ethyl 1-(4-azidobut-2-en-1-yl)-2-oxocyclopentanecarboxylate (2-170a), 
(S*,Z)-ethyl 1-(4-azidobut-2-en-1-yl)-2-oxocyclopentanecarboxylate (2-170b), and (S*)-
ethyl 1-((R*)-2-azidobut-3-en-1-yl)-2-oxocyclopentanecarboxylate (2-170c). and (S*)-
ethyl 1-((S*)-2-azidobut-3-en-1-yl)-2-oxocyclopentanecarboxylate (2-170d). According to 
the general procedure II, a mixture of (E)-ethyl 1-(4-bromobut-2-en-1-yl)-2-
oxocyclopentanecarboxylate and (Z)-ethyl 1-(4-bromobut-2-en-1-yl)-2-
oxocyclopentanecarboxylate afforded a mixture of azides 2-170a, 2-170b, 2-170c, and 2-
170d (850 mg, 89%, 87:10:1.5:1.5 from 1H NMR in CDCl3; 92:6:1:1from 
1H NMR in 
benzene; 92:6:1:1 from 1H NMR in DMSO) as a colorless oil. Azides 2-170a, 2-170b, 2-170c, 
and 2-170d: Rf = 0.35 (10% EtOAc/hexanes); IR (neat): 2979, 2100, 1748, 1728, 1228 cm
-1; 
HRMS (ESI) m/z calculated for C12H17N3O3Na (M+Na)
+ 274.1168, found: 274.1131. Azide 
2-170a: 
1H NMR (400 MHz, CDCl3) δ 1.20 (t, J = 7.2 Hz, 3H), 1.85-2.02 (m, 3H), 2.13-2.26 
(m, 1H), 2.33-2.44 (m, 3H), 2.66 (dd, J = 6.0 Hz, 13.6Hz, 1H), 3.67 (d, J = 5.6 Hz, 2H), 4.13 
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(q, J = 7.2 Hz, 2H), 5.56-5.64 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 14.0 (CH3), 19.5 
(CH2), 32.2 (CH2), 36.1 (CH2), 38.0 (CH2), 52.4 (CH2), 59.7 (CH2), 61.49 (CH2), 127.4 (CH), 
130.7 (CH), 170.7 (C), 214.3 (C). Azide 2-170b (diagnostic peaks only): 1H NMR (400 MHz, 
CDCl3) δ 3.82 (d, J = 5.6 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 19.6 (CH2), 31.0 (CH2), 
32.4 (CH2), 36.5 (CH2), 47.1 (CH2), 61.58 (CH2), 62.7 (C), 126.1 (CH), 129.4 (CH). 
 
(E)-7-Bromohept-5-en-2-one and (Z)-7-bromohept-5-en-2-one. According to the 
general procedure I, hex-5-en-2-one (3.92 g, 40.0 mmol), HG-2 (63 mg, 0.1 mmol) and allyl 
bromide (6.8 mL, 80 mmol) afforded a mixture of (E)-7-bromohept-5-en-2-one and (Z)-7-
bromohept-5-en-2-one (570 mg, 8%, 10:1 ratio) as a colorless oil after column 
chromatography (1-10% EtOAc/hexanes). Rf = 0.25 (20% EtOAc/hexanes); IR (neat): 2962, 
1716 cm-1; HRMS (ESI) m/z calculated for C20H29BrO2Na (2M-HBr+Na)
+ 323.0622, found: 
323.0620. E isomer: 1H NMR (400 MHz, CDCl3) δ 2.15 (s, 3H), 2.34 (q, J = 6.8 Hz, 2H), 
2.55 (q, J = 6.8 Hz, 2H), 3.93 (d, J = 6.4 Hz, 2H), 5.68-5.80 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ 26.0 (CH2), 29.98 (CH3), 33.0 (CH2), 42.46 (CH2), 127.3 (CH), 134.4 (CH), 207.5 
(C). Z isomer (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 2.16 (s, 3H), 2.41 (q, J 
= 7.2 Hz, 2H), 2.56 (q, J = 7.2 Hz, 2H), 4.02 (d, J = 8.0 Hz, 2H), 5.52-5.59 (m, 1H), 5.68-
5.80 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.1 (CH2), 26.8 (CH2), 30.01 (CH3), 42.50 
(CH2), 126.4 (CH), 133.7 (CH), 207.6 (C). 
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(E)-7-Azidohept-5-en-2-one (2-160a), (Z)-7-azidohept-5-en-2-one (2-160b) and 5-
azidohept-6-en-2-one (2-160c). According to the general procedure II, (E)-7-bromohept-5-
en-2-one and (Z)-7-bromohept-5-en-2-one (570 mg, 2.98 mmol) afforded a mixture of azides 
2-160a, 2-160b, and 2-160c (367 mg, 81%, 63:7:30 ratio in 1H NMR acetone; 63:7:30 ratio in 
1H NMR CDCl3) as a colorless oil after column chromatography (1-10% EtOAc/hexanes). 
Azides 2-160a, 2-160b, and 2-160c: Rf = 0.50 (20% EtOAc/hexanes); IR (neat): 2927, 2101, 
1717 cm-1; HRMS (ESI) m/z calculated for C14H23N6O2 (2M+H)
+ 307.1883, found: 307.1858. 
Azide 2-160a: 1H NMR (400 MHz, acetone) δ 2.11 (s, 3H), 2.27-2.38 (m, 2H), 2.55-2.61 (m, 
2H), 3.76 (d, J = 6.4 Hz, 2H), 5.50-5.64 (m, 1H), 5.71-5.87 (m, 1H); 13C NMR (100 MHz, 
acetone) δ 26.1 (CH3), 28.9 (CH2), 42.2 (CH2), 52.2 (CH2), 123.7 (CH), 135.2 (CH), 206.19 
(C). Azide 2-160b (diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.93 (d, J = 7.2 
Hz, 2H). Azide 2-160c (diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 1.71-1.81 (m, 
2H), 2.16 (s, 3H), 2.55-2.61 (m, 2H), 4.01 (q, J = 7.2 Hz, 1H), 5.29-5.36 (m, 2H), 5.71-5.87 
(m, 1H). Azide 2-160b, and 2-160c (diagnostic peaks only): 13C NMR (100 MHz, acetone) δ 
21.4 (CH3), 27.9 (CH2), 38.7 (CH2), 42.3 (CH2), 46.7 (CH2), 64.2 (CH), 117.9 (CH2), 123.0 
(CH), 134.5 (CH), 135.8 (CH), 206.23 (C). 
 
(R*,E)-Methyl 2-acetyl-6-azidohex-4-enoate (2-176a), (R*,Z)-methyl 2-acetyl-6-
azidohex-4-enoate (2-176b), (2R*,4R*)-methyl 2-acetyl-4-azidohex-5-enoate (2-176c), 
and (2R*,4S*)-methyl 2-acetyl-4-azidohex-5-enoate (2-176d). To a solution of methyl 1-
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acetyl-2-vinylcyclopropanecarboxylate (504 mg, 3.00 mmol) in dichloromethane (20 mL) 
under N2 atmosphere at -78 °C was added titanium tetrachloride (1 M in dichloromethane, 3.6 
mL, 3.6 mmol) over 10 min. After 30 min, TMSN3 (517 mg, 4.5 mmol) was added slowly to 
the resulting dark-red mixture. It was naturally warmed to room temperature and stirred 
overnight. The reaction was quenched with saturated ammonium chloride at 0 °C and 
extracted with dichloromethane. The combined organic extracts were washed with saturated 
sodium bicarbonate and brine, and then dried over anhydrous sodium sulfate. The 
concentrated residue was purified by column chromatography (1-7% EtOAc/hexanes) to 
afford methyl 2-methyl-5-vinyl-4,5-dihydrofuran-3-carboxylate (30 mg, 6%) as a colorless 
oil and a mixture of azides 2-176a, 2-176b, 2-176c, and 2-176d (150 mg, 24%, 66:20:7:7 
ratio from 1H NMR in CDCl3) as a colorless oil. Azides 2-176a, 2-176b, 2-176c, and 2-176d: 
Rf = 0.25 (20% EtOAc/hexanes); IR (neat): 2956, 2102, 1745, 1716 cm
-1; HRMS (ESI) m/z 
calculated for C9H13N3O3Na (M+Na)
+ 234.0855, found: 234.0880. Azide 2-176a: 1H NMR 
(400 MHz, CDCl3) δ 2.22 (s, 3H), 2.60 (t, J = 7.2 Hz, 2H), 3.53 (t, J = 7.2 Hz, 1H), 3.67 (d, J 
= 6.0 Hz, 2H), 3.72 (s, 3H), 5.56-5.69 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 29.2 (CH3), 
30.6 (CH2), 52.3 (CH or CH3), 52.5 (CH2), 59.0 (CH or CH3), 126.1 (CH), 131.8 (CH), 169.4 
(C), 210.9 (C). Azide 2-176b (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 3.95-
3.97 (m, 2H). Azides 2-176c and 2-176d (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) 
δ 5.27-5.32 (m, 2H), 5.56-5.69 (m, 1H). Azide 2-176b, 2-176c, and 2-176d (diagnostic peaks 
only): 13C NMR (100 MHz, CDCl3) δ 58.7 (CH), 62.7 (CH), 62.8 (CH), 119.1 (CH2), 119.2 
(CH2), 129.0 (CH), 130.9 (CH), 134.6 (C), 134.7 (C), 169.4 (C), 201.9 (C). 
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Methyl 2-methyl-5-vinyl-4,5-dihydrofuran-3-carboxylate. Rf = 0.55 (20% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 2.19 (s, 3H), 2.65 (dd, J = 8.0 Hz, 14.4 Hz, 
1H), 3.04 (t, J = 12.0 Hz, 1H), 3.69 (s, 3H), 5.02 (dd, J = 7.6 Hz, 17.2 Hz, 1H), 5.17-5.30 (m, 
2H), 5.87-5.95 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.0 (CH2), 35.5 (CH3), 50.8 (CH2), 
82.5 (CH2), 101.4 (C), 116.6 (CH2), 136.9 (CH), 166.4 (C), 167.8 (C).  
 
(2R)-2-((E)-5-azidopent-3-en-1-yl)-1-phenylcyclohexanol (2-315a),(2R)-2-((Z)-5-
azidopent-3-en-1-yl)-1-phenylcyclohexanol (2-315b), (2R)-2-((S)-3-azidopent-4-en-1-yl)-
1-phenylcyclohexanol (2-315c), and (2R)-2-((R)-3-azidopent-4-en-1-yl)-1-phenyl-
cyclohexanol (2-315d). To a solution of azides 65a, 65b, 65c and 65d (220 mg, 1.06 mmol) 
in THF (6 mL) at -78 °C under N2 atmosphere was added slowly phenyl magenesium 
bromide (3 M in diethyl ether, 0.53 mL, 1.59 mmol). After 30 min, the reaction was 
quenched with aqueous saturated ammonium chloride and extracted with ethyl acetate. The 
combined organic layers were washed with brine, and then dried over anhydrous sodium 
sulfate. The concentrated residue was purified by column chromatography (1-10% 
EtOAc/hexanes) to afford a mixture of azides 2-315a, 2-315b, 2-315c and 2-315d (161 mg, 
53%, ratio not determined) as a colorless oil.   
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5-Phenyl-3-vinyloctahydro-1H-pyrrolo[1,2-a]azepine (2-316a) and 9-phenyl-3-
vinyloctahydro-1H-pyrrolo[1,2-a]azepine (2-316b). To a solution of azides 2-315a, 2-315b, 
2-315c and 2-315d (66 mg, 0.23 mmol) in benzene (4 mL) at room temperature under N2 
atmosphere was slowly added tin tetrachloride (1 M in dichloromethane, 0.51 mL, 0.51 
mmol). After 15 h, the reaction was cooled to 0 °C, and followed by the slow addition of a 
solution of sodium borohydride (35 mg, 0.93 mmol) in methanol (3 mL). Afte 9 h, the 
reaction was quenched with aqueous NaOH (2 M), extracted with ethyl acetate. The 
combined organic extracts were washed with brine, and dried over anhydrous sodium sulfate. 
The concentrated residue was purified by column chromatography (1-15% EtOAc/hexanes) 
to afford a mixture of amines 2-316a and 2-316b (24 mg, 43%) as a colorless oil.   
 
(1R*,2R*)-1-Allyl-2-((E)-5-azidopent-3-en-1-yl)cyclopentanol (2-152a), 
(1R*,2R*)-1-allyl-2-((Z)-5-azidopent-3-en-1-yl)cyclopentanol (2-152b), (1R*,2R*)-1-allyl-
2-((S*)-3-azidopent-4-en-1-yl)cyclopentanol (2-152c), and (1R*,2R*)-1-allyl-2-((R*)-3-
azidopent-4-en-1-yl)cyclopentanol (2-152d). To a solution of azides 2-148 (350 mg, 1.81 
mmol) in THF (10 mL) under N2 atmosphere was added anhydrous CeCl3 (534 mg, 2.17 
mmol). After 1 h at room temperature, the mixture was cooled to 0 °C and allyl magnesium 
bromide (1 M in diethyl ether, 2.2 mL, 2.2 mmol) was slowly added. After 1 h, the reaction 
was quenched with 20% aqueous acetic acid (20 mL) and extracted with ethyl acetate. The 
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combined organic extracts were washed with saturated aqueous sodium bicarbonate and brine, 
then dried over anhydrous sodium sulfate and concentrated. The residue was purified by 
column chromatography (1-5% EtOAc/hexanes) to afford a mixture of azides 2-152a, 2-152b, 
2-152c and 2-152d (65 mg, 15%,  62:8:15:15 ratio from 1H NMR in acetone) as a colorless 
oil, a mixture of azides 2-162a, 2-162b, 2-162c and 2-162d (181 mg, 43%, 64:8:14:14 ratio 
from 1H NMR in acetone) as a colorless oil, and recoved azide 2-148 (104 mg). Azides 2-
152a, 2-152b, 2-152c and 2-152d (62:8:15:15 ratio): Rf = 0.30 (20% EtOAc/hexanes); IR 
(neat): 3445, 2945, 2098, 1243 cm-1; HRMS (ESI) m/z calculated for C26H43N4O2 (2M-
N2+H)
+ 443.3386, found: 443.3398. Azide 2-152a: 1H NMR (400 MHz, acetone) δ 1.11-1.21 
(m, 1H), 1.23-1.34 (m, 1H), 1.47-1.85 (m, 5H), 1.94-2.32 (m, 6H), 3.77 (d, J = 6.4 Hz, 2H), 
5.03-5.09 (m, 2H), 5.57-5.63 (m, 1H), 5.79-5.89 (m, 1H), 5.96-6.06 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 20.1 (CH2), 28.1 (CH2), 29.3 (CH2), 31.0 (CH2), 37.2 (CH2), 39.9 (CH2), 49.7 
(CH), 52.4 (CH2), 81.1 (C), 116.2 (CH2), 123.1 (CH), 135.6 (CH), 136.8 (CH). Azide 2-152b 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.90 (d, J = 7.2 Hz, 2H). Azides 2-
152c and 2-152d (diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.98 (q, J = 6.8 Hz, 
1H), 5.03-5.09 (m, 2H), 5.27-5.36 (m, 2H), 5.79-5.89 (m, 1H), 5.96-6.06 (m, 1H). Azides 2-
152b, 2-152c and 2-152d (diagnostic peaks only): 13C NMR (100 MHz, CDCl3) δ 65.1 (CH), 
65.2 (CH), 80.4 (C), 80.5 (C), 117.3 (CH2), 117.4 (CH2).  
 
 (1S*,2R*)-1-Allyl-2-((E)-5-azidopent-3-en-1-yl)cyclopentanol (2-162a), 
(1S*,2R*)-1-allyl-2-((Z)-5-azidopent-3-en-1-yl)cyclopentanol (2-162b), (1S*,2R*)-1-allyl-
2-((S*)-3-azidopent-4-en-1-yl)cyclopentanol (2-162c), and (1S*,2R*)-1-allyl-2-((R*)-3-
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azidopent-4-en-1-yl)cyclopentanol (2-162d). Azide 2-162a, 2-162b, 2-162c and 2-162d 
(64:8:14:14 ratio from 1H NMR in acetone): Rf = 0.25 (20% EtOAc/hexanes); IR (neat): 3473, 
2939, 2098 cm-1; HRMS (ESI) m/z calculated for C26H43N4O2 (2M-N2+H)
+ 443.3386, found: 
443.3353. Azide 2-162a: 1H NMR (400 MHz, acetone) δ 1.35-1.78 (m, 9H), 1.82-1.90 (m, 
1H), 2.01-2.10 (m, 1H), 2.15-2.21 (m, 1H), 2.41 (dd, J = 6.8 Hz, 13.6 Hz, 2H ) 3.77 (d, J = 
6.4 Hz, 2H), 5.01-5.08 (m, 2H), 5.56-5.63 (m, 1H), 5.77-5.98 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ 20.8 (CH2), 28.1 (CH2), 29.7 (CH2), 31.0 (CH2), 38.5 (CH2), 44.0 (CH2), 47.0 (CH), 
52.4 (CH2), 80.5 (C), 116.3 (CH2), 122.9 (CH), 135.5 (CH), 137.1 (CH). Azide 2-162b 
(diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.90 (d, J = 7.2 Hz, 2H). Azide 2-
162c and 2-162d (diagnostic peaks only): 1H NMR (400 MHz, acetone) δ 3.97 (q, J = 6.8 Hz, 
1H), 5.01-5.08 (m, 2H), 5.27-5.36 (m, 2H), 5.77-5.98 (m, 2H). Azide 2-162b, 2-162c and 2-
162d (diagnostic peaks only): 13C NMR (100 MHz, CDCl3) δ 49.7 (CH), 65.2 (CH), 65.4 
(CH), 80.5 (C), 81.1 (C), 116.2 (CH2), 116.4 (CH2), 117.2 (CH2), 117.5 (CH2), 122.0 (CH), 
123.1 (CH), 135.5 (CH), 136.0 (CH), 136.4 (CH), 136.8 (CH).  
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CHAPTER 3 
 
TOTAL SYNTHESIS OF ALKALOID 205B 
 
3.1 Introduction 
Tricyclic alkaloids have attracted considerable attention from synthetic and medicinal 
chemists due to their synthetically challenging skeletons and interesting biological activities 
(Figure 106). The most well-known class of tricyclic alkaloids has a 2-methyl-perhydro-9b-
azaphenalene skeleton, and includes propyleine, precoccineline, hippodamine, and myrrhine. 
Alkaloid 205B, with a unique tricyclic 8b-azaacenaphthylene ring system, was isolated from 
skin extracts of the Panamanian poisonous frog Dendrobates pumilio, and characterized in 
1987 by Daly and coworkers.
115
 A year later, its structure was re-assigned by the same 
group.116 Alkaloid (+)-205B was reported to selectively block the α7 nACHR over α4β2 and 
α3β4 receptors with modest potency.117 In addition, 0.9 mg of the related alkaloids 261C and 
263G were also isolated by the same group from skin extracts of a Madagascan poison frog 
Mantella betsileo in 2003.118  
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Figure 106. Tricyclic alkaloids.  
Four total syntheses of alkaloid 205B have been reported to date. The first was 
reported by Toyooka and coworkers (Scheme 74).119,120 It used a pair of double asymmetric 
conjugate additions to establish the trans 1,3-dimethyl groups of 3-4, followed by an imine-
mediated aldol reaction to construct tricyclic ring system 3-7. Further transformations 
completed the total synthesis in an overall 1.6% yield over 35 steps from commercial starting 
materials. A similar strategy was also used in an attempted synthesis of alkaloid 261C.120 
However, only the synthesis of 3-9, an advanced intermediate toward 261C, has been 
reported so far.  
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Scheme 74. The first total synthesis by Toyooka and coworkers.  
The second total synthesis of (-)-205B was reported by Smith and coworkers 
(Scheme 74),121,122 in which the construction of the indolidine ring system 3-14 was achieved 
by the dithiane-mediated coupling and Mitsunobu reaction. A cross-metathesis reaction 
finished the construction of tricyclic ring system 3-15, and further modifications completed 
the total synthesis in an overall yield of 5.8% over 23 steps from commercial starting 
materials.  
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Scheme 75. The second total synthesis by Smith and coworkers. 
Comins and coworkers reported another total synthesis of alkaloid (-)-205B in 2011 
(Scheme 76).123 It started from an allyl substituted dihydropyrididone 3-19, cross-metathesis 
and palladium-mediated cyclization of this material afforded the indolidine ring system 3-21. 
The subsequent incorporation of methyl group and allyl group led to the cross-metathesis 
precursor 3-23. Following the cross-metathesis, removal of carbonyl group accomplished the 
total synthesis in 11 steps in an 8% overall yield.  
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Scheme 76. The third total synthesis by Comins and coworkers. 
Micalizio and cowokers reported their total synthesis of alkaloid 205B in 2012 
through two stereoselective synthetic steps: titanium-mediated allylic imine cross-coupling 
reaction and a nitrone-involved [3+2] cycloaddition (Scheme 77).124,125 The final ring-closure 
was achieved by an allylsilane cyclization.  
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Scheme 77. The fourth total synthesis by Micalizio and coworkers.  
 
3.2 Retreosynthetic analysis 
With the combination of allylic azide rearrangement and the intramolecular Schmidt 
reaction in hand, we sought to apply this newly-developed methodology to the total synthesis 
of alkaloid 205B. Our synthetic route started with the diastereoselective synthesis of bicyclic 
lactam 3-36 (Figure 107). Subsequent methylation and reductive allylation of amide could 
provide the cross-metathesis precursor 3-34.  
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Figure 107. Retrosynthetic analysis of 205B.  
The total synthesis of alkaloid 261C could also be achieved by a similar strategy 
starting from 2-(but-3-en-1-yl)-3-ethylcyclopentanone 3-40 (Figure 108). Furthermore, this 
synthetic route could provide more isomers of 261C to confirm if wrong stereochemistry was 
assigned to natural isomer of alkaloid 261C.  
 
Figure 108. Retrosynthetic analysis of 261C.  
 
3.3 Preparation of 2-(but-3-en-1-yl)-3-methylcyclopentanone  
For the preparation of trans-2-(but-3-en-1-yl)-3-alkylcyclopentanone (3-38 and 3-40), 
the first methodology considered was the conjugate addition of an alkyl cuprate to 
cyclopentenone, followed by trapping of the in situ generated anion with 4-iodo-1-butene 
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(Figure 109). Such conjugate additions have been reported in both racemic and 
enantioselective fashions.126,127  
 
Figure 109. Synthesis of 2-(but-3-en-1-yl)-3-alkylcyclopentanone.  
However, 4-iodo-1-butene, unlike methyl iodide, benzyl iodide, and aldehyde, was 
not considered as a good electrophile.128 Two-step procedure can be an alternative route to 
2,3-dialkylated cyclopentanone. First, TMSCl is used to trap the anion generated from the 
conjugated addition of alkyl cuprate to cyclopentenone. In the second step, the formed TMS 
enol ether is treated with methyl lithium, and thus the generated enolate reacts with 
electrophile to afford the desired ketone.  
A TMS enol ether can be prepared by two methods (Scheme 78). One is to use one 
equivalent of methyl cuprate and the other is to use methyl Grignard reagent with a catalytic 
amount of copper iodide.129 Both methods were attempted and each was found to have 
advantages and disadvantages. Pure product was obtained from cuprate reaction, but scale-up 
was problematic. The second could be scaled up, but the product was contaminated with one 
regioisomer and the methylated ketone 3-43, which resulted from the hydrolysis of TMS enol 
ether.  
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Scheme 78. Preparation of TMS enol ether.  
Many attempts were made to get desired ketone 3-38 from enol ether 3-41, such as 
trying different base sources, e.g. n-BuLi, MeLi, MeLi-LiBr, and MeLi-LiI, different 
additives and various temperatures (Scheme 79). Unfortunately, no satisfactory results were 
obtained. The best result obtained so far was a 15% yield of four inseparable isomers 3-38, 3-
44, 3-45, and 3-46. When the products were treated with base in order to increase the ratio of 
desired 3-38, the ratio of mixtures remained similar, signaling that the alkylated products 
were obtained as their thermodynamic products. There are several possibilities for these 
results. The elimination of 4-iodo-1-butene is one of them because volatile butadiene may be 
generated under strong basic condition. However, a similar yield was obtained when using 5-
iodo-1-pentene, suggesting that the elimination of 4-iodo-1-butene was not a major 
contribution to the low yield. Although the steric hindrance of 3-methyl group in the 
cyclopentane ring system may block the alkylation, only a little better yield was obtained in 
our hands when (cyclopent-1-en-1-yloxy)trimethylsilane was used for this alkylation.   
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Scheme 79. Preparation of alklyated ketones.  
At that time, we didn’t have good explanations for the formation of four regioisomers. 
Thus they were alternatively prepared by alkylation of hydrazone 3-49 and hydrolysis of 
alkylated hydrazone (Scheme 80). It’s interesting that the ratio of four isomers changed 
dramatically after the treatment of base, which suggested that the products obtained from 
alkylation are kinetic products while the equilibrated products are thermodynamic ones.  
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Scheme 80. Alkylation route to ketone 3-38.  
The rationale for this phenomenon was proposed in Figure 110 and Figure 111. There 
are two enolates formed during the reaction, 2-enolate and 5-enolate, either during the attack 
of methyl lithium to TMS enol ether or the deprotonation of hydrazone. Two attacking 
models exist for each enolate, in which methyl group of the most stable conformation is 
located at the pseudo-equatorial positions. For 2-enolate, pathway a is favored over pathway 
b due to the steric hindrance of H3 in the puckered methylene carbon, suggesting that 2,3-
trans isomer (exo-alkylation) is favored than 2,3-cis isomer (endo-alkylation). Another 
possible explanation is the competition between the effect of 2-pseudo-axial hydrogen and 2-
pseudo-equatorial methyl group on the alkylation. Although H1 of 2-enolate is at pseudo-axial 
position, the pseudo-equatorial methyl group occupies much bigger space than the small 
hydrogen, and this difference may contribute to the formation of 2,3-trans as the major 
product.  
A similar hindrance exists for 5-enolate. But in this case, pathway b is favored over 
pathway a due to the big difference between pseudo-axial H1 and pseudo-equatorial H2. In 
such a scenario, 2,4-trans was produced as the major isomer. However, the existence of 
pseudo-axial H3 can compromise the contribution of endo-alkylation to some extent, which 
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may explain why the kinetic ratio of 3-45 and 3-46 (46:10) is lower than that of 3-38 and 3-
44 (44:2).  
 
Figure 110. The model for the alkylation of enolate.  
Cyclopentane has two stable conformations: envelope and half-chair. However, the 
difference between them is slight, with the envelope form being the more stable by 0.5 
kcal/mol.130 Due to the low flipping barrier, it is not surprising that cyclopentane is in a rapid 
conversion among different intermediate conformations. However, it is not true for 
substituted cyclopentane. For example, the barrier is 3.40 kcal/mol for methylcyclopentane, 
in which the most stable conformation (by 0.9 kcal/mol over other conformers) is with the 
methyl group at the flap of the envelope.130 The preferred conformation of cyclopentanone, 
by 2.4 kcal/mol, is the half-chair with the carbonyl group in the least puckered region with 
1.15 kcal/mol of the inter-conversion barrier.130  
There are four possible stable conformations for substituted cyclopentanone: A, B, C, 
and D (Figure 111). By comparison, 3-38A, 3-38B, 3-46A, and 3-46B have their both 
substituents on the pseudo-equatorial positions, and thus 3-38 and 3-46, the latter being 
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confirmed in the dynamic kinetic resolution,131 are the expected thermodynamic products. 
The experimental ratio of 3-38 over 3-44 is 39:5, and it is 38:18 for 3-46 and 3-45.  
 
Figure 111. Schematic presentation of cylopentanone conformations.  
Based on the above kinetic and thermodynamic analysis, all the ketones should be 
identified in the spectra. First, all the spectra were compared for ketones obtained from 
hydrazone method before with those after the equilibria were reached (Figure 112). The 
diagnostic peaks were tentatively assigned for each regioisomer, based on the aforementioned 
kinetic and thermodynamic analysis (Figure 113). Theoretically, four regioisomers of ketone 
would give eight peaks in the GC chromatogram while chiral GC column is used; however, 
some peaks may be overlapped or overlay, and then only six peaks were shown, the identity 
of which will be analyzed later in this chapter.  
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Figure 112. Spectral comparison before and after basic equilibration. 
 
Figure 113. Assignment for regioisomers. 
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Preparation of enantiopure ketone 3-38. Asymmetric conjugate addition has been 
extensively studied, and numerous catalysts have been developed to achieve high 
enantioselectivity for substituted cyclohexenones, but not for cyclopentenones.132 
Unsubstituted cyclopentenone was referred as “a special case” due to the flatness of this 
molecule, whose both faces are difficult to be differentiated by chiral catalysts.127 As an 
alternative method, asymmetric conjugate reduction has been developed for the preparation 
of the enantiopure ketones. Buchwald and coworkers reported a series of seminal studies 
using Cu-H catalyst.131,133-135 This methodology has been combined with other reactions, such 
as alkylations or arylation,17,134,135 and dynamic kinetic resolution.131 The dynamic kinetic 
resolution also confirmed that 2,4-cis cyclopentanone is more stable than 2,4-trans isomer. 
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Scheme 81. Buchwald’s asymmetric conjugate reduction and his applications. 
Following the preparation of silane diol intermediate 3-62, several alkylation 
conditions, similar to what described in Scheme 79, were tested in order to prepare ketone 3-
38 (Scheme 82). Only 34% yield was obtained for four regioisomers with less undesired 
regioisomers 3-45 and 3-46 (<10%), and high enantioselectivity of 3-38 (~95% ee).  
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Scheme 82. Preparation of enantiopure ketone 3-38. 
A similar equilibration, which was described in Scheme 80, was carried out for this 
enantiopure mixture of ketones. All the GC chromatograms were compared before and after 
equilibria of racemic and enantiopure ketones (Figure 114 and Figure 115). In theory, each 
isomer should present two identical peaks in the GC chromatogram while chiral GC column 
is used. The first and second peaks (from the left) always have the same percentage in 
different batches of alkylation, and even the equilibrations. Combined with NMR results, they 
are tentatively assigned as (S)-3-38 and (R)-3-38, and the first peak is assigned as the (S)-
isomer, based on the reported enantioselective conjugate reduction. Following a similar 
strategy, the rest peaks were correspondingly assigned (Figure 116).  
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Figure 114. GC chromatograms of racemic ketones. 
 
Figure 115. GC chromatograms of enantiopure ketones. 
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Figure 116. Peak assignment of GC chromatogram.  
 
3.4 Synthetic studies toward alkaloid 205B  
Although pure ketone 3-38 was prepared, studies directed forward advancing the 
mixture of ketones to alkaloid 205B were carried out in the hope that the desired isomer 
could be singled out in a subsequent step. Doing so would also help to find appropriate 
conditions for later conversions and accordingly save time to screen conditions after pure 
ketone 3-38 is obtained.  
A mixture of allylic azide was obtained in 64% yield following the one-pot procedure 
developed in the Chapter 2 (Scheme 83). The ratio of these mixtures could not be determined 
using NMR techniques due to the many possible isomers present.  
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Scheme 83. Preparation of allylic azides.  
Based on the decarboxylative allylation by Tunge and others,136 an alternative 
preparation of allylic azides 3-86 and 3-87 was proposed via palladium-facilitated azidation 
(Figure 117). Two competing pathways could occur upon treatment with Pd catalysts. In one, 
an azide source could react with intermediate 3-85 to give a set of allylic azides, and in the 
other, the intramolecular alkylation of 3-85 might occur to afford spirobicyclic ketones 3-88 
and 3-89.   
 
Figure 117. Pd(0)-facilitated decarbocylative preparation of allylic azides.  
For the preparation of 3-83, ethyl ester 3-90 was converted to allyl ester 3-91 
(Scheme 84). Alkylation afforded the intramolecular cross-metathesis precursor 3-92. 
However, all the tested conditions failed to afford 3-83. More different catalysts will be tested 
for this conversion.   
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Scheme 84. Preparation of ketone 3-83.  
Various conditions for the combination of allylic azide rearrangement and 
intramolecular Schmidt reaction have been screened. TiCl4 afforded the best yield in 68% 
yield of a mixture of 3-75 and 3-76, and 4% of pure 3-77 (Table 40). The relative 
stereochemistry of 3-77 was assigned based on the 2D NMR.  
Table 40. Allylic azide rearrangement/intramolecular Schmidt reaction condition screening. 
 
 
Conditions 
Yield  
(3-77) 
Yield  
(3-75+3-76) 
1 1.5 eq SnCl4, DCM, reflux  15% 
2 5 eq TiCl4, rt, reflux 7% 30% 
3 5 eq TiCl4, DCM reflux 9% 39% 
4 5 eq TiCl4, DCE, reflux 9% 61% 
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5 5 eq TiCl4, CHCl3, reflux 9% 58% 
6 
1.5 eq TiCl4, DCE, reflux 
 (1.1 g) 
4% 68% 
 
The LDA-mediated methylation was first tested on amide 3-77 with a scale of 13 mg 
(Scheme 85), and two products with 7:1 ratio were afforded. Their relative stereochemistry 
was assigned based on 2D NMR. However, this reaction could not be reproduced following 
further attempts.  
 
Scheme 85. LDA-assisted methylation.  
Because limited amount of 3-77 retarded the further testing, additional conditions for 
the methylation of amides 3-75 and 3-76 were screened, and the best result was obtained 
from the treatment with t-BuLi followed by methylation, which gave a total 94% yield 
(Scheme 86). One of the methylated isomers 3-82 was isolated; its relative stereochemistry 
was assigned by 2D NMR.  
 
Scheme 86. t-BuLi assisted methylation.  
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The next reductive allylation of amide 3-80 and 3-81 could give a mixture of amine 
3-83 and 3-84 (Scheme 87). The stereochemistry of this reaction could be controlled by either 
methyl group or bridgehead hydrogen atom. Alkaloid 205B could be obtained after the cross-
metathesis reaction.  
 
Scheme 87. Reductive allylation of amide.  
 
3.5 Conclusion  
In this chapter, the synthetic studies towards alkaloid 205B, which utilized the 
combination of allylic azide rearrangement and intramolecular Schmidt reaction, were 
presented.  
Three methods, enol ether-alkylation, hydrazone-alkylation, and conjugate reduction-
alkylation, have been tried to prepare trans-2-(but-3-en-1-yl)-3-alkylcyclopentanone, which 
is a key intermediate in the syntheses of alkaloids 205B and 261C. These methods afforded a 
mixture of four regioisomeric ketones with different ratios. Their results were analyzed from 
kinetic and dynamic perspectives and their diagnostic peaks on the 1H, 13C NMR and GC 
were assigned. An alternative route to prepare enantiopure ketone 3-38 from pulegone was 
proposed.  
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The mixture of ketones was pushed forwards to screen the conditions for next 
conversions to alkaloid 205B. Two pure isomers were separated in the combination and 
methylation step respectively. The reductive alkylation of amide is in progress. The 
decarboxylative allylation was proposed for the preparation of allylic azides.  
 
3.6 Experimental data  
 
1,1-Dimethyl-2-(3-methylcyclopentylidene)hydrazine (3-49). Following the 
general procedure IV in Chapter 2, 3-methylcyclopentanone (10 g, 0.10 mol) and 1,1-
dimethylhydrazine (23 mL, 0.30 mol) afforded after vacuum distillation (65-75 oC/65-75 
mmHg) hydrazone 3-49 (12.5 g, 87%) as an oil. Hydrazone 3-49 (1:1 ratio): 1H NMR (400 
MHz, CDCl3) δ 0.95-1.01 (m, 3H), 1.16-1.32 (m, 1H), 1.78-1.93 (m, 2H), 1.93-2.09 (m, 1H), 
2.18-2.33 (m, 1H), 2.33-2.45 (m, 6H), 2.45-2.68 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
19.7 (CH3), 19.9 (CH3), 29.1 (CH2), 32.2 (CH), 32.4 (CH2), 32.9 (CH2), 33.2 (CH2), 33.2 
(CH), 37.9 (CH2), 41.8 (CH2), 47.0 (4 CH3), 175.2 (C), 175.5 (C). 
 
 
Trimethyl((3-methylcyclopent-1-en-1-yl)oxy)silane (3-41) and trimethyl((4-
methylcyclopent-1-en-1-yl)oxy)silane (3-42).  
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Method 1:
129
 A flask with lithium chloride (518 mg, 12.2 mmol) was flame-dried. To 
this flask was added sequentially anhydrous THF (200 mL) and copper(I) iodide (1.16 g, 6.1 
mmol), and a light yellow solution formed. The resulting solution was cooled to -78 oC, 
followed by the addition of cyclopentenone (10 g, 0.12 mol) and trimethylsilyl chloride (14.6 
g, 134 mmol). MeMgCl (3M in THF, 48.8 mL, 147 mmol) was added dropwise over 30 min. 
The resulting mixture was stirred at -78 oC for another 3 h. The reaction mixture was poured 
into diethyl ether and saturated aqueous ammonium chloride, and the resulting solution was 
stirred until a blue transparent solution formed. After the separation, the aqueous layer was 
extracted with diethyl ether three times. The combined organic layers were washed with brine, 
dried over anhydrous sodium sulfate and concentrated. The residue was purified by vacuum 
distillation (65-70 oC/15-20 mmHg) to afford a mixture of enol ether 3-41 and 3-42 (9:1 ratio 
15.4 g, 74%) as a colorless oil. 
Method 2: To a suspension of CuBr·SMe2 (2.47 g, 12.0 mmol) in diethyl ether (150 
mL) at -78 ºC under N2 atmosphere was added MeLi (1.6 M in Et2O, 15 mL, 24.0 mmol) 
dropwise via syringe. The resulting suspension was slowly warm to -50 ºC, and stirred until 
most of the solids dissolved. The reaction mixture was cooled to -78 ºC again, and HMPA 
(5.2 mL, 30 mmol) was added slowly. After 20 min, a solution of cyclopentenone (0.99 g, 12 
mmol) and trimethylsilyl chloride in Et2O (18 mL) was added slowly via syringe. After 
stirring for 4 h at –78 ºC, triethylamine (5.0 mL, 36 mmol) was added, and the reaction 
mixture was stirred at –78 ºC for another 2 h. The mixture was poured into saturated aqueous 
ammonium chloride and pentane. After the separation, the aqueous layer was extracted with 
pentane three times. The combined organic layers were washed with brine, dried over 
anhydrous sodium sulfate. The concentration afforded enol ether 3-41 (1.4 g, 69%), which 
was directly used in the next step without further purification.  
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Enol ether 3-41 and 3-42 (9:1 ratio): IR (neat) 2954, 1742, 1643, 1251 cm-1; HRMS 
(ESI) m/z calculated for C9H19OSi (M+H)
+ 171.1205, found: 171.1217. Enol ether 3-41: 1H 
NMR (400 MHz, CDCl3) δ 0.23 (s, 9H), 1.01 (d, J = 6.8 Hz, 3H), 1.32-1.41 (m, 1H), 2.03-
2.12 (m, 1H), 2.24-2.33 (m, 2H), 2.65-2.76 (m, 1H), 4.60 (q, J = 1.8 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ -0.0 (CH3), 22.4 (CH3), 30.4 (CH2), 33.4 (CH2), 36.4 (CH), 108.9 (CH), 
154.2 (C). Enol ether 3-42 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.07 (d, J 
= 6.7 Hz, 3H), 1.83-1.93 (m, 2H),2.43-2.51 (m, 2H), 4.57 (p, J = 2.0 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 0.0 (CH3), 22.2 (CH3), 30.1 (CH), 37.2 (CH2), 41.9 (CH2), 101.5 (CH), 153.5 
(C).  
 
 
(2R*,3S*)-2-(But-3-en-1-yl)-3-methylcyclopentanone (38), (2S*,3S*)-2-(but-3-en-
1-yl)-3-methylcyclopentanone (3-44), (2R*,4R*)-2-(but-3-en-1-yl)-4-methylcyclo-
pentanone (3-45), and (2S*,4R*)-2-(but-3-en-1-yl)-4-methylcyclopentanone (3-46). 
Following the general procedure V in Chapter 2, hydrazone 3-49 (1:1 ratio, 7.0 g, 50 mmol), 
freshly-prepared LDA (60 mmol) and 4-bromo-1-butene (8.1 g, 60 mmol) afforded after 
vacuum distillation (66-70 oC/5 mmHg) ketone 3-38, 3-44, 3-45, and 3-46 (42:2:46:10 GC 
ratio, 6.38 g, 84%) as a colorless oil. 
Epimerization: To a solution of ketone 3-38, 3-44, 3-45, and 3-46 (1.52 g, 10 mmol) 
in methanol (30 mL) was added sodium methoxide (25% w/w in methanol, 2.16 g, 10 mmol) 
at room temperature. After stirring overnight, saturated aqueous ammonium chloride was 
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added to quench the reaction. Diethyl ether was used to extract the product, and the aqueous 
layer was extracted with diethyl ether three times. The combined organic layers were washed 
with brine, dried over anhydrous sodium sulfate and concentrated. The residue was purified 
by silica gel chromatography (1-2% ethyl acetate/hexanes) to afford ketone 3-38, 3-44, 3-45, 
and 3-46 (39:5:18:38 GC ratio, 1.20 g, 80%) as a colorless oil. Ketone 3-38: 1H NMR (400 
MHz, CDCl3) δ 1.16 (d, J = 6.2 Hz, 3H), 1.28-1.44 (m, 1H), 1.55-1.72 (m, 1H), 1.73-1.83 (m, 
2H), 1.84-1.96 (m, 1H), 2.02-2.20 (m, 3H), 2.20-2.49 (m, 2H), 4.91-4.98 (m, 1H), 4.99-5.05 
(m, 1H), 5.73-5.81 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 220.94 (C), 138.4 (CH), 114.9 
(CH2), 55.7 (CH), 38.0 (CH2), 37.0 (CH), 31.1 (CH2), 29.6 (CH2), 27.0 (CH2), 19.6 (CH3). 
Ketone 3-44 (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 0.87 (d, J = 7.2 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 220.38 (C), 138.1 (CH), 53.2 (CH), 34.8 (CH2), 32.7 (CH), 
28.0 (CH2), 23.8 (CH2), 14.5 (CH3). Ketone 3-45 (diagnostic peaks only): 
1H NMR (400 
MHz, CDCl3) δ 1.08 (d, J = 6.7 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 221.64 (C), 137.9 
(CH), 115.1 (CH2), 46.5 (CH2), 46.3 (CH), 36.8 (CH2), 31.6 (CH2), 29.7 (CH2), 28.2 (CH), 
20.8 (CH3). Ketone 3-46 (diagnostic peaks only): 
1H NMR (400 MHz, CDCl3) δ 1.14 (d, J = 
6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 220.72 (C), 138.1 (CH), 115.0 (CH2), 50.2 (CH), 
46.8 (CH2), 38.5 (CH2), 28.8 (CH2), 20.3 (CH3). 
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(3S*)-2-(5-Azidopent-3-en-1-yl)-3-methylcyclopentanone (3-71), (3S*)-2-(3-
azidopent-4-en-1-yl)-3-methylcyclopentanone (3-72), (4S*)-2-(5-azidopent-3-en-1-yl)-4-
methylcyclopentanone (3-73), and (4S*)-2-(3-azidopent-4-en-1-yl)-4-methyl-
cyclopentanone (3-74). Following the general procedure III in Chapter 2, a mixture of 
ketone 3-38, 3-44, 3-45, and 3-46 (39:5:18:38 GC ratio, 4.18 g, 27.5 mmol) afforded after 
silica gel column chrlomatography (1-3% ethyl acetate/hexanes) azides 3-71, 3-72, 3-73, and 
3-74 (without determined ratio, 3.64 g, 64%) as a colorless oil. Azides 3-71, 3-72, 3-73, and 
3-74: Rf = 0.45 (10% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 0.87 (d, J = 7.1 Hz, 
1H), 1.08 (d, J = 6.4 Hz, 3H), 1.15 (d, J = 6.5 Hz, 9H), 1.30-1.45 (m, 6H), 1.49-1.68 (m, 9H), 
1.72 (dd, J = 18.3, 11.5 Hz, 3H), 1.78-1.96 (m, 7H), 2.02-2.20 (m, 21H), 2.20-2.40 (m, 12H), 
2.45 (dd, J = 19.0, 7.0 Hz, 2H), 3.69 (d, J = 6.5 Hz, 8H), 3.81 (d, J = 6.7 Hz, 2H), 5.23-5.30 
(m, 3H), 5.50-5.58 (m, 5H), 5.67-5.78 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 14.2, 14.5, 
19.48, 19.56, 20.25, 20.28, 20.8, 23.7, 24.01, 24.12, 24.8, 25.3, 25.85, 26.06, 27.2, 27.6, 27.9, 
28.2, 28.9, 29.52, 29.57, 29.66, 29.82, 30.1, 31.2, 31.6, 32.0, 32.3, 32.8, 34.8, 36.76, 36.81, 
37.06, 37.10, 37.91, 37.98, 38.42, 38.47, 38.51, 46.10, 46.41, 46.63, 46.66, 46.72, 50.1, 50.36, 
50.42, 52.72, 52.75, 53.1, 55.6, 55.90, 56.01, 60.3, 65.03, 65.12, 65.3, 118.27, 118.31, 118.36, 
118.44, 122.81, 122.86, 123.46, 123.59, 123.68, 135.4, 135.5, 135.9, 136.02, 136.11, 136.4, 
219.98, 220.20, 220.40, 220.47, 220.8, 221.4. 
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(3R*,7R*,8aR*)-7-Methyl-3-vinylhexahydroindolizin-5(1H)-one (3-77). 
Following the general procedure VI in Chapter 2, azides 3-71, 3-72, 3-73, and 3-74 (1.09 g, 
5.26 mmol) and titanium tetrachloride (1M in dichloromethane, 8.0 mL, 7.9 mmol) in 
anhydrous 1,2-dichloroethane (55 mL) afforded after silica gel column chrlomatography (20-
40% ethyl acetate/hexanes) lactam 3-77 (40 mg, 4%) as a colorless oil and a mixture of 
lactam 3-75 and 3-76 (482 mg + 160 mg, 68%) as a colorless oil. Lactam 3-77: Rf = 0.60 
(EtOAc, twice); 1H NMR (500 MHz, CDCl3) δ 0.95 (d, J = 6.3 Hz, 2H), 0.92-1.00 (m, 1H), 
1.33 (qd, J = 11.6, 7.9 Hz, 1H), 1.50-1.58 (m, 1H), 1.83 (dd, J = 17.0, 11.6 Hz, 1H), 1.86-
1.93 (m, 1H), 1.94-2.03 (m, 2H), 2.10 (dtd, J = 12.9, 8.1, 1.8 Hz, 1H), 2.43-2.49 (m, 1H), 
3.46 (tt, J = 10.7, 4.6 Hz, 1H), 4.54 (q, J = 7.7 Hz, 1H), 5.02 (dt, J = 10.3, 1.3 Hz, 1H), 5.07 
(dt, J = 17.2, 1.3 Hz, 1H), 5.76 (ddd, J = 17.1, 10.3, 5.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
δ 21.5 (CH3), 28.2 (CH), 29.6 (CH2), 32.9 (CH2), 37.9 (CH2), 40.3 (CH2), 58.3 (CH), 58.7 
(CH), 114.0 (CH2), 138.4 (CH), 168.8 (C). Lactams 3-75 and 3-76 (two portions, diagnostic 
peaks only): Rf = 0.55 and 0.50 (EtOAc, twice). 
13C NMR (125 MHz, CDCl3) δ 54.1, 55.5, 
56.0, 57.7, 58.0, 58.1, 58.3, 58.68, 58.70, 58.9, 60.2, 61.3, 65.0, 113.5, 113.98, 113.99, 
114.01, 114.04, 137.7, 137.9, 138.3, 138.4, 168.7, 168.9, 170.2. The following data and NOE 
correlations were used to assign lactam 3-77. 
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(3R*,6S*,7R*,8aR*)-6,7-Dimethyl-3-vinylhexahydroindolizin-5(1H)-one (3-78). 
To a solution of lactam 3-77 (13 mg, 0.07 mmol) in anhydrous THF (10 mL) at -78 oC under 
N2 atmosphere was added dropwise freshly-prepared LDA (0.5M in THF, 0.21 mL, 0.11 
mmol). After stirring for 1 h, methyl iodide (170 mg, 1.20 mmol) was added dropwise. The 
reaction mixture is stirred for another 1.5 h, and saturated aqueous ammonium chloride was 
added to quench the reaction. The mixture was extracted with ethyl acetate three times. The 
combined organic layers were washed with brine, dried over anhydrous sodium sulfate and 
concentrated. The residue was purified by silica gel chromatography (15-50% ethyl 
acetate/hexanes) to afford lactam 3-78 (3.5 mg, 27%) as a colorless oil and lactam 3-79 (0.5 
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mg, 4%) as a colorless oil. Lactam 3-78: Rf = 0.40 (100% EtOAc/hexanes); IR (neat) 2927, 
1635, 1429, 1322 cm-1; HRMS (ESI) m/z calculated for C12H20NO (M+H)
+ 194.1545, found: 
194.1540; 1H NMR (500 MHz, CDCl3) δ 0.98 (d, J = 6.5 Hz, 3H), 1.00-1.07 (m, 1H), 1.21 (d, 
J = 7.2 Hz, 3H), 1.31 (qd, J = 11.8, 7.7 Hz, 1H), 1.47-1.56 (m, 2H), 1.75-1.83 (m, 1H), 1.92 
(dt, J = 12.9, 3.4 Hz, 1H), 1.95-2.02 (m, 1H), 2.09 (dtd, J = 12.8, 7.9, 1.7 Hz, 1H), 3.45 (tt, J 
= 10.7, 4.5 Hz, 1H), 4.53 (q, J = 7.8 Hz, 1H), 5.00 (dt, J = 10.3, 1.3 Hz, 1H), 5.05 (dt, J = 
17.2, 1.3 Hz, 1H), 5.75 (ddd, J = 17.1, 10.3, 5.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 16.4 
(CH3), 20.5 (CH3), 29.8 (CH2), 33.1 (CH2), 35.5 (CH), 37.9 (CH2), 44.5 (CH), 58.3 (CH), 
58.8 (CH), 113.8 (CH2), 138.6 (CH), 172.3 (C). Lactam 3-79 (diagnostic peaks only): Rf = 
0.35 (100% EtOAc/hexanes). 1H NMR (500 MHz, CDCl3) δ 1.81-1.88 (m, 1H), 1.88-2.02 (m, 
3H), 2.05-2.19 (m, 2H), 2.43-2.50 (m, 1H), 3.40-3.51 (m, 1H), 4.54 (q, J = 7.7 Hz, 1H), 4.95-
5.11 (m, 2H), 5.76 (ddd, J = 17.1, 10.3, 5.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 37.9, 
40.3, 58.3, 58.7, 114.0, 138.4. The following data and NOE correlations were used to assign 
lactam 3-78. 
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(3S*,6S*,8S*,8aR*)-6,8-Dimethyl-3-vinylhexahydroindolizin-5(1H)-one (3-82). 
To a solution of a mixture of lactams 3-75 and 3-76 (no ratio, 320 mg, 1.80 mmol) in 
anhydrous THF (20 mL) at -78 oC under N2 atmosphere was added dropwise tert-butyl 
lithium (1.7M in pentane, 1.2 mL, 2.0 mmol). The stirring was continued for 1 h, and methyl 
iodide (0.23 mL, 3.6 mmol) was added dropwise. The stirring was continued for another 2 h, 
and saturated aqueous sodium bicarbonate was used to quench the reaction. Ethyl acetate was 
used to extract the product, and the aqueous layer was extracted with ethyl acetate three times. 
The combined organic layers were washed with brine, dried over anhydrous sodium sulfate 
and concentrated. The residue was purified by silica gel chromatography (10-40% ethyl 
acetate/hexanes) to afford lactam 3-82 (20 mg, 6%) as a colorless oil and a mixture of lactams 
3-80 and 3-81 (292 mg + 13 mg, 88%) as a colorless oil. Lactam 3-82: Rf = 0.40 (100% 
EtOAc/hexanes); IR (neat) 2926, 1638, 1422 cm-1; HRMS (ESI) m/z calculated for C12H20NO 
(M+H)+ 194.1545, found: 194.1548; 1H NMR (500 MHz, CDCl3) δ 0.93 (d, J = 6.4 Hz, 3H), 
1.16 (d, J = 7.2 Hz, 3H), 1.42-1.52 (m, 1H), 1.52-1.60 (m, 2H), 1.60-1.66 (m, 1H), 1.69 (dd, J 
= 12.3, 6.1 Hz, 1H), 1.83-1.92 (m, 1H), 1.93-1.99 (m, 1H), 2.36-2.43 (m, 1H), 3.04 (td, J = 
10.5, 5.0 Hz, 1H), 4.48 (dd, J = 7.3, 6.1 Hz, 1H), 4.96 (dt, J = 17.1, 1.3 Hz, 1H), 5.00 (dt, J = 
10.4, 1.2 Hz, 1H), 5.70 (ddd, J = 17.1, 10.4, 5.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 18.4 
(CH3), 18.8 (CH3), 29.5 (CH2), 30.0 (CH2), 32.9 (CH), 35.3 (CH), 38.1 (CH2), 58.1 (CH), 
65.4 (CH), 113.8 (CH2), 137.9 (CH), 173.1 (C). Lactam 3-80 and 3-81(two portions, 
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diagnostic peaks only): Rf = 0.50 and 0.30 (100% EtOAc/hexanes). 
13C NMR (101 MHz, 
CDCl3) δ 53.9, 54.9, 58.0, 58.4, 58.9, 64.9, 65.5, 66.5, 113.4, 113.7, 113.8, 114.0, 114.1, 
137.8, 137.9, 138.3, 138.7, 172.2, 172.3, 173.0. The following data and NOE correlations 
were used to assign lactam 3-82.   
 
 
 
 
Allyl 2-oxocyclopentanecarboxylate (3-91). A solution of ethyl 2-
oxocyclopentanecarboxylate (18 mL, 0.12 mol), allyl alcohol (100 mL, 20 mol), and DMAP 
(1.8 g, 15 mmol) in toluene (100 mL) was refluxed overnight. After cooling to room 
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temperature, the concentrated residue was directly used for next step without further 
purification. Ester 3-91: 1H NMR (400 MHz, CDCl3) δ 1.82-1.95 (m, 1H), 2.11-2.22 (m, 1H), 
2.25-2.41 (m, 4H), 3.20 (t, J = 9.1 Hz, 1H), 4.61-4.71 (m, 2H), 5.26 (dq, J = 10.4, 1.0 Hz, 
2H), 5.36 (dq, J = 17.2, 1.5 Hz, 2H), 5.88-5.98 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.0 
(CH2), 27.4 (CH2), 38.1 (CH2), 54.7 (CH), 65.9 (CH2), 118.5 (CH2), 131.7 (CH), 169.1 (C), 
212.1 (C). 
 
Allyl 1-(but-3-en-1-yl)-2-oxocyclopentanecarboxylate (3-92). A suspension of 
ketoester 3-91 (~50 mmol), 4-bromo-1-butene (10.12 g, 75 mmol), potassium carbonate (13.8 
g, 100 mmol) and sodium iodide (750 mg, 5.00 mmol) in acetone (150 mL) was refluxed 
overnight. After cooling to room temperature, water and diethyl ether were added to the 
suspension until it became transparent. After the separation, the aqueous layer was extracted 
with diethyl ether three times. The combined organic layers were washed with brine, dried 
over anhydrous sodium sulfate and concentrated. The residue was purified by silica gel 
chromatography (3-5% ethyl acetate/hexanes) to afford ketoester 3-92 (10.5 g, 92%) as a 
colorless oil. Ketoester 3-92: Rf = 0.65 (20% EtOAc/hexanes); IR (neat) 2968, 1751, 1725, 
1154 cm-1; HRMS (ESI) m/z calculated for C13H18O3Na (M+Na)
+ 245.1154, found: 245.1156; 
1H NMR (400 MHz, CDCl3) δ 1.61-1.72 (m, 1H), 1.88-2.13 (m, 6H), 2.22-2.32 (m, 1H), 
2.37-2.47 (m, 1H), 2.51-2.60 (m, 1H), 4.60 (dt, J = 5.6, 1.3 Hz, 2H), 4.95 (d, J = 10.0 Hz, 
1H), 5.02 (dq, J = 17.2, 1.4 Hz, 1H), 5.23 (dq, J = 10.4, 1.2 Hz, 1H), 5.31 (dq, J = 17.2, 1.4 
Hz, 1H), 5.71-5.82 (m, 1H), 5.83-5.93 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 19.6 (CH2), 
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29.1 (CH2), 32.8 (CH2), 33.0 (CH2), 37.9 (CH2), 60.2 (C), 65.8 (CH2), 115.1 (CH2), 118.5 
(CH2), 131.6 (CH), 137.6 (CH), 170.5 (C), 214.4 (C). 
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CHAPTER 4 
 
THE APPLICATION OF HYDROXYL ALLYLIC AZIDE 
 
4.1 Introduction 
Having experienced combination of allylic azide rearrangement and intramolecular 
Schmidt reaction, we considered on the development of the combination between isomeric 
allylic azides and other reactions. This chapter describes initial studies of the combination 
between allylic azide rearrangement and intramolecular azide -alkyne Huisgen cycloaddition 
reaction.  
Azide-alkyne cycloaddition (AAC) can couple an azide and a terminal or internal 
alkyne to form a 1,2,3-triazole via a formal 1,3-dipolar cycloaddition, which can occur 
intermolecularly or intramolecularly (Scheme 88). This reaction has been extensively 
reviewed.137-140 Copper-catalyzed AAC reaction (CuACC) has been known as "the cream of 
the crop" of click chemistry, a term coined by Sharpless and coworkers.141 A click reaction is 
defined as a reaction with the properties of wide scope, high atom economy, rate and very 
high exothermicity.  
 
Scheme 88. Azide-alkyne cycloaddition. 
For intermolecular AAC reaction,139 there is two possible thermal triazoles, 1,4- and 
1,5-regioisomers with ca. 1:1 ratio, whose activation barriers (~26 kcal/mol) are pretty similar 
 394 
for concerted mechanism by computational studies.142 However, both reactions are highly 
exothermic, releasing ~61 kcal/mol en route to either isomer. The discovery of new metal 
catalysts has conferred new life for this reaction. Copper is the most common catalyst in this 
reaction and it selectively results in the formation of the 1,4-regioisomer. Ruthenium catalyst 
can produce the alternative 1,5-isomer as the major product. Tetraalkylammonium hydroxide 
has also been reported to catalyze this reaction affording 1,5-adducts with high yield and high 
regioselectivity.143  
Sharpless and coworkers reported the mechanistic DFT studies on the CuAAC 
reaction (Figure 118).142 The rate-determining step is the conversion of alkyne and azide 
coordinate copper species 4-6 to an unusual six-membered copper(III) metalacycle 
intermediate 4-7 with 15 kcal/mol activation barrier. In comparison with purely thermal 
condition, a 107-108 rate acceleration was expected from computational studies, which 
matched observed experimental results. Based on the mechanistic studies, only terminal 
alkynes are preferred substrates for CuAAC reaction. Furthermore, several side reactions are 
also involved in this reaction. Copper acetylide 4-3 can polymerize to 4-4, the hydrolysis of 
which upon work-up affords the starting alkyne. Intermediate 4-8 can be easily oxidized or 
coupled to give by-products 4-10, 4-11, or 4-12.  
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Figure 118. The mechanism of CuAAC reaction.  
Copper(I) reagents, which are the least thermodynamically stable among three 
oxidation states of copper (0, +1 and +2), have been most commonly utilized in this CuAAC 
reaction.137,138 In addition, copper (II) catalysts can be easily reduced in situ to copper(I) 
catalyst by amines, alcohols, acids, and promote the catalytic cycle. Studies showed by Fokin 
that the combination of copper sulfate and sodium ascorbate is a very convenient and 
practical procedure for CuAAC reaction.  
Cu(I) iodide should be avoided due to iodide anion’s ability to act as a bridge ligand 
for the metal, and this can result in the formation of poly copper acetylides to terminate the 
catalytic cycle. This polymerization can be inhibited by the addition of amine ligands (not 
additives or bases) (Figure 119). Those amine ligands can also a) increase the solubility of 
copper(I) catalyst, b) facilitate the coordination of azide and alkyne to metal, and c) protect 
the copper(I) from the oxidation. All the influences of amine ligands can contribute to 
enhance the reaction rate.   
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Figure 119. Amine ligands.  
Burgess and coworkers reported the synthesis of bistriazoles using Cu(I) catalyst 
(Scheme 89).144 They found that this reaction was dependent on the base used, with the best 
results obtained in aqueous sodium carbonate.  
 
Scheme 89. Synthesis of bistriazoles.  
Fokin and coworkers reported the ruthenium-catalyzed azide-alkyne cycloaddition 
(RuAAC) to generate 1,5-adducts with very high regio-selectivity (Figure 120).145 DFT 
computational studies were used to explain their experimental results. In this catalytic cycle, 
the rate-determining step is the conversion of alkyne and azide coordinate ruthenium species 
4-22 to the unusual six-membered ruthenacycle intermediate 4-23 with a 4.3 kcal/mol 
activation barrier. Based on this mechanistic study, both terminal and internal alkynes can be 
the substrates for this conversion.  
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Figure 120. The mechanism of RuAAC reaction.  
Most intramolecular AAC reactions are thermally conducted to produce fused 
bicyclic triazoles. For example, Datta and coworkers have reported a feasible sequence to 
prepare [5,6]-fused bicyclic triazoles (Scheme 90).146 The cycloaddition precursor 4-28 was 
easily prepared by epoxide opening and subsequent alkylation from cyclohexene epoxide.   
 
Scheme 90. Datta’s sequence to prepare [5,6]-fused bicyclic triazoles. 
Declerck and coworkers reported the synthesis of [7,5]-fused triazoles, in which only 
the anti isomer is the suitable starting material with unreacted syn isomer due to its steric 
inference between two neighboring groups (Scheme 91).147 This reaction suggested that it 
might be possible to achieve good selectivity in the combination of allylic azide 
rearrangement and AAC reaction.  
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Scheme 91. Selectivity in the intramolecular AAC reaction.  
Chandrasekhar and coworkers observed the dimerization and trimerization of ACC 
reaction in high yield utilizing an in-situ generated Cu(I) catalyst (Scheme 92).148 Due to the 
inherent 1,4-regioisomer formation utilizing copper(I) catalyst, the dimer has high possibility 
to be formed in comparison with highly strained monomer.  
 
Scheme 92. Dimerization of ACC reaction. 
Burgess and coworkers utilized the exo-like dimerized copper acetylide 4-37 to 
explain why dimerization is the major pathway in this CuAAC reaction (Scheme 93).149 
Copper catalyst can coordinate two alkyne species to make the intermediate stable in the 
catalytic cycle. Azide of the second molecule reacted with the triple bond of the first 
molecule to form a more stable intermediate, and then facilitated the dimerization in this 
reaction.  
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Scheme 93. Explanation of dimerization in the CuAAC reaction.  
Liskamp and coworkers reported the syntheses of the diverse macrocycles with 1,4- 
and 1,5-regioisomers, utilizing CuAAC and RuAAC reaction respectively (Scheme 94).150  
 
Scheme 94. Intramolecular CuAAC and RuAAC reaction. 
Besides azide-alkyne cycloaddition to prepare triazoles, we are also interested in 
other transformations starting from the similar starting materials.  
In 2005, Toste and coworkers reported gold-catalyzed pyrrole synthesis starting from 
azide-alkyne to give 5-endo-dig cyclization product 4-44 (Scheme 95).151 The extrusion of 
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nitrogen gas afforded 4-45, and hydrogen migration and tautomerization afforded the pyrrole 
4-47.  
 
Scheme 95. Gold-catalyzed pyrrole synthesis.  
Zhang and coworkers reported the synthesis of bicyclic imidazoles using a related 
[2+3] cycloaddition (Scheme 96).152 In this transformation, 5-exo-dig cyclization was utilized 
to generate α-imino gold carbene intermediate, and the following attack of nitrile and 
cyclization afforded product 4-53.  
 
Scheme 96. Gold-catalyzed azide-alkyne-nitrile reaction. 
They also reported the synthesis of 2,3-dihydro-1H-pyrrolizines utilizing the similar 
strategy (Scheme 97).153 After the 5-exo-dig cyclization, Nazarov electrocyclization and 
tautomerization afforded the pyrrolizine derivative 4-59.  
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Scheme 97. Gold-catalyzed pyrrolizine synthesis.  
 
4.2 Allylic azide rearrangement-involved combinations.  
Based on the stereo-control results in the combination of allylic azide rearrangement 
and intermolecular Schmidt reaction, we speculated that high selectivity could be obtained for 
the combination of allylic azide rearrangement and thermal intramolecular azide-alkyne 
cycloaddition (Figure 121). [5,6]-Fused bicyclic triazoles 4-64 and 4-66 should be the major 
products due to the slow formation of 8-membered ring to generate 4-65. Stereoselectivity 
could be controlled by the substituents in the substrates.  
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Figure 121. Allylic azide-involved thermal AAC reaction. 
Based on the mechanism of RuAAC reaction, productive intermediate 4-68 can only 
be generated from 4-63, and not from 4-61 or 4-62 due to the ring strain (Figure 122). 
Triazole 4-65 should be the sole product in this reaction.   
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Figure 122. Combined allylic azide and thermal RuAAC reaction.  
Based on the mechanism of CuAAC reaction, unusual six-membered copper 
intermediate 4-70 can only be generated from 4-63, and not from 4-61 or 4-62 due to the ring 
strain (Figure 123). Triazole 4-71 should be the major product in this reaction. If the 
intermediate ring is not big enough, dimerization to 4-72 may occur instead (see above).   
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Figure 123. Allylic azide-involved CuAAC reaction.  
Allylic azide alkynes could be employed for gold-catalyzed pyrrole synthesis to 
afford vinyl-substituted pyrrole 4-79 (Figure 124).   
 
Figure 124. Gold-catalyzed allylic azide-involved pyrrole synthesis. 
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Allylic azide alkynes are to be tested for gold-catalyzed imidazole synthesis to afford 
vinyl-substituted bicyclic imidazole 4-86 (Figure 125).   
 
Figure 125. Gold-catalyzed synthesis of bicyclic imidazoles. 
Diversity-oriented synthesis (DOS) is a strategy to quickly access a diverse pool of 
molecules from common intermediate utilizing different types of organic reactions. In 
principle, allylic azide may serve as precursors to a variety of diversified scaffolds using the 
reactions described above (Figure 126).  
 
Figure 126. Summarized allylic azide-involved combination with other reactions.  
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Hydroxyl allylic azide is a good partner for the synthesis of allylic azide alkynes 4-88 
and 4-91 (Scheme 98).  
 
Scheme 98. Preparation of allylic azide alkynes.  
Other than Schmidt reaction, our group has also developed hydroxyl azide involved-
Boyer reaction (Scheme 99).154 Under the promotions of Lewis acid, hydroxyl azide can 
reacted with ketone or aldehyde 4-93 to dihydrooxazolium ion 4-94, followed by the 
hydrolysis to 4-95.  
 
Scheme 99. Boyer reaction. 
Based on the successful experience of the combination of allylic azide rearrangement 
and intramolecular Schmidt reaction, we can speculate that hydroxyl allylic azides 4-96 and 
4-99 can be combined with Boyer reaction to give 4-98 and 4-101, respectively (Scheme 100). 
From the perspective of nitrogen’s oxidation state, 4-98 and 4-101 are the reduced forms of 
azides 4-96 and 4-99, and benzaldehyde was oxidized to benzoyl group, the protective group 
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of amine. Hence, this reaction is also a selective reduction of a mixture of terminal and 
internal allylic azides, which can not be achieved by conventional methods.  
 
Scheme 100. Boyer reaction mediated allylic azide reduction.  
 
4.3 Combination of allylic azide rearrangement with azide-alkyne cycloaddition.   
A mixture of hydroxyl allylic azides 4-103a, 4-103b and 4-103c was prepared from 
2-vinyloxirane with sodium azide in a 45% yield, along with 2% other regioisomer 4-104 
(Scheme 101).  
 
Scheme 101. Preparation of hydroxyl allylic azides 4-103.  
The alkylation of 4-103 was accomplished using sodium hydride with propargyl 
bromide to afford a mixture of allylic azide 4-105a, 4-105b and triazole 4-106 with 83:12:5 
ratio in 9% yield, and pure 4-105a with 25% yield after silica gel column chromatography 
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(Scheme 102). This result showed that the interconversion between 4-105a and 4-105b was 
not fast, and then a single pure isomer could be isolated.  
 
Scheme 102. Alkylation of allylic azides 4-103. 
We speculated that cycloaddition may happen during the separation or concentration 
steps. In any way, this cycloaddition is exothermic with very low activation barrier, and it can 
happen naturally. Then we used 1H NMR to track its ratio change with time (Table 41). The 
conversion for both isomers to triazole 4-106 is above 85% after 45 days. The initial rate for 
azide 4-105a to triazole 4-106 is much slower than that of azide 4-105b’s.  
Table 41. Ratio change in the cycloaddition.  
Time 
Ratio  
(4-105b: 4-105a: 4-106) 
Ratio  
(4-105b: 4-105a: 4-106) 
0 d 83:12:5 0:100:0 
1 d 36:45:18 18:80:3 
2 d 25:52:23 20:75:6 
2.5 d 21:52:26 21:71:8 
 409 
3.5 d 18:52:30 21:67:13 
6.5 d 15:45:39 17:59:24 
18 d 10:27:64 11:34:55 
38 d 4:11:85 5:16:79 
45 d 4:7:89 3:12:85 
 
A mixture of allylic azides 4-105a, 4-105b and triazole 4-106 with 18:58:24 ratio 
was refluxed in chloroform for 4 h to afford triazole 4-106 in 72% yield (Scheme 103).  
 
Scheme 103. Cycloaddition to triazole 4-106.  
Allylic azides 4-108a and 4-108b were prepared through the opening of epoxide 4-
107 by sodium azide in 81% yield with 82:18 ratio (Scheme 104). Why azide 4-108a is more 
thermodynamic than 4-108b is because of hydrogen bonding between hydroxyl group and 
azide. The alkylation afforded multiple products with 28% unreacted starting allylic azides. 
Alkylated products 4-109a and 4-109b were isolated as the major isomers in 10% and 7% 
yields respectively. Cyclized triazole 4-110 was also obtained in 28% yield, whose structure 
was confirmed by X-ray crystallography (Figure 127). We also noticed that the initial ratio of 
4-109a, 4-109b and 4-110 was changed from 1:0.1:0.15 to 0.1:0.1: 1 ratio after 7 days; after 
14 days, the ratio was 1:1:40. For the portion with 4-109b as the major product, the initial 
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ratio of 4-109a, 4-109b and 4-110 was changed from 1:10:0 to 0.4:0.3:1 ratio after 7 days; 
after 14 days, the ratio is 1:1:20. 
 
Scheme 104. The synthesis of triazole 4-110.  
 
Figure 127. ORTEP representation of triazole 4-110.  
The alkylation of propargyl alcohol 4-111 with 1,4-dibromobut-2-ene gave low yield, 
and its further optimization is in progress (Scheme 105). The following azide displacement 
also afforded triazoles 4-114a and 4-114b with 10% and 5% yield respectively, along with a 
mixture of allylic azides 4-113a, 4-113b, 4-113c and 4-113d (10:0:1:1) in 14% yield. The 
structures of 4-114a and 4-114b were confirmed by 2D NMRs.  
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Scheme 105. The synthesis of triazole 4-114a and 4-114b.  
In order to expand the scope of this combination, allylic azides 4-116 and 4-118 were 
prepared in a 5-gram scale, following the general procedure in Chapter 2 (Scheme 106)..  
 
Scheme 106. The preparation of allylic azides 4-116 and 4-118. 
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4.4 Reduction of hydroxyl allylic azides.   
We first conducted the reduction of allylic azides under conventional conditions, to 
find out the difference of selectivity for the normal reduction and the combination of Boyer 
reaction and hydrolysis, the latter being considered to be highly selective. The azides 4-108a 
and 4-108b were reduced under the assistance of tin(II) chloride and the following Boc 
protection afforded carbamate 4-119 and 4-120 with 4:1 ratio, which has the similar ratio as 
starting materials (Scheme 107). Higher selectivity (6:1 ratio) was obtained from LAH 
reduction and Boc protection.  
 
Scheme 107. Reduction of allylic azides 4-108.  
In order to make comparison, the Boyer reaction and hydrolysis sequence to 4-122 
were studied. However, the Boyer reaction didn’t work for this substrate. This might be 
resulted from ring strain of trans [5,6]-fused bicycle 4-121 (Scheme 108).  
 
Scheme 108. Boyer reaction and hydrolysis to 4-122.  
The similar combination to 4-101 was tested for allylic azides 4-116, which can not 
produce strained dihydrooxazole (Scheme 109). Low yields are obtained for both reactions, 
and their optimizations are in progress.  
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Scheme 109. Boyer reaction and hydrolysis to 4-101.  
 
4.5 Conclusion  
Initial studies were conducted for the combination of allylic azide rearrangement and 
azide-alkyne cycloaddition. This reaction could occur at room temperature with low 
activation energy barrier. Four vinyl-substituted bicyclic triazoles were synthesized, one of 
which was confirmed by X-ray crystallography. The selective reduction of allylic azides was 
also studied. The comparison between normal reduction and the combination for allylic 
azide-Boyer reaction and hydrolysis was conducted. The further optimization of these 
reactions is planned.  
 
4.6 Experimental data   
 
(E)-4-Azidobut-2-en-1-ol (103a), 2-azidobut-3-en-1-ol (4-103b), (Z)-4-azidobut-2-
en-1-ol (4-103c), and 1-azidobut-3-en-2-ol (4-104). To a solution of 2-vinyloxirane (370 mg, 
5.28 mmol) and ammonium chloride (1.41 g, 26.4 mmol) in a mixed solvent of ethanol (16 
mL) and water (2 mL), was added sodium azide (3.43 g, 52.8 mmol). The resulting mixture 
was refluxed for 24 h. After it was cooling to room temperature, water and dichloromethane 
were added. After separation, the aqueous layer was extracted with dichloromethane three 
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times. The combined organic layers were washed with brine, dried over anhydrous sodium 
sulfate and concentrated. The residue was purified by silica gel column chromatography (10-
20% EtOAC/hexanes) to afford 4-104 (10 mg, 2%) as a colorless oil and a mixture of azides 
4-103a, 4-103b, and 4-103c (15:15:1 ratio, 270 mg, 45%) as a colorless oil. Azide 4-103a, 4-
103b, and 4-103c: Rf = 0.30 (50% EtOAc/hexanes). Azide 4-103a: 
1H NMR (400 MHz, 
CDCl3) δ 2.28 (br, 1H), 3.79 (d, J = 6.4 Hz, 2H), 4.19 (d, J = 6.4 Hz, 2H), 5.73-5.80 (m, 1H), 
5.88-5.96 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 52.2 (CH2), 62.5 (CH2), 124.1 (CH), 134.4 
(CH). Azide 4-103b: 1H NMR (400 MHz, CDCl3) δ 2.54 (br, 1H), 3.53-3.57 (m, 1H), 3.63-
3.67 (m, 1H), 4.03-4.07 (m, 1H), 5.36-5.43(m, 2H), 5.73-5.80 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ 64.6 (CH2), 66.4 (CH), 120.2 (CH2), 132.0 (CH). Azide 4-103c (diagnostic peaks 
only): 1H NMR (400 MHz, CDCl3) δ 2.12 (br, 1H), 3.87 (d, J = 6.8 Hz, 2H), 4.23 (d, J = 6.8 
Hz, 2H). Azide 4-104: Rf = 0.45 (50% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 2.08 
(br, 1H), 3.33 (dd, J = 7.2 Hz, 12.3 Hz, 1H), 3.40 (dd, J = 3.6 Hz, 12.3 Hz, 1H), 4.34 (br, 1H), 
5.28 (dt, J = 10.4 Hz, 1.2 Hz, 1H), 5.41 (dt, J = 17.2 Hz, 1.2 Hz, 1H), 5.85-5.93 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 56.4 (CH2), 72.0 (CH), 117.2 (CH2), 136.9 (CH).  
 
 
(E)-1-Azido-4-(prop-2-yn-1-yloxy)but-2-ene (4-105a) and 3-Azido-4-(prop-2-yn-
1-yloxy)but-1-ene (4-105b). To a solution of a mixture of azides 4-103a, 4-103b, and 4-103c 
(500 mg, 4.42 mmol) in anhydrous DMF (20 mL) at 0 °C under N2 atmosphere was added 
sodium hydride (60% in mineral oil, 221 mg, 5.52 mmol). After the resulting mixture was 
stirred at 0 °C for 30 min, propargyl bromide (80% w/w in toluene, 821 mg, 5.52 mmol) was 
added slowly. The resulting mixture was stirred overnight, and quenched with saturated 
aqueous ammonium chloride. Products were extracted with diethyl ether three times. The 
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combined organic layers were washed with brine, dried over anhydrous sodium sulfate and 
concentrated. The residue was purified by silica gel column chromatography (0.5-2% 
EtOAC/hexanes) to afford a mixture of azides 4-105a, 4-105b, and triazole 4-106 (12:83:5 
ratio, 60 mg, 9%) as a colorless oil and azide 4-105a (165 mg, 25%) as a colorless oil. Azide 
4-105a: Rf = 0.30 (5% EtOAc/hexanes); IR (neat) 2859, 2100 cm
-1; HRMS (ESI) m/z 
calculated for C7H10N3O (M+H)
+ 152.0824, found: 152.0830; 1H NMR (400 MHz, CDCl3) δ 
2.46 (t, J = 2.4 Hz, 1H), 3.80 (d, J = 4.6 Hz, 2H), 4.11 (d, J = 4.1 Hz, 2H), 4.17 (d, J = 2.4 Hz, 
2H), 5.84 (q, J = 4.8 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 52.2 (CH2), 57.3 (CH2), 69.0 
(CH2), 74.7 (CH), 79.4 (C), 126.6 (CH), 130.7 (CH). Azide 4-105b: Rf = 0.40 (5% 
EtOAc/hexanes); IR (neat) 2859, 2100, 1089 cm-1; HRMS (ESI) m/z calculated for C7H10N3O 
(M+H)+ 152.0824, found: 152.0830; 1H NMR (400 MHz, CDCl3) δ 2.48 (t, J = 2.4 Hz, 1H), 
3.55 (dd, J = 9.9, 7.4 Hz, 1H), 3.65 (dd, J = 9.9, 4.4 Hz, 1H), 4.10-4.16 (m, 1H), 4.23 (t, J = 
2.4 Hz, 1H), 5.36 (dt, J = 10.3, 1.0 Hz, 2H), 5.41 (dt, J = 17.1, 1.1 Hz, 2H), 5.79 (ddd, J = 
17.3, 10.3, 7.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 58.5 (CH2), 63.5 (CH), 71.6 (CH2), 
75.1 (CH), 79.0 (C), 119.6 (CH2), 132.2 (CH).  
 
 
7-Vinyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine (4-106). A mixture of 
azides 4-105a, 4-105b and triazole 4-106 (18:58:24 ratio, 32 mg, 0.20 mmol) in chloroform 
(11 mL) under N2 atmosphere was refluxed for 4 h. After the reaction was cooled to room 
temperature, solvent was removed under reduced pressure. The residue was purified by silica 
gel column chromatography (20-50% EtOAC/hexanes) to afford triazole 4-106 (23 mg, 72%) 
as a colorless oil. Triazole 4-106: Rf = 0.45 (100% EtOAc); IR (neat) 2923, 2101 cm
-1; 
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HRMS (ESI) m/z calculated for C7H10N3O (M+H)
+ 152.0824, found: 152.0824; 1H NMR (400 
MHz, CDCl3) δ 3.90 (dd, J = 12.1, 6.0 Hz, 1H), 4.12 (dd, J = 12.1, 4.3 Hz, 1H), 4.94 (s, 2H), 
5.06 (q, J = 6.1 Hz, 1H), 5.37-5.47 (m, 2H), 5.99 (ddd, J = 17.4, 10.4, 7.2 Hz, 1H), 7.51 (s, 
1H); 13C NMR (100 MHz, CDCl3) δ 58.6 (CH), 62.5 (CH2), 68.3 (CH2), 120.7 (CH2), 128.1 
(CH), 130.4 (CH), 132.3 (C). 
 
(1R*,2R*)-2-Azidocyclohex-3-enol (4-108a) and (1R*,4R*)-4-azidocyclohex-2-
enol (4-108b). To a solution of 7-oxabicyclo-[4.1.0]hept-2-ene (4-107) (3.0 g, 30 mmol) in a 
mixed solvent of ethanol (40 mL) and water (10 mL) was added sodium azide (2.93 g, 45.0 
mmol) and ammonium chloride (2.43 g, 45.0 mmol). The resulting mixture was refluxed for 
12 h. After it was cooling to room temperature, water and diethyl ether were added. After 
phase separation, the aqueous layer was washed with diethyl ether three times. The combined 
organic layers were washed with brine, dried over anhydrous sodium sulfate and concentrated. 
The residue was purified by silica gel column chromatography (5-20% EtOAC/hexanes) to 
afford a mixture of azides 4-108a and 4-108b (82:18 ratio, 3.50 g, 81%) as a colorless oil. 
Pure samples of 4-108a and 4-108b were obtained by flash chromatography. Azide 4-108a: 
Rf = 0.60 (50% EtOAc/hexanes); IR (neat) 3340, 2929, 2089 cm
-1; 1H NMR (400 MHz, 
CDCl3) δ 1.65-1.76 (m, 1H), 1.93-2.01 (m, 1H), 2.16-2.23 (m, 2H), 2.56 (br, 1H), 3.71-3.78 
(m, 1H), 3.81-3.86 (m, 1H), 5.58 (dq, J = 9.9, 2.3 Hz, 1H), 5.87-5.95 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ 24.1 (CH2), 28.6 (CH2), 64.3 (CH), 70.9 (CH), 123.1 (CH), 131.5 (CH). 
Azide 4-108b: Rf = 0.50 (50% EtOAc/hexanes); IR (neat) 3340, 2929, 2089 cm
-1; 1H NMR 
(400 MHz, CDCl3) δ 1.47-1.57 (m, 1H), 1.57-1.66 (m, 1H), 2.00-2.16 (m, 2H), 2.80 (d, J = 
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5.2 Hz, 1H), 3.88-3.93 (m, 1H), 4.22 (br, 1H), 5.74 (dm, J = 10.1 Hz, 1H), 5.93 (dm, J = 10.1 
Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 26.2 (CH2), 29.9 (CH2), 56.2 (CH), 65.2 (CH), 127.4 
(CH), 134.7 (CH). 
 
 
(3R*,4R*)-3-Azido-4-(prop-2-yn-1-yloxy)cyclohex-1-ene (4-109a), (3R*,6R*)-3-
azido-6-(prop-2-yn-1-yloxy)cyclohex-1-ene (4-109b), and (4aR*,8aS*)-5,6,8a,9-
tetrahydro-4aH-benzo[e][1,2,3]triazolo[5,1-b][1,3]oxazine (4-110). To a solution of a 
mixture of azides 4-108a and 4-108b (900 mg, 5.00 mmol) in anhydrous DMF (20 mL) at 
0 °C under N2 atmosphere was added sodium hydride (60% in mineral oil, 240 mg, 6.00 
mmol). After the resulting mixture was stirred at 0 °C for 1 h, propargyl bromide (80% w/w 
in toluene, 900 mg, 6.00 mmol) was added slowly. The resulting mixture was stirred 
overnight. The reaction mixture was quenched with saturated aqueous ammonium chloride. 
Diethyl ether was used to extract the products and the aqueous layer was washed with diethyl 
ether three times. The combined organic layers were washed with brine, dried over anhydrous 
sodium sulfate and concentrated. The residue was purified by silica gel column 
chromatography (0.5-30% EtOAC/hexanes) to afford a mixture of azides 4-109a, 4-109b and 
triazole 4-110 (1:0.05:0.15 ratio, 100 mg, 10%) as a colorless oil, a mixture of azides 4-109b, 
and 4-109a (10:1 ratio, 70 mg, 7%) as a colorless oil, unreacted starting azides 4-108a and 4-
108b (195 mg, 22% recovered) as a colorless oil, and triazole 4-110 (250 mg, 28%) as a 
white solid. Azide 4-109a (1:0.05:0.15 ratio): Rf = 0.80 (20% EtOAc/hexanes); IR (neat) 
2877, 2095, 1084 cm-1; HRMS (ESI) m/z calculated for C9H12N3O (M+H)
+ 178.0980, found: 
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178.0977; 1H NMR (400 MHz, CDCl3) δ 1.63-1.75 (m, 1H), 1.99-2.08 (m, 1H), 2.09-2.27 (m, 
2H), 2.48 (t, J = 2.4 Hz, 1H), 3.67-3.74 (m, 1H), 3.91-3.96 (m, 1H), 4.32 (dd, J = 2.3, 1.7 Hz, 
2H), 5.56 (dq, J = 9.9, 2.6 Hz, 1H), 5.89-5.97 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 23.5 
(CH2), 25.3 (CH2), 56.6 (CH2), 61.4 (CH), 74.5 (CH), 77.4 (CH), 79.7 (C), 123.3 (CH), 131.5 
(CH). (Note: After 7 days, the ratio was determined to 0.1:0.1: 1; After another 7 days, the 
ratio was determined to 1:1:40.) Azide 4-109b (10:1:0 ratio): Rf = 0.70 (20% EtOAc/hexanes); 
IR (neat) 2936, 2093 cm-1; HRMS (ESI) m/z calculated for C9H12N3O (M+H)
+ 178.0980, 
found: 178.0975; 1H NMR (400 MHz, CDCl3) δ 1.61-1.70 (m, 2H), 2.096-2.18 (m, 2H), 2.46 
(t, J = 2.4 Hz, 1H), 3.92-3.98 (m, 1H), 4.14-4.19 (m, 1H), 4.23 (t, J = 2.7 Hz, 1H), 5.85 (dt, J 
= 10.2, 1.2 Hz, 1H), 6.05 (dt, J = 10.2, 2.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 26.0 
(CH2), 26.1 (CH2), 55.7 (CH2), 56.1 (CH), 71.3 (CH), 74.4 (CH), 79.9 (C), 128.4 (CH), 132.0 
(CH). (After 7 days, the ratio was determined to 0.4:0.3:1; After another 7 days, the ratio was 
determined to 1:1:20). Triazole 4-110: Rf = 0.20 (50% EtOAc/hexanes); IR (neat) 2878, 2096, 
1084 cm-1; HRMS (ESI) m/z calculated for C9H12N3O (M+H)
+ 178.0980, found: 178.0987; 1H 
NMR (400 MHz, CDCl3) δ 1.78-1.92 (m, 1H), 2.12-2.19 (m, 1H), 2.24-2.43 (m, 2H), 3.63 
(ddd, J = 12.2, 8.8, 3.5 Hz, 1H), 4.65 (d, J = 8.4 Hz, 1H), 4.91 (dm, J = 15.2 Hz, 1H), 5.09 (d, 
J = 15.1 Hz, 1H), 5.80-5.87 (m, 1H), 6.47 (d, J = 10.0 Hz, 1H), 7.43 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ 25.1 (CH2), 25.9 (CH2), 59.3 (CH), 62.6 (CH2), 76.1 (CH), 121.1 (CH), 128.5 
(CH), 130.0 (CH), 130.6 (C). 
 
 
(E)-1-Bromo-4-(but-3-yn-2-yloxy)but-2-ene (4-112). To a solution of but-3-yn-2-ol 
(1.40 g, 20.0 mmol) in anhydrous DMF (20 mL) at room temperature under N2 atmosphere 
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was added portion-wise sodium hydride (60% in mineral oil, 880 mg, 22.0 mmol). After 30 
min, the above solution was slowly added to a solution of (E)-1,4-dibromobut-2-ene (5.56 g, 
26.0 mmol) in anhydrous DMF (20 mL) at 0 °C. After the resulting mixture was stirred 
overnight, saturated ammonium chloride was used to quench the reaction. Diethyl ether was 
used to extract the product and the aqueous layer was washed with diethyl ether three times. 
The combined organic layers were washed with brine, dried over anhydrous sodium sulfate 
and concentrated. The residue was purified by silica gel column chromatography (0.5-2% 
EtOAC/hexanes) to afford bromide 4-112 (395 mg, 10%) as a colorless oil. Bromide 4-112: 
Rf = 0.75 (20% EtOAc/hexanes); IR (neat) 3292, 2986, 1727 cm
-1; 1H NMR (400 MHz, 
CDCl3) δ 1.47 (d, J = 6.6 Hz, 3H), 2.45 (d, J = 2.0 Hz, 1H), 3.97-4.05 (m, 3H), 4.21 (qd, J = 
6.6, 2.0 Hz, 2H), 4.27-4.33 (m, 1H), 5.83-5.94 (m, 1H), 5.95-6.05 (m, 1H); 13C NMR (101 
MHz, CDCl3) δ 22.0 (CH3), 31.9 (CH2), 64.6 (CH), 67.9 (CH2), 73.2 (CH), 83.4 (C), 129.0 
(CH), 131.2 (CH). 
 
 
(E)-1-Azido-4-(but-3-yn-2-yloxy)but-2-ene (4-113a), (Z)-1-azido-4-(but-3-yn-2-
yloxy)but-2-ene (4-113b), (R*)-3-azido-4-((S*)-but-3-yn-2-yloxy)but-1-ene (4-113c) and 
(S*)-3-azido-4-((S*)-but-3-yn-2-yloxy)but-1-ene (4-113d). A suspension of bromide 4-112 
(820 mg, 4.00 mmol) and sodium azide (780 mg, 12.0 mmol) in DMF (15 mL) was stirred 
overnight at room temperature. The reaction mixture was quenched with saturated aqueous 
ammonium chloride. Diethyl ether was used to extract the products and the aqueous layer was 
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washed with diethyl ether three times. The combined organic layers were washed with brine, 
dried over anhydrous sodium sulfate and concentrated. The residue was purified by silica gel 
column chromatography (0.5-100% EtOAC/hexanes) to afford a mixture of azides 4-113a, 4-
113b, 4-113c and 4-113d (10:0:1:1 ratio, 90 mg, 14%) as a colorless oil, triazole 4-114a (63 
mg, 10%) as a colorless oil and triazole 4-114b (27 mg, 5%) as a colorless oil. Azides 4-113a, 
4-113b, 4-113c, and 4-113d (10:0:1:1 ratio): Rf = 0.55 (10% EtOAc/hexanes); IR (neat) 3299, 
2989, 2865, 2097 cm-1; HRMS (ESI) m/z calculated for C8H12N3O (M+H)
+ 166.0980, found: 
166.0979. Azide 4-113a: 1H NMR (400 MHz, CDCl3) δ 1.47 (d, J = 6.6 Hz, 3H), 2.45 (d, J = 
2.0 Hz, 1H), 3.77-3.83 (m, 2H), 4.02 (dd, J = 12.3, 5.3 Hz, 1H), 4.22 (qd, J = 6.6, 2.0 Hz, 1H), 
4.30 (dd, J = 12.5, 4.6 Hz, 1H), 5.78-5.92 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 22.0 
(CH3), 52.2 (CH2), 64.5 (CH), 68.0 (CH2), 73.2 (CH), 83.4 (C), 126.1 (CH), 131.2 (CH). 
Azides 4-113c and 4-113d (diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 2.46 (d, J 
= 2.0 Hz, 1H), 3.41 (dd, J = 9.9, 8.1 Hz, 1H), 3.53 (dd, J = 10.0, 4.3 Hz, 1H), 5.29-5.36 (m, 
1H), 5.36-5.44 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 21.9 (CH3), 22.0 (CH3), 63.3 (CH), 
63.6 (CH), 65.5 (CH), 65.9 (CH), 70.4 (CH2), 70.9 (CH2), 73.4 (CH), 73.5 (CH), 83.0 (C), 
83.2 (C), 119.3 (CH2), 119.4 (CH2), 132.35 (CH), 132.48 (CH).  
 
 
(4S*,7R*)-4-Methyl-7-vinyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine (4-
114a) and (4S*,7S*)-4-Methyl-7-vinyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine 
(4-114b). Triazole 4-114a: Rf = 0.25 (100% EtOAc/hexanes); IR (neat) 2984, 2099 cm
-1; 
HRMS (ESI) m/z calculated for C8H12N3O (M+H)
+ 166.0980, found: 166.0982; 1H NMR (400 
MHz, CDCl3) δ 1.57 (d, J = 6.5 Hz, 3H), 3.69 (dd, J = 12.2, 10.0 Hz, 1H), 4.23 (dd, J = 12.2, 
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5.0 Hz, 1H), 4.89 (q, J = 6.5 Hz, 1H), 4.95-5.01 (m, 1H), 5.53 (dt, J = 10.3, 0.7 Hz, 1H), 5.55 
(dt, J = 17.2, 0.7 Hz, 1H), 5.93 (ddd, J = 17.2, 10.3, 7.8 Hz, 1H), 7.49 (d, J = 0.8 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 20.3 (CH3), 59.1 (CH), 67.9 (CH2), 69.2 (CH), 121.9 (CH2), 128.6 
(CH), 131.1 (CH), 135.6 (C). Triazole 4-114b: Rf = 0.20 (100% EtOAc/hexanes); IR (neat) 
2984, 2100, 1110 cm-1; HRMS (ESI) m/z calculated for C8H12N3O (M+H)
+ 166.0980, found: 
166.0978; 1H NMR (400 MHz, CDCl3) δ 1.59 (d, J = 6.6 Hz, 3H), 4.05 (dd, J = 12.1, 3.6 Hz, 
1H), 4.20 (dd, J = 12.1, 1.5 Hz, 1H), 4.92 (q, J = 6.5 Hz, 1H), 5.06-5.10 (m, 1H), 5.17 (dq, J 
= 17.2, 0.6 Hz, 1H), 5.36 (d, J = 10.4 Hz, 1H), 6.07 (ddd, J = 17.0, 10.4, 6.6 Hz, 1H), 7.50 (d, 
J = 0.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 20.5 (CH3), 57.7 (CH), 67.5 (CH2), 69.1 
(CH), 119.1 (CH2), 128.4 (CH), 134.3 (CH), 135.2 (C). The following data and NOE 
correlations were used to assign triazoles 4-114a and 4-114b.  
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(E)-5-Azidopent-3-en-1-ol (4-116a), (Z)-5-azidopent-3-en-1-ol (4-116b) and 3-
azidopent-4-en-1-ol (4-116c). Following the general procedure III in chapter 2, but-3-en-1-
ol (7.2 g, 0.10 mol), allyl bromide (26 mL, 0.30 mol), HG-2 (206 mg, 0.330 mmol), and 
sodium azide (26 g, 0.40 mol) afforded a mixture of azides 4-116a, 4-116b, and 4-116c 
(75:7:18 ratio, 5.0 g, 40%) as a colorless oil after silica gel column chromatography (5-20% 
EtOAc/hexanes). Rf = 0.55 (100% EtOAc/hexanes). Azide 4-116a: IR (neat) 3340, 2932, 
2094, 1236 cm-1; HRMS (ESI) m/z calculated for C10H19N6O2 (2M+H)
+ 255.1569, found: 
255.1567; 1H NMR (400 MHz, CDCl3) δ 2.36 (q, J = 6.5 Hz, 2H), 3.69 (q, J = 6.0 Hz, 2H), 
3.75 (d, J = 6.4 Hz, 2H), 5.60-5.69 (m, 1H), 5.73-5.83 (m, 1H); 13C NMR (100 MHz, CDCl3) 
δ 35.5 (CH2), 52.7 (CH2), 61.7 (CH2), 125.7 (CH), 132.6 (CH). Azide 4-116b (diagnostic 
peaks only): 1H NMR (400 MHz, CDCl3) δ 3.86 (d, J = 7.2 Hz, 1H). Azide 4-116c: IR (neat) 
3342, 2931, 2094, 1236 cm-1; HRMS (ESI) m/z calculated for C10H19N6O2 (2M+H)
+ 255.1569, 
found: 255.1552; 1H NMR (400 MHz, CDCl3) δ 1.75-1.81 (m, 2H), 2.00 (t, J = 4.5 Hz, 1H), 
3.68-3.80 (m, 2H), 4.10 (q, J = 7.4 Hz, 1H), 5.31 (dt, J = 4.1, 0.9 Hz, 1H), 5.34 (dt, J = 11.1, 
1.0 Hz, 1H), 5.80 (ddd, J = 17.2, 10.2, 7.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 36.7 
(CH2), 59.3 (CH2), 62.3 (CH), 118.5 (CH2), 135.3 (CH). 
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(E)-5-Azidopent-3-en-2-ol (4-118a), (2R*,3R*)-3-Azidopent-4-en-2-ol (4-118b), 
and (2R*,3S*)-3-Azidopent-4-en-2-ol (4-118c). Following the general procedure III in 
chapter 2, but-3-en-2-ol (7.2 g, 0.10 mol), allyl bromide (26 mL, 0.30 mol), HG-2 (206 mg, 
0.330 mmol), and sodium azide (26 g, 0.40 mol) afforded a mixture of azides 4-118a, 4-118b, 
and 4-118c (57:23:20 ratio, 5.64 g, 44%) as a colorless oil after silica gel column 
chromatography (5-20% EtOAc/hexanes). Azide 4-118a: Rf = 0.45 (50% EtOAc/hexanes); 
1H 
NMR (400 MHz, CDCl3) δ 1.23-1.29 (m, 3H), 2.46 (br, 1H), 3.74 (d, J = 5.7 Hz, 2H), 4.27-
4.37 (m, 1H), 5.64-5.75 (m, 1H), 5.77-5.86 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 23.3 
(CH3), 52.1 (CH2), 67.7 (CH), 122.4 (CH), 139.5 (CH). Azide 4-118b: IR (neat) 3374, 2977, 
2096, 1244 cm-1; HRMS (ESI) m/z calculated for C10H19N6O2 (2M+H)
+ 255.1569, found: 
255.1590; 1H NMR (400 MHz, CDCl3) δ 1.17 (d, J = 6.2 Hz, 3H), 2.53 (br, 1H), 3.63-3.70 
(m, 1H), 3.74 (t, J = 7.6 Hz, 1H), 5.33-5.40 (m, 2H), 5.76 (ddd, J = 16.6, 10.6, 8.2 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ 19.2 (CH3), 69.2 (CH), 71.7 (CH), 120.6 (CH2), 132.4 (CH). 
Azide 4-118c: 1H NMR (400 MHz, CDCl3) δ 1.17 (d, J = 6.3 Hz, 3H), 2.20 (br, 1H), 3.80-
3.85 (m, 1H), 3.86-3.91 (m, 1H), 5.38 (d, J = 17.1 Hz, 1H), 5.44 (d, J = 10.1 Hz, 1H), 5.84 
(ddd, J = 17.2, 10.3, 8.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 18.5 (CH3), 68.9 (CH), 70.5 
(CH), 121.2 (CH2), 131.5 (CH). 
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tert-Butyl ((1R*,6R*)-6-hydroxycyclohex-2-en-1-yl)carbamate (4-119) and tert-
butyl ((1R*,4R*)-4-hydroxycyclohex-2-en-1-yl)carbamate (4-120). To a solution of azide 
4-108a and 4-108b (82:18 ratio, 280 mg, 2.00 mmol) in methanol (20 mL) was added tin(II) 
chloride (760 mg, 4.00 mmol). After the resulting mixture was stirred for 11 h, dioxane (20 
mL) and water (5 mL) were added, followed by the addition of (Boc)2O (900 mg, 4.00 mmol), 
sodium carbonate (864 mg, 8.00 mmol) and catalytic amount of DMAP. The resulting 
mixture was stirred overnigh before the addition of 1 M aqueous hydrochloride solution to 
acidify the solution. The aqueous layer was extracted with ethyl acetate three times. The 
combined organic layers were washed with brine, dried over anhydrous sodium sulfate and 
concentrated. The residue was purified by silica gel column chromatography (5-20% 
EtOAC/hexanes) to afford carbamate 4-119 (250 mg, 59%) as a colorless oil and carbamate 
4-120 (70 mg, 17%) as a colorless oil. Carbamate 4-119: Rf = 0.30 (50% EtOAc/hexanes); IR 
(neat) 3323, 2979, 1681, 1517 cm-1; HRMS (ESI) m/z calculated for C11H19NO3Na (M+Na)
+ 
236.1263, found: 236.1261; 1H NMR (400 MHz, CDCl3) δ 1.45 (s, 9H), 1.59-1.72 (m, 1H), 
1.91-1.97 (m, 1H), 2.03-2.20 (m, 2H), 3.63 (ddd, J = 10.7, 7.3, 3.5 Hz, 1H), 3.88 (br, 1H), 
4.05 (br, 1H), 4.78 (d, J = 6.3 Hz, 1H), 5.40 (d, J = 9.5 Hz, 1H), 5.80 (d, J = 7.8 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 23.9 (CH2), 28.4 (CH3), 28.9 (CH2), 55.0 (CH), 73.0 (CH), 80.2 
(C), 125.6 (CH), 130.6 (CH), 157.3 (C). Carbamate 4-120: Rf = 0.20 (50% EtOAc/hexanes); 
IR (neat) 3316, 2930, 1680, 1525, 1168 cm-1; HRMS (ESI) m/z calculated for C11H19NO3Na 
(M+Na)+ 236.1263, found: 236.1249; 1H NMR (400 MHz, CDCl3) δ 1.46 (s, 9H), 1.53-1.63 
(m, 2H), 2.05-2.18 (m, 2H), 4.24 (br, 2H), 4.48 (br, 1H), 5.72 (d, J = 10.1 Hz, 1H), 5.83 (d, J 
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= 10.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 28.1 (CH2), 28.4 (CH3), 30.9 (CH2), 46.4 
(CH), 66.0 (CH), 79.5 (C), 131.0 (CH), 132.9 (CH), 155.2 (C). 
 
 
2-Phenyl-4-vinyl-5,6-dihydro-4H-1,3-oxazine (4-100). To a refluxing solution of a 
mixture of azides 4-116a, 4-116b, and 4-116c (210 mg, 1.65 mmol) and benzaldehyde (175 
mg, 1.65 mmol) in 1,2-dichloroethane (16 mL) under N2 atmosphere, was slowly added 
BF3∙OEt2 (467 mg, 3.3 mmol). The resulting mixture was refluxed overnight. Saturated 
ammonium chloride was used to quench the reaction and dichloromethane was used to extract 
the product. The aqueous layer was extracted with dichloromethane three times. The 
combined organic layers were washed with brine, dried over anhydrous sodium sulfate and 
concentrated. The residue was purified by silica gel column chromatography (2-10% 
EtOAC/hexanes) to afford oxazine 4-100 (70 mg, 23%) as a colorless oil. Oxazine 4-100: Rf 
= 0.70 (20% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 1.76-1.85 (m, 1H), 2.09-2.18 
(m, 1H), 4.20-4.26 (m, 1H), 4.32-4.39 (m, 2H), 5.24 (dt, J = 10.3, 1.6 Hz, 1H), 5.30 (dt, J = 
17.1, 1.7 Hz, 1H), 6.02 (ddd, J = 17.1, 10.3, 5.2 Hz, 1H), 7.35-7.47 (m, 3H), 7.96-8.02 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 27.0 (CH2), 53.0 (CH), 63.2 (CH2), 115.2 (CH2), 127.1 
(CH), 128.0 (CH), 130.4 (CH), 134.0 (C), 140.2 (CH), 155.1 (C).  
 
 
N-(5-Hydroxypent-1-en-3-yl)benzamide (4-101). To a solution of oxazine 4-100 
(90 mg, 0.5 mmol) in a mixed solvent of acetone (5 mL) and water (5 mL), was added 
potassium carbonate (350 mg, 2.5 mmol). The resulting mixture was stirred overnight. 1N 
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HCl solution was used to neutralize the solution, and ethyl acetate was used to extract the 
product. The aqueous layer was extracted with ethyl acetate three times. The combined 
organic layers were washed with brine, dried over anhydrous sodium sulfate and concentrated. 
The residue was purified by silica gel column chromatography (5-100% EtOAC/hexanes) to 
afford alcohol 4-101 (12 mg, 12%) as a colorless oil. Alcohol 4-101: Rf = 0.30 (100% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 1.60-1.68 (m, 1H), 2.04-2.13 (m, 1H), 3.55 
(br, 1H), 3.69-3.79 (m, 2H), 4.89-4.97 (m, 1H), 5.25 (ddd, J = 10.5, 1.6, 0.9 Hz, 1H), 5.32 
(ddd, J = 17.3, 1.7, 0.9 Hz, 1H), 5.97 (ddd, J = 17.3, 10.5, 5.1 Hz, 1H), 6.58 (br-d, J = 7.4 Hz, 
1H), 7.43-7.50 (m, 2H), 7.51-7.57 (m, 1H), 7.79-7.85 (m, 2H). 
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CHAPTER 5 
 
THE REORGANIZATION OF ALLYLIC AZIDE TO AZADIENE 
 
5.1 Introduction 
Under strong acidic conditions, there are two possible migrating groups in benzyl 
azide 5-1; the migration of hydrogen atom leads to the formation of protonated benzylimine 
5-3 (route b), and the migration of phenyl group yields a protonated 2-azadiene 5-2 (route a) 
(Scheme 110). In 1997, Pearson and coworkers reported the reorganization of benzyl azide to 
2-azadiene and its subsequent Diels-Alder reactions to tetrahydroquinoline 5-4.155 A year 
later, our group reported the same reorganization and the following Mannich reactions to β-
amino ketone 5-5.156-158 Diels-Alder reactions of intermediate 5-2 with indoles or enamides 
have been reported recently.159,160  
 
Scheme 110. Reorganization involving benzyl azides. 
Based on our discoveries involving allylic azides, we theorized that the allylic azide 
could undergo a similar reorganization (Scheme 111). Similar to benzyl azide, the migration 
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of vinyl group would give protonated 2-azadiene 5-7, and the migration of H group leads to 
the formation of protonated 1-azadiene 5-8. Such reorganization could potentially have more 
synthetic applications than the one involving benzyl azide, which has limited its utility owing 
to the necessary presence of phenyl ring.  
 
Scheme 111. Reorganization involving allylic azides.  
1-Azadiene has been considered a π-electron deficient diene system due to its low 
reactivity with electron-poor dienophiles in the normal Diels-Alder reaction.161,162 Based on a 
rudimentary calculation of bond cleavage and formation by Jung and coworkers,163 2-
azadiene only has two C=C bond cleavages and four C-C bond formations, which is the same 
as butadiene, thus it was preferred in the Diels-Alder reaction by 20 kcal/mol over 1-azadiene, 
which only has C=C and C=N bond cleavages, and 2 C-C and 2 C-N bond formations. This is 
probably a result of the relatively weak C-N bond (C-N 73 kcal/mol vs C-C 86 kcal/mol; 
C=N 147 kcal/mol vs C=C 146 kcal/mol). Bachrach and coworkers calculated the relative 
activation and reaction energy for these dienes,164 and they found by any methods used that 1-
azadiene always has higher activation energy and lower reaction energy over 2-azadiene, 
which has similar numbers to butadiene.  
Thus the generated protonated 1-azadiene (5-3 and 5-8) and 2-azadiene (5-2 and 5-7), 
from either benzyl azide or allylic azide under strong acidic conditions, are different from 
what we discussed about above, because the nitrogen atom is protonated. Hence, their 
behavior and performance in organic synthesis may be different. 
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To the best of our knowledge, there are no general methods to prepare mono-
substituted 1-azadiene and 2-azadiene. Herein, we are only focusing on the recent 
development of 2-azadiene with fewer than two substituents.  
Recently, Scott and coworkers reported the generation of a 2-azadiene precursor by 
the migration of the double bond along the alkyl chain (Scheme 112).165 Upon activation by a 
Lewis acid, 2-azadiene iminium ion 5-11 was generated and reacted with electron-neutral 
dienes to produce substituted piperidines 5-13.  
 
Scheme 112. Scott’s preparation of 2-azadiene and reactions.  
Hashimoto and coworkers reported the Rh(II)-catalyzed enantioselective Diels-Alder 
reaction of 2-azadiene, which was prepared from imine and acyl chloride via [1,3]-Brook 
rearrangement (Scheme 113).166 This reaction can tolerate a wide range of aliphatic and 
aromatic aldehydes with either electron-donating or electron-withdrawing substituents.  
 
Scheme 113. Rh(II)-catalyzed enantio-selective Diels-Alder reaction of 2-azadiene. 
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5.2 Results and discussion 
Following the reported procedure,155 we first tried to achieve the reorganization of 
benzyl azide 5-20 (Scheme 114). When 4-bromobenzyl azide 5-20 was treated with triflic 
acid, a stable 2-azadiene intermediate 5-21 was generated; the spectral data of the obtained 
material compares to that of the reported intermediate 5-2. We conducted the following 
Diels-Alder reaction with cyclopentene using two types of addition sequence: the early and 
late addition of cyclopentene to 2-azadiene 5-21. In the case of late addition sequence, 
hydrolyzed product of 2-azadiene intermediate, 4-bromoaniline 5-23, was obtained. 
Unreacted benzyl azide was recovered for the reaction involving early addition sequence, 
which may be a result of the initial reaction of triflic acid with cyclopentene to form 
cyclopentyl carbocation, instead of the reaction with benzyl azide to generate 5-21.  
 
Scheme 114. Reorganization of 4-bromobenzyl azide.  
Preparation of allylic azides. Five allylic azides were prepared by either azide 
displacement or Mitsunobu reaction (Scheme 115). When perillyl alcohol was converted to 
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allylic azides, a mixture of 5-33, 5-34, and 5-35 in a 1:0.11:0.17 ratio was obtained. 
Compound 5-35 with the axial azide group is more stable than 5-34 due to A1,3 strain 
generated from azide and vinyl hydrogen.  
 
Scheme 115. Preparation of allylic azides.  
When allylic azide 5-25 was treated with triflic acid, intermediates 5-36 and 5-37 
may be generated (Scheme 116). They can react with electron-rich or electron-deficient 
dienophiles to produce tetrahydropyridines 5-38 and 5-40, which may isomerize to 5-39 and 
5-41, respectively, under acidic conditions. This equilibration is in the favor of the stable 
thermodynamic product based on their conformations.  
A number of dienophiles with electron-donating, electron-neutral, and electron-
withdrawing substituents were tested and did not yield cycloadducts. We also investigated the 
same reaction at different temperatures, solvents, addition sequences, and bases without 
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success. A similar result was observed when triethylamine and 2,6-di-t-butyl 4-methyl 
pyridine were added in an attempt to make the reaction conditions less acidic. The spectral 
data of intermediate 5-36 or 5-37 was also acquired; however, it did not match with our 
desired intermediate. It also indicated the existence of one intermediate without the starting 
allylic azide. Diels-Alder cycloaddition with different dienes yielded a complicated mixture, 
and no useful information could be deduced from these reactions.  
We also tested allylic azide 5-27 for this conversion, and it was more complex than 
azide 5-25 because the spectrum of intermediate showed the existence of two intermediates, 
one of which resembles an intermediate from 5-25 and the other one resembles 5-37.  
 
Scheme 116. Diels-Alder reaction of reorganized allylic azide 5-25.  
Fortunately, we came cross one paper by Denis and coworkers,167 in which they 
reported the synthesis of 1-azetine and its thermal ring opening to 2-azabutadiene (Scheme 
117). They also mentioned that 1-azetine polymerizes in a few seconds in sealed degassed 
tubes at 20 °C, and its half-life in CFCl3 solution is 3 days in the presence of hydroquinone. If 
trace amounts of oxygen or acid were present, polymerization occurred rapidly. The structure 
of 1-azetine was confirmed by LAH reduction and cyanide attack, and the 1H NMR spectrum 
of 2-azabutadiene was acquired at -60 °C. Its polymerization in a dilute solution only takes a 
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few minutes at 25 °C. From this data, it can be inferred that 2-azabutadiene is less stable than 
1-azetine.  
 
Scheme 117. Preparation of 2-azabutadiene.  
We then considered if the similar electrocyclization did occur in our system. First, we 
compared our data with reported data167 (Scheme 117 and Figure 128) and found that the 
chemical shift pattern of proton and carbon NMR, as well as coupling constants, are similar 
to the reported data of 1-azetine.167 This comparison suggested that electrocyclization could 
occur after the initial reorganization of the allylic azides.  
 
Figure 128. 1H and 13C NMR data of intermediates.  
Upon the electrocyclization of 2-azadiene 5-36, the generated intermediate 5-45 
should react with strong nucleophiles to produce azetidine 5-46 (Scheme 118). With this in 
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mind, we re-examined our results, and did not find evidence for the existence of 5-46 in the 
crude products. Stronger conditions should be utilized to achieve this conversion. 
Furthermore, the azetine 5-45 did not react with furan to afford Diels-Alder adducts.  
 
Scheme 118. Re-examination of our results. 
In order to further confirm this, we tried to reduce the 1-azetine 5-45 to azetidine 5-
47, hoping the subsequent sulfonylation could provide us the protected azetidine 5-48 
(Scheme 119). We expected to get a usable crystal for X-ray crystallography to confirm the 
structure. Unfortunately, we obtained a mixture of 5-48 and 5-49, the latter being confirmed 
by X-ray (Figure 129), in a very low yield with a 4:1 ratio.  
 
Scheme 119. Reduction of azetine.  
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Figure 129. ORTEP representation of 5-49.  
We proposed a mechanism for the formation of compound 5-49 (Figure 130). The 
internal nitrogen of azide 5-25 could be protonated by triflic acid, and the generated 
trifluomethylsulfonate counter ion could attack dichloromethane to produce a chloride ion. 
Aziridine 5-51 could be generated upon the attack of chloride on 5-50 and with the 
concomitant extrusion of nitrogen gas. The subsequent chloride attack might afford amine 5-
52, whose subsequent sulfonylation would give 5-49.  
 
Figure 130. Proposed mechanism for the formation of 5-49.  
Allylic azide 5-27 was treated with triflic acid, and 5-54 was obtained along with 
azetine 5-53, whose spectral data is shown in Figure 128. Although the initial ratio of 5-53 
and 5-54 is 2:1, s-cis 5-54 was slowly transferred with time to s-trans 5-55 (Scheme 120). 
The relative stereochemistry of s-cis 5-54 was confirmed by 2D NMR.  
 436 
 
Scheme 120. Reorganization of azide 5-27.  
In order to further confirm the structure of azetine 5-53, we treated the mixture of 5-
53 and 5-54 with sodium borohydride, followed by the subsequent Boc protection, and this 
reaction afforded four compounds (Scheme 121). The existence of 5-59, whose spectral data 
matched reported data,168 might indicate the existence of the proposed intermediate 5-54 or 5-
55. Another possibility is the direct reduction of azide 5-27 to 5-59. The presence of 5-62 and 
5-63, whose structures were confirmed by 2D NMR, indicated that dimerization occurred 
before electrocyclization.  
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Scheme 121. Reduction and protection of azide 5-27 intermediates.  
The comparison of intermediate 5-53 and 5-57 indicated that their spectral data 
should be very similar. The coupling constant of two methylene groups in 5-57 should be 
larger because the ring system of 5-57 is more flexible than 5-53. Currently, we only have the 
NMR data of one compound and it is difficult to conclude whether it is 5-58, 5-60 or 5-61. 
HRMS analysis did not provide any useful information. We attempted to incorporate the 
second Boc group in the compounds 5-62 and 5-63 to get 5-60 and 5-61 (Scheme 122). Thus, 
we could compare the spectral data of 5-62 and 5-63 with the data on hand to identify them; 
and further we can know if the reaction is the dimerization or electrocyclization. 
Unfortunately, the reaction, which is similar to reduction-protection shown in Scheme 121, 
did not work out as planned. Retrospectively, we should get 5-60 or 5-61 if the compound on 
hand is 5-60 or 5-61. This further enhances the probability of 5-58 in this reaction. Additional 
experiments need to be conducted to confirm this conversion.  
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Scheme 122. Boc protection of mono-protected dimer. 
Currently we speculated that an equilibrium exists between 1-azetine and 2-azadiene. 
In order to inhibit the electrocyclization to 1-azetine and push 2-azadiene forward for Diels-
Alder reaction, we plan to add electron-donating or electron-withdrawing groups to allylic 
azides to test which kind of group is better for this reorganization (Scheme 123). 
 
Scheme 123. Future directions.  
 
5.3 Conclusion 
In this chapter, attempts were made to reorganize allylic azide for Diels-Alder 
reaction. Initial studies indicated that there may be electrocyclization for protonated 2-
azadiene to 1-azetine, after the comparison of our intermediates with reported data. However, 
this conversion needs to be further confirmed.  
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5.4 Experimental data 
 
3-Azido-2-methylprop-1-ene (5-25). To a solution of 3-chloro-2-methylprop-1-ene 
(9.06 g, 0.10 mol) in DMF (50 mL) was added sodium azide (13 g, 0.20 mol) portionwise. 
The resulting mixture was stirred overnight, and water was used to quench the reaction. 
Diethyl ether was used to extract the product and the aqueous layer was washed with diethyl 
ether three times. The combined organic layers were washed with brine, dried over anhydrous 
sodium sulfate, and concentrated at 1 atm atmospheric pressure. The residue was purified by 
reductive distillation (55-65 °C/110 mmHg) to afford azide 5-25 (5.2 g, 54%) as a colorless 
oil. Azide 5-25: 1H NMR (400 MHz, CDCl3) δ 1.82 (s, 3H), 3.73 (s, 2H), 4.99-5.02 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 20.2 (CH3), 57.2 (CH2), 114.3 (CH2), 139.5 (C); 
1H NMR 
(400 MHz, CD2Cl2) δ 1.82 (t, J = 1.1 Hz, 3H), 3.76 (s, 2H), 5.01 (q, J = 1.1 Hz, 2H); 
13C 
NMR (100 MHz, CD2Cl2) δ 19.9, 57.1, 113.7, 139.9. 
 
 
4-Methyl-2,3-dihydroazet-1-ium trifluoromethanesulfonate (5-45). To a solution 
of azide 5-25 (60 mg, 0.62 mmol) in CD2Cl2 (1 mL) under N2 atmosphere at 0 °C was added 
triflic acid (116 mg, 0.740 mmol) slowly. After the addition, ice bath was removed and the 
resulting mixture was continued to stir for 30 min before NMR spectra were acquired. 1H 
NMR (400 MHz, CD2Cl2) δ 2.54-2.59 (m, 3H), 3.42 (t, J = 2.4 Hz, 2H), 4.41 (h, J = 2.0 Hz, 
2H), 12.05 (br t, J = ~68 Hz, 1H); 13C NMR (100 MHz, CD2Cl2) δ 20.1 (CH3), 36.2 (CH2), 
52.5 (CH2), 119.9 (q, J = 316 Hz, 1C), 124.6, 204.1 (C). 
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1-((4-Bromophenyl)sulfonyl)-2-methylazetidine (5-48) and 4-bromo-N-(1,3-
dichloro-2-methylpropan-2-yl)benzenesulfonamide (5-49). To a solution of azide 5-25 
(135 mg, 1.39 mmol) in CH2Cl2 (3 mL) under N2 atmosphere at -78 °C was added triflic acid 
(250 mg, 1.67 mmol) slowly. Gas emission was observed and the white solid was gradually 
formed as the reaction is stirred. After 20 min at -78 °C, cyclopentene (0.4 mL) was added 
slowly and the resulting mixture was warmed slowly to room temperature (NMR showed no 
reaction). The mixture was cooled to -78 °C, and sodium borohydride (120 mg, 3.2 mmol) 
was added. After the reaction was warmed to room temperature, methanol was used to 
quench the reaction. Dichloromethane and water were added to the reaction mixture. After 
separation, the aqueous layer was washed with dichloromethane three times. The combined 
organic layers were washed with brine, dried over anhydrous sodium sulfate, and 
concentrated. To the residue and triethylamine (303 mg, 3.00 mmol) in dichloromethane (15 
mL) at room temperature was added 4-bromobenzene sulfonyl chloride (360 mg, 1.4 mmol) 
slowly. The resulting mixture was stirred overnight. 1M HCl was used to quench the reaction. 
Dichloromethane was used to extract the product, and the aqueous layer was washed with 
dichloromethane three times. The combined organic layers were washed with brine, dried 
over anhydrous sodium sulfate, and concentrated. The residue was purified by silica gel 
column chromatography (1-15% EtOAc/hexanes) to afford a mixture of 5-48 and 5-49 (4:1 
ratio, 16 mg, 3% + 0.75%) as a powder. Amine 5-48: Rf = 0.30 (20% EtOAc/hexanes); IR 
(neat) 2971, 1342, 1160 cm-1; HRMS (ESI) m/z calculated for C10H12BrNO2Na (2M+Na)
+ 
311.9670, found: 311.9688; 1H NMR (400 MHz, CDCl3) δ 1.43 (d, J = 6.2 Hz, 3H), 1.88-
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1.98 (m, 1H), 2.01-2.10 (m, 1H), 3.53 (q, J = 8.7 Hz, 2H),3.67-3.76 (m, 1H), 3.97-4.07 (m, 
1H), 7.65-7.81 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 22.3 (CH3), 24.1 (CH2), 47.6 (CH2), 
60.6 (CH), 128.1 (C), 129.7 (CH), 132.4 (CH), 134.4 (C). Amine 5-49 (diagnostic peaks 
only): 1H NMR (400 MHz, CDCl3) δ 1.38 (s, 3H), 3.62 (d, J = 11.3 Hz, 2H), 3.78 (d, J = 11.3 
Hz, 2H), 5.09 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 19.6 (CH3), 49.0 (CH2), 59.5 (C), 128.5 
(CH), 132.5 (CH).  
 
 
(3-Azidoprop-1-en-2-yl)benzene (5-27). A suspension of α-methylstyrene (50 g, 
0.42 mol) and N-bromosuccinimide (46 g, 0.26 mol) in carbon tetrachloride (20 mL) was 
rapidly heated to 160-170 °C until the solids were dissolved. The reaction is very exothermic 
and the released heat energy assisted to keep the reaction mixture in the refluxing condition 
for 8 h. After the mixture was allowed to cool to room temperature, the precipitates were 
filtered out and washed with carbon tetrachloride. The filtrate was concentrated to afford a 
mixture of α-methylstyrene, (3-bromoprop-1-en-2-yl)benzene, and (1-bromoprop-1-en-2-
yl)benzene (1:1:0.6 ratio, 75 g). To a solution of the above residue (37.5 g) in DMF (60 mL) 
was added slowly sodium azide (16.3 g, 0.25 mol) at room temperature. The resulting 
mixture was stirred overnight and diethyl ether and were added to the mixture. After 
separation, the aqueous layer was washed with diethyl ether three times. The combined 
organic layers were washed with brine, dried over anhydrous sodium sulfate, and 
concentrated. The residue was purified by silica gel column chromatography (1-5% 
EtOAc/hexanes) to afford azide 5-27 (6.64 g, 32%) as a colorless oil. Azide 5-27: Rf = 0.30 (1% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 4.22 (s, 2H), 5.36-5.41 (m, 1H), 5.65 (s, 1H), 
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7.34-7.43 (m, 2H); 7.47-7.53 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 55.0 (CH2), 116.2 
(CH2), 126.0 (CH), 128.3 (CH), 128.6 (CH), 138.1 (C), 141.8 (C). 
 
 
4-Phenyl-2,3-dihydroazet-1-ium trifluoromethanesulfonate (5-53) and 2-
phenylprop-2-en-1-iminium trifluoromethanesulfonate (5-54). To a solution of azide 5-27 
(165 mg, 1.04 mmol) in CD2Cl2 (1.5 mL) under N2 atmosphere at 0 °C was added triflic acid 
(187 mg, 1.24 mmol) slowly. After the addition, ice bath was removed and the resulting green 
mixture was continued to stir for 20 min before NMR spectra were acquired. Iminium salts 5-
53 and 5-54 (2:1 ratio). Iminium salt 5-53: 1H NMR (400 MHz, CD2Cl2) δ 3.78 (t, J = 2.6 Hz, 
2H), 4.54 (t, J = 2.6 Hz, 2H), 7.67 (t, J = 7.6 Hz, 2H), 7.90 (t, J = 7.6 Hz, 1H), 8.02 (t, J = 7.8 
Hz, 2H), 12.35 (br t, J = ~40 Hz, 1H); 
13
C NMR (100 MHz, CD2Cl2) δ 32.2 (CH2), 51.3 
(CH2), 119.8 (q, J = 316 Hz, 1C), 125.0 (C), 129.9 (CH), 130.3 (CH), 138.5 (CH), 191.2 (C). 
Iminium salt 5-54: 1H NMR (400 MHz, CD2Cl2) δ 6.74 (s, 1H), 6.85 (s, 1H), 7.32-7.43 (m, 
3H), 7.47-7.57 (m, 2H), 8.88 (dd, J = 18.8, 9.7 Hz, 1H), 10.20 (br t, J = ~55 Hz, 1H), 11.64 
(br t, J = ~55 Hz, 1H); 13C NMR (100 MHz, CD2Cl2) δ 128.0 (CH), 129.8 (CH), 130.4 (CH), 
130.7 (C), 141.6 (C), 146.4 (CH2), 176.0 (CH). The following data and NOE correlations 
were used to assign iminium salts 5-53 and 5-54. 
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tert-Butyl (2-phenylallyl)carbamate (5-59), tert-butyl 2-phenylazetidine-1-
carboxylate (5-58), (2S*,6S*)-tert-butyl 2,6-diphenyl-1,5-diazocane-1-carboxylate (5-63) 
and (2S*,6R*)-tert-butyl 2,6-diphenyl-1,5-diazocane-1-carboxylate (5-62). To a solution of 
azide 5-27 (159 mg, 1.00 mmol) in CH2Cl2 (6 mL) under N2 atmosphere at 0 °C was added 
triflic acid (193 mg, 1.29 mmol) slowly. The resulting green reaction was stirred for 10 min 
before sodium borohydride (190 mg, 5.00 mmol) was added. After the mixture was warmed 
to room temperature, methanol (1 mL) was added slowly. The resulting mixture was 
continued to stir for 2.5 h, and aqueous sodium hydroxide (3 M, 1 mL, 3 mmol) was added 
before the addition of (Boc)2O (660 mg, 3.00 mmol) and catalytic amount of DMAP were 
added. The resulting mixture was heated to reflux for 3.5 h. After the reaction was cooled to 
room temperature, ethyl acetate and water were added to the reaction mixture. After 
separation, the aqueous layer was washed with ethyl acetate three times. The combined 
organic layers were washed with brine, dried over anhydrous sodium sulfate, and 
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concentrated. The residue was purified by silica gel column chromatography (0.5-5% 
EtOAc/hexanes) to afford amine 5-59 (7 mg, 3%) as a colorless oil, amine 5-58 (27 mg, 12% ) 
as a colorless oil, amine 5-63 (or 5-62) (12 mg, 3%) as a colorless oil and amine 5-62 (or 5-63) 
(12 mg, 3%) as a colorless oil. Amine 5-59: Rf = 0.35 (20% EtOAc/hexanes); 
1H NMR (400 
MHz, CDCl3) δ 1.46 (s, 9H), 4.22 (d, J = 5.4 Hz, 2H), 4.67 (br, 1H), 5.24-5.27 (m, 1H), 5.45 
(s, 1H), 7.30-7.40 (m, 3H), 7.45 (d, J = 7.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 28.4 
(CH3), 44.4 (CH2), 79.5 (C), 113.2 (CH2), 126.2 (CH), 127.9 (CH), 128.5 (CH), 138.7 (C), 
144.9 (C), 155.7 (C). Amine 5-58 : Rf = 0.30 (20% EtOAc/hexanes); IR (neat) 2975, 1697 
cm-1; HRMS (ESI) m/z calculated for C14H19NO2Na (2M+Na)
+ 256.1313, found: 256.1312; 
1H NMR (400 MHz, CDCl3) δ 1.35 (br, 9H), 2.11-2.20 (m, 1H), 2.59-2.69 (m, 1H), 4.02 (t, J 
= 7.6 Hz, 2H), 5.20 (t, J = 7.6 Hz, 1H), 7.26-7.32 (m, 1H), 7.36-7.40 (m, 4H); 13C NMR (100 
MHz, CDCl3) δ 25.4 (CH2), 28.3 (CH3), 46.6 (CH), 64.3 (CH2), 79.4 (C), 125.9 (CH), 127.3 
(CH), 128.4 (CH), 142.6 (C), 156.6 (C). Amine 5-63 (or 5-62): Rf = 0.50 (100% 
EtOAc/hexanes); IR (neat) 3357, 2974, 1699 cm-1; HRMS (ESI) m/z calculated for 
C23H31N2O2 (M+H)
+ 367.2386, found: 367.2358; C23H30N2O2Na (M+Na)
+ 389.2205, found: 
389.2200; 1H NMR (500 MHz, CDCl3) δ 1.30 (s, 9H), 1.29-1.38 (m, 1H), 1.59-1.66 (m, 1H), 
1.88 (pentet, J = 9.0, 4.8 Hz, 1H), 2.15 (qd, J = 8.0, 1.8 Hz, 1H), 2.63 (q, J = 8.0 Hz, 1H), 
2.66-2.73 (m, 1H), 2.77-2.86 (m, 1H), 3.01 (t, J = 6.8 Hz, 1H), 3.31 (dd, J = 8.3, 4.8 Hz, 1H), 
4.01 (t, J = 8.1 Hz, 1H), 4.29 (br, 1H), 7.17-7.31 (m, 8H), 7.47-7.50 (m, 2H); 13C NMR (125 
MHz, CDCl3) δ 26.6 (CH2), 27.4 (3CH3), 32.5 (CH2), 36.8 (CH2), 47.6 (CH2), 67.0 (CH), 
69.5 (CH), 77.8 (C), 125.8 (2CH), 126.1 (CH), 126.3 (CH), 127.16 (2CH), 127.28 (4CH), 
139.3 (C), 143.7 (C), 154.6 (C). Amine 5-62 (or 5-63): Rf = 0.40 (100% EtOAc/hexanes); IR 
(neat) 3347, 2975, 1693 cm-1; HRMS (ESI) m/z calculated for C23H31N2O2 (M+H)
+ 367.2386, 
found: 367.2351; C23H30N2O2Na (M+Na)
+ 389.2205, found: 389.2204; 1H NMR (500 MHz, 
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CDCl3) δ 1.36 (s, 9H), 1.61-1.69 (m, 1H), 1.76-1.83 (m, 1H), 2.08 (pentet, J = 9.3 Hz, 1H), 
2.13-2.20 (m, 1H), 2.76-2.83 (m, 1H), 2.87-2.95 (m, 2H), 3.25-3.30 (m, 1H), 3.53 (t, J = 6.6 
Hz, 1H), 3.79 (t, J = 8.2 Hz, 1H), 4.70 (br, 1H), 6.85-6.94 (m, 4H), 6.95-7.00 (m, 4H), 7.16-
7.30 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 24.6 (CH2), 26.5 (3CH3), 31.6 (CH2), 35.6 
(CH2), 48.8 (CH2), 66.7 (CH), 70.1 (CH), 77.0 (C), 124.6 (CH), 125.2 (CH), 125.3 (2CH), 
125.54 (2CH), 125.62 (2CH), 126.8 (2CH), 137.1 (C), 141.4 (C), 153.9 (C). The following 
data were used to assign amines 5-62 and 5-63.  
 
 
 
 
 
1-(Azidomethyl)-4-bromobenzene (5-20). To a solution of 4-bromobenzyl bromide 
(11.25 g, 45.00 mmol) in acetone (30 mL) and water (25 mL) was added sodium azide (8.8 g, 
0.14 mol) portionwise. After the suspension was stirred overnight, diethyl ether and water 
were added. After separation, the aqueous layer was washed with diethyl ether three times. 
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The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, 
and concentrated. The residue was purified by silica gel column chromatography (1-4% 
EtOAc/hexanes) to afford azide 5-20 (8.42 g, 88%) as a colorless oil. Azide 5-20: Rf = 0.30 
(100% hexanes); 1H NMR (400 MHz, CDCl3) δ 4.33 (s, 2H), 7.22 (d, J = 8.4 Hz, 2H), 7.54 (d, 
J = 8.4 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 54.1 (CH2), 122.4 (C), 129.8 (CH), 132.0 
(CH), 134.4 (C). 
 
4-Bromo-N-methylenebenzenaminium trifluoromethanesulfonate (5-21). To a 
solution of azide 5-20 (145 mg, 0.684 mmol) in CD2Cl2 (1.5 mL) under N2 atmosphere at 
0 °C was added triflic acid (140 mg, 0.933 mmol) slowly. After the addition, ice bath was 
removed and the resulting green mixture was continued to stir for 20 min before NMR 
spectra were acquired. 1H NMR (400 MHz, CD2Cl2) δ 7.62 (d, J = 9.0 Hz, 1H), 7.78 (d, J = 
9.0 Hz, 1H), 8.26 (dd, J = 10.3, 7.0 Hz, 1H), 8.53 (dd, J = 17.2, 7.0 Hz, 1H), 14.38 (br, 1H); 
13C NMR (100 MHz, CD2Cl2) δ 119.5 (q, J = 316 Hz, 1C), 122.7 (CH), 128.0 (C), 133.9 
(CH), 134.3 (C), 161.2 (CH2). 
 
 
(S)-1-(Azidomethyl)-4-(prop-1-en-2-yl)cyclohex-1-ene (5-33), (2R,4S)-2-azido-1-
methylene-4-(prop-1-en-2-yl)cyclohexane (5-34) and (2S,4S)-2-azido-1-methylene-4-
(prop-1-en-2-yl)cyclohexane (5-35). Following the reported procedure,169 to a solution of 
(S)-(-)-perillyl alcohol (6.1 g, 40 mmol) in Et2O (50 mL) under N2 atmosphere at 0 °C was 
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added DBU (7.31 g, 48 mmol) and diphenyl phosphoryl azide (13.21 g, 48 mmol). After 
allowing to warm to room temperature overnight, the precipitate was filtered and washed 
three times with pentane. The filtrate was concentrated under vacuum and the residue was 
purified by flash chromatography (100% hexanes) to afford an inseparable mixture of azide 
5-33, 5-34, and 5-35 (1:0.11:0.17 ratio, 3.6 mg, 51%) as a colorless liquid. Allylic azide 5-33, 
5-34, and 5-35: Rf = 0.25 (100% hexanes); IR (neat) 2922, 2094 cm
-1; HRMS (ESI) m/z 
calculated for C20H31N6 (2M+H)
+ 355.2610, found: 355.2613. Azide 5-33: 1H NMR (400 
MHz, CDCl3) δ 1.27-1.35 (m, 1H), 1.50-1.60 (m, 1H), 1.77 (s, 3H), 1.85-1.93 (m, 1H), 1.97-
2.08 (m, 1H), 2.09-2.25 (m, 3H),3.63-3.73 (m, 2H), 4.73-4.75 (m, 1H), 4.75-4.78 (m, 1H), 
5.77 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 20.8 (CH3), 27.1 (CH2), 27.3 (CH2), 30.5 (CH2), 
40.7 (CH), 57.4 (CH2), 108.9 (CH2), 126.4 (CH), 132.2 (C), 149.3 (C). Azide 5-34 
(diagnostic peaks only): 1H NMR (400 MHz, CDCl3) δ 1.73 (s, 3H), 4.25 (t, J = 3.1 Hz, 1H), 
4.71 (br, 1H), 4.92 (br, 1H), 4.97 (br, 1H). Azide 5-35 (diagnostic peaks only): 1H NMR (400 
MHz, CDCl3) δ 1.75 (s, 3H), 3.87 (dm, J = 12.0 Hz, 1H), 4.87 (br, 0H), 5.01 (br, 1H). Azides 
5-34 and 5-35 (diagnostic peaks only): 13C NMR (100 MHz, CDCl3) δ 63.1 (CH), 64.8 (CH), 
106.9 (CH2), 109.2 (CH2), 109.6 (CH2), 112.6 (CH2), 144.4 (C), 145.8 (C), 148.0 (C), 148.8 
(C).  
 
 
Ethyl 2-(azidomethyl)acrylate (5-31). To a suspension of ethyl 2-
(hydroxymethyl)acrylate (430 mg, 3.30 mmol), PPh3 (1.74 g, 6.62 mmol), and Zn(N3)2∙2Pyr 
(760 mg, 2.48 mmol) in benzene (20 mL) at 0 °C under N2 atmosphere was slowly added 
DEAD (2.88 g, 40% in toluene, 6.62 mmol). The resulting mixture was heated to reflux for 
20 h. The reaction was cooled to rt and the solvent was removed in vacuo. The residue was 
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purified by chromatography (1-5% EtOAc/hexanes) to afford azide 5-31 (86 mg, 17%) as a 
colorless oil. Azide 5-31 : Rf = 0.30 (5% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) δ 
1.35 (t, J = 7.1 Hz, 3H), 4.08 (s, 2H), 4.28 (q, J = 7.1 Hz, 2H), 5.86 (q, J = 1.2 Hz, 1H), 6.37-
6.45 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.2 (CH3), 51.5 (CH2), 61.2 (CH2), 127.8 
(CH2), 135.3 (C), 165.4 (C).  
 
 
(E)-(3-Azidoprop-1-en-1-yl)benzene (5-29). A suspension of (E)-(3-bromoprop-1-
en-1-yl)benzene (7.8 g, 40 mmol) and sodium azide (7.8 g, 0.12 mol) in DMF (60 mL) at 
room temperature was stirred overnight, before diethyl ether and water were added. After 
separation, the aqueous layer was washed with diethyl ether three times. The combined 
organic layers were washed with brine, dried over anhydrous sodium sulfate, and 
concentrated. The residue was purified by silica gel column chromatography (1-5% 
EtOAc/hexanes) to afford azide 5-29 (6.2 g, 97%) as a colorless oil. Azide 5-29: Rf = 0.40 (5% 
EtOAc/hexanes); IR (neat): 3028, 2100 cm-1; HRMS (ESI) m/z calculated for C18H19N6 
(2M+H)+ 319.1671, found: 319.1670; 1H NMR (400 MHz, CD2Cl2) δ 4.01 (dd, J = 0.8 Hz, 
6.4 Hz, 1H), 6.33 (dt, J = 6.4 Hz, 16.0 Hz, 1H), 6.73 (d, J = 16.0 Hz, 1H), 7.33-7.51 (m, 5H); 
13C NMR (100 MHz, CD2Cl2) δ 53.0 (CH2), 122.7 (CH), 126.6 (CH), 128.2 (CH), 128.7 (CH), 
134.3 (CH), 136.2 (CH).  
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